P-value | ln(P) | Term | GO Tree | GO ID | # of Genes in Term | # of Target Genes in Term | # of Total Genes | # of Target Genes | Common Genes |
2.518e-09 | -19.80 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma | 7205 | 40 | 16828 | 47 |
FHOD3,NFIA,PREX2,SLC1A2,ELOVL2,FGFR3,LAMA4,PREX1,PRDM16,FARP1,ZBTB20,FKBP5,RORA,PTN,UNC93A,NHSL1,NCKAP5,QKI,BCAR3,LRIG1,DGKB,TRPS1,GPM6B,SNTB1,EGF,GRK5,SLC4A4,SLC39A12,SOX5,USP6NL,SLC1A3,SLC6A11,GPC5,TNS3,PTPRZ1,NPAS3,LPIN2,RFX4,ASPA,SORCS2 |
7.912e-09 | -18.65 | acute_myeloid_leukaemia_therapy_related | COSMIC cancer mutations | acute_myeloid_leukaemia_therapy_related | 1523 | 19 | 16828 | 47 |
GRK5,PREX1,PRDM16,LAMA4,SOX5,DGKB,FHOD3,PREX2,QKI,NCKAP5,BCAR3,AMOT,SORCS2,FARP1,SLC1A3,RORA,SLC6A11,TNS3,GPC5 |
7.912e-09 | -18.65 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia_therapy_related | 1523 | 19 | 16828 | 47 |
DGKB,PREX2,FHOD3,GRK5,LAMA4,SOX5,PREX1,PRDM16,RORA,SLC1A3,FARP1,GPC5,TNS3,SLC6A11,AMOT,BCAR3,NCKAP5,QKI,SORCS2 |
1.026e-08 | -18.39 | system development | biological process | GO:0048731 | 3533 | 28 | 18204 | 50 |
AMOT,TRPS1,ADGRB3,QKI,NFIA,SOX5,PRKN,RORA,SLC39A12,LRIG1,FGFR3,PLPP3,FGFRL1,PTN,PREX2,RFX4,EGF,FARP1,SLC1A2,BCAR3,APOA1,GJA1,SLC1A3,ASPA,MSI2,FHOD3,GPM6B,PTPRZ1 |
3.348e-08 | -17.21 | cell junction | cellular component | GO:0030054 | 2224 | 21 | 19108 | 49 |
QKI,DGKB,PTN,FGFR3,PLPP3,ADGRB3,SNTB1,PRKN,SORCS2,SLC1A3,PTPRZ1,NFIA,FGFRL1,AMOT,FARP1,SLC1A2,SLC6A11,CTBP1,BCAR3,GJA1,TNS3 |
8.769e-08 | -16.25 | nervous system development | biological process | GO:0007399 | 2185 | 21 | 18204 | 50 |
PLPP3,LRIG1,GPM6B,PTPRZ1,PRKN,SOX5,GJA1,RORA,SLC1A3,ASPA,SLC39A12,MSI2,QKI,EGF,ADGRB3,FARP1,SLC1A2,NFIA,RFX4,PTN,PREX2 |
1.128e-07 | -16.00 | stomach-carcinoma-intestinal_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-intestinal_adenocarcinoma | 7225 | 38 | 16828 | 47 |
FARP1,RORA,ZBTB20,PTN,UNC93A,NHSL1,NCKAP5,QKI,BCAR3,AQP4,APOA1,FHOD3,NFIA,PREX2,SLC1A2,FGFR3,LAMA4,PRDM16,PREX1,USP6NL,SLC6A11,TNS3,PTPRZ1,NPAS3,CTBP1,RFX4,AMOT,SORCS2,LRIG1,DGKB,TRPS1,SNTB1,EGF,GRK5,SLC4A4,SLC39A12,FGFRL1,SOX5 |
1.128e-07 | -16.00 | intestinal_adenocarcinoma | COSMIC cancer mutations | intestinal_adenocarcinoma | 7225 | 38 | 16828 | 47 |
GRK5,EGF,SNTB1,SOX5,FGFRL1,SLC4A4,SLC39A12,DGKB,LRIG1,TRPS1,RFX4,AMOT,NPAS3,CTBP1,PTPRZ1,SORCS2,USP6NL,TNS3,SLC6A11,SLC1A2,PREX1,PRDM16,LAMA4,FGFR3,APOA1,PREX2,NFIA,FHOD3,BCAR3,QKI,NCKAP5,AQP4,PTN,RORA,ZBTB20,FARP1,NHSL1,UNC93A |
1.344e-07 | -15.82 | multicellular organism development | biological process | GO:0007275 | 3957 | 28 | 18204 | 50 |
PREX2,PTN,RFX4,FARP1,EGF,SLC1A2,BCAR3,APOA1,GJA1,MSI2,ASPA,SLC1A3,FHOD3,PTPRZ1,GPM6B,AMOT,TRPS1,ADGRB3,QKI,NFIA,RORA,PRKN,SOX5,SLC39A12,FGFRL1,LRIG1,PLPP3,FGFR3 |
4.230e-07 | -14.68 | brainstem | COSMIC cancer mutations | brainstem | 3102 | 24 | 16828 | 47 |
SOX5,SLC39A12,GRK5,EGF,SNTB1,TNS3,GPC5,SLC1A3,USP6NL,NPAS3,PTPRZ1,PREX2,FHOD3,PRDM16,PREX1,FGFR3,ELOVL2,SLC1A2,PTN,ZBTB20,RORA,BCAR3,QKI,NCKAP5 |
5.047e-07 | -14.50 | developmental process | biological process | GO:0032502 | 5716 | 33 | 18204 | 50 |
NFIA,ADGRB3,QKI,TRPS1,NHSL1,AMOT,GRK5,LRIG1,FGFR3,PLPP3,FGFRL1,SLC39A12,PRKN,SOX5,PREX1,RORA,BCAR3,SLC1A2,EGF,FARP1,PREX2,PTN,RFX4,CTBP1,PRDM16,GPM6B,PTPRZ1,FHOD3,SLC1A3,ASPA,MSI2,APOA1,GJA1 |
6.193e-07 | -14.29 | anatomical structure morphogenesis | biological process | GO:0009653 | 2225 | 20 | 18204 | 50 |
PREX2,PTN,AMOT,NFIA,BCAR3,QKI,EGF,ADGRB3,FARP1,SLC1A3,SLC39A12,SOX5,RORA,GJA1,PTPRZ1,PLPP3,FGFR3,FHOD3,LRIG1,FGFRL1 |
9.820e-07 | -13.83 | positive regulation of oligodendrocyte differentiation | biological process | GO:0048714 | 28 | 4 | 18204 | 50 |
PTN,ASPA,PTPRZ1,QKI |
1.309e-06 | -13.55 | neurotransmitter uptake | biological process | GO:0001504 | 30 | 4 | 18204 | 50 |
SLC1A2,SLC1A3,SLC6A11,PRKN |
1.699e-06 | -13.29 | neurogenesis | biological process | GO:0022008 | 1334 | 15 | 18204 | 50 |
PTPRZ1,GPM6B,PLPP3,SLC39A12,SLC1A3,ASPA,RORA,GJA1,SOX5,NFIA,FARP1,ADGRB3,QKI,PTN,PREX2 |
3.587e-06 | -12.54 | multicellular organismal process | biological process | GO:0032501 | 6177 | 33 | 18204 | 50 |
QKI,ADGRB3,NFIA,AMOT,DGKB,SNTB1,TRPS1,FGFRL1,PLPP3,FGFR3,LRIG1,RORA,SOX5,PREX1,PRKN,SLC39A12,FARP1,EGF,BCAR3,SLC1A2,SLC4A4,AQP4,RFX4,PTN,PREX2,FHOD3,PTPRZ1,GPM6B,GJA1,APOA1,MSI2,ASPA,SLC1A3 |
5.208e-06 | -12.17 | central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV | COSMIC cancer mutations | central_nervous_system-brainstem-glioma-astrocytoma_Grade_IV | 2531 | 20 | 16828 | 47 |
PREX2,FHOD3,GRK5,SNTB1,PREX1,PRDM16,SOX5,SLC39A12,ELOVL2,PTN,SLC1A3,USP6NL,RORA,ZBTB20,TNS3,GPC5,BCAR3,QKI,PTPRZ1,NCKAP5 |
7.169e-06 | -11.85 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-Burkitt_lymphoma | 2119 | 18 | 16828 | 47 |
FHOD3,PREX2,LRIG1,DGKB,SOX5,LAMA4,PRDM16,SNTB1,EGF,SLC1A2,GRK5,NHSL1,GPC5,SLC1A3,SORCS2,NCKAP5,NPAS3,RFX4 |
7.169e-06 | -11.85 | Burkitt_lymphoma | COSMIC cancer mutations | Burkitt_lymphoma | 2119 | 18 | 16828 | 47 |
SLC1A3,GPC5,NHSL1,NCKAP5,NPAS3,RFX4,SORCS2,LRIG1,DGKB,FHOD3,PREX2,SNTB1,EGF,GRK5,SLC1A2,SOX5,LAMA4,PRDM16 |
7.547e-06 | -11.79 | regulation of oligodendrocyte differentiation | biological process | GO:0048713 | 46 | 4 | 18204 | 50 |
QKI,ASPA,PTN,PTPRZ1 |
7.547e-06 | -11.79 | positive regulation of glial cell differentiation | biological process | GO:0045687 | 46 | 4 | 18204 | 50 |
PTN,ASPA,PTPRZ1,QKI |
8.161e-06 | -11.72 | cell differentiation | biological process | GO:0030154 | 3645 | 24 | 18204 | 50 |
GJA1,SLC1A3,ASPA,MSI2,FHOD3,GPM6B,PRDM16,PTPRZ1,CTBP1,PREX2,PTN,FARP1,SOX5,PREX1,RORA,SLC39A12,FGFR3,PLPP3,GRK5,NHSL1,AMOT,QKI,ADGRB3,NFIA |
8.282e-06 | -11.70 | cellular developmental process | biological process | GO:0048869 | 3648 | 24 | 18204 | 50 |
FARP1,PTN,PREX2,CTBP1,GPM6B,PRDM16,PTPRZ1,FHOD3,SLC1A3,ASPA,MSI2,GJA1,NFIA,QKI,ADGRB3,NHSL1,AMOT,GRK5,PLPP3,FGFR3,SLC39A12,PREX1,SOX5,RORA |
1.305e-05 | -11.25 | myelodysplastic_syndrome | COSMIC cancer mutations | myelodysplastic_syndrome | 1174 | 13 | 16828 | 47 |
SLC6A11,SORCS2,NCKAP5,NPAS3,FHOD3,NFIA,PREX2,DGKB,FGFR3,SOX5,EGF,GRK5,SLC1A2 |
1.305e-05 | -11.25 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic_syndrome | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-myelodysplastic_syndrome | 1174 | 13 | 16828 | 47 |
SORCS2,NPAS3,NCKAP5,SLC6A11,FGFR3,SOX5,EGF,GRK5,SLC1A2,FHOD3,PREX2,NFIA,DGKB |
1.311e-05 | -11.24 | anatomical structure development | biological process | GO:0048856 | 5207 | 29 | 18204 | 50 |
BCAR3,SLC1A2,FARP1,EGF,RFX4,PTN,PREX2,PTPRZ1,GPM6B,FHOD3,MSI2,ASPA,SLC1A3,GJA1,APOA1,NFIA,QKI,ADGRB3,TRPS1,AMOT,FGFRL1,PLPP3,FGFR3,LRIG1,SLC39A12,RORA,PRKN,SOX5,PREX1 |
1.417e-05 | -11.16 | chondroblastoma | COSMIC cancer mutations | chondroblastoma | 534 | 9 | 16828 | 47 |
EGF,SNTB1,NCKAP5,PREX1,SOX5,LAMA4,FARP1,GPC5,FHOD3 |
1.423e-05 | -11.16 | solute:monoatomic cation symporter activity | molecular function | GO:0015294 | 117 | 5 | 18094 | 48 |
SLC1A2,SLC39A12,SLC6A11,SLC4A4,SLC1A3 |
1.707e-05 | -10.98 | cell periphery | cellular component | GO:0071944 | 6020 | 30 | 19108 | 49 |
GPM6B,DGKB,SNTB1,LAMA4,SLC1A3,PTPRZ1,USP6NL,ADGRB3,AMOT,FARP1,SLC1A2,SLC6A11,AQP4,CTBP1,GJA1,APOA1,PLPP3,PTN,FGFR3,SORCS2,PREX1,EGF,SLC39A12,GPC5,FGFRL1,LRIG1,UNC93A,GRK5,SLC4A4,PREX2 |
1.861e-05 | -10.89 | bone-humerus-other-chondroblastoma | COSMIC cancer mutations | bone-humerus-other-chondroblastoma | 301 | 7 | 16828 | 47 |
NCKAP5,EGF,LAMA4,SOX5,FARP1,GPC5,FHOD3 |
2.071e-05 | -10.78 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_B_cell_leukaemia | 3828 | 24 | 16828 | 47 |
BCAR3,NCKAP5,ZBTB20,RORA,SLC1A2,PRDM16,LAMA4,PREX2,NFIA,FHOD3,LPIN2,AMOT,PTPRZ1,SORCS2,SLC1A3,USP6NL,TNS3,GPC5,SLC6A11,GRK5,EGF,SNTB1,SOX5,SLC4A4 |
2.071e-05 | -10.78 | acute_lymphoblastic_B_cell_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_B_cell_leukaemia | 3828 | 24 | 16828 | 47 |
BCAR3,NCKAP5,RORA,ZBTB20,SLC1A2,LAMA4,PRDM16,NFIA,PREX2,FHOD3,LPIN2,AMOT,PTPRZ1,SORCS2,USP6NL,SLC1A3,GPC5,TNS3,SLC6A11,GRK5,SNTB1,EGF,SOX5,SLC4A4 |
2.151e-05 | -10.75 | AKT2 (AKT serine/threonine kinase 2) | protein interactions | 208 | 134 | 5 | 19454 | 49 |
FKBP5,GJA1,APOA1,GRK5,PRKN |
2.892e-05 | -10.45 | glial cell differentiation | biological process | GO:0010001 | 219 | 6 | 18204 | 50 |
PTPRZ1,GPM6B,ASPA,NFIA,QKI,PLPP3 |
2.894e-05 | -10.45 | neurotransmitter reuptake | biological process | GO:0098810 | 22 | 3 | 18204 | 50 |
PRKN,SLC6A11,SLC1A2 |
2.989e-05 | -10.42 | amino acid:sodium symporter activity | molecular function | GO:0005283 | 23 | 3 | 18094 | 48 |
SLC1A2,SLC6A11,SLC1A3 |
3.520e-05 | -10.25 | plasma membrane | cellular component | GO:0005886 | 5538 | 28 | 19108 | 49 |
PLPP3,APOA1,FGFR3,PTN,SORCS2,SLC39A12,EGF,PREX1,FGFRL1,GPC5,SLC4A4,PREX2,LRIG1,UNC93A,GRK5,GPM6B,DGKB,PTPRZ1,SLC1A3,SNTB1,ADGRB3,USP6NL,SLC1A2,FARP1,SLC6A11,AMOT,AQP4,GJA1 |
3.717e-05 | -10.20 | Ctbp2 (C-terminal binding protein 2) | protein interactions | 13017 | 4 | 2 | 19454 | 49 |
PRDM16,TRPS1 |
3.717e-05 | -10.20 | GOT1L1 (glutamic-oxaloacetic transaminase 1 like 1) | protein interactions | 137362 | 4 | 2 | 19454 | 49 |
APOA1,GRK5 |
3.941e-05 | -10.14 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm | 764 | 10 | 16828 | 47 |
DGKB,PREX2,GPC5,FHOD3,SLC6A11,SLC1A2,GRK5,NCKAP5,SORCS2,SOX5 |
4.065e-05 | -10.11 | SOX6 (SRY-box transcription factor 6) | protein interactions | 55553 | 153 | 5 | 19454 | 49 |
CTBP1,SOX5,NFIA,PRDM16,TRPS1 |
4.135e-05 | -10.09 | soft_tissue | COSMIC cancer mutations | soft_tissue | 5828 | 30 | 16828 | 47 |
SLC1A3,USP6NL,TNS3,GPC5,NPAS3,CTBP1,PTPRZ1,SORCS2,DGKB,TRPS1,GRK5,EGF,SNTB1,FGFRL1,SOX5,SLC39A12,PTN,RORA,FARP1,NHSL1,GJA1,NCKAP5,AQP4,PREX2,NFIA,FHOD3,SLC1A2,PRDM16,FGFR3,ELOVL2 |
4.209e-05 | -10.08 | MBNL2 (muscleblind like splicing regulator 2) | protein interactions | 10150 | 27 | 3 | 19454 | 49 |
PRKN,MSI2,QKI |
4.413e-05 | -10.03 | symporter activity | molecular function | GO:0015293 | 148 | 5 | 18094 | 48 |
SLC6A11,SLC1A2,SLC39A12,SLC4A4,SLC1A3 |
4.580e-05 | -9.99 | autonomic_ganglia | COSMIC cancer mutations | autonomic_ganglia | 4005 | 24 | 16828 | 47 |
NHSL1,TNS3,USP6NL,AQP4,SORCS2,PTPRZ1,NCKAP5,NPAS3,RFX4,LPIN2,AMOT,GJA1,TRPS1,FHOD3,NFIA,GPM6B,PREX2,FGFR3,SLC4A4,PREX1,PRDM16,SNTB1,EGF,SLC1A2 |
4.590e-05 | -9.99 | Astrocytic Glutamate-Glutamine Uptake And Metabolism | REACTOME pathways | R-HSA-210455 | 4 | 2 | 10285 | 29 |
SLC1A3,SLC1A2 |
4.590e-05 | -9.99 | Neurotransmitter uptake and Metabolism In Glial Cells | REACTOME pathways | R-HSA-112313 | 4 | 2 | 10285 | 29 |
SLC1A3,SLC1A2 |
5.029e-05 | -9.90 | positive regulation of gliogenesis | biological process | GO:0014015 | 74 | 4 | 18204 | 50 |
PTN,ASPA,PTPRZ1,QKI |
5.266e-05 | -9.85 | generation of neurons | biological process | GO:0048699 | 1158 | 12 | 18204 | 50 |
SOX5,RORA,GJA1,PREX2,SLC1A3,PTN,SLC39A12,ADGRB3,FARP1,GPM6B,NFIA,PTPRZ1 |
5.345e-05 | -9.84 | blood_vessel | COSMIC cancer mutations | blood_vessel | 2211 | 17 | 16828 | 47 |
PTN,SLC1A3,FARP1,TNS3,GPC5,NCKAP5,PTPRZ1,SORCS2,DGKB,PREX2,FHOD3,SLC1A2,SNTB1,PRDM16,SOX5,FGFR3,SLC39A12 |
5.377e-05 | -9.83 | GSC (goosecoid homeobox) | protein interactions | 145258 | 82 | 4 | 19454 | 49 |
SOX5,NFIA,TRPS1,PRDM16 |
5.554e-05 | -9.80 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm | 7307 | 34 | 16828 | 47 |
FKBP5,RORA,PTN,FARP1,NHSL1,UNC93A,BCAR3,NCKAP5,QKI,PREX2,FHOD3,SLC1A2,LAMA4,PRDM16,PREX1,ELOVL2,USP6NL,SLC1A3,GPC5,TNS3,SLC6A11,RFX4,LPIN2,PTPRZ1,CTBP1,SORCS2,ASPA,LRIG1,DGKB,GRK5,SNTB1,EGF,FGFRL1,SOX5 |
5.946e-05 | -9.73 | solute:sodium symporter activity | molecular function | GO:0015370 | 80 | 4 | 18094 | 48 |
SLC1A3,SLC4A4,SLC6A11,SLC1A2 |
6.099e-05 | -9.70 | amino acid:monoatomic cation symporter activity | molecular function | GO:0005416 | 29 | 3 | 18094 | 48 |
SLC1A3,SLC1A2,SLC6A11 |
6.103e-05 | -9.70 | synapse | cellular component | GO:0045202 | 1473 | 13 | 19108 | 49 |
CTBP1,SLC6A11,FARP1,SLC1A2,ADGRB3,SORCS2,PRKN,SNTB1,PTPRZ1,SLC1A3,PTN,QKI,DGKB |
6.243e-05 | -9.68 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-mast_cell_neoplasm | 248 | 6 | 16828 | 47 |
NFIA,GPC5,SORCS2,GRK5,DGKB,NPAS3 |
6.243e-05 | -9.68 | mast_cell_neoplasm | COSMIC cancer mutations | mast_cell_neoplasm | 248 | 6 | 16828 | 47 |
NFIA,GPC5,DGKB,SORCS2,GRK5,NPAS3 |
6.432e-05 | -9.65 | central nervous system development | biological process | GO:0007417 | 995 | 11 | 18204 | 50 |
GPM6B,SLC1A2,PTPRZ1,QKI,EGF,PLPP3,RFX4,ASPA,MSI2,PRKN,RORA |
6.501e-05 | -9.64 | regulation of glial cell differentiation | biological process | GO:0045685 | 79 | 4 | 18204 | 50 |
QKI,PTPRZ1,ASPA,PTN |
6.856e-05 | -9.59 | glutamate:sodium symporter activity | molecular function | GO:0015501 | 5 | 2 | 18094 | 48 |
SLC1A2,SLC1A3 |
6.856e-05 | -9.59 | high-affinity L-glutamate transmembrane transporter activity | molecular function | GO:0005314 | 5 | 2 | 18094 | 48 |
SLC1A3,SLC1A2 |
6.856e-05 | -9.59 | fibroblast growth factor receptor activity | molecular function | GO:0005007 | 5 | 2 | 18094 | 48 |
FGFRL1,FGFR3 |
7.057e-05 | -9.56 | carcinoid-endocrine_tumour | COSMIC cancer mutations | carcinoid-endocrine_tumour | 7752 | 35 | 16828 | 47 |
LAMA4,PRDM16,PREX1,ELOVL2,FGFR3,SLC1A2,PREX2,FHOD3,BCAR3,NCKAP5,QKI,NHSL1,UNC93A,FKBP5,RORA,PTN,FARP1,FGFRL1,SOX5,SLC4A4,GRK5,SNTB1,EGF,TRPS1,LRIG1,DGKB,ASPA,RFX4,PTPRZ1,CTBP1,GPC5,TNS3,SLC6A11,USP6NL,SLC1A3 |
7.058e-05 | -9.56 | RAB35 (RAB35, member RAS oncogene family) | protein interactions | 11021 | 559 | 8 | 19454 | 49 |
PLPP3,PRKN,SLC1A3,ELOVL2,USP6NL,AMOT,FARP1,GJA1 |
7.089e-05 | -9.55 | DYRK1B (dual specificity tyrosine phosphorylation regulated kinase 1B) | protein interactions | 9149 | 88 | 4 | 19454 | 49 |
PRKN,LPIN2,CTBP1,FKBP5 |
7.270e-05 | -9.53 | organic anion transmembrane transporter activity | molecular function | GO:0008514 | 268 | 6 | 18094 | 48 |
SLC4A4,SLC1A3,SLC6A11,GJA1,SLC39A12,SLC1A2 |
7.355e-05 | -9.52 | D-aspartate import across plasma membrane | biological process | GO:0070779 | 5 | 2 | 18204 | 50 |
SLC1A3,SLC1A2 |
7.355e-05 | -9.52 | D-aspartate transmembrane transport | biological process | GO:0070777 | 5 | 2 | 18204 | 50 |
SLC1A3,SLC1A2 |
7.560e-05 | -9.49 | positive regulation of biological process | biological process | GO:0048518 | 6326 | 31 | 18204 | 50 |
AMOT,NFIA,ADGRB3,QKI,SLC39A12,SOX5,PREX1,PRKN,RORA,GRK5,FGFR3,PLPP3,NPAS3,PTN,RFX4,CTBP1,SLC4A4,SLC1A2,BCAR3,GPC5,LPIN2,EGF,FARP1,ASPA,SLC1A3,ZBTB20,APOA1,GJA1,PRDM16,GPM6B,PTPRZ1 |
8.505e-05 | -9.37 | HGH1 (HGH1 homolog) | protein interactions | 51236 | 34 | 3 | 19454 | 49 |
PRKN,FKBP5,PTN |
8.584e-05 | -9.36 | prostate-carcinoma | COSMIC cancer mutations | prostate-carcinoma | 9000 | 38 | 16828 | 47 |
DGKB,LRIG1,TRPS1,GRK5,EGF,SNTB1,FGFRL1,SOX5,SLC39A12,SLC4A4,SLC1A3,TNS3,GPC5,RFX4,LPIN2,NPAS3,PTPRZ1,SORCS2,ASPA,MSI2,APOA1,PREX2,NFIA,FHOD3,SLC1A2,PREX1,PRDM16,LAMA4,FGFR3,ELOVL2,ZBTB20,RORA,FARP1,NHSL1,UNC93A,BCAR3,QKI,NCKAP5 |
1.024e-04 | -9.19 | gliogenesis | biological process | GO:0042063 | 275 | 6 | 18204 | 50 |
PTPRZ1,GPM6B,NFIA,PLPP3,QKI,ASPA |
1.080e-04 | -9.13 | organic acid:sodium symporter activity | molecular function | GO:0005343 | 35 | 3 | 18094 | 48 |
SLC1A3,SLC1A2,SLC6A11 |
1.101e-04 | -9.11 | L-aspartate import across plasma membrane | biological process | GO:0140009 | 6 | 2 | 18204 | 50 |
SLC1A2,SLC1A3 |
1.101e-04 | -9.11 | D-amino acid transport | biological process | GO:0042940 | 6 | 2 | 18204 | 50 |
SLC1A3,SLC1A2 |
1.101e-04 | -9.11 | CARM1 (coactivator associated arginine methyltransferase 1) | protein interactions | 10498 | 304 | 6 | 19454 | 49 |
QKI,CTBP1,NCKAP5,RORA,PRKN,SNTB1 |
1.191e-04 | -9.04 | Pcbp1 (poly(rC) binding protein 1) | protein interactions | 23983 | 38 | 3 | 19454 | 49 |
CTBP1,QKI,MSI2 |
1.279e-04 | -8.96 | positive regulation of multicellular organismal process | biological process | GO:0051240 | 1691 | 14 | 18204 | 50 |
ADGRB3,EGF,QKI,AMOT,PTN,PTPRZ1,PRDM16,GPM6B,RORA,GJA1,ZBTB20,SOX5,SLC39A12,ASPA |
1.295e-04 | -8.95 | FGF5 (fibroblast growth factor 5) | protein interactions | 2250 | 7 | 2 | 19454 | 49 |
EGF,FGFR3 |
1.320e-04 | -8.93 | autonomic_ganglia-neuroblastoma | COSMIC cancer mutations | autonomic_ganglia-neuroblastoma | 3970 | 23 | 16828 | 47 |
PREX2,NFIA,FHOD3,SLC1A2,PRDM16,PREX1,FGFR3,GJA1,NCKAP5,AQP4,GPM6B,TRPS1,EGF,SNTB1,SLC4A4,USP6NL,TNS3,LPIN2,RFX4,AMOT,NPAS3,PTPRZ1,SORCS2 |
1.326e-04 | -8.93 | neuroblastoma | COSMIC cancer mutations | neuroblastoma | 3971 | 23 | 16828 | 47 |
TRPS1,FHOD3,NFIA,GPM6B,PREX2,FGFR3,SLC4A4,PRDM16,PREX1,SNTB1,EGF,SLC1A2,TNS3,USP6NL,AQP4,SORCS2,NCKAP5,PTPRZ1,NPAS3,RFX4,AMOT,LPIN2,GJA1 |
1.352e-04 | -8.91 | regulation of multicellular organismal development | biological process | GO:2000026 | 1484 | 13 | 18204 | 50 |
ADGRB3,EGF,QKI,AMOT,TRPS1,PTN,PTPRZ1,GPM6B,GJA1,SOX5,LAMA4,SLC39A12,ASPA |
1.427e-04 | -8.85 | regulation of carbohydrate metabolic process | biological process | GO:0006109 | 183 | 5 | 18204 | 50 |
EGF,ZBTB20,PRKN,RORA,SLC4A4 |
1.487e-04 | -8.81 | Na-dicarboxylate_symporter_CS | interpro domains | IPR018107 | 7 | 2 | 18521 | 50 |
SLC1A2,SLC1A3 |
1.487e-04 | -8.81 | Na:dicarbo_symporter_sf | interpro domains | IPR036458 | 7 | 2 | 18521 | 50 |
SLC1A3,SLC1A2 |
1.487e-04 | -8.81 | Na-dicarboxylate_symporter | interpro domains | IPR001991 | 7 | 2 | 18521 | 50 |
SLC1A2,SLC1A3 |
1.532e-04 | -8.78 | pancreas-carcinoid-endocrine_tumour | COSMIC cancer mutations | pancreas-carcinoid-endocrine_tumour | 7250 | 33 | 16828 | 47 |
USP6NL,SLC1A3,SLC6A11,GPC5,TNS3,CTBP1,RFX4,ASPA,LRIG1,DGKB,SNTB1,EGF,GRK5,SLC4A4,FGFRL1,SOX5,FARP1,FKBP5,RORA,PTN,UNC93A,NHSL1,NCKAP5,QKI,BCAR3,FHOD3,PREX2,SLC1A2,ELOVL2,FGFR3,LAMA4,PREX1,PRDM16 |
1.551e-04 | -8.77 | Sodium:dicarboxylate symporter | gene3d domains | 1.10.3860.10 | 7 | 2 | 14470 | 40 |
SLC1A3,SLC1A2 |
1.610e-04 | -8.73 | SDF | pfam domains | PF00375 | 7 | 2 | 17795 | 50 |
SLC1A3,SLC1A2 |
1.703e-04 | -8.68 | upper_aerodigestive_tract-larynx-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-larynx-carcinoma-squamous_cell_carcinoma | 1946 | 15 | 16828 | 47 |
AMOT,NCKAP5,NPAS3,SORCS2,RORA,ZBTB20,PTN,SOX5,LAMA4,PREX1,SLC4A4,FGFR3,SLC39A12,DGKB,FHOD3 |
1.723e-04 | -8.67 | larynx | COSMIC cancer mutations | larynx | 1948 | 15 | 16828 | 47 |
NPAS3,NCKAP5,AMOT,SORCS2,PTN,ZBTB20,RORA,SLC4A4,SLC39A12,FGFR3,PREX1,SOX5,LAMA4,DGKB,FHOD3 |
1.813e-04 | -8.62 | soft_tissue-blood_vessel-angiosarcoma | COSMIC cancer mutations | soft_tissue-blood_vessel-angiosarcoma | 2192 | 16 | 16828 | 47 |
NCKAP5,PTPRZ1,SORCS2,FARP1,PTN,SLC1A3,GPC5,TNS3,SNTB1,SLC1A2,SLC39A12,SOX5,PRDM16,DGKB,FHOD3,PREX2 |
1.813e-04 | -8.62 | angiosarcoma | COSMIC cancer mutations | angiosarcoma | 2192 | 16 | 16828 | 47 |
GPC5,TNS3,FARP1,PTN,SLC1A3,SORCS2,PTPRZ1,NCKAP5,FHOD3,PREX2,DGKB,SLC39A12,SOX5,PRDM16,SNTB1,SLC1A2 |
1.963e-04 | -8.54 | neural precursor cell proliferation | biological process | GO:0061351 | 105 | 4 | 18204 | 50 |
NFIA,SOX5,EGF,RORA |
1.990e-04 | -8.52 | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | COSMIC cancer mutations | central_nervous_system-brain-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | 1117 | 11 | 16828 | 47 |
SORCS2,PRDM16,SOX5,QKI,NCKAP5,GRK5,SLC1A2,UNC93A,FHOD3,GPC5,DGKB |
2.048e-04 | -8.49 | cell proliferation in hindbrain | biological process | GO:0021534 | 8 | 2 | 18204 | 50 |
RORA,EGF |
2.048e-04 | -8.49 | cell proliferation in external granule layer | biological process | GO:0021924 | 8 | 2 | 18204 | 50 |
EGF,RORA |
2.048e-04 | -8.49 | cerebellar granule cell precursor proliferation | biological process | GO:0021930 | 8 | 2 | 18204 | 50 |
EGF,RORA |
2.071e-04 | -8.48 | cellular response to endogenous stimulus | biological process | GO:0071495 | 1135 | 11 | 18204 | 50 |
LPIN2,NFIA,BCAR3,SLC1A2,FGFRL1,FGFR3,APOA1,GJA1,SOX5,PRKN,SLC1A3 |
2.075e-04 | -8.48 | NA_DICARBOXYL_SYMP_2 | prosite domains | PS00714 | 7 | 2 | 12186 | 39 |
SLC1A2,SLC1A3 |
2.075e-04 | -8.48 | NA_DICARBOXYL_SYMP_1 | prosite domains | PS00713 | 7 | 2 | 12186 | 39 |
SLC1A3,SLC1A2 |
2.136e-04 | -8.45 | ELK3 (ETS transcription factor ELK3) | protein interactions | 2004 | 117 | 4 | 19454 | 49 |
PRDM16,TRPS1,NFIA,CTBP1 |
2.212e-04 | -8.42 | SPEF2 (sperm flagellar 2) | protein interactions | 79925 | 9 | 2 | 19454 | 49 |
PRKN,APOA1 |
2.329e-04 | -8.37 | EDTRNSPORT | prints domains | PR00173 | 7 | 2 | 5227 | 18 |
SLC1A2,SLC1A3 |
2.339e-04 | -8.36 | human chr6q26 | chromosome location | human chr6q26 | 12 | 2 | 26134 | 50 |
PRKN,QKI |
2.421e-04 | -8.33 | mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | COSMIC cancer mutations | mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | 951 | 10 | 16828 | 47 |
PTN,PREX2,GPC5,UNC93A,SLC1A2,EGF,SNTB1,NCKAP5,PREX1,PRDM16 |
2.421e-04 | -8.33 | stomach-carcinoma-mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | COSMIC cancer mutations | stomach-carcinoma-mixed_intestinal_and_diffuse_adenocarcinoma-unclassifiable | 951 | 10 | 16828 | 47 |
PRDM16,PREX1,SLC1A2,SNTB1,NCKAP5,EGF,GPC5,PREX2,UNC93A,PTN |
2.432e-04 | -8.32 | kidney-other-neoplasm | COSMIC cancer mutations | kidney-other-neoplasm | 10653 | 41 | 16828 | 47 |
SLC1A2,ELOVL2,FGFR3,LAMA4,PREX1,PRDM16,APOA1,FHOD3,PREX2,NCKAP5,QKI,BCAR3,AQP4,FARP1,ZBTB20,RORA,FKBP5,PTN,UNC93A,NHSL1,SNTB1,EGF,GRK5,SLC39A12,SOX5,FGFRL1,LRIG1,DGKB,TRPS1,PTPRZ1,CTBP1,NPAS3,RFX4,LPIN2,ASPA,SORCS2,USP6NL,SLC1A3,SLC6A11,GPC5,TNS3 |
2.494e-04 | -8.30 | KLF3 (KLF transcription factor 3) | protein interactions | 51274 | 225 | 5 | 19454 | 49 |
NFIA,PRDM16,TRPS1,CTBP1,SOX5 |
2.514e-04 | -8.29 | regulation of gliogenesis | biological process | GO:0014013 | 112 | 4 | 18204 | 50 |
PTPRZ1,ASPA,PTN,QKI |
2.551e-04 | -8.27 | acidic amino acid transport | biological process | GO:0015800 | 45 | 3 | 18204 | 50 |
GJA1,SLC1A3,SLC1A2 |
2.629e-04 | -8.24 | negative regulation of neurotransmitter transport | biological process | GO:0051589 | 9 | 2 | 18204 | 50 |
PRKN,GPM6B |
2.692e-04 | -8.22 | diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | diffuse_large_B_cell_lymphoma | 4151 | 23 | 16828 | 47 |
EGF,SNTB1,GRK5,SOX5,DGKB,TRPS1,SORCS2,SLC1A3,USP6NL,SLC6A11,TNS3,GPC5,SLC1A2,FGFR3,PRDM16,LAMA4,FHOD3,PREX2,QKI,NCKAP5,AQP4,FARP1,RORA |
2.718e-04 | -8.21 | positive regulation of cellular process | biological process | GO:0048522 | 5719 | 28 | 18204 | 50 |
SLC1A3,ASPA,ZBTB20,GJA1,APOA1,PRDM16,PTPRZ1,PTN,RFX4,CTBP1,SLC4A4,BCAR3,SLC1A2,GPC5,LPIN2,EGF,FARP1,PRKN,SOX5,PREX1,RORA,GRK5,PLPP3,FGFR3,NPAS3,NFIA,ADGRB3,QKI |
2.736e-04 | -8.20 | regulation of developmental process | biological process | GO:0050793 | 2540 | 17 | 18204 | 50 |
ADGRB3,EGF,QKI,PTN,TRPS1,AMOT,GPM6B,PTPRZ1,FGFR3,ASPA,SLC39A12,PREX1,PRKN,SOX5,LAMA4,RORA,GJA1 |
2.796e-04 | -8.18 | NRAS (NRAS proto-oncogene, GTPase) | protein interactions | 4893 | 683 | 8 | 19454 | 49 |
USP6NL,SLC39A12,GJA1,PREX1,FARP1,FGFRL1,PLPP3,SLC1A3 |
2.802e-04 | -8.18 | enzyme-linked receptor protein signaling pathway | biological process | GO:0007167 | 626 | 8 | 18204 | 50 |
APOA1,PTN,FGFR3,EGF,FGFRL1,FARP1,BCAR3,NFIA |
2.877e-04 | -8.15 | positive regulation of developmental process | biological process | GO:0051094 | 1385 | 12 | 18204 | 50 |
PTN,AMOT,ADGRB3,EGF,QKI,ASPA,SLC39A12,PRKN,SOX5,GJA1,GPM6B,PTPRZ1 |
2.917e-04 | -8.14 | GTPase regulator activity | molecular function | GO:0030695 | 491 | 7 | 18094 | 48 |
ADGRB3,BCAR3,USP6NL,PREX2,EGF,FARP1,PREX1 |
2.917e-04 | -8.14 | nucleoside-triphosphatase regulator activity | molecular function | GO:0060589 | 491 | 7 | 18094 | 48 |
PREX2,USP6NL,BCAR3,ADGRB3,PREX1,FARP1,EGF |
2.990e-04 | -8.12 | ear | COSMIC cancer mutations | ear | 624 | 8 | 16828 | 47 |
NPAS3,GRK5,FGFR3,LAMA4,FGFRL1,ZBTB20,SLC6A11,UNC93A |
3.042e-04 | -8.10 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-diffuse_large_B_cell_lymphoma | 3608 | 21 | 16828 | 47 |
EGF,SNTB1,GRK5,SLC1A2,FGFR3,PRDM16,SOX5,LAMA4,DGKB,FHOD3,PREX2,QKI,NCKAP5,AQP4,SORCS2,FARP1,RORA,USP6NL,SLC6A11,TNS3,GPC5 |
3.043e-04 | -8.10 | FGF2 (fibroblast growth factor 2) | protein interactions | 2247 | 52 | 3 | 19454 | 49 |
FGFRL1,PRKN,FGFR3 |
3.043e-04 | -8.10 | ABCA1 (ATP binding cassette subfamily A member 1) | protein interactions | 19 | 52 | 3 | 19454 | 49 |
APOA1,SNTB1,PRKN |
3.143e-04 | -8.07 | lymphoid_neoplasm | COSMIC cancer mutations | lymphoid_neoplasm | 12233 | 44 | 16828 | 47 |
TRPS1,DGKB,LRIG1,SLC4A4,SOX5,FGFRL1,SNTB1,SLC6A11,ASPA,SORCS2,NPAS3,AMOT,FHOD3,FGFR3,ELOVL2,PREX1,LAMA4,SLC1A2,UNC93A,NHSL1,FKBP5,ZBTB20,AQP4,QKI,NCKAP5,SLC39A12,EGF,GRK5,TNS3,GPC5,SLC1A3,USP6NL,MSI2,CTBP1,PTPRZ1,LPIN2,RFX4,PREX2,NFIA,PRDM16,FARP1,PTN,RORA,BCAR3 |
3.155e-04 | -8.06 | plasma membrane region | cellular component | GO:0098590 | 1278 | 11 | 19108 | 49 |
DGKB,PLPP3,ADGRB3,SORCS2,SLC1A3,SLC1A2,FARP1,SLC6A11,GJA1,AQP4,SLC4A4 |
3.212e-04 | -8.04 | upper_aerodigestive_tract-mouth-carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma | 6426 | 30 | 16828 | 47 |
TNS3,GPC5,SLC1A3,USP6NL,SORCS2,CTBP1,NPAS3,RFX4,TRPS1,DGKB,SLC4A4,SLC39A12,SOX5,EGF,SNTB1,GRK5,UNC93A,NHSL1,ZBTB20,RORA,QKI,NCKAP5,FHOD3,PREX2,APOA1,FGFR3,PREX1,PRDM16,LAMA4,SLC1A2 |
3.281e-04 | -8.02 | cellular response to cocaine | biological process | GO:0071314 | 10 | 2 | 18204 | 50 |
SLC1A3,SLC1A2 |
3.349e-04 | -8.00 | guanyl-nucleotide exchange factor activity | molecular function | GO:0005085 | 228 | 5 | 18094 | 48 |
PREX2,BCAR3,PREX1,FARP1,EGF |
3.689e-04 | -7.91 | FOXP1 (forkhead box P1) | protein interactions | 27086 | 135 | 4 | 19454 | 49 |
PRKN,NFIA,SOX5,CTBP1 |
3.833e-04 | -7.87 | Neurotransmitter Release Cycle | REACTOME pathways | R-HSA-112310 | 51 | 3 | 10285 | 29 |
SLC1A3,SLC6A11,SLC1A2 |
3.977e-04 | -7.83 | PRNP (prion protein (Kanno blood group)) | protein interactions | 5621 | 1118 | 10 | 19454 | 49 |
MSI2,PTPRZ1,SLC4A4,NHSL1,GJA1,QKI,ASPA,AQP4,SLC1A3,TRPS1 |
3.992e-04 | -7.83 | cervix-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | cervix-carcinoma-squamous_cell_carcinoma | 11789 | 43 | 16828 | 47 |
QKI,NCKAP5,BCAR3,GJA1,FARP1,RORA,ZBTB20,FKBP5,UNC93A,NHSL1,SLC1A2,FGFR3,ELOVL2,PREX1,PRDM16,LAMA4,FHOD3,PREX2,NFIA,NPAS3,CTBP1,PTPRZ1,RFX4,AMOT,LPIN2,ASPA,SORCS2,SLC1A3,USP6NL,SLC6A11,TNS3,GPC5,EGF,SNTB1,GRK5,SLC4A4,SLC39A12,SOX5,FGFRL1,DGKB,LRIG1,TRPS1,GPM6B |
4.003e-04 | -7.82 | L-glutamate import across plasma membrane | biological process | GO:0098712 | 11 | 2 | 18204 | 50 |
SLC1A3,SLC1A2 |
4.003e-04 | -7.82 | L-aspartate transmembrane transport | biological process | GO:0070778 | 11 | 2 | 18204 | 50 |
SLC1A3,SLC1A2 |
4.010e-04 | -7.82 | NFIB (nuclear factor I B) | protein interactions | 4781 | 138 | 4 | 19454 | 49 |
NFIA,GRK5,TRPS1,SOX5 |
4.039e-04 | -7.81 | cervix | COSMIC cancer mutations | cervix | 11793 | 43 | 16828 | 47 |
SORCS2,ASPA,AMOT,LPIN2,RFX4,PTPRZ1,NPAS3,CTBP1,GPC5,TNS3,SLC6A11,USP6NL,SLC1A3,FGFRL1,SOX5,SLC4A4,SLC39A12,GRK5,SNTB1,EGF,GPM6B,TRPS1,LRIG1,DGKB,BCAR3,GJA1,NCKAP5,QKI,NHSL1,UNC93A,ZBTB20,FKBP5,RORA,FARP1,LAMA4,PRDM16,PREX1,ELOVL2,FGFR3,SLC1A2,NFIA,PREX2,FHOD3 |
4.198e-04 | -7.78 | CRX (cone-rod homeobox) | protein interactions | 1406 | 252 | 5 | 19454 | 49 |
TRPS1,PRDM16,PRKN,NFIA,SOX5 |
4.198e-04 | -7.78 | human chr4p16.3 | chromosome location | human chr4p16.3 | 76 | 3 | 26134 | 50 |
FGFR3,FGFRL1,CTBP1 |
4.350e-04 | -7.74 | SNTB2 (syntrophin beta 2) | protein interactions | 6645 | 141 | 4 | 19454 | 49 |
SNTB1,FGFR3,PRKN,TNS3 |
4.588e-04 | -7.69 | BAZ1A (bromodomain adjacent to zinc finger domain 1A) | protein interactions | 11177 | 143 | 4 | 19454 | 49 |
CTBP1,PRKN,FGFR3,GRK5 |
4.698e-04 | -7.66 | amino acid transport | biological process | GO:0006865 | 132 | 4 | 18204 | 50 |
SLC1A2,SLC1A3,GJA1,SLC6A11 |
4.752e-04 | -7.65 | pleura | COSMIC cancer mutations | pleura | 4914 | 25 | 16828 | 47 |
GRK5,SNTB1,FGFRL1,SOX5,LRIG1,DGKB,GPM6B,TRPS1,AMOT,LPIN2,PTPRZ1,MSI2,USP6NL,LAMA4,PREX1,PRDM16,FGFR3,PREX2,FHOD3,BCAR3,NCKAP5,QKI,FKBP5,RORA,FARP1 |
4.763e-04 | -7.65 | PLEKHH1 (pleckstrin homology, MyTH4 and FERM domain containing H1) | protein interactions | 57475 | 13 | 2 | 19454 | 49 |
FKBP5,PRKN |
4.833e-04 | -7.63 | face | COSMIC cancer mutations | face | 2139 | 15 | 16828 | 47 |
PTPRZ1,AQP4,MSI2,FARP1,RORA,SLC6A11,GPC5,EGF,GRK5,FGFR3,PRDM16,LAMA4,FHOD3,TRPS1,PREX2 |
4.877e-04 | -7.63 | TSPAN10 (tetraspanin 10) | protein interactions | 83882 | 61 | 3 | 19454 | 49 |
PRKN,GJA1,ELOVL2 |
5.132e-04 | -7.57 | sulfur compound transmembrane transporter activity | molecular function | GO:1901682 | 59 | 3 | 18094 | 48 |
SLC1A2,SLC6A11,GJA1 |
5.276e-04 | -7.55 | monoatomic cation:bicarbonate symporter activity | molecular function | GO:0140410 | 13 | 2 | 18094 | 48 |
SLC39A12,SLC4A4 |
5.297e-04 | -7.54 | synaptic membrane | cellular component | GO:0097060 | 400 | 6 | 19108 | 49 |
SLC1A2,FARP1,SLC6A11,SORCS2,ADGRB3,DGKB |
5.558e-04 | -7.50 | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-mouth-carcinoma-squamous_cell_carcinoma | 6953 | 31 | 16828 | 47 |
SLC1A2,LAMA4,PREX1,PRDM16,ELOVL2,FGFR3,APOA1,PREX2,FHOD3,BCAR3,NCKAP5,QKI,ZBTB20,RORA,PTN,NHSL1,UNC93A,GRK5,SNTB1,SOX5,SLC4A4,SLC39A12,LRIG1,DGKB,TRPS1,RFX4,PTPRZ1,SORCS2,USP6NL,GPC5,TNS3 |
5.775e-04 | -7.46 | ARFGAP2 (ADP ribosylation factor GTPase activating protein 2) | protein interactions | 84364 | 152 | 4 | 19454 | 49 |
PRKN,BCAR3,GJA1,CTBP1 |
5.865e-04 | -7.44 | neurotransmitter transport | biological process | GO:0006836 | 140 | 4 | 18204 | 50 |
PRKN,SLC6A11,SLC1A2,SLC1A3 |
6.032e-04 | -7.41 | ERBB2 (erb-b2 receptor tyrosine kinase 2) | protein interactions | 2064 | 583 | 7 | 19454 | 49 |
EGF,FGFR3,GJA1,BCAR3,TNS3,GPM6B,LRIG1 |
6.037e-04 | -7.41 | astrocytoma_Grade_I | COSMIC cancer mutations | astrocytoma_Grade_I | 139 | 4 | 16828 | 47 |
FGFR3,PRDM16,GPC5,QKI |
6.093e-04 | -7.40 | neuron differentiation | biological process | GO:0030182 | 1081 | 10 | 18204 | 50 |
PTPRZ1,NFIA,GPM6B,FARP1,ADGRB3,SLC39A12,PTN,SLC1A3,PREX2,RORA |
6.145e-04 | -7.39 | phosphatidate phosphatase activity | molecular function | GO:0008195 | 14 | 2 | 18094 | 48 |
LPIN2,PLPP3 |
6.145e-04 | -7.39 | L-glutamate transmembrane transporter activity | molecular function | GO:0005313 | 14 | 2 | 18094 | 48 |
SLC1A2,SLC1A3 |
6.354e-04 | -7.36 | serous_carcinoma | COSMIC cancer mutations | serous_carcinoma | 10987 | 41 | 16828 | 47 |
NPAS3,CTBP1,PTPRZ1,LPIN2,AMOT,MSI2,ASPA,SORCS2,SLC1A3,USP6NL,SLC6A11,TNS3,GPC5,EGF,SNTB1,GRK5,SLC39A12,SLC4A4,SOX5,FGFRL1,DGKB,LRIG1,TRPS1,GPM6B,QKI,NCKAP5,GJA1,BCAR3,FARP1,FKBP5,RORA,ZBTB20,NHSL1,SLC1A2,FGFR3,ELOVL2,PRDM16,PREX1,LAMA4,FHOD3,PREX2 |
6.579e-04 | -7.33 | sulfur compound transport | biological process | GO:0072348 | 62 | 3 | 18204 | 50 |
SLC1A2,GJA1,SLC6A11 |
6.985e-04 | -7.27 | cell development | biological process | GO:0048468 | 2236 | 15 | 18204 | 50 |
FHOD3,PTPRZ1,GPM6B,RORA,GJA1,PREX1,SLC39A12,MSI2,SLC1A3,ASPA,FARP1,QKI,ADGRB3,PREX2,PTN |
7.220e-04 | -7.23 | dendrite morphogenesis | biological process | GO:0048813 | 64 | 3 | 18204 | 50 |
FARP1,PTN,PREX2 |
7.292e-04 | -7.22 | HLA-H (major histocompatibility complex, class I, H (pseudogene)) | protein interactions | 3136 | 16 | 2 | 19454 | 49 |
PRKN,FGFR3 |
7.339e-04 | -7.22 | postsynaptic membrane | cellular component | GO:0045211 | 280 | 5 | 19108 | 49 |
FARP1,SLC6A11,SORCS2,ADGRB3,DGKB |
7.414e-04 | -7.21 | organic anion transport | biological process | GO:0015711 | 398 | 6 | 18204 | 50 |
SLC6A11,GJA1,SLC4A4,SLC39A12,SLC1A3,SLC1A2 |
7.426e-04 | -7.21 | humerus | COSMIC cancer mutations | humerus | 546 | 7 | 16828 | 47 |
GPC5,FHOD3,FARP1,SOX5,LAMA4,NCKAP5,EGF |
7.504e-04 | -7.19 | MTA3 (metastasis associated 1 family member 3) | protein interactions | 57504 | 163 | 4 | 19454 | 49 |
TRPS1,PRKN,BCAR3,SOX5 |
7.604e-04 | -7.18 | bone | COSMIC cancer mutations | bone | 8157 | 34 | 16828 | 47 |
UNC93A,RORA,ZBTB20,FARP1,QKI,NCKAP5,PREX2,FHOD3,PRDM16,PREX1,LAMA4,FGFR3,ELOVL2,TNS3,GPC5,SLC6A11,SLC1A3,USP6NL,SORCS2,ASPA,LPIN2,NPAS3,PTPRZ1,GPM6B,TRPS1,DGKB,LRIG1,SOX5,FGFRL1,SLC39A12,SLC4A4,GRK5,EGF,SNTB1 |
7.721e-04 | -7.17 | active monoatomic ion transmembrane transporter activity | molecular function | GO:0022853 | 274 | 5 | 18094 | 48 |
SLC6A11,SLC39A12,SLC1A2,SLC1A3,SLC4A4 |
7.789e-04 | -7.16 | regulation of cold-induced thermogenesis | biological process | GO:0120161 | 151 | 4 | 18204 | 50 |
QKI,LAMA4,GJA1,PRDM16 |
7.853e-04 | -7.15 | EGR2 (early growth response 2) | protein interactions | 1959 | 165 | 4 | 19454 | 49 |
SOX5,PRDM16,TRPS1,NFIA |
7.930e-04 | -7.14 | BCOR (BCL6 corepressor) | protein interactions | 54880 | 290 | 5 | 19454 | 49 |
NFIA,PRKN,CTBP1,AMOT,SOX5 |
7.953e-04 | -7.14 | Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 7434 | 32 | 16828 | 47 |
NCKAP5,QKI,ZBTB20,RORA,FARP1,UNC93A,LAMA4,PREX1,PRDM16,ELOVL2,FGFR3,PREX2,FHOD3,LPIN2,PTPRZ1,NPAS3,SORCS2,ASPA,USP6NL,SLC1A3,TNS3,SLC6A11,GRK5,SNTB1,EGF,SOX5,FGFRL1,SLC4A4,SLC39A12,LRIG1,GPM6B,TRPS1 |
8.055e-04 | -7.12 | oligoastrocytoma_Grade_III | COSMIC cancer mutations | oligoastrocytoma_Grade_III | 263 | 5 | 16828 | 47 |
FGFR3,SOX5,PREX2,AMOT,SLC1A2 |
8.077e-04 | -7.12 | sodium ion transmembrane transporter activity | molecular function | GO:0015081 | 158 | 4 | 18094 | 48 |
SLC1A2,SLC6A11,SLC1A3,SLC4A4 |
8.923e-04 | -7.02 | DH-domain | interpro domains | IPR000219 | 70 | 3 | 18521 | 50 |
FARP1,PREX2,PREX1 |
9.299e-04 | -6.98 | DBL_dom_sf | interpro domains | IPR035899 | 71 | 3 | 18521 | 50 |
PREX1,PREX2,FARP1 |
9.320e-04 | -6.98 | Signaling by MET | REACTOME pathways | R-HSA-6806834 | 69 | 3 | 10285 | 29 |
LAMA4,TNS3,LRIG1 |
9.508e-04 | -6.96 | Glycerolipid metabolism | KEGG pathways | hsa00561 | 59 | 3 | 7161 | 24 |
PLPP3,LPIN2,DGKB |
9.508e-04 | -6.96 | Glycerolipid metabolism | KEGG pathways | ko00561 | 59 | 3 | 7161 | 24 |
DGKB,PLPP3,LPIN2 |
9.571e-04 | -6.95 | NME2 (NME/NM23 nucleoside diphosphate kinase 2) | protein interactions | 4831 | 174 | 4 | 19454 | 49 |
PREX1,RORA,PRKN,CTBP1 |
9.685e-04 | -6.94 | skin-face-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-face-carcinoma-squamous_cell_carcinoma | 2036 | 14 | 16828 | 47 |
GRK5,EGF,PTPRZ1,PRDM16,LAMA4,FGFR3,AQP4,MSI2,RORA,FARP1,PREX2,GPC5,FHOD3,TRPS1 |
9.794e-04 | -6.93 | viral genome replication | biological process | GO:0019079 | 17 | 2 | 18204 | 50 |
CTBP1,NFIA |
9.804e-04 | -6.93 | secondary active transmembrane transporter activity | molecular function | GO:0015291 | 289 | 5 | 18094 | 48 |
SLC4A4,SLC1A3,SLC1A2,SLC39A12,SLC6A11 |
9.819e-04 | -6.93 | Dbl homology (DH) domain | gene3d domains | 1.20.900.10 | 71 | 3 | 14470 | 40 |
FARP1,PREX1,PREX2 |
1.001e-03 | -6.91 | RhoGEF | pfam domains | PF00621 | 70 | 3 | 17795 | 50 |
PREX1,FARP1,PREX2 |
1.025e-03 | -6.88 | ovary-carcinoma-serous_carcinoma | COSMIC cancer mutations | ovary-carcinoma-serous_carcinoma | 10710 | 40 | 16828 | 47 |
SLC39A12,SLC4A4,SOX5,FGFRL1,SNTB1,GRK5,TRPS1,GPM6B,LRIG1,DGKB,MSI2,ASPA,SORCS2,PTPRZ1,CTBP1,NPAS3,AMOT,LPIN2,SLC6A11,GPC5,TNS3,USP6NL,SLC1A3,ELOVL2,FGFR3,LAMA4,PRDM16,PREX1,SLC1A2,FHOD3,PREX2,NCKAP5,QKI,GJA1,BCAR3,NHSL1,FARP1,ZBTB20,RORA,FKBP5 |
1.026e-03 | -6.88 | acidic amino acid transmembrane transporter activity | molecular function | GO:0015172 | 18 | 2 | 18094 | 48 |
SLC1A3,SLC1A2 |
1.029e-03 | -6.88 | striated_muscle | COSMIC cancer mutations | striated_muscle | 4228 | 22 | 16828 | 47 |
NFIA,PREX2,TRPS1,FHOD3,DGKB,FGFRL1,PRDM16,ELOVL2,FGFR3,GRK5,EGF,NHSL1,RORA,USP6NL,SLC1A3,SORCS2,AQP4,GJA1,NCKAP5,PTPRZ1,NPAS3,CTBP1 |
1.033e-03 | -6.88 | regulation of multicellular organismal process | biological process | GO:0051239 | 3113 | 18 | 18204 | 50 |
PRDM16,GPM6B,PTPRZ1,PLPP3,ASPA,SLC39A12,SOX5,ZBTB20,LAMA4,APOA1,RORA,GJA1,ADGRB3,EGF,QKI,PTN,TRPS1,AMOT |
1.041e-03 | -6.87 | ERBB4 (erb-b2 receptor tyrosine kinase 4) | protein interactions | 2066 | 178 | 4 | 19454 | 49 |
GJA1,BCAR3,TNS3,LRIG1 |
1.046e-03 | -6.86 | MCAM (melanoma cell adhesion molecule) | protein interactions | 4162 | 464 | 6 | 19454 | 49 |
GJA1,FARP1,SNTB1,LAMA4,PLPP3,USP6NL |
1.071e-03 | -6.84 | astrocyte projection | cellular component | GO:0097449 | 19 | 2 | 19108 | 49 |
AQP4,SLC1A2 |
1.085e-03 | -6.83 | EPHA4 (EPH receptor A4) | protein interactions | 2043 | 180 | 4 | 19454 | 49 |
USP6NL,TNS3,GJA1,FGFR3 |
1.145e-03 | -6.77 | lipid phosphatase activity | molecular function | GO:0042577 | 19 | 2 | 18094 | 48 |
PLPP3,LPIN2 |
1.156e-03 | -6.76 | LRRC40 (leucine rich repeat containing 40) | protein interactions | 55631 | 82 | 3 | 19454 | 49 |
PRKN,LRIG1,FKBP5 |
1.201e-03 | -6.72 | KLF12 (KLF transcription factor 12) | protein interactions | 11278 | 185 | 4 | 19454 | 49 |
TRPS1,PRDM16,NFIA,CTBP1 |
1.227e-03 | -6.70 | regulation of neurotransmitter uptake | biological process | GO:0051580 | 19 | 2 | 18204 | 50 |
GPM6B,PRKN |
1.235e-03 | -6.70 | response to endogenous stimulus | biological process | GO:0009719 | 1402 | 11 | 18204 | 50 |
NFIA,SLC1A2,BCAR3,LPIN2,SLC1A3,SOX5,PRKN,APOA1,GJA1,FGFR3,FGFRL1 |
1.240e-03 | -6.69 | FXYD6 (FXYD domain containing ion transport regulator 6) | protein interactions | 53826 | 84 | 3 | 19454 | 49 |
GPC5,SLC39A12,ELOVL2 |
1.240e-03 | -6.69 | MAPK12 (mitogen-activated protein kinase 12) | protein interactions | 6300 | 84 | 3 | 19454 | 49 |
SNTB1,PRKN,FKBP5 |
1.280e-03 | -6.66 | positive regulation of nervous system development | biological process | GO:0051962 | 296 | 5 | 18204 | 50 |
PTPRZ1,ASPA,PTN,QKI,ADGRB3 |
1.283e-03 | -6.66 | positive regulation of carbohydrate metabolic process | biological process | GO:0045913 | 78 | 3 | 18204 | 50 |
SLC4A4,ZBTB20,EGF |
1.283e-03 | -6.66 | dicarboxylic acid transport | biological process | GO:0006835 | 78 | 3 | 18204 | 50 |
GJA1,SLC1A2,SLC1A3 |
1.285e-03 | -6.66 | prostate | COSMIC cancer mutations | prostate | 13883 | 46 | 16828 | 47 |
SLC6A11,NPAS3,ASPA,SORCS2,LRIG1,DGKB,TRPS1,GPM6B,SNTB1,SLC4A4,SOX5,FGFRL1,FKBP5,ZBTB20,UNC93A,NHSL1,NCKAP5,QKI,GJA1,AQP4,APOA1,FHOD3,SLC1A2,ELOVL2,FGFR3,LAMA4,PREX1,USP6NL,SLC1A3,GPC5,TNS3,PTPRZ1,CTBP1,RFX4,LPIN2,MSI2,EGF,GRK5,SLC39A12,FARP1,RORA,PTN,BCAR3,NFIA,PREX2,PRDM16 |
1.343e-03 | -6.61 | lung-right_upper_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-right_upper_lobe-carcinoma-adenocarcinoma | 10376 | 39 | 16828 | 47 |
APOA1,PREX2,NFIA,FHOD3,SLC1A2,PREX1,PRDM16,LAMA4,FGFR3,ELOVL2,PTN,ZBTB20,RORA,FARP1,UNC93A,BCAR3,NCKAP5,DGKB,LRIG1,GPM6B,TRPS1,GRK5,EGF,SOX5,FGFRL1,SLC39A12,SLC4A4,SLC1A3,USP6NL,TNS3,GPC5,SLC6A11,RFX4,AMOT,LPIN2,CTBP1,NPAS3,PTPRZ1,SORCS2 |
1.343e-03 | -6.61 | right_upper_lobe | COSMIC cancer mutations | right_upper_lobe | 10376 | 39 | 16828 | 47 |
SLC1A2,LAMA4,PRDM16,PREX1,ELOVL2,FGFR3,APOA1,NFIA,PREX2,FHOD3,BCAR3,NCKAP5,ZBTB20,RORA,PTN,FARP1,UNC93A,GRK5,EGF,FGFRL1,SOX5,SLC39A12,SLC4A4,LRIG1,DGKB,GPM6B,TRPS1,AMOT,RFX4,LPIN2,PTPRZ1,NPAS3,CTBP1,SORCS2,USP6NL,SLC1A3,GPC5,TNS3,SLC6A11 |
1.354e-03 | -6.60 | APC (APC regulator of WNT signaling pathway) | protein interactions | 324 | 327 | 5 | 19454 | 49 |
GJA1,NCKAP5,AMOT,CTBP1,LAMA4 |
1.361e-03 | -6.60 | aspartate transmembrane transport | biological process | GO:0015810 | 20 | 2 | 18204 | 50 |
SLC1A3,SLC1A2 |
1.377e-03 | -6.59 | scalp | COSMIC cancer mutations | scalp | 2110 | 14 | 16828 | 47 |
PREX1,LAMA4,SOX5,SLC4A4,FGFR3,PREX2,NFIA,TRPS1,PTPRZ1,PTN,RORA,FARP1,GPC5,SLC6A11 |
1.390e-03 | -6.58 | Dusp14 (dual specificity phosphatase 14) | protein interactions | 56405 | 22 | 2 | 19454 | 49 |
CTBP1,QKI |
1.404e-03 | -6.57 | MED1 (mediator complex subunit 1) | protein interactions | 5469 | 193 | 4 | 19454 | 49 |
QKI,CTBP1,RORA,PRKN |
1.410e-03 | -6.56 | LGALS3 (galectin 3) | protein interactions | 3958 | 330 | 5 | 19454 | 49 |
PTPRZ1,LAMA4,PRKN,SLC1A3,APOA1 |
1.425e-03 | -6.55 | behavior | biological process | GO:0007610 | 619 | 7 | 18204 | 50 |
SLC1A2,PTPRZ1,ADGRB3,SLC1A3,PREX2,PTN,PRKN |
1.431e-03 | -6.55 | DH_2 | prosite domains | PS50010 | 70 | 3 | 12186 | 39 |
FARP1,PREX2,PREX1 |
1.452e-03 | -6.54 | GDS_CDC24_CS | interpro domains | IPR001331 | 21 | 2 | 18521 | 50 |
PREX2,PREX1 |
1.482e-03 | -6.51 | regulation of bone mineralization | biological process | GO:0030500 | 82 | 3 | 18204 | 50 |
GJA1,GPM6B,PTN |
1.501e-03 | -6.50 | central_nervous_system-brain-glioma-astrocytoma_Grade_III | COSMIC cancer mutations | central_nervous_system-brain-glioma-astrocytoma_Grade_III | 1419 | 11 | 16828 | 47 |
PRDM16,FGFR3,SLC39A12,GRK5,BCAR3,SNTB1,NCKAP5,GPC5,TNS3,FHOD3,FARP1 |
1.502e-03 | -6.50 | positive regulation of nucleotide catabolic process | biological process | GO:0030813 | 21 | 2 | 18204 | 50 |
SLC4A4,ZBTB20 |
1.502e-03 | -6.50 | positive regulation of purine nucleotide catabolic process | biological process | GO:0033123 | 21 | 2 | 18204 | 50 |
SLC4A4,ZBTB20 |
1.502e-03 | -6.50 | positive regulation of stem cell differentiation | biological process | GO:2000738 | 21 | 2 | 18204 | 50 |
PTN,SOX5 |
1.502e-03 | -6.50 | positive regulation of glycolytic process | biological process | GO:0045821 | 21 | 2 | 18204 | 50 |
ZBTB20,SLC4A4 |
1.520e-03 | -6.49 | SIM2 (SIM bHLH transcription factor 2) | protein interactions | 6493 | 23 | 2 | 19454 | 49 |
PRKN,PREX1 |
1.520e-03 | -6.49 | Rbm38 (RNA binding motif protein 38) | protein interactions | 56190 | 23 | 2 | 19454 | 49 |
MSI2,QKI |
1.526e-03 | -6.49 | FAM120A (family with sequence similarity 120 member A) | protein interactions | 23196 | 336 | 5 | 19454 | 49 |
PRDM16,GRK5,PRKN,FKBP5,QKI |
1.570e-03 | -6.46 | DEP | pfam domains | PF00610 | 21 | 2 | 17795 | 50 |
PREX2,PREX1 |
1.594e-03 | -6.44 | DEP_dom | interpro domains | IPR000591 | 22 | 2 | 18521 | 50 |
PREX1,PREX2 |
1.644e-03 | -6.41 | oligodendrocyte differentiation | biological process | GO:0048709 | 85 | 3 | 18204 | 50 |
PTPRZ1,GPM6B,ASPA |
1.662e-03 | -6.40 | DMRTB1 (DMRT like family B with proline rich C-terminal 1) | protein interactions | 63948 | 93 | 3 | 19454 | 49 |
QKI,CTBP1,MSI2 |
1.668e-03 | -6.40 | positive regulation of hydrolase activity | biological process | GO:0051345 | 466 | 6 | 18204 | 50 |
BCAR3,FGFR3,PREX2,USP6NL,APOA1,PREX1 |
1.676e-03 | -6.39 | bone-femur-other-chondroblastoma | COSMIC cancer mutations | bone-femur-other-chondroblastoma | 183 | 4 | 16828 | 47 |
GPC5,PREX1,NCKAP5,SNTB1 |
1.680e-03 | -6.39 | RhoGEF | smart domains | SM00325 | 68 | 3 | 9717 | 34 |
FARP1,PREX2,PREX1 |
1.683e-03 | -6.39 | fibroblast growth factor binding | molecular function | GO:0017134 | 23 | 2 | 18094 | 48 |
FGFRL1,FGFR3 |
1.700e-03 | -6.38 | transport across blood-brain barrier | biological process | GO:0150104 | 86 | 3 | 18204 | 50 |
SLC4A4,SLC1A2,SLC1A3 |
1.700e-03 | -6.38 | vascular transport | biological process | GO:0010232 | 86 | 3 | 18204 | 50 |
SLC1A2,SLC1A3,SLC4A4 |
1.713e-03 | -6.37 | diffuse_adenocarcinoma | COSMIC cancer mutations | diffuse_adenocarcinoma | 4383 | 22 | 16828 | 47 |
PREX2,TRPS1,FHOD3,DGKB,LAMA4,SOX5,PREX1,ELOVL2,SLC39A12,FGFR3,SNTB1,NHSL1,SLC6A11,FKBP5,PTN,SLC1A3,FARP1,SORCS2,RFX4,NCKAP5,PTPRZ1,QKI |
1.713e-03 | -6.37 | stomach-carcinoma-diffuse_adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-diffuse_adenocarcinoma | 4383 | 22 | 16828 | 47 |
FGFR3,SLC39A12,ELOVL2,PREX1,LAMA4,SOX5,SNTB1,FHOD3,TRPS1,PREX2,DGKB,SORCS2,QKI,NCKAP5,PTPRZ1,RFX4,SLC6A11,NHSL1,FARP1,PTN,SLC1A3,FKBP5 |
1.714e-03 | -6.37 | WWC1 (WW and C2 domain containing 1) | protein interactions | 23286 | 94 | 3 | 19454 | 49 |
USP6NL,AMOT,PRKN |
1.751e-03 | -6.35 | UTRN (utrophin) | protein interactions | 7402 | 205 | 4 | 19454 | 49 |
FGFR3,SNTB1,GJA1,TNS3 |
1.797e-03 | -6.32 | DDX59 (DEAD-box helicase 59) | protein interactions | 83479 | 25 | 2 | 19454 | 49 |
FKBP5,PRKN |
1.820e-03 | -6.31 | KCTD5 (potassium channel tetramerization domain containing 5) | protein interactions | 54442 | 96 | 3 | 19454 | 49 |
GRK5,PRKN,GJA1 |
1.846e-03 | -6.29 | GATAD2A (GATA zinc finger domain containing 2A) | protein interactions | 54815 | 208 | 4 | 19454 | 49 |
SOX5,TRPS1,PRDM16,PRKN |
1.861e-03 | -6.29 | skin-face-malignant_melanoma-lentigo_maligna | COSMIC cancer mutations | skin-face-malignant_melanoma-lentigo_maligna | 23 | 2 | 16828 | 47 |
FGFR3,PREX2 |
1.868e-03 | -6.28 | pharynx | COSMIC cancer mutations | pharynx | 2696 | 16 | 16828 | 47 |
SORCS2,RFX4,NPAS3,QKI,PTPRZ1,NCKAP5,GPC5,NHSL1,FGFRL1,SLC4A4,SLC39A12,FGFR3,SLC1A2,EGF,PREX2,NFIA |
1.871e-03 | -6.28 | CTBP2 (C-terminal binding protein 2) | protein interactions | 1488 | 352 | 5 | 19454 | 49 |
MSI2,CTBP1,PRDM16,TRPS1,PRKN |
1.894e-03 | -6.27 | ESYT2 (extended synaptotagmin 2) | protein interactions | 57488 | 353 | 5 | 19454 | 49 |
PRKN,ELOVL2,GJA1,FARP1,USP6NL |
1.906e-03 | -6.26 | oesophagus-middle_third-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-middle_third-carcinoma-squamous_cell_carcinoma | 3531 | 19 | 16828 | 47 |
SORCS2,PTPRZ1,BCAR3,UNC93A,NHSL1,GPC5,TNS3,FARP1,ZBTB20,FKBP5,SLC4A4,SLC39A12,LAMA4,SOX5,PRDM16,GRK5,FHOD3,PREX2,LRIG1 |
1.913e-03 | -6.26 | human chr6q12-q13 | chromosome location | human chr6q12-q13 | 1 | 1 | 26134 | 50 |
ADGRB3 |
1.920e-03 | -6.26 | middle_third | COSMIC cancer mutations | middle_third | 3533 | 19 | 16828 | 47 |
UNC93A,GPC5,NHSL1,TNS3,FARP1,ZBTB20,FKBP5,SORCS2,PTPRZ1,BCAR3,FHOD3,PREX2,LRIG1,SLC39A12,SLC4A4,LAMA4,SOX5,PRDM16,GRK5 |
1.928e-03 | -6.25 | anchoring junction | cellular component | GO:0070161 | 902 | 8 | 19108 | 49 |
PLPP3,AMOT,FGFR3,FGFRL1,TNS3,SNTB1,BCAR3,GJA1 |
1.931e-03 | -6.25 | PSMF1 (proteasome inhibitor subunit 1) | protein interactions | 9491 | 98 | 3 | 19454 | 49 |
QKI,CTBP1,PRKN |
1.942e-03 | -6.24 | TLE3 (TLE family member 3, transcriptional corepressor) | protein interactions | 7090 | 355 | 5 | 19454 | 49 |
NFIA,PRKN,TRPS1,QKI,FKBP5 |
1.943e-03 | -6.24 | ZNF750 (zinc finger protein 750) | protein interactions | 79755 | 26 | 2 | 19454 | 49 |
CTBP1,PRKN |
1.943e-03 | -6.24 | TSSK2 (testis specific serine kinase 2) | protein interactions | 23617 | 26 | 2 | 19454 | 49 |
APOA1,FKBP5 |
1.943e-03 | -6.24 | AP3M2 (adaptor related protein complex 3 subunit mu 2) | protein interactions | 10947 | 26 | 2 | 19454 | 49 |
PRKN,GRK5 |
2.013e-03 | -6.21 | ANKFY1 (ankyrin repeat and FYVE domain containing 1) | protein interactions | 51479 | 213 | 4 | 19454 | 49 |
FARP1,GRK5,PRKN,CTBP1 |
2.013e-03 | -6.21 | AP1M1 (adaptor related protein complex 1 subunit mu 1) | protein interactions | 8907 | 213 | 4 | 19454 | 49 |
BCAR3,PRDM16,PRKN,AMOT |
2.017e-03 | -6.21 | DH_1 | prosite domains | PS00741 | 21 | 2 | 12186 | 39 |
PREX1,PREX2 |
2.017e-03 | -6.21 | DEP | prosite domains | PS50186 | 21 | 2 | 12186 | 39 |
PREX2,PREX1 |
2.031e-03 | -6.20 | CTNNB1 (catenin beta 1) | protein interactions | 1499 | 926 | 8 | 19454 | 49 |
PRKN,PTN,NHSL1,GJA1,CTBP1,PTPRZ1,USP6NL,AMOT |
2.039e-03 | -6.20 | Glutamate Neurotransmitter Release Cycle | REACTOME pathways | R-HSA-210500 | 24 | 2 | 10285 | 29 |
SLC1A2,SLC1A3 |
2.090e-03 | -6.17 | regulation of small molecule metabolic process | biological process | GO:0062012 | 331 | 5 | 18204 | 50 |
PRKN,ZBTB20,APOA1,SLC4A4,RORA |
2.095e-03 | -6.17 | ARMCX5 (armadillo repeat containing X-linked 5) | protein interactions | 64860 | 27 | 2 | 19454 | 49 |
FKBP5,PRKN |
2.130e-03 | -6.15 | rhabdomyosarcoma | COSMIC cancer mutations | rhabdomyosarcoma | 4150 | 21 | 16828 | 47 |
DGKB,PREX2,NFIA,FHOD3,TRPS1,GRK5,PRDM16,FGFRL1,FGFR3,ELOVL2,SLC1A3,RORA,USP6NL,NHSL1,GJA1,NPAS3,CTBP1,NCKAP5,PTPRZ1,SORCS2,AQP4 |
2.130e-03 | -6.15 | L-glutamate transmembrane transport | biological process | GO:0015813 | 25 | 2 | 18204 | 50 |
SLC1A2,SLC1A3 |
2.155e-03 | -6.14 | pancreas-carcinoma | COSMIC cancer mutations | pancreas-carcinoma | 14770 | 47 | 16828 | 47 |
AQP4,GJA1,NCKAP5,QKI,NHSL1,UNC93A,FKBP5,ZBTB20,LAMA4,PREX1,ELOVL2,FGFR3,SLC1A2,FHOD3,APOA1,SORCS2,ASPA,AMOT,NPAS3,SLC6A11,FGFRL1,SOX5,SLC4A4,SNTB1,GPM6B,TRPS1,LRIG1,DGKB,BCAR3,RORA,PTN,FARP1,PRDM16,NFIA,PREX2,MSI2,RFX4,LPIN2,PTPRZ1,CTBP1,GPC5,TNS3,USP6NL,SLC1A3,SLC39A12,GRK5,EGF |
2.164e-03 | -6.14 | PATJ (PATJ crumbs cell polarity complex component) | protein interactions | 10207 | 102 | 3 | 19454 | 49 |
PRKN,PRDM16,AMOT |
2.195e-03 | -6.12 | neuron development | biological process | GO:0048666 | 859 | 8 | 18204 | 50 |
PTPRZ1,SLC39A12,SLC1A3,PREX2,PTN,GPM6B,FARP1,ADGRB3 |
2.253e-03 | -6.10 | SYT11 (synaptotagmin 11) | protein interactions | 23208 | 28 | 2 | 19454 | 49 |
PRKN,ZBTB20 |
2.253e-03 | -6.10 | RCOR2 (REST corepressor 2) | protein interactions | 283248 | 28 | 2 | 19454 | 49 |
CTBP1,PRDM16 |
2.304e-03 | -6.07 | central nervous system myelination | biological process | GO:0022010 | 26 | 2 | 18204 | 50 |
GPM6B,ASPA |
2.304e-03 | -6.07 | axon ensheathment in central nervous system | biological process | GO:0032291 | 26 | 2 | 18204 | 50 |
ASPA,GPM6B |
2.304e-03 | -6.07 | C4-dicarboxylate transport | biological process | GO:0015740 | 26 | 2 | 18204 | 50 |
SLC1A2,SLC1A3 |
2.328e-03 | -6.06 | integrin-mediated signaling pathway | biological process | GO:0007229 | 96 | 3 | 18204 | 50 |
PTN,PLPP3,APOA1 |
2.366e-03 | -6.05 | amino acid transmembrane transporter activity | molecular function | GO:0015171 | 100 | 3 | 18094 | 48 |
SLC6A11,SLC1A2,SLC1A3 |
2.377e-03 | -6.04 | skeletal system development | biological process | GO:0001501 | 500 | 6 | 18204 | 50 |
NFIA,TRPS1,SOX5,FGFR3,FGFRL1,GJA1 |
2.394e-03 | -6.03 | DEP | smart domains | SM00049 | 21 | 2 | 9717 | 34 |
PREX1,PREX2 |
2.398e-03 | -6.03 | amino acid transmembrane transport | biological process | GO:0003333 | 97 | 3 | 18204 | 50 |
SLC6A11,SLC1A2,SLC1A3 |
2.410e-03 | -6.03 | pleura-mesothelioma | COSMIC cancer mutations | pleura-mesothelioma | 4189 | 21 | 16828 | 47 |
FGFR3,PREX1,PRDM16,SOX5,SNTB1,GRK5,TRPS1,PREX2,GPM6B,DGKB,LRIG1,MSI2,QKI,PTPRZ1,BCAR3,LPIN2,AMOT,FARP1,USP6NL,RORA,FKBP5 |
2.415e-03 | -6.03 | USP30 (ubiquitin specific peptidase 30) | protein interactions | 84749 | 106 | 3 | 19454 | 49 |
FGFR3,PRKN,QKI |
2.415e-03 | -6.03 | PTN (pleiotrophin) | protein interactions | 5764 | 106 | 3 | 19454 | 49 |
PTN,LAMA4,PTPRZ1 |
2.416e-03 | -6.03 | ALG6 (ALG6 alpha-1,3-glucosyltransferase) | protein interactions | 29929 | 29 | 2 | 19454 | 49 |
PRKN,FGFR3 |
2.484e-03 | -6.00 | gastrulation with mouth forming second | biological process | GO:0001702 | 27 | 2 | 18204 | 50 |
PLPP3,AMOT |
2.498e-03 | -5.99 | cellular response to organonitrogen compound | biological process | GO:0071417 | 505 | 6 | 18204 | 50 |
SLC1A3,GJA1,PRKN,SLC1A2,BCAR3,LPIN2 |
2.519e-03 | -5.98 | Apob (apolipoprotein B) | protein interactions | 238055 | 1 | 1 | 19454 | 49 |
APOA1 |
2.519e-03 | -5.98 | Sh2b1 (SH2B adaptor protein 1) | protein interactions | 20399 | 1 | 1 | 19454 | 49 |
FGFR3 |
2.519e-03 | -5.98 | GRXCR2 (glutaredoxin and cysteine rich domain containing 2) | protein interactions | 643226 | 1 | 1 | 19454 | 49 |
PRKN |
2.519e-03 | -5.98 | C1QL2 (complement C1q like 2) | protein interactions | 165257 | 1 | 1 | 19454 | 49 |
ADGRB3 |
2.519e-03 | -5.98 | PCDHGA1 (protocadherin gamma subfamily A, 1) | protein interactions | 56114 | 1 | 1 | 19454 | 49 |
PRKN |
2.519e-03 | -5.98 | C1orf141 (chromosome 1 open reading frame 141) | protein interactions | 400757 | 1 | 1 | 19454 | 49 |
PRKN |
2.519e-03 | -5.98 | fgf3.L (fibroblast growth factor 3 L homeolog) | protein interactions | 373669 | 1 | 1 | 19454 | 49 |
FGFR3 |
2.519e-03 | -5.98 | Atxn3 (ataxin 3) | protein interactions | 60331 | 1 | 1 | 19454 | 49 |
PRKN |
2.519e-03 | -5.98 | CFAP61 (cilia and flagella associated protein 61) | protein interactions | 26074 | 1 | 1 | 19454 | 49 |
PRKN |
2.519e-03 | -5.98 | IGHV3-15 (immunoglobulin heavy variable 3-15) | protein interactions | 28448 | 1 | 1 | 19454 | 49 |
PRKN |
2.519e-03 | -5.98 | FAM20A (FAM20A golgi associated secretory pathway pseudokinase) | protein interactions | 54757 | 1 | 1 | 19454 | 49 |
PRKN |
2.519e-03 | -5.98 | SNCA (synuclein alpha) | protein interactions | 282857 | 1 | 1 | 19454 | 49 |
GRK5 |
2.519e-03 | -5.98 | ERVK-10 (endogenous retrovirus group K member 10) | protein interactions | 100616101 | 1 | 1 | 19454 | 49 |
APOA1 |
2.519e-03 | -5.98 | FRMPD3 (FERM and PDZ domain containing 3) | protein interactions | 84443 | 1 | 1 | 19454 | 49 |
PRKN |
2.519e-03 | -5.98 | RFX8 (regulatory factor X8) | protein interactions | 731220 | 1 | 1 | 19454 | 49 |
PRKN |
2.519e-03 | -5.98 | MRO (maestro) | protein interactions | 83876 | 1 | 1 | 19454 | 49 |
PRKN |
2.519e-03 | -5.98 | Grik2 (glutamate ionotropic receptor kainate type subunit 2) | protein interactions | 54257 | 1 | 1 | 19454 | 49 |
PRKN |
2.519e-03 | -5.98 | IQCA1 (IQ motif containing with AAA domain 1) | protein interactions | 79781 | 1 | 1 | 19454 | 49 |
PRKN |
2.519e-03 | -5.98 | OR8G1 (olfactory receptor family 8 subfamily G member 1) | protein interactions | 26494 | 1 | 1 | 19454 | 49 |
PRKN |
2.519e-03 | -5.98 | LINC01553 (long intergenic non-protein coding RNA 1553) | protein interactions | 283025 | 1 | 1 | 19454 | 49 |
PRKN |
2.519e-03 | -5.98 | IZUMO3 (IZUMO family member 3) | protein interactions | 100129669 | 1 | 1 | 19454 | 49 |
PRKN |
2.519e-03 | -5.98 | Ube2l3 (ubiquitin-conjugating enzyme E2L 3) | protein interactions | 363836 | 1 | 1 | 19454 | 49 |
PRKN |
2.519e-03 | -5.98 | CALM1P1 (calmodulin 1 pseudogene 1) | protein interactions | 802 | 1 | 1 | 19454 | 49 |
PRKN |
2.519e-03 | -5.98 | Pals1 (protein associated with LIN7 1, MAGUK family member) | protein interactions | 56217 | 1 | 1 | 19454 | 49 |
AMOT |
2.519e-03 | -5.98 | E1A (E1A) | protein interactions | 2958468 | 1 | 1 | 19454 | 49 |
CTBP1 |
2.519e-03 | -5.98 | FAM47C (family with sequence similarity 47 member C) | protein interactions | 442444 | 1 | 1 | 19454 | 49 |
PRKN |
2.519e-03 | -5.98 | AKR1E2 (aldo-keto reductase family 1 member E2) | protein interactions | 83592 | 1 | 1 | 19454 | 49 |
PRKN |
2.519e-03 | -5.98 | HDAC2 (histone deacetylase 2) | protein interactions | 395635 | 1 | 1 | 19454 | 49 |
PRDM16 |
2.519e-03 | -5.98 | MSB4 (Rab GTPase-activating protein MSB4) | protein interactions | 854037 | 1 | 1 | 19454 | 49 |
USP6NL |
2.519e-03 | -5.98 | Patj (PATJ, crumbs cell polarity complex component) | protein interactions | 12695 | 1 | 1 | 19454 | 49 |
AMOT |
2.519e-03 | -5.98 | OR10A5 (olfactory receptor family 10 subfamily A member 5) | protein interactions | 144124 | 1 | 1 | 19454 | 49 |
PRKN |
2.521e-03 | -5.98 | B3GAT1 (beta-1,3-glucuronyltransferase 1) | protein interactions | 27087 | 377 | 5 | 19454 | 49 |
FARP1,GJA1,ELOVL2,PLPP3,FGFRL1 |
2.536e-03 | -5.98 | MAP4K4 (mitogen-activated protein kinase kinase kinase kinase 4) | protein interactions | 9448 | 227 | 4 | 19454 | 49 |
AMOT,GRK5,PRKN,GJA1 |
2.573e-03 | -5.96 | cell morphogenesis | biological process | GO:0000902 | 687 | 7 | 18204 | 50 |
PREX2,SLC1A3,PTN,SLC39A12,FARP1,NFIA,PTPRZ1 |
2.578e-03 | -5.96 | mouth | COSMIC cancer mutations | mouth | 9004 | 35 | 16828 | 47 |
RORA,ZBTB20,PTN,UNC93A,NHSL1,NCKAP5,QKI,BCAR3,APOA1,FHOD3,PREX2,SLC1A2,ELOVL2,FGFR3,LAMA4,PRDM16,PREX1,USP6NL,SLC1A3,GPC5,TNS3,PTPRZ1,CTBP1,NPAS3,RFX4,SORCS2,LRIG1,DGKB,TRPS1,SNTB1,EGF,GRK5,SLC39A12,SLC4A4,SOX5 |
2.614e-03 | -5.95 | regulation of dendrite development | biological process | GO:0050773 | 100 | 3 | 18204 | 50 |
PTN,PREX1,ADGRB3 |
2.638e-03 | -5.94 | USP9X (ubiquitin specific peptidase 9 X-linked) | protein interactions | 8239 | 381 | 5 | 19454 | 49 |
AMOT,GJA1,GRK5,PRKN,FGFR3 |
2.653e-03 | -5.93 | aspartoacylase activity | molecular function | GO:0019807 | 1 | 1 | 18094 | 48 |
ASPA |
2.653e-03 | -5.93 | internal N(7)-methylguanine-containing RNA reader activity | molecular function | GO:0160089 | 1 | 1 | 18094 | 48 |
QKI |
2.663e-03 | -5.93 | positive regulation of GTPase activity | biological process | GO:0043547 | 211 | 4 | 18204 | 50 |
PREX2,BCAR3,USP6NL,PREX1 |
2.700e-03 | -5.91 | RING-HC_RBR_parkin | interpro domains | IPR047535 | 1 | 1 | 18521 | 50 |
PRKN |
2.700e-03 | -5.91 | Pro-epidermal_GF | interpro domains | IPR016317 | 1 | 1 | 18521 | 50 |
EGF |
2.700e-03 | -5.91 | Quaking_NLS | interpro domains | IPR032367 | 1 | 1 | 18521 | 50 |
QKI |
2.700e-03 | -5.91 | STAR_dimer | interpro domains | IPR032377 | 1 | 1 | 18521 | 50 |
QKI |
2.700e-03 | -5.91 | C1_DGKbeta_rpt2 | interpro domains | IPR047470 | 1 | 1 | 18521 | 50 |
DGKB |
2.700e-03 | -5.91 | Na/ntran_symport_GABA_GAT3 | interpro domains | IPR002982 | 1 | 1 | 18521 | 50 |
SLC6A11 |
2.700e-03 | -5.91 | Rcat_RBR_parkin | interpro domains | IPR047536 | 1 | 1 | 18521 | 50 |
PRKN |
2.700e-03 | -5.91 | Rex2_DEP_1 | interpro domains | IPR037367 | 1 | 1 | 18521 | 50 |
PREX2 |
2.700e-03 | -5.91 | Znf-RING_14 | interpro domains | IPR041170 | 1 | 1 | 18521 | 50 |
PRKN |
2.700e-03 | -5.91 | Connexin43_C | interpro domains | IPR013124 | 1 | 1 | 18521 | 50 |
GJA1 |
2.700e-03 | -5.91 | Parkin_Znf-RING | interpro domains | IPR041565 | 1 | 1 | 18521 | 50 |
PRKN |
2.700e-03 | -5.91 | Alpha_helix_dom_sf | interpro domains | IPR035091 | 1 | 1 | 18521 | 50 |
GJA1 |
2.700e-03 | -5.91 | BRcat_RBR_parkin | interpro domains | IPR047534 | 1 | 1 | 18521 | 50 |
PRKN |
2.700e-03 | -5.91 | Parkin | interpro domains | IPR003977 | 1 | 1 | 18521 | 50 |
PRKN |
2.700e-03 | -5.91 | Connexin43 | interpro domains | IPR002261 | 1 | 1 | 18521 | 50 |
GJA1 |
2.700e-03 | -5.91 | ELOVL2 | interpro domains | IPR033680 | 1 | 1 | 18521 | 50 |
ELOVL2 |
2.700e-03 | -5.91 | TRPS1 | interpro domains | IPR028440 | 1 | 1 | 18521 | 50 |
TRPS1 |
2.700e-03 | -5.91 | C1_DGKbeta-like_rpt1 | interpro domains | IPR047471 | 1 | 1 | 18521 | 50 |
DGKB |
2.700e-03 | -5.91 | PRDM16_PR-SET | interpro domains | IPR044410 | 1 | 1 | 18521 | 50 |
PRDM16 |
2.735e-03 | -5.90 | large_cell | COSMIC cancer mutations | large_cell | 14845 | 47 | 16828 | 47 |
FGFR3,ELOVL2,PREX1,LAMA4,SLC1A2,FHOD3,APOA1,AQP4,QKI,NCKAP5,GJA1,UNC93A,NHSL1,FKBP5,ZBTB20,SLC4A4,FGFRL1,SOX5,SNTB1,TRPS1,GPM6B,DGKB,LRIG1,ASPA,SORCS2,NPAS3,AMOT,SLC6A11,PRDM16,PREX2,NFIA,BCAR3,FARP1,PTN,RORA,SLC39A12,EGF,GRK5,MSI2,CTBP1,PTPRZ1,LPIN2,RFX4,TNS3,GPC5,SLC1A3,USP6NL |
2.742e-03 | -5.90 | kidney-carcinoma-renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-renal_cell_carcinoma | 4535 | 22 | 16828 | 47 |
GRK5,SNTB1,PREX1,PRDM16,SOX5,FGFR3,SLC39A12,DGKB,LRIG1,PREX2,GPM6B,TRPS1,BCAR3,LPIN2,AMOT,QKI,PTPRZ1,MSI2,FKBP5,RORA,USP6NL,FARP1 |
2.742e-03 | -5.90 | renal_cell_carcinoma | COSMIC cancer mutations | renal_cell_carcinoma | 4535 | 22 | 16828 | 47 |
BCAR3,LPIN2,AMOT,QKI,PTPRZ1,MSI2,USP6NL,RORA,FKBP5,FARP1,GRK5,SNTB1,PREX1,PRDM16,SOX5,FGFR3,SLC39A12,DGKB,LRIG1,PREX2,GPM6B,TRPS1 |
2.743e-03 | -5.90 | CDC23 (cell division cycle 23) | protein interactions | 8697 | 232 | 4 | 19454 | 49 |
FHOD3,PRKN,CTBP1,SOX5 |
2.747e-03 | -5.90 | negative regulation of spontaneous neurotransmitter secretion | biological process | GO:1904049 | 1 | 1 | 18204 | 50 |
PRKN |
2.747e-03 | -5.90 | atrial ventricular junction remodeling | biological process | GO:0003294 | 1 | 1 | 18204 | 50 |
GJA1 |
2.747e-03 | -5.90 | milk ejection reflex | biological process | GO:0060156 | 1 | 1 | 18204 | 50 |
GJA1 |
2.758e-03 | -5.89 | C5orf34 (chromosome 5 open reading frame 34) | protein interactions | 375444 | 31 | 2 | 19454 | 49 |
FKBP5,PRKN |
2.764e-03 | -5.89 | Connexin43 | gene3d domains | 1.20.5.1130 | 1 | 1 | 14470 | 40 |
GJA1 |
2.764e-03 | -5.89 | - | gene3d domains | 1.20.5.20 | 1 | 1 | 14470 | 40 |
APOA1 |
2.764e-03 | -5.89 | - | gene3d domains | 1.20.5.4010 | 1 | 1 | 14470 | 40 |
QKI |
2.764e-03 | -5.89 | - | gene3d domains | 6.10.140.380 | 1 | 1 | 14470 | 40 |
APOA1 |
2.764e-03 | -5.89 | - | gene3d domains | 6.10.250.1740 | 1 | 1 | 14470 | 40 |
FGFR3 |
2.810e-03 | -5.87 | Quaking_NLS | pfam domains | PF16551 | 1 | 1 | 17795 | 50 |
QKI |
2.810e-03 | -5.87 | zf-RING_12 | pfam domains | PF17976 | 1 | 1 | 17795 | 50 |
PRKN |
2.810e-03 | -5.87 | zf-RING_14 | pfam domains | PF17978 | 1 | 1 | 17795 | 50 |
PRKN |
2.810e-03 | -5.87 | FGFR3_TM | pfam domains | PF21165 | 1 | 1 | 17795 | 50 |
FGFR3 |
2.810e-03 | -5.87 | Connexin43 | pfam domains | PF03508 | 1 | 1 | 17795 | 50 |
GJA1 |
2.810e-03 | -5.87 | STAR_dimer | pfam domains | PF16544 | 1 | 1 | 17795 | 50 |
QKI |
2.820e-03 | -5.87 | t(4;14) translocations of FGFR3 | REACTOME pathways | R-HSA-2033515 | 1 | 1 | 10285 | 29 |
FGFR3 |
2.820e-03 | -5.87 | Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane | REACTOME pathways | R-HSA-190840 | 1 | 1 | 10285 | 29 |
GJA1 |
2.823e-03 | -5.87 | TBR1 (T-box brain transcription factor 1) | protein interactions | 10716 | 112 | 3 | 19454 | 49 |
TRPS1,NFIA,SOX5 |
2.843e-03 | -5.86 | regulation of neural precursor cell proliferation | biological process | GO:2000177 | 103 | 3 | 18204 | 50 |
EGF,PTPRZ1,PTN |
2.843e-03 | -5.86 | regulation of biomineral tissue development | biological process | GO:0070167 | 103 | 3 | 18204 | 50 |
PTN,GPM6B,GJA1 |
2.866e-03 | -5.85 | beta-catenin binding | molecular function | GO:0008013 | 107 | 3 | 18094 | 48 |
RORA,GJA1,PRKN |
2.906e-03 | -5.84 | ARF6 (ADP ribosylation factor 6) | protein interactions | 382 | 568 | 6 | 19454 | 49 |
SLC1A3,GJA1,FARP1,ELOVL2,USP6NL,PLPP3 |
2.937e-03 | -5.83 | C1orf21 (chromosome 1 open reading frame 21) | protein interactions | 81563 | 32 | 2 | 19454 | 49 |
PRKN,GJA1 |
2.940e-03 | -5.83 | astrocytoma_Grade_III | COSMIC cancer mutations | astrocytoma_Grade_III | 1544 | 11 | 16828 | 47 |
TNS3,GPC5,FARP1,NCKAP5,BCAR3,FHOD3,SLC39A12,FGFR3,PRDM16,SNTB1,GRK5 |
2.958e-03 | -5.82 | lung-carcinoma | COSMIC cancer mutations | lung-carcinoma | 4255 | 21 | 16828 | 47 |
TRPS1,GPM6B,PREX2,LRIG1,DGKB,FGFR3,SOX5,PRDM16,PREX1,SNTB1,GRK5,FARP1,RORA,USP6NL,FKBP5,MSI2,PTPRZ1,QKI,LPIN2,AMOT,BCAR3 |
3.042e-03 | -5.80 | non_small_cell_carcinoma | COSMIC cancer mutations | non_small_cell_carcinoma | 5198 | 24 | 16828 | 47 |
USP6NL,SLC1A3,PTPRZ1,NPAS3,LPIN2,AMOT,MSI2,LRIG1,DGKB,TRPS1,GPM6B,SNTB1,GRK5,SOX5,FARP1,FKBP5,RORA,QKI,BCAR3,FHOD3,PREX2,FGFR3,PRDM16,PREX1 |
3.042e-03 | -5.80 | lung-carcinoma-non_small_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-non_small_cell_carcinoma | 5198 | 24 | 16828 | 47 |
TRPS1,GPM6B,LRIG1,DGKB,SOX5,SNTB1,GRK5,USP6NL,SLC1A3,MSI2,PTPRZ1,NPAS3,AMOT,LPIN2,FHOD3,PREX2,FGFR3,PRDM16,PREX1,FARP1,RORA,FKBP5,QKI,BCAR3 |
3.062e-03 | -5.79 | L-glutamate import | biological process | GO:0051938 | 30 | 2 | 18204 | 50 |
SLC1A3,SLC1A2 |
3.087e-03 | -5.78 | oesophagus-carcinoma | COSMIC cancer mutations | oesophagus-carcinoma | 4269 | 21 | 16828 | 47 |
SORCS2,RFX4,PTPRZ1,NCKAP5,NHSL1,UNC93A,PTN,USP6NL,ZBTB20,PRDM16,PREX1,SOX5,SLC39A12,FGFR3,SLC4A4,ELOVL2,PREX2,NFIA,FHOD3,TRPS1,LRIG1 |
3.115e-03 | -5.77 | MAPK3 (mitogen-activated protein kinase 3) | protein interactions | 5595 | 396 | 5 | 19454 | 49 |
PRKN,TRPS1,GJA1,AMOT,FKBP5 |
3.122e-03 | -5.77 | SNCAIP (synuclein alpha interacting protein) | protein interactions | 9627 | 33 | 2 | 19454 | 49 |
PTN,PRKN |
3.136e-03 | -5.76 | central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-cerebellum-glioma-astrocytoma_Grade_I | 105 | 3 | 16828 | 47 |
QKI,GPC5,PRDM16 |
3.160e-03 | -5.76 | skin-malignant_melanoma-acral_lentiginous | COSMIC cancer mutations | skin-malignant_melanoma-acral_lentiginous | 30 | 2 | 16828 | 47 |
PREX2,FGFR3 |
3.160e-03 | -5.76 | lentigo_maligna | COSMIC cancer mutations | lentigo_maligna | 30 | 2 | 16828 | 47 |
FGFR3,PREX2 |
3.174e-03 | -5.75 | blood vessel development | biological process | GO:0001568 | 530 | 6 | 18204 | 50 |
GJA1,RORA,AMOT,PLPP3,QKI,EGF |
3.194e-03 | -5.75 | CHORDC1 (cysteine and histidine rich domain containing 1) | protein interactions | 26973 | 117 | 3 | 19454 | 49 |
FKBP5,AMOT,PRKN |
3.202e-03 | -5.74 | skin-head_neck-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-head_neck-carcinoma-squamous_cell_carcinoma | 14191 | 46 | 16828 | 47 |
NFIA,PREX2,PRDM16,FARP1,RORA,PTN,BCAR3,EGF,GRK5,SLC39A12,USP6NL,SLC1A3,GPC5,TNS3,PTPRZ1,CTBP1,LPIN2,RFX4,APOA1,FHOD3,SLC1A2,ELOVL2,FGFR3,LAMA4,PREX1,ZBTB20,FKBP5,UNC93A,NHSL1,NCKAP5,QKI,GJA1,AQP4,LRIG1,DGKB,TRPS1,GPM6B,SNTB1,SLC4A4,FGFRL1,SOX5,SLC6A11,NPAS3,AMOT,ASPA,SORCS2 |
3.238e-03 | -5.73 | functioning | COSMIC cancer mutations | functioning | 1803 | 12 | 16828 | 47 |
PTPRZ1,NCKAP5,LPIN2,RFX4,SLC6A11,TNS3,NHSL1,FARP1,ZBTB20,SOX5,GRK5,SLC1A2 |
3.238e-03 | -5.73 | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-functioning | COSMIC cancer mutations | adrenal_gland-adrenal_gland-adrenal_cortical_carcinoma-functioning | 1803 | 12 | 16828 | 47 |
FARP1,ZBTB20,SLC6A11,NHSL1,TNS3,NCKAP5,PTPRZ1,RFX4,LPIN2,GRK5,SLC1A2,SOX5 |
3.249e-03 | -5.73 | bicarbonate transmembrane transporter activity | molecular function | GO:0015106 | 32 | 2 | 18094 | 48 |
SLC4A4,SLC39A12 |
3.286e-03 | -5.72 | Transport of inorganic cations/anions and amino acids/oligopeptides | REACTOME pathways | R-HSA-425393 | 107 | 3 | 10285 | 29 |
SLC1A3,SLC4A4,SLC1A2 |
3.312e-03 | -5.71 | PTPRZ1 (protein tyrosine phosphatase receptor type Z1) | protein interactions | 5803 | 34 | 2 | 19454 | 49 |
PTN,PTPRZ1 |
3.335e-03 | -5.70 | TAB1 (TGF-beta activated kinase 1 (MAP3K7) binding protein 1) | protein interactions | 10454 | 245 | 4 | 19454 | 49 |
FARP1,GRK5,PRKN,FKBP5 |
3.350e-03 | -5.70 | ANKRD26 (ankyrin repeat domain containing 26) | protein interactions | 22852 | 119 | 3 | 19454 | 49 |
GJA1,AMOT,NCKAP5 |
3.350e-03 | -5.70 | TTC4 (tetratricopeptide repeat domain 4) | protein interactions | 7268 | 119 | 3 | 19454 | 49 |
FGFR3,PRKN,FKBP5 |
3.372e-03 | -5.69 | RAC1 (Rac family small GTPase 1) | protein interactions | 5879 | 1005 | 8 | 19454 | 49 |
TNS3,USP6NL,FARP1,PREX1,GJA1,PREX2,PRKN,SLC1A3 |
3.393e-03 | -5.69 | MET promotes cell motility | REACTOME pathways | R-HSA-8875878 | 31 | 2 | 10285 | 29 |
LAMA4,TNS3 |
3.444e-03 | -5.67 | GAT3TRNSPORT | prints domains | PR01197 | 1 | 1 | 5227 | 18 |
SLC6A11 |
3.444e-03 | -5.67 | CONNEXINA1 | prints domains | PR01132 | 1 | 1 | 5227 | 18 |
GJA1 |
3.444e-03 | -5.67 | AQUAPORIN4 | prints domains | PR02016 | 1 | 1 | 5227 | 18 |
AQP4 |
3.444e-03 | -5.67 | PARKIN | prints domains | PR01475 | 1 | 1 | 5227 | 18 |
PRKN |
3.479e-03 | -5.66 | transepithelial transport | biological process | GO:0070633 | 32 | 2 | 18204 | 50 |
SLC1A2,SLC1A3 |
3.479e-03 | -5.66 | positive regulation of ATP metabolic process | biological process | GO:1903580 | 32 | 2 | 18204 | 50 |
SLC4A4,ZBTB20 |
3.484e-03 | -5.66 | MET (MET proto-oncogene, receptor tyrosine kinase) | protein interactions | 4233 | 248 | 4 | 19454 | 49 |
TNS3,LRIG1,BCAR3,GJA1 |
3.498e-03 | -5.66 | cell population proliferation | biological process | GO:0008283 | 726 | 7 | 18204 | 50 |
SOX5,RORA,GJA1,APOA1,NFIA,FGFR3,EGF |
3.574e-03 | -5.63 | kidney-carcinoma | COSMIC cancer mutations | kidney-carcinoma | 3720 | 19 | 16828 | 47 |
USP6NL,RORA,FKBP5,FARP1,MSI2,BCAR3,LPIN2,QKI,PTPRZ1,PREX2,TRPS1,DGKB,LRIG1,PRDM16,PREX1,SOX5,FGFR3,GRK5,SNTB1 |
3.593e-03 | -5.63 | AVPR2 (arginine vasopressin receptor 2) | protein interactions | 554 | 122 | 3 | 19454 | 49 |
GJA1,ELOVL2,GRK5 |
3.632e-03 | -5.62 | aggresome | cellular component | GO:0016235 | 35 | 2 | 19108 | 49 |
PRDM16,PRKN |
3.652e-03 | -5.61 | circulatory system development | biological process | GO:0072359 | 933 | 8 | 18204 | 50 |
GJA1,AMOT,RORA,FHOD3,QKI,EGF,PLPP3,FGFRL1 |
3.676e-03 | -5.61 | RIOK2 (RIO kinase 2) | protein interactions | 55781 | 123 | 3 | 19454 | 49 |
BCAR3,PRDM16,PRKN |
3.692e-03 | -5.60 | dendrite development | biological process | GO:0016358 | 113 | 3 | 18204 | 50 |
FARP1,PTN,PREX2 |
3.697e-03 | -5.60 | blood vessel endothelial cell migration | biological process | GO:0043534 | 33 | 2 | 18204 | 50 |
APOA1,AMOT |
3.697e-03 | -5.60 | response to auditory stimulus | biological process | GO:0010996 | 33 | 2 | 18204 | 50 |
SLC1A3,PTN |
3.740e-03 | -5.59 | PRKAA1 (protein kinase AMP-activated catalytic subunit alpha 1) | protein interactions | 5562 | 253 | 4 | 19454 | 49 |
SLC4A4,PRKN,CTBP1,FKBP5 |
3.741e-03 | -5.59 | Glycerophospholipid metabolism | KEGG pathways | ko00564 | 95 | 3 | 7161 | 24 |
DGKB,PLPP3,LPIN2 |
3.741e-03 | -5.59 | Glycerophospholipid metabolism | KEGG pathways | hsa00564 | 95 | 3 | 7161 | 24 |
PLPP3,LPIN2,DGKB |
3.807e-03 | -5.57 | vasculature development | biological process | GO:0001944 | 550 | 6 | 18204 | 50 |
AMOT,GJA1,RORA,QKI,EGF,PLPP3 |
3.846e-03 | -5.56 | TCHP (trichoplein keratin filament binding) | protein interactions | 84260 | 125 | 3 | 19454 | 49 |
PRDM16,PRKN,AMOT |
3.846e-03 | -5.56 | STXBP1 (syntaxin binding protein 1) | protein interactions | 6812 | 125 | 3 | 19454 | 49 |
GJA1,PREX1,PRKN |
3.847e-03 | -5.56 | DYNLL2 (dynein light chain LC8-type 2) | protein interactions | 140735 | 255 | 4 | 19454 | 49 |
TRPS1,NFIA,NHSL1,AMOT |
3.901e-03 | -5.55 | IARS2 (isoleucyl-tRNA synthetase 2, mitochondrial) | protein interactions | 55699 | 256 | 4 | 19454 | 49 |
GJA1,FGFR3,PRKN,FKBP5 |
3.913e-03 | -5.54 | MOCOS (molybdenum cofactor sulfurase) | protein interactions | 55034 | 37 | 2 | 19454 | 49 |
PRKN,APOA1 |
3.913e-03 | -5.54 | DGAT1 (diacylglycerol O-acyltransferase 1) | protein interactions | 8694 | 37 | 2 | 19454 | 49 |
APOA1,PRKN |
3.913e-03 | -5.54 | TRNAU1AP (tRNA selenocysteine 1 associated protein 1) | protein interactions | 54952 | 37 | 2 | 19454 | 49 |
ZBTB20,QKI |
3.953e-03 | -5.53 | central_nervous_system-brainstem-glioma-oligoastrocytoma_Grade_III | COSMIC cancer mutations | central_nervous_system-brainstem-glioma-oligoastrocytoma_Grade_III | 114 | 3 | 16828 | 47 |
SLC1A2,SOX5,PREX2 |
4.021e-03 | -5.52 | PAX9 (paired box 9) | protein interactions | 5083 | 127 | 3 | 19454 | 49 |
QKI,NFIA,TRPS1 |
4.046e-03 | -5.51 | central_nervous_system-parietal_lobe-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-parietal_lobe-glioma-astrocytoma_Grade_I | 34 | 2 | 16828 | 47 |
FGFR3,QKI |
4.052e-03 | -5.51 | glial cell projection | cellular component | GO:0097386 | 37 | 2 | 19108 | 49 |
SLC1A2,AQP4 |
4.111e-03 | -5.49 | ATG5 (autophagy related 5) | protein interactions | 9474 | 128 | 3 | 19454 | 49 |
FGFR3,PRKN,GJA1 |
4.123e-03 | -5.49 | STK33 (serine/threonine kinase 33) | protein interactions | 65975 | 38 | 2 | 19454 | 49 |
PRKN,FKBP5 |
4.201e-03 | -5.47 | CHD7 (chromodomain helicase DNA binding protein 7) | protein interactions | 55636 | 129 | 3 | 19454 | 49 |
SOX5,FKBP5,ZBTB20 |
4.202e-03 | -5.47 | Choline metabolism in cancer | KEGG pathways | ko05231 | 99 | 3 | 7161 | 24 |
EGF,DGKB,PLPP3 |
4.202e-03 | -5.47 | Choline metabolism in cancer | KEGG pathways | hsa05231 | 99 | 3 | 7161 | 24 |
DGKB,EGF,PLPP3 |
4.339e-03 | -5.44 | PDK2 (pyruvate dehydrogenase kinase 2) | protein interactions | 5164 | 39 | 2 | 19454 | 49 |
FKBP5,PRKN |
4.339e-03 | -5.44 | CHPF (chondroitin polymerizing factor) | protein interactions | 79586 | 39 | 2 | 19454 | 49 |
PRKN,SLC39A12 |
4.386e-03 | -5.43 | TRPS1 (transcriptional repressor GATA binding 1) | protein interactions | 7227 | 131 | 3 | 19454 | 49 |
CTBP1,SOX5,NFIA |
4.480e-03 | -5.41 | DCAF11 (DDB1 and CUL4 associated factor 11) | protein interactions | 80344 | 132 | 3 | 19454 | 49 |
CTBP1,PRKN,LPIN2 |
4.488e-03 | -5.41 | extremity | COSMIC cancer mutations | extremity | 1876 | 12 | 16828 | 47 |
USP6NL,FKBP5,APOA1,PREX2,SLC6A11,FHOD3,BCAR3,PTPRZ1,CTBP1,PRDM16,SORCS2,FGFR3 |
4.528e-03 | -5.40 | central_nervous_system-thalamus-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-thalamus-glioma-astrocytoma_Grade_I | 36 | 2 | 16828 | 47 |
QKI,FGFR3 |
4.555e-03 | -5.39 | prostate-adenoma | COSMIC cancer mutations | prostate-adenoma | 1634 | 11 | 16828 | 47 |
NPAS3,EGF,PTPRZ1,PREX1,SOX5,FARP1,PTN,ZBTB20,FHOD3,SLC6A11,GPC5 |
4.561e-03 | -5.39 | GJC1 (gap junction protein gamma 1) | protein interactions | 10052 | 40 | 2 | 19454 | 49 |
GJA1,SLC39A12 |
4.561e-03 | -5.39 | CHGB (chromogranin B) | protein interactions | 1114 | 40 | 2 | 19454 | 49 |
PRKN,FGFR3 |
4.575e-03 | -5.39 | DUT (deoxyuridine triphosphatase) | protein interactions | 1854 | 133 | 3 | 19454 | 49 |
PRKN,FKBP5,CTBP1 |
4.588e-03 | -5.38 | MCM6 (minichromosome maintenance complex component 6) | protein interactions | 4175 | 268 | 4 | 19454 | 49 |
PRDM16,TRPS1,PRKN,FKBP5 |
4.605e-03 | -5.38 | positive regulation of neurogenesis | biological process | GO:0050769 | 246 | 4 | 18204 | 50 |
QKI,ASPA,PTN,PTPRZ1 |
4.628e-03 | -5.38 | focal adhesion | cellular component | GO:0005925 | 427 | 5 | 19108 | 49 |
SNTB1,TNS3,GJA1,BCAR3,FGFR3 |
4.631e-03 | -5.38 | positive regulation of nucleotide metabolic process | biological process | GO:0045981 | 37 | 2 | 18204 | 50 |
ZBTB20,SLC4A4 |
4.631e-03 | -5.38 | positive regulation of purine nucleotide metabolic process | biological process | GO:1900544 | 37 | 2 | 18204 | 50 |
SLC4A4,ZBTB20 |
4.631e-03 | -5.38 | bicarbonate transport | biological process | GO:0015701 | 37 | 2 | 18204 | 50 |
SLC39A12,SLC4A4 |
4.631e-03 | -5.38 | positive regulation of morphogenesis of an epithelium | biological process | GO:1905332 | 37 | 2 | 18204 | 50 |
EGF,GJA1 |
4.649e-03 | -5.37 | RND3 (Rho family GTPase 3) | protein interactions | 390 | 269 | 4 | 19454 | 49 |
USP6NL,CTBP1,SNTB1,FARP1 |
4.649e-03 | -5.37 | SRPRA (SRP receptor subunit alpha) | protein interactions | 6734 | 269 | 4 | 19454 | 49 |
PRKN,FGFR3,GJA1,SLC39A12 |
4.692e-03 | -5.36 | hand | COSMIC cancer mutations | hand | 566 | 6 | 16828 | 47 |
AMOT,FARP1,PREX2,PREX1,FGFR3,SLC4A4 |
4.705e-03 | -5.36 | positive regulation of molecular function | biological process | GO:0044093 | 1192 | 9 | 18204 | 50 |
USP6NL,APOA1,PREX1,PRKN,PREX2,FGFR3,PLPP3,EGF,BCAR3 |
4.710e-03 | -5.36 | WDR6 (WD repeat domain 6) | protein interactions | 11180 | 270 | 4 | 19454 | 49 |
GJA1,FARP1,PRKN,FKBP5 |
4.770e-03 | -5.35 | CEP350 (centrosomal protein 350) | protein interactions | 9857 | 135 | 3 | 19454 | 49 |
PRKN,AMOT,NCKAP5 |
4.777e-03 | -5.34 | ZFPL1 (zinc finger protein like 1) | protein interactions | 7542 | 438 | 5 | 19454 | 49 |
PRKN,GJA1,FARP1,SLC39A12,USP6NL |
4.778e-03 | -5.34 | central_nervous_system-third_ventricle-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-third_ventricle-glioma-astrocytoma_Grade_I | 37 | 2 | 16828 | 47 |
QKI,FGFR3 |
4.788e-03 | -5.34 | regulation of ossification | biological process | GO:0030278 | 124 | 3 | 18204 | 50 |
PTN,GPM6B,GJA1 |
4.788e-03 | -5.34 | fat cell differentiation | biological process | GO:0045444 | 124 | 3 | 18204 | 50 |
GRK5,PRDM16,CTBP1 |
4.808e-03 | -5.34 | bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 6023 | 26 | 16828 | 47 |
EGF,SLC4A4,SLC39A12,SOX5,FGFRL1,LRIG1,GPM6B,PTPRZ1,NPAS3,LPIN2,ASPA,SORCS2,SLC1A3,SLC6A11,TNS3,FGFR3,LAMA4,PRDM16,PREX1,FHOD3,PREX2,NCKAP5,FARP1,RORA,ZBTB20,UNC93A |
4.834e-03 | -5.33 | enzyme activator activity | molecular function | GO:0008047 | 599 | 6 | 18094 | 48 |
APOA1,PREX1,USP6NL,PREX2,ADGRB3,EGF |
4.869e-03 | -5.32 | SNX9 (sorting nexin 9) | protein interactions | 51429 | 136 | 3 | 19454 | 49 |
CTBP1,SLC1A3,PRKN |
4.880e-03 | -5.32 | amino acid import across plasma membrane | biological process | GO:0089718 | 38 | 2 | 18204 | 50 |
SLC1A3,SLC1A2 |
4.880e-03 | -5.32 | positive regulation of DNA binding | biological process | GO:0043388 | 38 | 2 | 18204 | 50 |
EGF,PRKN |
4.915e-03 | -5.32 | soft_tissue-striated_muscle-rhabdomyosarcoma-alveolar | COSMIC cancer mutations | soft_tissue-striated_muscle-rhabdomyosarcoma-alveolar | 2414 | 14 | 16828 | 47 |
GRK5,FGFRL1,FGFR3,PREX2,NFIA,FHOD3,TRPS1,CTBP1,NPAS3,NCKAP5,SORCS2,SLC1A3,USP6NL,NHSL1 |
4.915e-03 | -5.32 | alveolar | COSMIC cancer mutations | alveolar | 2414 | 14 | 16828 | 47 |
GRK5,FGFR3,FGFRL1,FHOD3,TRPS1,PREX2,NFIA,NPAS3,CTBP1,NCKAP5,SORCS2,SLC1A3,USP6NL,NHSL1 |
4.916e-03 | -5.32 | RHOQ (ras homolog family member Q) | protein interactions | 23433 | 441 | 5 | 19454 | 49 |
TNS3,USP6NL,FARP1,GJA1,SNTB1 |
4.928e-03 | -5.31 | cellular response to nitrogen compound | biological process | GO:1901699 | 580 | 6 | 18204 | 50 |
SLC1A3,GJA1,PRKN,SLC1A2,BCAR3,LPIN2 |
4.951e-03 | -5.31 | heat shock protein binding | molecular function | GO:0031072 | 130 | 3 | 18094 | 48 |
APOA1,PRKN,FKBP5 |
4.969e-03 | -5.30 | TBL1X (transducin beta like 1 X-linked) | protein interactions | 6907 | 137 | 3 | 19454 | 49 |
NFIA,SOX5,CTBP1 |
5.000e-03 | -5.30 | skin-ear-malignant_melanoma | COSMIC cancer mutations | skin-ear-malignant_melanoma | 124 | 3 | 16828 | 47 |
GRK5,FGFRL1,SLC6A11 |
5.018e-03 | -5.29 | FGF1 (fibroblast growth factor 1) | protein interactions | 2246 | 42 | 2 | 19454 | 49 |
FGFR3,FARP1 |
5.031e-03 | -5.29 | Fkbp3 (FK506 binding protein 3) | protein interactions | 30795 | 2 | 1 | 19454 | 49 |
CTBP1 |
5.031e-03 | -5.29 | NT5DC4 (5'-nucleotidase domain containing 4) | protein interactions | 284958 | 2 | 1 | 19454 | 49 |
PRKN |
5.031e-03 | -5.29 | SLC9B2 (solute carrier family 9 member B2) | protein interactions | 133308 | 2 | 1 | 19454 | 49 |
PRKN |
5.031e-03 | -5.29 | CCNYL2 (cyclin Y like 2 (pseudogene)) | protein interactions | 414194 | 2 | 1 | 19454 | 49 |
PRKN |
5.031e-03 | -5.29 | THSD1 (thrombospondin type 1 domain containing 1) | protein interactions | 55901 | 2 | 1 | 19454 | 49 |
GJA1 |
5.031e-03 | -5.29 | LRGUK (leucine rich repeats and guanylate kinase domain containing) | protein interactions | 136332 | 2 | 1 | 19454 | 49 |
PRKN |
5.031e-03 | -5.29 | ZFP92 (ZFP92 zinc finger protein) | protein interactions | 139735 | 2 | 1 | 19454 | 49 |
PRKN |
5.031e-03 | -5.29 | MSB3 (Rab GTPase-activating protein MSB3) | protein interactions | 855423 | 2 | 1 | 19454 | 49 |
USP6NL |
5.031e-03 | -5.29 | SLC24A4 (solute carrier family 24 member 4) | protein interactions | 123041 | 2 | 1 | 19454 | 49 |
PRKN |
5.031e-03 | -5.29 | CACNA1B (calcium voltage-gated channel subunit alpha1 B) | protein interactions | 100008979 | 2 | 1 | 19454 | 49 |
PRKN |
5.031e-03 | -5.29 | BTBD17 (BTB domain containing 17) | protein interactions | 388419 | 2 | 1 | 19454 | 49 |
PRDM16 |
5.031e-03 | -5.29 | EYS (eyes shut homolog) | protein interactions | 346007 | 2 | 1 | 19454 | 49 |
PRKN |
5.031e-03 | -5.29 | HERC2P3 (HERC2 pseudogene 3) | protein interactions | 283755 | 2 | 1 | 19454 | 49 |
PRKN |
5.031e-03 | -5.29 | BHLHE22 (basic helix-loop-helix family member e22) | protein interactions | 27319 | 2 | 1 | 19454 | 49 |
PRKN |
5.031e-03 | -5.29 | Septin5 (septin 5) | protein interactions | 18951 | 2 | 1 | 19454 | 49 |
PRKN |
5.031e-03 | -5.29 | CSRNP3 (cysteine and serine rich nuclear protein 3) | protein interactions | 80034 | 2 | 1 | 19454 | 49 |
PRKN |
5.031e-03 | -5.29 | DEFB126 (defensin beta 126) | protein interactions | 81623 | 2 | 1 | 19454 | 49 |
GJA1 |
5.031e-03 | -5.29 | TTC34 (tetratricopeptide repeat domain 34) | protein interactions | 100287898 | 2 | 1 | 19454 | 49 |
PRKN |
5.031e-03 | -5.29 | EVPLL (envoplakin like) | protein interactions | 645027 | 2 | 1 | 19454 | 49 |
PRKN |
5.031e-03 | -5.29 | SIDT1 (SID1 transmembrane family member 1) | protein interactions | 54847 | 2 | 1 | 19454 | 49 |
PRKN |
5.035e-03 | -5.29 | central_nervous_system-brainstem-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-brainstem-glioma-astrocytoma_Grade_I | 38 | 2 | 16828 | 47 |
QKI,FGFR3 |
5.070e-03 | -5.28 | APOB (apolipoprotein B) | protein interactions | 338 | 138 | 3 | 19454 | 49 |
PRKN,APOA1,GJA1 |
5.100e-03 | -5.28 | cell-substrate junction | cellular component | GO:0030055 | 437 | 5 | 19108 | 49 |
FGFR3,BCAR3,GJA1,TNS3,SNTB1 |
5.134e-03 | -5.27 | cellular response to alkaloid | biological process | GO:0071312 | 39 | 2 | 18204 | 50 |
SLC1A2,SLC1A3 |
5.167e-03 | -5.27 | cerebellum | COSMIC cancer mutations | cerebellum | 769 | 7 | 16828 | 47 |
FHOD3,GPC5,PRDM16,SORCS2,QKI,NPAS3,PTPRZ1 |
5.231e-03 | -5.25 | nasopharyngeal_carcinoma | COSMIC cancer mutations | nasopharyngeal_carcinoma | 1425 | 10 | 16828 | 47 |
NFIA,NHSL1,PREX2,NCKAP5,QKI,RFX4,SLC1A2,FGFR3,SLC4A4,FGFRL1 |
5.231e-03 | -5.25 | upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-pharynx-carcinoma-nasopharyngeal_carcinoma | 1425 | 10 | 16828 | 47 |
NHSL1,NFIA,PREX2,NCKAP5,QKI,SLC1A2,RFX4,SLC4A4,FGFR3,FGFRL1 |
5.231e-03 | -5.25 | myelination | biological process | GO:0042552 | 128 | 3 | 18204 | 50 |
ASPA,GPM6B,QKI |
5.234e-03 | -5.25 | Fatty acid, triacylglycerol, and ketone body metabolism | REACTOME pathways | R-HSA-535734 | 253 | 4 | 10285 | 29 |
LPIN2,ELOVL2,APOA1,RORA |
5.254e-03 | -5.25 | FGF4 (fibroblast growth factor 4) | protein interactions | 2249 | 43 | 2 | 19454 | 49 |
FGFR3,FARP1 |
5.254e-03 | -5.25 | GPRIN3 (GPRIN family member 3) | protein interactions | 285513 | 43 | 2 | 19454 | 49 |
GJA1,PRKN |
5.254e-03 | -5.25 | PDCD2 (programmed cell death 2) | protein interactions | 5134 | 43 | 2 | 19454 | 49 |
FKBP5,PRKN |
5.254e-03 | -5.25 | SDC3 (syndecan 3) | protein interactions | 9672 | 43 | 2 | 19454 | 49 |
FARP1,PTN |
5.353e-03 | -5.23 | TSG101 (tumor susceptibility 101) | protein interactions | 7251 | 280 | 4 | 19454 | 49 |
QKI,GJA1,PRKN,PRDM16 |
5.359e-03 | -5.23 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-follicular_lymphoma | 981 | 8 | 16828 | 47 |
DGKB,RORA,FHOD3,GPC5,NCKAP5,SORCS2,PRDM16,SOX5 |
5.377e-03 | -5.23 | skin-hand-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-hand-carcinoma-squamous_cell_carcinoma | 407 | 5 | 16828 | 47 |
SLC4A4,FGFR3,PREX1,FARP1,AMOT |
5.382e-03 | -5.22 | MAEA (macrophage erythroblast attacher, E3 ubiquitin ligase) | protein interactions | 10296 | 141 | 3 | 19454 | 49 |
NCKAP5,GRK5,PRKN |
5.382e-03 | -5.22 | LLGL1 (LLGL scribble cell polarity complex component 1) | protein interactions | 3996 | 141 | 3 | 19454 | 49 |
FKBP5,GJA1,PRKN |
5.382e-03 | -5.22 | AP3M1 (adaptor related protein complex 3 subunit mu 1) | protein interactions | 26985 | 141 | 3 | 19454 | 49 |
AQP4,PRKN,GRK5 |
5.382e-03 | -5.22 | NUDCD3 (NudC domain containing 3) | protein interactions | 23386 | 141 | 3 | 19454 | 49 |
PRKN,FGFR3,FKBP5 |
5.386e-03 | -5.22 | membrane | cellular component | GO:0016020 | 9220 | 33 | 19108 | 49 |
UNC93A,LRIG1,GRK5,SLC4A4,PREX2,GPC5,FKBP5,FGFRL1,PREX1,EGF,SLC39A12,ELOVL2,SORCS2,PTN,FGFR3,APOA1,PLPP3,LPIN2,BCAR3,GJA1,AQP4,AMOT,FARP1,SLC1A2,SLC6A11,USP6NL,ADGRB3,SNTB1,PRKN,SLC1A3,PTPRZ1,DGKB,GPM6B |
5.392e-03 | -5.22 | PTN_MK_heparin-bd_GF_CS | interpro domains | IPR020092 | 2 | 1 | 18521 | 50 |
PTN |
5.392e-03 | -5.22 | PTN/MK_diS_sf | interpro domains | IPR020091 | 2 | 1 | 18521 | 50 |
PTN |
5.392e-03 | -5.22 | MSI_RRM2 | interpro domains | IPR034126 | 2 | 1 | 18521 | 50 |
MSI2 |
5.392e-03 | -5.22 | Aste_AspA | interpro domains | IPR007036 | 2 | 1 | 18521 | 50 |
ASPA |
5.392e-03 | -5.22 | Aspartoacylase | interpro domains | IPR016708 | 2 | 1 | 18521 | 50 |
ASPA |
5.392e-03 | -5.22 | Midkine_heparin-bd_GF | interpro domains | IPR000762 | 2 | 1 | 18521 | 50 |
PTN |
5.392e-03 | -5.22 | ZIP4_N | interpro domains | IPR041137 | 2 | 1 | 18521 | 50 |
SLC39A12 |
5.392e-03 | -5.22 | NCKAP5_C | interpro domains | IPR032769 | 2 | 1 | 18521 | 50 |
NCKAP5 |
5.392e-03 | -5.22 | Ion_channel_UNC-93 | interpro domains | IPR010291 | 2 | 1 | 18521 | 50 |
UNC93A |
5.392e-03 | -5.22 | ZIP4_12_EF-hand | interpro domains | IPR049406 | 2 | 1 | 18521 | 50 |
SLC39A12 |
5.392e-03 | -5.22 | CtBP | interpro domains | IPR043322 | 2 | 1 | 18521 | 50 |
CTBP1 |
5.392e-03 | -5.22 | PTN/MK_N_dom_sf | interpro domains | IPR037122 | 2 | 1 | 18521 | 50 |
PTN |
5.392e-03 | -5.22 | Alpha_CARP_receptor-type | interpro domains | IPR041887 | 2 | 1 | 18521 | 50 |
PTPRZ1 |
5.392e-03 | -5.22 | PTN/MK_C_dom | interpro domains | IPR020090 | 2 | 1 | 18521 | 50 |
PTN |
5.392e-03 | -5.22 | PTN/MK_C_dom_sf | interpro domains | IPR038130 | 2 | 1 | 18521 | 50 |
PTN |
5.392e-03 | -5.22 | FHOD1_GBD_N | interpro domains | IPR041387 | 2 | 1 | 18521 | 50 |
FHOD3 |
5.392e-03 | -5.22 | Nckap5l | interpro domains | IPR026163 | 2 | 1 | 18521 | 50 |
NCKAP5 |
5.392e-03 | -5.22 | PTN/MK_N_dom | interpro domains | IPR020089 | 2 | 1 | 18521 | 50 |
PTN |
5.432e-03 | -5.22 | Ig_I-set | interpro domains | IPR013098 | 132 | 3 | 18521 | 50 |
LRIG1,FGFR3,FGFRL1 |
5.461e-03 | -5.21 | axon ensheathment | biological process | GO:0008366 | 130 | 3 | 18204 | 50 |
ASPA,GPM6B,QKI |
5.461e-03 | -5.21 | ensheathment of neurons | biological process | GO:0007272 | 130 | 3 | 18204 | 50 |
QKI,ASPA,GPM6B |
5.486e-03 | -5.21 | regulation of protein linear polyubiquitination | biological process | GO:1902528 | 2 | 1 | 18204 | 50 |
PRKN |
5.486e-03 | -5.21 | fibroblast growth factor receptor apoptotic signaling pathway | biological process | GO:1902178 | 2 | 1 | 18204 | 50 |
FGFR3 |
5.486e-03 | -5.21 | negative regulation of primary amine oxidase activity | biological process | GO:1902283 | 2 | 1 | 18204 | 50 |
PRKN |
5.486e-03 | -5.21 | negative regulation of endosome organization | biological process | GO:1904979 | 2 | 1 | 18204 | 50 |
PRKN |
5.486e-03 | -5.21 | positive regulation of protein linear polyubiquitination | biological process | GO:1902530 | 2 | 1 | 18204 | 50 |
PRKN |
5.486e-03 | -5.21 | positive regulation of retrograde transport, endosome to Golgi | biological process | GO:1905281 | 2 | 1 | 18204 | 50 |
PRKN |
5.486e-03 | -5.21 | dendrite regeneration | biological process | GO:0031104 | 2 | 1 | 18204 | 50 |
PTN |
5.486e-03 | -5.21 | negative regulation of 3'-UTR-mediated mRNA stabilization | biological process | GO:1905869 | 2 | 1 | 18204 | 50 |
QKI |
5.486e-03 | -5.21 | regulation of intralumenal vesicle formation | biological process | GO:1905365 | 2 | 1 | 18204 | 50 |
PRKN |
5.486e-03 | -5.21 | negative regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway | biological process | GO:1903382 | 2 | 1 | 18204 | 50 |
PRKN |
5.486e-03 | -5.21 | retrograde trans-synaptic signaling by trans-synaptic protein complex | biological process | GO:0098942 | 2 | 1 | 18204 | 50 |
FARP1 |
5.486e-03 | -5.21 | regulation protein catabolic process at presynapse | biological process | GO:0140251 | 2 | 1 | 18204 | 50 |
PRKN |
5.486e-03 | -5.21 | retrograde transport, plasma membrane to Golgi | biological process | GO:0035526 | 2 | 1 | 18204 | 50 |
USP6NL |
5.486e-03 | -5.21 | negative regulation of intralumenal vesicle formation | biological process | GO:1905366 | 2 | 1 | 18204 | 50 |
PRKN |
5.486e-03 | -5.21 | myofibroblast contraction | biological process | GO:1990764 | 2 | 1 | 18204 | 50 |
QKI |
5.486e-03 | -5.21 | regulation of sphingolipid mediated signaling pathway | biological process | GO:1902068 | 2 | 1 | 18204 | 50 |
PLPP3 |
5.486e-03 | -5.21 | regulation of spontaneous neurotransmitter secretion | biological process | GO:1904048 | 2 | 1 | 18204 | 50 |
PRKN |
5.489e-03 | -5.21 | SDC2 (syndecan 2) | protein interactions | 6383 | 142 | 3 | 19454 | 49 |
FGFRL1,FARP1,FGFR3 |
5.489e-03 | -5.21 | GIT1 (GIT ArfGAP 1) | protein interactions | 28964 | 142 | 3 | 19454 | 49 |
GRK5,PRKN,PTPRZ1 |
5.496e-03 | -5.20 | OGFR (opioid growth factor receptor) | protein interactions | 11054 | 44 | 2 | 19454 | 49 |
FKBP5,PRKN |
5.496e-03 | -5.20 | PGK2 (phosphoglycerate kinase 2) | protein interactions | 5232 | 44 | 2 | 19454 | 49 |
PRKN,ASPA |
5.496e-03 | -5.20 | FER (FER tyrosine kinase) | protein interactions | 2241 | 44 | 2 | 19454 | 49 |
PRKN,FKBP5 |
5.505e-03 | -5.20 | Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways | WikiPathways | WP706 | 162 | 4 | 5310 | 24 |
GJA1,AQP4,RORA,SLC1A3 |
5.521e-03 | -5.20 | Pleiotrophin/Midkine, N-terminal domain | gene3d domains | 2.20.60.10 | 2 | 1 | 14470 | 40 |
PTN |
5.521e-03 | -5.20 | - | gene3d domains | 6.10.250.2260 | 2 | 1 | 14470 | 40 |
GRK5 |
5.521e-03 | -5.20 | - | gene3d domains | 2.20.25.160 | 2 | 1 | 14470 | 40 |
ASPA |
5.545e-03 | -5.19 | neutral L-amino acid transmembrane transporter activity | molecular function | GO:0015175 | 42 | 2 | 18094 | 48 |
SLC1A2,SLC1A3 |
5.566e-03 | -5.19 | lower_back | COSMIC cancer mutations | lower_back | 40 | 2 | 16828 | 47 |
SLC6A11,FGFR3 |
5.612e-03 | -5.18 | PTN_MK_C | pfam domains | PF01091 | 2 | 1 | 17795 | 50 |
PTN |
5.612e-03 | -5.18 | NCKAP5 | pfam domains | PF15246 | 2 | 1 | 17795 | 50 |
NCKAP5 |
5.612e-03 | -5.18 | UNC-93 | pfam domains | PF05978 | 2 | 1 | 17795 | 50 |
UNC93A |
5.612e-03 | -5.18 | PTN_MK_N | pfam domains | PF05196 | 2 | 1 | 17795 | 50 |
PTN |
5.612e-03 | -5.18 | Formin_GBD_N | pfam domains | PF18382 | 2 | 1 | 17795 | 50 |
FHOD3 |
5.612e-03 | -5.18 | AstE_AspA | pfam domains | PF04952 | 2 | 1 | 17795 | 50 |
ASPA |
5.612e-03 | -5.18 | EF-hand_Zip | pfam domains | PF21116 | 2 | 1 | 17795 | 50 |
SLC39A12 |
5.612e-03 | -5.18 | ZIP4_domain | pfam domains | PF18292 | 2 | 1 | 17795 | 50 |
SLC39A12 |
5.624e-03 | -5.18 | follicular_lymphoma | COSMIC cancer mutations | follicular_lymphoma | 1209 | 9 | 16828 | 47 |
NCKAP5,AQP4,PRDM16,SORCS2,SOX5,DGKB,RORA,FHOD3,GPC5 |
5.632e-03 | -5.18 | Signaling by Overexpressed Wild-Type EGFR in Cancer | REACTOME pathways | R-HSA-5638302 | 2 | 1 | 10285 | 29 |
EGF |
5.632e-03 | -5.18 | Inhibition of Signaling by Overexpressed EGFR | REACTOME pathways | R-HSA-5638303 | 2 | 1 | 10285 | 29 |
EGF |
5.632e-03 | -5.18 | Transport of connexons to the plasma membrane | REACTOME pathways | R-HSA-190872 | 2 | 1 | 10285 | 29 |
GJA1 |
5.657e-03 | -5.17 | African trypanosomiasis | KEGG pathways | hsa05143 | 34 | 2 | 7161 | 24 |
APOA1,LAMA4 |
5.657e-03 | -5.17 | African trypanosomiasis | KEGG pathways | ko05143 | 34 | 2 | 7161 | 24 |
APOA1,LAMA4 |
5.658e-03 | -5.17 | mesothelioma | COSMIC cancer mutations | mesothelioma | 4477 | 21 | 16828 | 47 |
BCAR3,LPIN2,AMOT,QKI,PTPRZ1,MSI2,RORA,FKBP5,USP6NL,FARP1,GRK5,SNTB1,PRDM16,PREX1,SOX5,FGFR3,DGKB,LRIG1,PREX2,GPM6B,TRPS1 |
5.685e-03 | -5.17 | endometrium-carcinoma-serous_carcinoma | COSMIC cancer mutations | endometrium-carcinoma-serous_carcinoma | 1442 | 10 | 16828 | 47 |
GPC5,FHOD3,TRPS1,DGKB,FARP1,PRDM16,SLC4A4,AMOT,EGF,NCKAP5 |
5.706e-03 | -5.17 | USP8 (ubiquitin specific peptidase 8) | protein interactions | 9101 | 144 | 3 | 19454 | 49 |
LRIG1,PRKN,GJA1 |
5.706e-03 | -5.17 | PH_domain | interpro domains | IPR001849 | 266 | 4 | 18521 | 50 |
FARP1,SNTB1,PREX1,PREX2 |
5.742e-03 | -5.16 | skin-leg-malignant_melanoma-nodular | COSMIC cancer mutations | skin-leg-malignant_melanoma-nodular | 258 | 4 | 16828 | 47 |
PTPRZ1,EGF,GRK5,SLC4A4 |
5.742e-03 | -5.16 | PRKD3 (protein kinase D3) | protein interactions | 23683 | 45 | 2 | 19454 | 49 |
FKBP5,PRKN |
5.742e-03 | -5.16 | ARAP1 (ArfGAP with RhoGAP domain, ankyrin repeat and PH domain 1) | protein interactions | 116985 | 45 | 2 | 19454 | 49 |
FGFR3,PRKN |
5.742e-03 | -5.16 | SMARCAL1 (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a like 1) | protein interactions | 50485 | 45 | 2 | 19454 | 49 |
FKBP5,PRKN |
5.766e-03 | -5.16 | SERPINH1 (serpin family H member 1) | protein interactions | 871 | 286 | 4 | 19454 | 49 |
FKBP5,CTBP1,FGFR3,PRKN |
5.784e-03 | -5.15 | phosphatase activity | molecular function | GO:0016791 | 272 | 4 | 18094 | 48 |
PTPRZ1,PLPP3,LPIN2,TNS3 |
5.816e-03 | -5.15 | ACAD11 (acyl-CoA dehydrogenase family member 11) | protein interactions | 84129 | 145 | 3 | 19454 | 49 |
PRKN,AMOT,SOX5 |
5.836e-03 | -5.14 | NAT10 (N-acetyltransferase 10) | protein interactions | 55226 | 287 | 4 | 19454 | 49 |
FKBP5,PRDM16,PRKN,GRK5 |
5.836e-03 | -5.14 | PARD3 (par-3 family cell polarity regulator) | protein interactions | 56288 | 287 | 4 | 19454 | 49 |
USP6NL,AMOT,GJA1,FARP1 |
5.859e-03 | -5.14 | GTPase activator activity | molecular function | GO:0005096 | 273 | 4 | 18094 | 48 |
PREX2,USP6NL,PREX1,ADGRB3 |
5.928e-03 | -5.13 | SAV1 (salvador family WW domain containing protein 1) | protein interactions | 60485 | 146 | 3 | 19454 | 49 |
SNTB1,PRKN,AMOT |
5.929e-03 | -5.13 | postsynapse | cellular component | GO:0098794 | 646 | 6 | 19108 | 49 |
DGKB,ADGRB3,PRKN,SORCS2,SLC6A11,FARP1 |
5.935e-03 | -5.13 | triglyceride homeostasis | biological process | GO:0070328 | 42 | 2 | 18204 | 50 |
RORA,APOA1 |
5.935e-03 | -5.13 | regulation of protein localization to cell surface | biological process | GO:2000008 | 42 | 2 | 18204 | 50 |
GPM6B,EGF |
5.941e-03 | -5.13 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-mantle_cell_lymphoma | 2737 | 15 | 16828 | 47 |
SORCS2,NCKAP5,RFX4,GPC5,FARP1,SLC1A3,ELOVL2,PREX1,PRDM16,SOX5,SLC1A2,TRPS1,PREX2,DGKB,LRIG1 |
5.978e-03 | -5.12 | PH-like_dom_sf | interpro domains | IPR011993 | 431 | 5 | 18521 | 50 |
TNS3,FARP1,PREX1,SNTB1,PREX2 |
5.994e-03 | -5.12 | RADX (RPA1 related single stranded DNA binding protein, X-linked) | protein interactions | 55086 | 46 | 2 | 19454 | 49 |
PRKN,FKBP5 |
5.998e-03 | -5.12 | growth | biological process | GO:0040007 | 424 | 5 | 18204 | 50 |
FGFR3,GJA1,PTN,SLC1A2,SLC39A12 |
5.998e-03 | -5.12 | developmental growth | biological process | GO:0048589 | 424 | 5 | 18204 | 50 |
SLC39A12,PTN,SLC1A2,GJA1,FGFR3 |
6.041e-03 | -5.11 | PIP5K1A (phosphatidylinositol-4-phosphate 5-kinase type 1 alpha) | protein interactions | 8394 | 147 | 3 | 19454 | 49 |
PRKN,PREX1,GJA1 |
6.041e-03 | -5.11 | TFAP4 (transcription factor AP-4) | protein interactions | 7023 | 147 | 3 | 19454 | 49 |
CTBP1,NFIA,PRDM16 |
6.062e-03 | -5.11 | organic acid transmembrane transport | biological process | GO:1903825 | 135 | 3 | 18204 | 50 |
SLC6A11,SLC1A2,SLC1A3 |
6.064e-03 | -5.11 | I-set | pfam domains | PF07679 | 132 | 3 | 17795 | 50 |
LRIG1,FGFRL1,FGFR3 |
6.087e-03 | -5.10 | regulation of cellular component biogenesis | biological process | GO:0044087 | 1016 | 8 | 18204 | 50 |
SLC39A12,APOA1,USP6NL,PREX1,PRKN,GPM6B,FARP1,ADGRB3 |
6.130e-03 | -5.09 | central_nervous_system-brain-glioma-astrocytoma_Grade_II | COSMIC cancer mutations | central_nervous_system-brain-glioma-astrocytoma_Grade_II | 420 | 5 | 16828 | 47 |
PREX1,FGFR3,ZBTB20,GJA1,FARP1 |
6.141e-03 | -5.09 | metal ion transmembrane transporter activity | molecular function | GO:0046873 | 442 | 5 | 18094 | 48 |
SLC6A11,SLC1A2,SLC39A12,SLC4A4,SLC1A3 |
6.155e-03 | -5.09 | ATXN1L (ataxin 1 like) | protein interactions | 342371 | 148 | 3 | 19454 | 49 |
NFIA,SOX5,CTBP1 |
6.213e-03 | -5.08 | acylglycerol homeostasis | biological process | GO:0055090 | 43 | 2 | 18204 | 50 |
APOA1,RORA |
6.213e-03 | -5.08 | positive regulation of substrate adhesion-dependent cell spreading | biological process | GO:1900026 | 43 | 2 | 18204 | 50 |
APOA1,PREX1 |
6.213e-03 | -5.08 | bone remodeling | biological process | GO:0046849 | 43 | 2 | 18204 | 50 |
GJA1,PTN |
6.250e-03 | -5.08 | SACS (sacsin molecular chaperone) | protein interactions | 26278 | 47 | 2 | 19454 | 49 |
FKBP5,PRKN |
6.250e-03 | -5.08 | KIF3B (kinesin family member 3B) | protein interactions | 9371 | 47 | 2 | 19454 | 49 |
NCKAP5,PRKN |
6.250e-03 | -5.08 | LRIG3 (leucine rich repeats and immunoglobulin like domains 3) | protein interactions | 121227 | 47 | 2 | 19454 | 49 |
LRIG1,GJA1 |
6.257e-03 | -5.07 | active transmembrane transporter activity | molecular function | GO:0022804 | 444 | 5 | 18094 | 48 |
SLC4A4,SLC1A3,SLC1A2,SLC39A12,SLC6A11 |
6.260e-03 | -5.07 | astrocytoma_Grade_II | COSMIC cancer mutations | astrocytoma_Grade_II | 601 | 6 | 16828 | 47 |
GJA1,ZBTB20,FARP1,PREX2,PREX1,FGFR3 |
6.288e-03 | -5.07 | basal plasma membrane | cellular component | GO:0009925 | 288 | 4 | 19108 | 49 |
SLC1A3,PLPP3,AQP4,SLC4A4 |
6.297e-03 | -5.07 | response to xenobiotic stimulus | biological process | GO:0009410 | 429 | 5 | 18204 | 50 |
RORA,SLC6A11,SLC1A3,BCAR3,SLC1A2 |
6.324e-03 | -5.06 | monoatomic anion transmembrane transporter activity | molecular function | GO:0008509 | 142 | 3 | 18094 | 48 |
SLC1A2,SLC6A11,SLC4A4 |
6.387e-03 | -5.05 | KDM2B (lysine demethylase 2B) | protein interactions | 84678 | 150 | 3 | 19454 | 49 |
NFIA,SOX5,CTBP1 |
6.388e-03 | -5.05 | Pleckstrin-homology domain (PH domain)/Phosphotyrosine-binding domain (PTB) | gene3d domains | 2.30.29.30 | 431 | 5 | 14470 | 40 |
SNTB1,FARP1,TNS3,PREX2,PREX1 |
6.391e-03 | -5.05 | D_2_HYDROXYACID_DH_1 | prosite domains | PS00065 | 2 | 1 | 12186 | 39 |
CTBP1 |
6.391e-03 | -5.05 | PTN_MK_1 | prosite domains | PS00619 | 2 | 1 | 12186 | 39 |
PTN |
6.391e-03 | -5.05 | PTN_MK_2 | prosite domains | PS00620 | 2 | 1 | 12186 | 39 |
PTN |
6.420e-03 | -5.05 | response to wounding | biological process | GO:0009611 | 431 | 5 | 18204 | 50 |
SLC1A2,SLC1A3,NFIA,PLPP3,DGKB |
6.441e-03 | -5.05 | membrane raft | cellular component | GO:0045121 | 290 | 4 | 19108 | 49 |
GJA1,GPM6B,PLPP3,SLC1A2 |
6.441e-03 | -5.04 | regulation of generation of precursor metabolites and energy | biological process | GO:0043467 | 138 | 3 | 18204 | 50 |
PRDM16,ZBTB20,SLC4A4 |
6.498e-03 | -5.04 | positive regulation of bone mineralization | biological process | GO:0030501 | 44 | 2 | 18204 | 50 |
GPM6B,PTN |
6.574e-03 | -5.02 | actin filament-based process | biological process | GO:0030029 | 616 | 6 | 18204 | 50 |
QKI,FHOD3,FARP1,PREX1,AMOT,GJA1 |
6.576e-03 | -5.02 | SP7 (Sp7 transcription factor) | protein interactions | 121340 | 297 | 4 | 19454 | 49 |
NFIA,TRPS1,QKI,SOX5 |
6.597e-03 | -5.02 | membrane microdomain | cellular component | GO:0098857 | 292 | 4 | 19108 | 49 |
GJA1,GPM6B,PLPP3,SLC1A2 |
6.624e-03 | -5.02 | TRIP11 (thyroid hormone receptor interactor 11) | protein interactions | 9321 | 152 | 3 | 19454 | 49 |
FGFR3,PRKN,GJA1 |
6.645e-03 | -5.01 | (4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoate biosynthesis II (4-desaturase) | BIOCYC pathways | META_PWY-7728 | 3 | 1 | 902 | 2 |
ELOVL2 |
6.645e-03 | -5.01 | docosahexaenoate biosynthesis III (mammals) | BIOCYC pathways | HUMAN_PWY-7606 | 3 | 1 | 902 | 2 |
ELOVL2 |
6.645e-03 | -5.01 | docosahexaenoate biosynthesis IV (4-desaturase, mammals) | BIOCYC pathways | META_PWY-7727 | 3 | 1 | 902 | 2 |
ELOVL2 |
6.659e-03 | -5.01 | enzyme regulator activity | molecular function | GO:0030234 | 1305 | 9 | 18094 | 48 |
USP6NL,PREX2,PTN,BCAR3,ADGRB3,PREX1,APOA1,EGF,FARP1 |
6.670e-03 | -5.01 | blood vessel morphogenesis | biological process | GO:0048514 | 435 | 5 | 18204 | 50 |
QKI,EGF,GJA1,RORA,AMOT |
6.749e-03 | -5.00 | Retinoid metabolism and transport | REACTOME pathways | R-HSA-975634 | 44 | 2 | 10285 | 29 |
APOA1,GPC5 |
6.777e-03 | -4.99 | TNFAIP8L1 (TNF alpha induced protein 8 like 1) | protein interactions | 126282 | 49 | 2 | 19454 | 49 |
GRK5,PRKN |
6.777e-03 | -4.99 | GCNT2 (glucosaminyl (N-acetyl) transferase 2 (I blood group)) | protein interactions | 2651 | 49 | 2 | 19454 | 49 |
PRKN,CTBP1 |
6.876e-03 | -4.98 | PTNMIDKINE | prints domains | PR00269 | 2 | 1 | 5227 | 18 |
PTN |
6.890e-03 | -4.98 | learning or memory | biological process | GO:0007611 | 276 | 4 | 18204 | 50 |
ADGRB3,PRKN,PTPRZ1,PTN |
6.904e-03 | -4.98 | transcription corepressor binding | molecular function | GO:0001222 | 47 | 2 | 18094 | 48 |
RORA,CTBP1 |
6.969e-03 | -4.97 | monoatomic anion transmembrane transport | biological process | GO:0098656 | 142 | 3 | 18204 | 50 |
SLC4A4,SLC1A2,SLC1A3 |
6.969e-03 | -4.97 | positive regulation of small molecule metabolic process | biological process | GO:0062013 | 142 | 3 | 18204 | 50 |
ZBTB20,APOA1,SLC4A4 |
6.986e-03 | -4.96 | PTN | smart domains | SM00193 | 2 | 1 | 9717 | 34 |
PTN |
6.990e-03 | -4.96 | VPS45 (vacuolar protein sorting 45 homolog) | protein interactions | 11311 | 155 | 3 | 19454 | 49 |
PRKN,BCAR3,GJA1 |
7.002e-03 | -4.96 | third_ventricle | COSMIC cancer mutations | third_ventricle | 45 | 2 | 16828 | 47 |
FGFR3,QKI |
7.010e-03 | -4.96 | prostate-carcinoma-adenocarcinoma | COSMIC cancer mutations | prostate-carcinoma-adenocarcinoma | 12379 | 42 | 16828 | 47 |
ASPA,SORCS2,CTBP1,NPAS3,PTPRZ1,RFX4,SLC6A11,TNS3,GPC5,SLC1A3,USP6NL,SLC39A12,FGFRL1,SOX5,EGF,SNTB1,GRK5,TRPS1,GPM6B,DGKB,LRIG1,AQP4,QKI,NCKAP5,GJA1,BCAR3,UNC93A,NHSL1,FARP1,PTN,FKBP5,ZBTB20,RORA,FGFR3,ELOVL2,PRDM16,PREX1,LAMA4,SLC1A2,FHOD3,PREX2,NFIA |
7.049e-03 | -4.95 | ZNF516 (zinc finger protein 516) | protein interactions | 9658 | 50 | 2 | 19454 | 49 |
CTBP1,PRDM16 |
7.049e-03 | -4.95 | ANXA3 (annexin A3) | protein interactions | 306 | 50 | 2 | 19454 | 49 |
PRKN,FGFR3 |
7.065e-03 | -4.95 | regulation of GTPase activity | biological process | GO:0043087 | 278 | 4 | 18204 | 50 |
PREX1,USP6NL,PREX2,BCAR3 |
7.084e-03 | -4.95 | regulation of myelination | biological process | GO:0031641 | 46 | 2 | 18204 | 50 |
PTPRZ1,PTN |
7.115e-03 | -4.95 | ABCF2 (ATP binding cassette subfamily F member 2) | protein interactions | 10061 | 156 | 3 | 19454 | 49 |
FGFR3,PRKN,PRDM16 |
7.175e-03 | -4.94 | PDZ | interpro domains | IPR001478 | 146 | 3 | 18521 | 50 |
PREX2,SNTB1,PREX1 |
7.191e-03 | -4.93 | cell morphogenesis involved in neuron differentiation | biological process | GO:0048667 | 443 | 5 | 18204 | 50 |
PTN,PREX2,SLC1A3,PTPRZ1,FARP1 |
7.241e-03 | -4.93 | ACOT9 (acyl-CoA thioesterase 9) | protein interactions | 23597 | 157 | 3 | 19454 | 49 |
FKBP5,PRKN,FGFR3 |
7.263e-03 | -4.93 | cellular response to oxygen-containing compound | biological process | GO:1901701 | 1047 | 8 | 18204 | 50 |
SLC1A2,BCAR3,LPIN2,SLC1A3,GJA1,RORA,PRKN,ZBTB20 |
7.272e-03 | -4.92 | Ig_3 | pfam domains | PF13927 | 141 | 3 | 17795 | 50 |
LRIG1,FGFRL1,FGFR3 |
7.342e-03 | -4.91 | adrenal_cortical_carcinoma | COSMIC cancer mutations | adrenal_cortical_carcinoma | 2256 | 13 | 16828 | 47 |
PTPRZ1,NCKAP5,RFX4,LPIN2,FARP1,ZBTB20,SLC6A11,NHSL1,TNS3,GRK5,SLC1A2,SOX5,LRIG1 |
7.368e-03 | -4.91 | GJA8 (gap junction protein alpha 8) | protein interactions | 2703 | 158 | 3 | 19454 | 49 |
UNC93A,GJA1,AQP4 |
7.423e-03 | -4.90 | RCOR1 (REST corepressor 1) | protein interactions | 23186 | 487 | 5 | 19454 | 49 |
PRDM16,TRPS1,AMOT,SOX5,CTBP1 |
7.493e-03 | -4.89 | cell surface | cellular component | GO:0009986 | 896 | 7 | 19108 | 49 |
GPC5,FGFR3,AMOT,SLC1A2,AQP4,SLC4A4,SLC1A3 |
7.496e-03 | -4.89 | APOA1 (apolipoprotein A1) | protein interactions | 335 | 159 | 3 | 19454 | 49 |
TNS3,APOA1,GJA1 |
7.521e-03 | -4.89 | adult behavior | biological process | GO:0030534 | 146 | 3 | 18204 | 50 |
SLC1A2,PREX2,PRKN |
7.538e-03 | -4.89 | MROH2A (maestro heat like repeat family member 2A) | protein interactions | 339766 | 3 | 1 | 19454 | 49 |
PRKN |
7.538e-03 | -4.89 | IL34 (interleukin 34) | protein interactions | 146433 | 3 | 1 | 19454 | 49 |
PTPRZ1 |
7.538e-03 | -4.89 | WDR64 (WD repeat domain 64) | protein interactions | 128025 | 3 | 1 | 19454 | 49 |
PRKN |
7.538e-03 | -4.89 | LINC02907 (long intergenic non-protein coding RNA 2907) | protein interactions | 157927 | 3 | 1 | 19454 | 49 |
PRKN |
7.538e-03 | -4.89 | SMPDL3A (sphingomyelin phosphodiesterase acid like 3A) | protein interactions | 10924 | 3 | 1 | 19454 | 49 |
APOA1 |
7.538e-03 | -4.89 | IQSEC3 (IQ motif and Sec7 domain ArfGEF 3) | protein interactions | 440073 | 3 | 1 | 19454 | 49 |
PRKN |
7.538e-03 | -4.89 | ADGRG4 (adhesion G protein-coupled receptor G4) | protein interactions | 139378 | 3 | 1 | 19454 | 49 |
PRKN |
7.538e-03 | -4.89 | C4orf36 (chromosome 4 open reading frame 36) | protein interactions | 132989 | 3 | 1 | 19454 | 49 |
PRKN |
7.538e-03 | -4.89 | SLC4A11 (solute carrier family 4 member 11) | protein interactions | 83959 | 3 | 1 | 19454 | 49 |
PRKN |
7.538e-03 | -4.89 | VWA3A (von Willebrand factor A domain containing 3A) | protein interactions | 146177 | 3 | 1 | 19454 | 49 |
PRKN |
7.538e-03 | -4.89 | FBXO39 (F-box protein 39) | protein interactions | 162517 | 3 | 1 | 19454 | 49 |
PRKN |
7.538e-03 | -4.89 | APOL1 (apolipoprotein L1) | protein interactions | 8542 | 3 | 1 | 19454 | 49 |
APOA1 |
7.538e-03 | -4.89 | ERV3-1 (endogenous retrovirus group 3 member 1, envelope) | protein interactions | 2086 | 3 | 1 | 19454 | 49 |
PRKN |
7.538e-03 | -4.89 | TTLL13 (tubulin tyrosine ligase like 13) | protein interactions | 440307 | 3 | 1 | 19454 | 49 |
PRKN |
7.538e-03 | -4.89 | LRRC71 (leucine rich repeat containing 71) | protein interactions | 149499 | 3 | 1 | 19454 | 49 |
PRKN |
7.538e-03 | -4.89 | MROH9 (maestro heat like repeat family member 9) | protein interactions | 80133 | 3 | 1 | 19454 | 49 |
PRKN |
7.538e-03 | -4.89 | SLC6A17 (solute carrier family 6 member 17) | protein interactions | 388662 | 3 | 1 | 19454 | 49 |
PRKN |
7.538e-03 | -4.89 | E1A (control protein E1A;control protein E1A 243R) | protein interactions | 2652980 | 3 | 1 | 19454 | 49 |
CTBP1 |
7.538e-03 | -4.89 | PDPK2P (3-phosphoinositide dependent protein kinase 2, pseudogene) | protein interactions | 653650 | 3 | 1 | 19454 | 49 |
PRKN |
7.538e-03 | -4.89 | CNTD1 (cyclin N-terminal domain containing 1) | protein interactions | 124817 | 3 | 1 | 19454 | 49 |
PRKN |
7.538e-03 | -4.89 | Mfn2 (mitofusin 2) | protein interactions | 170731 | 3 | 1 | 19454 | 49 |
PRKN |
7.538e-03 | -4.89 | CDH26 (cadherin 26) | protein interactions | 60437 | 3 | 1 | 19454 | 49 |
PRKN |
7.538e-03 | -4.89 | Phum_PHUM577390 (serine/threonine-protein kinase PINK1, putative) | protein interactions | 8239562 | 3 | 1 | 19454 | 49 |
PRKN |
7.538e-03 | -4.89 | Lep (leptin) | protein interactions | 16846 | 3 | 1 | 19454 | 49 |
APOA1 |
7.538e-03 | -4.89 | CT45A6 (cancer/testis antigen family 45 member A6) | protein interactions | 541465 | 3 | 1 | 19454 | 49 |
PRKN |
7.538e-03 | -4.89 | cbx2.L (chromobox 2 L homeolog) | protein interactions | 398110 | 3 | 1 | 19454 | 49 |
CTBP1 |
7.538e-03 | -4.89 | DEFB124 (defensin beta 124) | protein interactions | 245937 | 3 | 1 | 19454 | 49 |
GJA1 |
7.538e-03 | -4.89 | FAM83C (family with sequence similarity 83 member C) | protein interactions | 128876 | 3 | 1 | 19454 | 49 |
APOA1 |
7.538e-03 | -4.89 | Eps15 (epidermal growth factor receptor pathway substrate 15) | protein interactions | 313474 | 3 | 1 | 19454 | 49 |
PRKN |
7.538e-03 | -4.89 | OR1L3 (olfactory receptor family 1 subfamily L member 3) | protein interactions | 26735 | 3 | 1 | 19454 | 49 |
PRKN |
7.587e-03 | -4.88 | PDZ_sf | interpro domains | IPR036034 | 149 | 3 | 18521 | 50 |
PREX2,PREX1,SNTB1 |
7.605e-03 | -4.88 | OSGIN1 (oxidative stress induced growth inhibitor 1) | protein interactions | 29948 | 52 | 2 | 19454 | 49 |
PRKN,BCAR3 |
7.626e-03 | -4.88 | SOX5 (SRY-box transcription factor 5) | protein interactions | 6660 | 160 | 3 | 19454 | 49 |
SOX5,NFIA,TRPS1 |
7.631e-03 | -4.88 | human chr8q23.3 | chromosome location | human chr8q23.3 | 4 | 1 | 26134 | 50 |
TRPS1 |
7.658e-03 | -4.87 | PH_DOMAIN | prosite domains | PS50003 | 246 | 4 | 12186 | 39 |
SNTB1,PREX1,PREX2,FARP1 |
7.674e-03 | -4.87 | Parkin-FBXW7-Cul1 ubiquitin ligase complex | cellular component | GO:1990452 | 3 | 1 | 19108 | 49 |
PRKN |
7.674e-03 | -4.87 | mitochondrion-derived vesicle | cellular component | GO:0099073 | 3 | 1 | 19108 | 49 |
PRKN |
7.677e-03 | -4.87 | HADHA (hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha) | protein interactions | 3030 | 491 | 5 | 19454 | 49 |
LAMA4,FARP1,FGFR3,PRKN,PRDM16 |
7.694e-03 | -4.87 | negative regulation of cold-induced thermogenesis | biological process | GO:0120163 | 48 | 2 | 18204 | 50 |
QKI,LAMA4 |
7.793e-03 | -4.85 | developmental maturation | biological process | GO:0021700 | 286 | 4 | 18204 | 50 |
GJA1,FGFR3,ADGRB3,NFIA |
7.800e-03 | -4.85 | clear_cell_renal_cell_carcinoma | COSMIC cancer mutations | clear_cell_renal_cell_carcinoma | 13924 | 45 | 16828 | 47 |
BCAR3,FARP1,RORA,PTN,PRDM16,NFIA,PREX2,PTPRZ1,CTBP1,LPIN2,MSI2,USP6NL,SLC1A3,GPC5,TNS3,EGF,GRK5,SLC39A12,NCKAP5,QKI,GJA1,AQP4,ZBTB20,FKBP5,UNC93A,NHSL1,SLC1A2,ELOVL2,FGFR3,LAMA4,PREX1,FHOD3,NPAS3,AMOT,ASPA,SORCS2,SLC6A11,SNTB1,SLC4A4,FGFRL1,SOX5,LRIG1,DGKB,TRPS1,GPM6B |
7.800e-03 | -4.85 | kidney-carcinoma-clear_cell_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-clear_cell_renal_cell_carcinoma | 13924 | 45 | 16828 | 47 |
FHOD3,SLC1A2,PREX1,LAMA4,FGFR3,ELOVL2,ZBTB20,FKBP5,NHSL1,UNC93A,GJA1,QKI,NCKAP5,AQP4,DGKB,LRIG1,GPM6B,TRPS1,SNTB1,FGFRL1,SOX5,SLC4A4,SLC6A11,AMOT,NPAS3,SORCS2,ASPA,PREX2,NFIA,PRDM16,PTN,RORA,FARP1,BCAR3,GRK5,EGF,SLC39A12,SLC1A3,USP6NL,TNS3,GPC5,LPIN2,CTBP1,PTPRZ1,MSI2 |
7.847e-03 | -4.85 | basal part of cell | cellular component | GO:0045178 | 307 | 4 | 19108 | 49 |
SLC1A3,SLC4A4,AQP4,PLPP3 |
7.888e-03 | -4.84 | ossification | biological process | GO:0001503 | 287 | 4 | 18204 | 50 |
GJA1,FGFR3,GPM6B,PTN |
7.891e-03 | -4.84 | RIPK3 (receptor interacting serine/threonine kinase 3) | protein interactions | 11035 | 53 | 2 | 19454 | 49 |
FKBP5,PRKN |
7.938e-03 | -4.84 | F-box domain binding | molecular function | GO:1990444 | 3 | 1 | 18094 | 48 |
PRKN |
7.938e-03 | -4.84 | ceramide-1-phosphate phosphatase activity | molecular function | GO:0106235 | 3 | 1 | 18094 | 48 |
PLPP3 |
7.938e-03 | -4.84 | high-density lipoprotein particle receptor binding | molecular function | GO:0070653 | 3 | 1 | 18094 | 48 |
APOA1 |
7.938e-03 | -4.84 | taurine:sodium symporter activity | molecular function | GO:0005369 | 3 | 1 | 18094 | 48 |
SLC6A11 |
7.938e-03 | -4.84 | cysteine transmembrane transporter activity | molecular function | GO:0033229 | 3 | 1 | 18094 | 48 |
SLC1A2 |
7.974e-03 | -4.83 | SMG7 (SMG7 nonsense mediated mRNA decay factor) | protein interactions | 9887 | 314 | 4 | 19454 | 49 |
TRPS1,PRKN,FGFR3,AMOT |
7.997e-03 | -4.83 | chest | COSMIC cancer mutations | chest | 147 | 3 | 16828 | 47 |
PREX2,SLC6A11,FGFR3 |
8.001e-03 | -4.83 | - | gene3d domains | 2.30.42.10 | 149 | 3 | 14470 | 40 |
SNTB1,PREX1,PREX2 |
8.007e-03 | -4.83 | oligodendrocyte development | biological process | GO:0014003 | 49 | 2 | 18204 | 50 |
ASPA,GPM6B |
8.024e-03 | -4.83 | ANK3 (ankyrin 3) | protein interactions | 288 | 163 | 3 | 19454 | 49 |
PRKN,FARP1,GJA1 |
8.078e-03 | -4.82 | LIPIN | interpro domains | IPR026058 | 3 | 1 | 18521 | 50 |
LPIN2 |
8.078e-03 | -4.82 | AGRB_N | interpro domains | IPR043838 | 3 | 1 | 18521 | 50 |
ADGRB3 |
8.078e-03 | -4.82 | Connexin_C | interpro domains | IPR034634 | 3 | 1 | 18521 | 50 |
GJA1 |
8.078e-03 | -4.82 | Lipin_mid | interpro domains | IPR031703 | 3 | 1 | 18521 | 50 |
LPIN2 |
8.078e-03 | -4.82 | Angiomotin | interpro domains | IPR009114 | 3 | 1 | 18521 | 50 |
AMOT |
8.078e-03 | -4.82 | DGK_typeI_N_sf | interpro domains | IPR038199 | 3 | 1 | 18521 | 50 |
DGKB |
8.078e-03 | -4.82 | PHsplit_syntrophin | interpro domains | IPR041428 | 3 | 1 | 18521 | 50 |
SNTB1 |
8.078e-03 | -4.82 | DAG_kinase_typeI_N | interpro domains | IPR029477 | 3 | 1 | 18521 | 50 |
DGKB |
8.078e-03 | -4.82 | FARP1/FARP2/FRMD7_FERM_C | interpro domains | IPR041788 | 3 | 1 | 18521 | 50 |
FARP1 |
8.078e-03 | -4.82 | NR_DBD_ROR | interpro domains | IPR044101 | 3 | 1 | 18521 | 50 |
RORA |
8.078e-03 | -4.82 | Tensin-like_SH2 | interpro domains | IPR035012 | 3 | 1 | 18521 | 50 |
TNS3 |
8.078e-03 | -4.82 | ROR_rcpt | interpro domains | IPR003079 | 3 | 1 | 18521 | 50 |
RORA |
8.078e-03 | -4.82 | SH2_SHEP1/BCAR3/NSP1 | interpro domains | IPR044102 | 3 | 1 | 18521 | 50 |
BCAR3 |
8.078e-03 | -4.82 | Myelin_PLP | interpro domains | IPR001614 | 3 | 1 | 18521 | 50 |
GPM6B |
8.078e-03 | -4.82 | Angiomotin_C | interpro domains | IPR024646 | 3 | 1 | 18521 | 50 |
AMOT |
8.078e-03 | -4.82 | LNS2 | interpro domains | IPR013209 | 3 | 1 | 18521 | 50 |
LPIN2 |
8.078e-03 | -4.82 | GPCR_2_brain_angio_inhib | interpro domains | IPR008077 | 3 | 1 | 18521 | 50 |
ADGRB3 |
8.078e-03 | -4.82 | Lipin_N | interpro domains | IPR007651 | 3 | 1 | 18521 | 50 |
LPIN2 |
8.078e-03 | -4.82 | Myelin_PLP_CS | interpro domains | IPR018237 | 3 | 1 | 18521 | 50 |
GPM6B |
8.078e-03 | -4.82 | D-isomer_DH_CS1 | interpro domains | IPR029752 | 3 | 1 | 18521 | 50 |
CTBP1 |
8.079e-03 | -4.82 | muscle cell differentiation | biological process | GO:0042692 | 289 | 4 | 18204 | 50 |
ADGRB3,FHOD3,QKI,RORA |
8.085e-03 | -4.82 | signaling | biological process | GO:0023052 | 4968 | 22 | 18204 | 50 |
SLC1A3,APOA1,GJA1,SLC1A2,BCAR3,EGF,FARP1,PTN,PREX2,GRK5,FGFR3,PLPP3,FGFRL1,SLC39A12,SORCS2,PRKN,PREX1,RORA,NFIA,ADGRB3,AMOT,DGKB |
8.088e-03 | -4.82 | amino acid binding | molecular function | GO:0016597 | 51 | 2 | 18094 | 48 |
SLC1A3,SLC6A11 |
8.097e-03 | -4.82 | regulation of nervous system development | biological process | GO:0051960 | 456 | 5 | 18204 | 50 |
PTPRZ1,PTN,ASPA,QKI,ADGRB3 |
8.136e-03 | -4.81 | SLC-mediated transmembrane transport | REACTOME pathways | R-HSA-425407 | 287 | 4 | 10285 | 29 |
SLC1A3,SLC6A11,SLC1A2,SLC4A4 |
8.151e-03 | -4.81 | Fat digestion and absorption | KEGG pathways | ko04975 | 41 | 2 | 7161 | 24 |
PLPP3,APOA1 |
8.151e-03 | -4.81 | Bladder cancer | KEGG pathways | hsa05219 | 41 | 2 | 7161 | 24 |
FGFR3,EGF |
8.151e-03 | -4.81 | Bladder cancer | KEGG pathways | ko05219 | 41 | 2 | 7161 | 24 |
EGF,FGFR3 |
8.151e-03 | -4.81 | Fat digestion and absorption | KEGG pathways | hsa04975 | 41 | 2 | 7161 | 24 |
PLPP3,APOA1 |
8.181e-03 | -4.81 | NOS1 (nitric oxide synthase 1) | protein interactions | 4842 | 54 | 2 | 19454 | 49 |
CTBP1,SNTB1 |
8.181e-03 | -4.81 | LONP2 (lon peptidase 2, peroxisomal) | protein interactions | 83752 | 54 | 2 | 19454 | 49 |
AMOT,PRKN |
8.181e-03 | -4.81 | DCXR (dicarbonyl and L-xylulose reductase) | protein interactions | 51181 | 54 | 2 | 19454 | 49 |
PRKN,FGFR3 |
8.181e-03 | -4.81 | NSUN5 (NOP2/Sun RNA methyltransferase 5) | protein interactions | 55695 | 54 | 2 | 19454 | 49 |
PRKN,FKBP5 |
8.181e-03 | -4.81 | EPM2A (EPM2A glucan phosphatase, laforin) | protein interactions | 7957 | 54 | 2 | 19454 | 49 |
FKBP5,PREX1 |
8.218e-03 | -4.80 | mitochondrion-derived vesicle mediated transport | biological process | GO:0099075 | 3 | 1 | 18204 | 50 |
PRKN |
8.218e-03 | -4.80 | negative regulation of serotonin uptake | biological process | GO:0051612 | 3 | 1 | 18204 | 50 |
GPM6B |
8.218e-03 | -4.80 | cell communication by chemical coupling | biological process | GO:0010643 | 3 | 1 | 18204 | 50 |
GJA1 |
8.218e-03 | -4.80 | regulation of endoplasmic reticulum stress-induced neuron intrinsic apoptotic signaling pathway | biological process | GO:1903381 | 3 | 1 | 18204 | 50 |
PRKN |
8.218e-03 | -4.80 | positive regulation of mitochondrial fusion | biological process | GO:0010636 | 3 | 1 | 18204 | 50 |
PRKN |
8.218e-03 | -4.80 | establishment of cell polarity involved in ameboidal cell migration | biological process | GO:0003365 | 3 | 1 | 18204 | 50 |
AMOT |
8.218e-03 | -4.80 | cysteine transport | biological process | GO:0042883 | 3 | 1 | 18204 | 50 |
SLC1A2 |
8.218e-03 | -4.80 | mitochondrion to lysosome vesicle-mediated transport | biological process | GO:0099074 | 3 | 1 | 18204 | 50 |
PRKN |
8.218e-03 | -4.80 | negative regulation of neurotransmitter uptake | biological process | GO:0051581 | 3 | 1 | 18204 | 50 |
GPM6B |
8.218e-03 | -4.80 | acetate metabolic process | biological process | GO:0006083 | 3 | 1 | 18204 | 50 |
ASPA |
8.218e-03 | -4.80 | cysteine transmembrane transport | biological process | GO:1903712 | 3 | 1 | 18204 | 50 |
SLC1A2 |
8.218e-03 | -4.80 | ossification involved in bone remodeling | biological process | GO:0043932 | 3 | 1 | 18204 | 50 |
PTN |
8.239e-03 | -4.80 | LGALS1 (galectin 1) | protein interactions | 3956 | 317 | 4 | 19454 | 49 |
LAMA4,PTPRZ1,FKBP5,PRKN |
8.271e-03 | -4.80 | Diacylglycerol kinase alpha | gene3d domains | 1.10.238.110 | 3 | 1 | 14470 | 40 |
DGKB |
8.310e-03 | -4.79 | HNRNPL (heterogeneous nuclear ribonucleoprotein L) | protein interactions | 3191 | 1958 | 11 | 19454 | 49 |
QKI,FGFRL1,FGFR3,PRKN,TRPS1,NFIA,MSI2,FKBP5,CTBP1,ZBTB20,FARP1 |
8.327e-03 | -4.79 | epidermal growth factor receptor signaling pathway | biological process | GO:0007173 | 50 | 2 | 18204 | 50 |
BCAR3,EGF |
8.356e-03 | -4.78 | urinary_tract-bladder-papilloma | COSMIC cancer mutations | urinary_tract-bladder-papilloma | 3 | 1 | 16828 | 47 |
FGFR3 |
8.356e-03 | -4.78 | skin-lentigo | COSMIC cancer mutations | skin-lentigo | 3 | 1 | 16828 | 47 |
FGFR3 |
8.356e-03 | -4.78 | skin-forearm-lentigo | COSMIC cancer mutations | skin-forearm-lentigo | 3 | 1 | 16828 | 47 |
FGFR3 |
8.356e-03 | -4.78 | lentigo | COSMIC cancer mutations | lentigo | 3 | 1 | 16828 | 47 |
FGFR3 |
8.356e-03 | -4.78 | skin-leg-lentigo | COSMIC cancer mutations | skin-leg-lentigo | 3 | 1 | 16828 | 47 |
FGFR3 |
8.356e-03 | -4.78 | skin-trunk-other-seborrhoeic_keratosis | COSMIC cancer mutations | skin-trunk-other-seborrhoeic_keratosis | 3 | 1 | 16828 | 47 |
FGFR3 |
8.356e-03 | -4.78 | skin-trunk-lentigo | COSMIC cancer mutations | skin-trunk-lentigo | 3 | 1 | 16828 | 47 |
FGFR3 |
8.356e-03 | -4.78 | skin-face-lentigo | COSMIC cancer mutations | skin-face-lentigo | 3 | 1 | 16828 | 47 |
FGFR3 |
8.356e-03 | -4.78 | skin-hand-lentigo | COSMIC cancer mutations | skin-hand-lentigo | 3 | 1 | 16828 | 47 |
FGFR3 |
8.356e-03 | -4.78 | skin-leg-other-seborrhoeic_keratosis | COSMIC cancer mutations | skin-leg-other-seborrhoeic_keratosis | 3 | 1 | 16828 | 47 |
FGFR3 |
8.397e-03 | -4.78 | regulation of lipid transport | biological process | GO:0032368 | 152 | 3 | 18204 | 50 |
APOA1,EGF,PRKN |
8.406e-03 | -4.78 | Lipin_N | pfam domains | PF04571 | 3 | 1 | 17795 | 50 |
LPIN2 |
8.406e-03 | -4.78 | LNS2 | pfam domains | PF08235 | 3 | 1 | 17795 | 50 |
LPIN2 |
8.406e-03 | -4.78 | Angiomotin_C | pfam domains | PF12240 | 3 | 1 | 17795 | 50 |
AMOT |
8.406e-03 | -4.78 | AGRB_N | pfam domains | PF19188 | 3 | 1 | 17795 | 50 |
ADGRB3 |
8.406e-03 | -4.78 | Lipin_mid | pfam domains | PF16876 | 3 | 1 | 17795 | 50 |
LPIN2 |
8.406e-03 | -4.78 | Myelin_PLP | pfam domains | PF01275 | 3 | 1 | 17795 | 50 |
GPM6B |
8.406e-03 | -4.78 | PH_17 | pfam domains | PF18012 | 3 | 1 | 17795 | 50 |
SNTB1 |
8.406e-03 | -4.78 | DAG_kinase_N | pfam domains | PF14513 | 3 | 1 | 17795 | 50 |
DGKB |
8.434e-03 | -4.78 | STK38 (serine/threonine kinase 38) | protein interactions | 11329 | 166 | 3 | 19454 | 49 |
GJA1,PRKN,GRK5 |
8.436e-03 | -4.78 | TCF7L2 mutants don't bind CTBP | REACTOME pathways | R-HSA-5339700 | 3 | 1 | 10285 | 29 |
CTBP1 |
8.436e-03 | -4.78 | Regulation of gap junction activity | REACTOME pathways | R-HSA-191650 | 3 | 1 | 10285 | 29 |
GJA1 |
8.436e-03 | -4.78 | Transport of connexins along the secretory pathway | REACTOME pathways | R-HSA-190827 | 3 | 1 | 10285 | 29 |
GJA1 |
8.436e-03 | -4.78 | c-src mediated regulation of Cx43 function and closure of gap junctions | REACTOME pathways | R-HSA-191647 | 3 | 1 | 10285 | 29 |
GJA1 |
8.436e-03 | -4.78 | Oligomerization of connexins into connexons | REACTOME pathways | R-HSA-190704 | 3 | 1 | 10285 | 29 |
GJA1 |
8.476e-03 | -4.77 | integrin binding | molecular function | GO:0005178 | 158 | 3 | 18094 | 48 |
PLPP3,PTPRZ1,PTN |
8.514e-03 | -4.77 | lung-carcinoma-small_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-small_cell_carcinoma | 9908 | 36 | 16828 | 47 |
GJA1,BCAR3,QKI,PTN,FKBP5,RORA,FARP1,UNC93A,PREX1,PRDM16,LAMA4,FGFR3,APOA1,PREX2,NFIA,FHOD3,AMOT,LPIN2,RFX4,NPAS3,PTPRZ1,MSI2,USP6NL,TNS3,GPC5,GRK5,EGF,SNTB1,FGFRL1,SOX5,SLC39A12,SLC4A4,DGKB,LRIG1,GPM6B,TRPS1 |
8.547e-03 | -4.76 | positive regulation of cellular metabolic process | biological process | GO:0031325 | 3164 | 16 | 18204 | 50 |
FGFR3,PLPP3,NPAS3,PRDM16,PRKN,ZBTB20,GJA1,RORA,LPIN2,EGF,QKI,NFIA,BCAR3,CTBP1,SLC4A4,RFX4 |
8.608e-03 | -4.76 | small_cell_carcinoma | COSMIC cancer mutations | small_cell_carcinoma | 9913 | 36 | 16828 | 47 |
PREX2,NFIA,FHOD3,APOA1,PRDM16,PREX1,LAMA4,FGFR3,UNC93A,PTN,FKBP5,RORA,FARP1,GJA1,BCAR3,QKI,GPM6B,TRPS1,DGKB,LRIG1,FGFRL1,SOX5,SLC4A4,SLC39A12,GRK5,EGF,SNTB1,TNS3,GPC5,USP6NL,MSI2,RFX4,AMOT,LPIN2,NPAS3,PTPRZ1 |
8.642e-03 | -4.75 | mantle_cell_lymphoma | COSMIC cancer mutations | mantle_cell_lymphoma | 2849 | 15 | 16828 | 47 |
RFX4,NCKAP5,SORCS2,SLC1A3,FARP1,GPC5,SLC1A2,PREX1,PRDM16,SOX5,ELOVL2,DGKB,LRIG1,PREX2,TRPS1 |
8.702e-03 | -4.74 | learning | biological process | GO:0007612 | 154 | 3 | 18204 | 50 |
ADGRB3,PRKN,PTN |
8.713e-03 | -4.74 | GAB1 (GRB2 associated binding protein 1) | protein interactions | 2549 | 168 | 3 | 19454 | 49 |
TNS3,BCAR3,GJA1 |
8.713e-03 | -4.74 | VPS51 (VPS51 subunit of GARP complex) | protein interactions | 738 | 168 | 3 | 19454 | 49 |
PRKN,GJA1,CTBP1 |
8.855e-03 | -4.73 | PIAS2 (protein inhibitor of activated STAT 2) | protein interactions | 9063 | 169 | 3 | 19454 | 49 |
PRKN,CTBP1,SOX5 |
8.873e-03 | -4.72 | carboxylic acid transport | biological process | GO:0046942 | 297 | 4 | 18204 | 50 |
GJA1,SLC6A11,SLC1A2,SLC1A3 |
8.893e-03 | -4.72 | RHOH (ras homolog family member H) | protein interactions | 399 | 509 | 5 | 19454 | 49 |
USP6NL,PRKN,FARP1,GJA1,PREX1 |
8.941e-03 | -4.72 | Bladder Cancer | WikiPathways | WP2828 | 32 | 2 | 5310 | 24 |
EGF,FGFR3 |
8.976e-03 | -4.71 | organic acid transport | biological process | GO:0015849 | 298 | 4 | 18204 | 50 |
SLC6A11,GJA1,SLC1A2,SLC1A3 |
8.978e-03 | -4.71 | cell communication | biological process | GO:0007154 | 5010 | 22 | 18204 | 50 |
SLC39A12,SORCS2,RORA,PREX1,PRKN,GRK5,FGFRL1,PLPP3,FGFR3,DGKB,AMOT,NFIA,ADGRB3,SLC1A3,APOA1,GJA1,PTN,PREX2,SLC1A2,BCAR3,FARP1,EGF |
8.982e-03 | -4.71 | ERK1 and ERK2 cascade | biological process | GO:0070371 | 52 | 2 | 18204 | 50 |
EGF,APOA1 |
8.982e-03 | -4.71 | regulation of purine nucleotide catabolic process | biological process | GO:0033121 | 52 | 2 | 18204 | 50 |
ZBTB20,SLC4A4 |
8.982e-03 | -4.71 | regulation of glycolytic process | biological process | GO:0006110 | 52 | 2 | 18204 | 50 |
ZBTB20,SLC4A4 |
8.982e-03 | -4.71 | regulation of nucleotide catabolic process | biological process | GO:0030811 | 52 | 2 | 18204 | 50 |
SLC4A4,ZBTB20 |
8.999e-03 | -4.71 | GLMN (glomulin, FKBP associated protein) | protein interactions | 11146 | 170 | 3 | 19454 | 49 |
FGFR3,PRDM16,FKBP5 |
8.999e-03 | -4.71 | PIK3C2A (phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 alpha) | protein interactions | 5286 | 170 | 3 | 19454 | 49 |
PRKN,FKBP5,AMOT |
9.070e-03 | -4.70 | KLF8 (KLF transcription factor 8) | protein interactions | 11279 | 326 | 4 | 19454 | 49 |
NFIA,TRPS1,CTBP1,SOX5 |
9.081e-03 | -4.70 | RSU1 (Ras suppressor protein 1) | protein interactions | 6251 | 57 | 2 | 19454 | 49 |
PRKN,FKBP5 |
9.081e-03 | -4.70 | ALG11 (ALG11 alpha-1,2-mannosyltransferase) | protein interactions | 440138 | 57 | 2 | 19454 | 49 |
GPM6B,PRKN |
9.081e-03 | -4.70 | CCDC18 (coiled-coil domain containing 18) | protein interactions | 343099 | 57 | 2 | 19454 | 49 |
PRKN,AMOT |
9.081e-03 | -4.70 | NR2F1 (nuclear receptor subfamily 2 group F member 1) | protein interactions | 7025 | 57 | 2 | 19454 | 49 |
PRKN,GRK5 |
9.081e-03 | -4.70 | TRIM6 (tripartite motif containing 6) | protein interactions | 117854 | 57 | 2 | 19454 | 49 |
APOA1,PRKN |
9.129e-03 | -4.70 | positive regulation of catalytic activity | biological process | GO:0043085 | 868 | 7 | 18204 | 50 |
PREX2,PREX1,APOA1,USP6NL,BCAR3,EGF,FGFR3 |
9.137e-03 | -4.70 | anaplastic_carcinoma | COSMIC cancer mutations | anaplastic_carcinoma | 856 | 7 | 16828 | 47 |
FHOD3,LAMA4,NFIA,SNTB1,FARP1,AMOT,GRK5 |
9.137e-03 | -4.70 | thyroid-carcinoma-anaplastic_carcinoma | COSMIC cancer mutations | thyroid-carcinoma-anaplastic_carcinoma | 856 | 7 | 16828 | 47 |
FARP1,FHOD3,NFIA,SNTB1,AMOT,GRK5,LAMA4 |
9.143e-03 | -4.69 | PPFIBP1 (PPFIA binding protein 1) | protein interactions | 8496 | 171 | 3 | 19454 | 49 |
PRKN,GRK5,GJA1 |
9.143e-03 | -4.69 | DDX47 (DEAD-box helicase 47) | protein interactions | 51202 | 171 | 3 | 19454 | 49 |
PRKN,FGFR3,PRDM16 |
9.172e-03 | -4.69 | MAPT (microtubule associated protein tau) | protein interactions | 4137 | 948 | 7 | 19454 | 49 |
FARP1,CTBP1,FKBP5,PRKN,SLC1A3,PLPP3,SLC1A2 |
9.254e-03 | -4.68 | RBM14 (RNA binding motif protein 14) | protein interactions | 10432 | 514 | 5 | 19454 | 49 |
FGFR3,PRKN,PRDM16,CTBP1,QKI |
9.273e-03 | -4.68 | NR3C1 (nuclear receptor subfamily 3 group C member 1) | protein interactions | 2908 | 950 | 7 | 19454 | 49 |
NFIA,TRPS1,APOA1,SLC1A3,PREX1,ZBTB20,FKBP5 |
9.289e-03 | -4.68 | WDR26 (WD repeat domain 26) | protein interactions | 80232 | 172 | 3 | 19454 | 49 |
PRKN,FGFR3,PRDM16 |
9.318e-03 | -4.68 | neutral amino acid transport | biological process | GO:0015804 | 53 | 2 | 18204 | 50 |
SLC1A2,SLC1A3 |
9.318e-03 | -4.68 | regulation of chondrocyte differentiation | biological process | GO:0032330 | 53 | 2 | 18204 | 50 |
TRPS1,SOX5 |
9.335e-03 | -4.67 | adenoma | COSMIC cancer mutations | adenoma | 2873 | 15 | 16828 | 47 |
GPC5,SLC6A11,ZBTB20,PTN,FARP1,NCKAP5,PTPRZ1,NPAS3,FHOD3,LAMA4,SOX5,PREX1,PRDM16,FGFR3,EGF |
9.358e-03 | -4.67 | NCOR1 (nuclear receptor corepressor 1) | protein interactions | 9611 | 329 | 4 | 19454 | 49 |
PRKN,NFIA,SOX5,CTBP1 |
9.390e-03 | -4.67 | NAXE (NAD(P)HX epimerase) | protein interactions | 128240 | 58 | 2 | 19454 | 49 |
PRKN,APOA1 |
9.390e-03 | -4.67 | DRG2 (developmentally regulated GTP binding protein 2) | protein interactions | 1819 | 58 | 2 | 19454 | 49 |
PRKN,FKBP5 |
9.390e-03 | -4.67 | MANEA (mannosidase endo-alpha) | protein interactions | 79694 | 58 | 2 | 19454 | 49 |
SLC39A12,LAMA4 |
9.390e-03 | -4.67 | PPWD1 (peptidylprolyl isomerase domain and WD repeat containing 1) | protein interactions | 23398 | 58 | 2 | 19454 | 49 |
PRKN,FKBP5 |
9.390e-03 | -4.67 | CILK1 (ciliogenesis associated kinase 1) | protein interactions | 22858 | 58 | 2 | 19454 | 49 |
MSI2,FKBP5 |
9.437e-03 | -4.66 | KRT16 (keratin 16) | protein interactions | 3868 | 173 | 3 | 19454 | 49 |
PRKN,APOA1,AMOT |
9.492e-03 | -4.66 | monoatomic anion transport | biological process | GO:0006820 | 159 | 3 | 18204 | 50 |
SLC1A2,SLC1A3,SLC4A4 |
9.530e-03 | -4.65 | human chr13q32.2 | chromosome location | human chr13q32.2 | 5 | 1 | 26134 | 50 |
FARP1 |
9.571e-03 | -4.65 | MYELIN_PLP_2 | prosite domains | PS01004 | 3 | 1 | 12186 | 39 |
GPM6B |
9.571e-03 | -4.65 | MYELIN_PLP_1 | prosite domains | PS00575 | 3 | 1 | 12186 | 39 |
GPM6B |
9.586e-03 | -4.65 | SCYL2 (SCY1 like pseudokinase 2) | protein interactions | 55681 | 174 | 3 | 19454 | 49 |
PRKN,GJA1,AMOT |
9.659e-03 | -4.64 | positive regulation of biomineral tissue development | biological process | GO:0070169 | 54 | 2 | 18204 | 50 |
PTN,GPM6B |
9.659e-03 | -4.64 | positive regulation of ossification | biological process | GO:0045778 | 54 | 2 | 18204 | 50 |
PTN,GPM6B |
9.659e-03 | -4.64 | regulation of cholesterol efflux | biological process | GO:0010874 | 54 | 2 | 18204 | 50 |
EGF,APOA1 |
9.678e-03 | -4.64 | Metabolism of fat-soluble vitamins | REACTOME pathways | R-HSA-6806667 | 53 | 2 | 10285 | 29 |
GPC5,APOA1 |
9.704e-03 | -4.64 | KDM4B (lysine demethylase 4B) | protein interactions | 23030 | 59 | 2 | 19454 | 49 |
PRKN,FKBP5 |
9.704e-03 | -4.64 | HBA1 (hemoglobin subunit alpha 1) | protein interactions | 3039 | 59 | 2 | 19454 | 49 |
APOA1,PRKN |
9.736e-03 | -4.63 | LHX3 (LIM homeobox 3) | protein interactions | 8022 | 175 | 3 | 19454 | 49 |
TRPS1,NFIA,SOX5 |
9.819e-03 | -4.62 | positive regulation of peptidyl-tyrosine phosphorylation | biological process | GO:0050731 | 161 | 3 | 18204 | 50 |
PLPP3,FGFR3,EGF |
9.827e-03 | -4.62 | regulation of small GTPase mediated signal transduction | biological process | GO:0051056 | 306 | 4 | 18204 | 50 |
PREX2,PREX1,AMOT,APOA1 |
9.887e-03 | -4.62 | AP3B1 (adaptor related protein complex 3 subunit beta 1) | protein interactions | 8546 | 176 | 3 | 19454 | 49 |
FGFRL1,GRK5,PRKN |
9.887e-03 | -4.62 | CDK11A (cyclin dependent kinase 11A) | protein interactions | 728642 | 176 | 3 | 19454 | 49 |
FKBP5,APOA1,PRKN |
1.001e-02 | -4.60 | response to cocaine | biological process | GO:0042220 | 55 | 2 | 18204 | 50 |
SLC1A3,SLC1A2 |
1.002e-02 | -4.60 | SNTB1 (syntrophin beta 1) | protein interactions | 6641 | 60 | 2 | 19454 | 49 |
FGFR3,TNS3 |
1.002e-02 | -4.60 | CTNNAL1 (catenin alpha like 1) | protein interactions | 8727 | 60 | 2 | 19454 | 49 |
TNS3,GJA1 |
1.002e-02 | -4.60 | CA2 (carbonic anhydrase 2) | protein interactions | 760 | 60 | 2 | 19454 | 49 |
PRKN,SLC4A4 |
1.002e-02 | -4.60 | Znf_NHR/GATA | interpro domains | IPR013088 | 56 | 2 | 18521 | 50 |
TRPS1,RORA |
1.004e-02 | -4.60 | MCTP1 (multiple C2 and transmembrane domain containing 1) | protein interactions | 79772 | 4 | 1 | 19454 | 49 |
PRKN |
1.004e-02 | -4.60 | NLRP13 (NLR family pyrin domain containing 13) | protein interactions | 126204 | 4 | 1 | 19454 | 49 |
PRKN |
1.004e-02 | -4.60 | PLEKHD1 (pleckstrin homology and coiled-coil domain containing D1) | protein interactions | 400224 | 4 | 1 | 19454 | 49 |
PRKN |
1.004e-02 | -4.60 | AVPR1A (arginine vasopressin receptor 1A) | protein interactions | 552 | 4 | 1 | 19454 | 49 |
GRK5 |
1.004e-02 | -4.60 | BPIFA3 (BPI fold containing family A member 3) | protein interactions | 128861 | 4 | 1 | 19454 | 49 |
PRKN |
1.004e-02 | -4.60 | SP5 (Sp5 transcription factor) | protein interactions | 389058 | 4 | 1 | 19454 | 49 |
PRKN |
1.004e-02 | -4.60 | UNC5D (unc-5 netrin receptor D) | protein interactions | 137970 | 4 | 1 | 19454 | 49 |
PRKN |
1.004e-02 | -4.60 | TIGD2 (tigger transposable element derived 2) | protein interactions | 166815 | 4 | 1 | 19454 | 49 |
PRKN |
1.004e-02 | -4.60 | SPATA31G1 (SPATA31 subfamily G member 1) | protein interactions | 138724 | 4 | 1 | 19454 | 49 |
PRKN |
1.004e-02 | -4.60 | PRKACA (protein kinase cAMP-activated catalytic subunit alpha) | protein interactions | 282322 | 4 | 1 | 19454 | 49 |
PRKN |
1.004e-02 | -4.60 | WDSUB1 (WD repeat, sterile alpha motif and U-box domain containing 1) | protein interactions | 151525 | 4 | 1 | 19454 | 49 |
PRKN |
1.004e-02 | -4.60 | Nrip1 (nuclear receptor interacting protein 1) | protein interactions | 268903 | 4 | 1 | 19454 | 49 |
CTBP1 |
1.004e-02 | -4.60 | ST18 (ST18 C2H2C-type zinc finger transcription factor) | protein interactions | 9705 | 4 | 1 | 19454 | 49 |
PRKN |
1.004e-02 | -4.60 | Nme2 (NME/NM23 nucleoside diphosphate kinase 2) | protein interactions | 18103 | 4 | 1 | 19454 | 49 |
RORA |
1.004e-02 | -4.60 | ACTL7A (actin like 7A) | protein interactions | 10881 | 4 | 1 | 19454 | 49 |
PRKN |
1.004e-02 | -4.60 | MYO1H (myosin IH) | protein interactions | 283446 | 4 | 1 | 19454 | 49 |
PRKN |
1.004e-02 | -4.60 | FAT2 (FAT atypical cadherin 2) | protein interactions | 2196 | 4 | 1 | 19454 | 49 |
PRKN |
1.004e-02 | -4.60 | EFCAB5 (EF-hand calcium binding domain 5) | protein interactions | 374786 | 4 | 1 | 19454 | 49 |
PRKN |
1.004e-02 | -4.60 | MATCAP1 (microtubule associated tyrosine carboxypeptidase 1) | protein interactions | 653319 | 4 | 1 | 19454 | 49 |
PRKN |
1.004e-02 | -4.60 | KANK3 (KN motif and ankyrin repeat domains 3) | protein interactions | 256949 | 4 | 1 | 19454 | 49 |
PRKN |
1.004e-02 | -4.60 | METTL25B (methyltransferase like 25B) | protein interactions | 51093 | 4 | 1 | 19454 | 49 |
PRKN |
1.004e-02 | -4.60 | FBXO48 (F-box protein 48) | protein interactions | 554251 | 4 | 1 | 19454 | 49 |
PRKN |
1.004e-02 | -4.60 | P2RY14 (purinergic receptor P2Y14) | protein interactions | 9934 | 4 | 1 | 19454 | 49 |
PRKN |
1.004e-02 | -4.60 | IGKV2-24 (immunoglobulin kappa variable 2-24) | protein interactions | 28923 | 4 | 1 | 19454 | 49 |
PRKN |
1.004e-02 | -4.60 | APOF (apolipoprotein F) | protein interactions | 319 | 4 | 1 | 19454 | 49 |
APOA1 |
1.004e-02 | -4.60 | ERICH6B (glutamate rich 6B) | protein interactions | 220081 | 4 | 1 | 19454 | 49 |
PRKN |
1.004e-02 | -4.60 | Egfr (epidermal growth factor receptor) | protein interactions | 13649 | 4 | 1 | 19454 | 49 |
PRKN |
1.004e-02 | -4.60 | KIFBP (kinesin family binding protein) | protein interactions | 26128 | 177 | 3 | 19454 | 49 |
FKBP5,PRKN,FGFR3 |
1.004e-02 | -4.60 | GATA3 (GATA binding protein 3) | protein interactions | 2625 | 177 | 3 | 19454 | 49 |
QKI,NFIA,TRPS1 |
1.006e-02 | -4.60 | YWHAB (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein beta) | protein interactions | 7529 | 965 | 7 | 19454 | 49 |
GRK5,NHSL1,USP6NL,AMOT,TNS3,PRKN,FGFR3 |
1.009e-02 | -4.60 | C1_1 | pfam domains | PF00130 | 54 | 2 | 17795 | 50 |
DGKB,TNS3 |
1.026e-02 | -4.58 | Transmembrane transport of small molecules | REACTOME pathways | R-HSA-382551 | 677 | 6 | 10285 | 29 |
SLC1A3,APOA1,SLC6A11,SLC4A4,SLC1A2,AQP4 |
1.026e-02 | -4.58 | ERBB3 (erb-b2 receptor tyrosine kinase 3) | protein interactions | 2065 | 338 | 4 | 19454 | 49 |
BCAR3,EGF,LRIG1,TNS3 |
1.030e-02 | -4.58 | RORNUCRECPTR | prints domains | PR01293 | 3 | 1 | 5227 | 18 |
RORA |
1.030e-02 | -4.58 | BAIPRECURSOR | prints domains | PR01694 | 3 | 1 | 5227 | 18 |
ADGRB3 |
1.030e-02 | -4.58 | ANGIOMOTIN | prints domains | PR01807 | 3 | 1 | 5227 | 18 |
AMOT |
1.030e-02 | -4.58 | MYELINPLP | prints domains | PR00214 | 3 | 1 | 5227 | 18 |
GPM6B |
1.032e-02 | -4.57 | parietal_lobe | COSMIC cancer mutations | parietal_lobe | 55 | 2 | 16828 | 47 |
FGFR3,QKI |
1.035e-02 | -4.57 | MAPK15 (mitogen-activated protein kinase 15) | protein interactions | 225689 | 61 | 2 | 19454 | 49 |
FKBP5,PRKN |
1.035e-02 | -4.57 | PTBP2 (polypyrimidine tract binding protein 2) | protein interactions | 58155 | 61 | 2 | 19454 | 49 |
QKI,PRKN |
1.043e-02 | -4.56 | adrenal_gland | COSMIC cancer mutations | adrenal_gland | 2628 | 14 | 16828 | 47 |
RFX4,LPIN2,NCKAP5,PTPRZ1,ZBTB20,FARP1,NHSL1,TNS3,SLC6A11,GRK5,SLC1A2,SOX5,FGFR3,LRIG1 |
1.044e-02 | -4.56 | Erythroid Transcription Factor GATA-1, subunit A | gene3d domains | 3.30.50.10 | 56 | 2 | 14470 | 40 |
TRPS1,RORA |
1.046e-02 | -4.56 | PLP | smart domains | SM00002 | 3 | 1 | 9717 | 34 |
GPM6B |
1.049e-02 | -4.56 | neuron projection morphogenesis | biological process | GO:0048812 | 486 | 5 | 18204 | 50 |
FARP1,PREX2,PTN,PTPRZ1,SLC39A12 |
1.049e-02 | -4.56 | import across plasma membrane | biological process | GO:0098739 | 165 | 3 | 18204 | 50 |
SLC1A2,SLC1A3,SLC39A12 |
1.051e-02 | -4.56 | VTN (vitronectin) | protein interactions | 7448 | 180 | 3 | 19454 | 49 |
PRKN,EGF,NFIA |
1.051e-02 | -4.56 | CYFIP1 (cytoplasmic FMR1 interacting protein 1) | protein interactions | 23191 | 180 | 3 | 19454 | 49 |
PRDM16,PRKN,SLC1A3 |
1.051e-02 | -4.56 | MYOD1 (myogenic differentiation 1) | protein interactions | 4654 | 180 | 3 | 19454 | 49 |
TRPS1,NFIA,RORA |
1.057e-02 | -4.55 | beta-adrenergic receptor kinase activity | molecular function | GO:0047696 | 4 | 1 | 18094 | 48 |
GRK5 |
1.057e-02 | -4.55 | angiostatin binding | molecular function | GO:0043532 | 4 | 1 | 18094 | 48 |
AMOT |
1.057e-02 | -4.55 | apolipoprotein A-I receptor binding | molecular function | GO:0034191 | 4 | 1 | 18094 | 48 |
APOA1 |
1.061e-02 | -4.55 | positive regulation of nucleobase-containing compound metabolic process | biological process | GO:0045935 | 2118 | 12 | 18204 | 50 |
NFIA,LPIN2,QKI,EGF,RFX4,SLC4A4,CTBP1,PRDM16,NPAS3,RORA,PRKN,ZBTB20 |
1.062e-02 | -4.54 | PDZ | prosite domains | PS50106 | 143 | 3 | 12186 | 39 |
PREX2,PREX1,SNTB1 |
1.067e-02 | -4.54 | ZKSCAN1 (zinc finger with KRAB and SCAN domains 1) | protein interactions | 7586 | 62 | 2 | 19454 | 49 |
QKI,PRKN |
1.067e-02 | -4.54 | MTMR7 (myotubularin related protein 7) | protein interactions | 9108 | 62 | 2 | 19454 | 49 |
CTBP1,FKBP5 |
1.070e-02 | -4.54 | regulation of signaling | biological process | GO:0023051 | 3534 | 17 | 18204 | 50 |
AMOT,PTN,PREX2,EGF,GPC5,BCAR3,PREX1,PRKN,APOA1,RORA,GJA1,SLC1A3,SORCS2,PLPP3,FGFR3,PRDM16,GRK5 |
1.072e-02 | -4.54 | fibroblast growth factor receptor signaling pathway | biological process | GO:0008543 | 57 | 2 | 18204 | 50 |
FGFRL1,FGFR3 |
1.076e-02 | -4.53 | CTF/NFI | interpro domains | IPR000647 | 4 | 1 | 18521 | 50 |
NFIA |
1.076e-02 | -4.53 | Tensin_PTB | interpro domains | IPR033929 | 4 | 1 | 18521 | 50 |
TNS3 |
1.076e-02 | -4.53 | FGF_rcpt_fam | interpro domains | IPR016248 | 4 | 1 | 18521 | 50 |
FGFR3 |
1.076e-02 | -4.53 | CTF/NFI_DNA-bd_N | interpro domains | IPR019548 | 4 | 1 | 18521 | 50 |
NFIA |
1.076e-02 | -4.53 | D-isomer_DH_CS | interpro domains | IPR029753 | 4 | 1 | 18521 | 50 |
CTBP1 |
1.076e-02 | -4.53 | CTF/NFI_DNA-bd-dom | interpro domains | IPR020604 | 4 | 1 | 18521 | 50 |
NFIA |
1.076e-02 | -4.53 | ApoA_E | interpro domains | IPR000074 | 4 | 1 | 18521 | 50 |
APOA1 |
1.076e-02 | -4.53 | D-isomer_2_OHA_DH_cat_dom | interpro domains | IPR006139 | 4 | 1 | 18521 | 50 |
CTBP1 |
1.076e-02 | -4.53 | CTF/NFI_DNA-bd_CS | interpro domains | IPR019739 | 4 | 1 | 18521 | 50 |
NFIA |
1.076e-02 | -4.53 | D-isomer_DH_NAD-bd | interpro domains | IPR006140 | 4 | 1 | 18521 | 50 |
CTBP1 |
1.076e-02 | -4.53 | NHS-like | interpro domains | IPR024845 | 4 | 1 | 18521 | 50 |
NHSL1 |
1.080e-02 | -4.53 | tube morphogenesis | biological process | GO:0035239 | 685 | 6 | 18204 | 50 |
EGF,QKI,AMOT,GJA1,RORA,SLC39A12 |
1.084e-02 | -4.52 | stomach-adenocarcinoma | COSMIC cancer mutations | stomach-adenocarcinoma | 4101 | 19 | 16828 | 47 |
PREX2,FHOD3,TRPS1,LRIG1,PREX1,SLC39A12,FGFR3,SLC4A4,SLC1A2,EGF,TNS3,GPC5,SLC6A11,PTN,FKBP5,RORA,ASPA,RFX4,QKI |
1.092e-02 | -4.52 | regulation of cell communication | biological process | GO:0010646 | 3541 | 17 | 18204 | 50 |
EGF,BCAR3,GPC5,AMOT,PTN,PREX2,PLPP3,FGFR3,PRDM16,GRK5,PRKN,PREX1,APOA1,GJA1,RORA,SLC1A3,SORCS2 |
1.092e-02 | -4.52 | papillary_renal_cell_carcinoma | COSMIC cancer mutations | papillary_renal_cell_carcinoma | 6364 | 26 | 16828 | 47 |
NFIA,PREX2,FHOD3,LAMA4,PRDM16,PREX1,FGFR3,UNC93A,RORA,ZBTB20,FARP1,BCAR3,NCKAP5,LRIG1,FGFRL1,SOX5,SLC4A4,GRK5,SNTB1,EGF,GPC5,TNS3,RFX4,LPIN2,AMOT,PTPRZ1 |
1.092e-02 | -4.52 | kidney-carcinoma-papillary_renal_cell_carcinoma | COSMIC cancer mutations | kidney-carcinoma-papillary_renal_cell_carcinoma | 6364 | 26 | 16828 | 47 |
SLC4A4,SOX5,FGFRL1,EGF,SNTB1,GRK5,LRIG1,PTPRZ1,LPIN2,RFX4,AMOT,TNS3,GPC5,FGFR3,PRDM16,PREX1,LAMA4,FHOD3,PREX2,NFIA,NCKAP5,BCAR3,UNC93A,FARP1,ZBTB20,RORA |
1.093e-02 | -4.52 | plasma membrane bounded cell projection morphogenesis | biological process | GO:0120039 | 491 | 5 | 18204 | 50 |
PREX2,PTN,PTPRZ1,SLC39A12,FARP1 |
1.094e-02 | -4.52 | positive regulation of hyaluronan biosynthetic process | biological process | GO:1900127 | 4 | 1 | 18204 | 50 |
EGF |
1.094e-02 | -4.52 | positive regulation of phospholipid efflux | biological process | GO:1902995 | 4 | 1 | 18204 | 50 |
APOA1 |
1.094e-02 | -4.52 | negative regulation of glucokinase activity | biological process | GO:0033132 | 4 | 1 | 18204 | 50 |
PRKN |
1.094e-02 | -4.52 | negative regulation of very-low-density lipoprotein particle remodeling | biological process | GO:0010903 | 4 | 1 | 18204 | 50 |
APOA1 |
1.094e-02 | -4.52 | parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization | biological process | GO:0061734 | 4 | 1 | 18204 | 50 |
PRKN |
1.094e-02 | -4.52 | regulation of phospholipid efflux | biological process | GO:1902994 | 4 | 1 | 18204 | 50 |
APOA1 |
1.094e-02 | -4.52 | positive regulation of mesenchymal stem cell differentiation | biological process | GO:2000741 | 4 | 1 | 18204 | 50 |
SOX5 |
1.094e-02 | -4.52 | positive regulation of mesodermal cell differentiation | biological process | GO:1905772 | 4 | 1 | 18204 | 50 |
GJA1 |
1.094e-02 | -4.52 | positive regulation of striated muscle tissue development | biological process | GO:0045844 | 4 | 1 | 18204 | 50 |
GJA1 |
1.094e-02 | -4.52 | positive regulation of muscle organ development | biological process | GO:0048636 | 4 | 1 | 18204 | 50 |
GJA1 |
1.094e-02 | -4.52 | negative regulation of hexokinase activity | biological process | GO:1903300 | 4 | 1 | 18204 | 50 |
PRKN |
1.094e-02 | -4.52 | regulation of serotonin uptake | biological process | GO:0051611 | 4 | 1 | 18204 | 50 |
GPM6B |
1.094e-02 | -4.52 | negative regulation of exosomal secretion | biological process | GO:1903542 | 4 | 1 | 18204 | 50 |
PRKN |
1.094e-02 | -4.52 | gamma-aminobutyric acid reuptake | biological process | GO:0051936 | 4 | 1 | 18204 | 50 |
SLC6A11 |
1.095e-02 | -4.51 | import into cell | biological process | GO:0098657 | 687 | 6 | 18204 | 50 |
SLC6A11,CTBP1,PRKN,SLC39A12,SLC1A3,SLC1A2 |
1.099e-02 | -4.51 | QKI (QKI, KH domain containing RNA binding) | protein interactions | 9444 | 183 | 3 | 19454 | 49 |
QKI,SLC39A12,MSI2 |
1.101e-02 | -4.51 | DHX33 (DEAH-box helicase 33) | protein interactions | 56919 | 63 | 2 | 19454 | 49 |
FKBP5,PRKN |
1.101e-02 | -4.51 | PLA2G4A (phospholipase A2 group IVA) | protein interactions | 5321 | 63 | 2 | 19454 | 49 |
PRKN,FKBP5 |
1.106e-02 | -4.50 | (4Z,7Z,10Z,13Z,16Z)-docosa-4,7,10,13,16-pentaenoate biosynthesis (6-desaturase) | BIOCYC pathways | META_PWY-7726 | 5 | 1 | 902 | 2 |
ELOVL2 |
1.106e-02 | -4.50 | docosahexaenoate biosynthesis III (6-desaturase, mammals) | BIOCYC pathways | META_PWY-7606 | 5 | 1 | 902 | 2 |
ELOVL2 |
1.107e-02 | -4.50 | inorganic molecular entity transmembrane transporter activity | molecular function | GO:0015318 | 714 | 6 | 18094 | 48 |
SLC6A11,AQP4,SLC1A2,SLC39A12,SLC1A3,SLC4A4 |
1.107e-02 | -4.50 | transcription regulator activity | molecular function | GO:0140110 | 1937 | 11 | 18094 | 48 |
RFX4,PRKN,CTBP1,SOX5,RORA,TRPS1,PRDM16,NPAS3,ZBTB20,LPIN2,NFIA |
1.110e-02 | -4.50 | cellular homeostasis | biological process | GO:0019725 | 689 | 6 | 18204 | 50 |
PRKN,ZBTB20,SLC4A4,AQP4,SLC1A3,SLC39A12 |
1.111e-02 | -4.50 | SLC3A2 (solute carrier family 3 member 2) | protein interactions | 6520 | 346 | 4 | 19454 | 49 |
SLC1A2,GJA1,PRKN,PRDM16 |
1.113e-02 | -4.50 | SQSTM1 (sequestosome 1) | protein interactions | 8878 | 984 | 7 | 19454 | 49 |
FHOD3,FGFR3,PRKN,AMOT,FARP1,GJA1,SNTB1 |
1.113e-02 | -4.50 | skin-benign_melanocytic_nevus-junctional | COSMIC cancer mutations | skin-benign_melanocytic_nevus-junctional | 4 | 1 | 16828 | 47 |
FGFR3 |
1.113e-02 | -4.50 | skin-lower_leg-malignant_melanoma-nodular | COSMIC cancer mutations | skin-lower_leg-malignant_melanoma-nodular | 4 | 1 | 16828 | 47 |
PREX2 |
1.113e-02 | -4.50 | inverted | COSMIC cancer mutations | inverted | 4 | 1 | 16828 | 47 |
FGFR3 |
1.113e-02 | -4.50 | skin-face-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-face-malignant_melanoma-superficial_spreading | 4 | 1 | 16828 | 47 |
PREX2 |
1.113e-02 | -4.50 | urinary_tract-bladder-other-normal | COSMIC cancer mutations | urinary_tract-bladder-other-normal | 4 | 1 | 16828 | 47 |
FGFR3 |
1.113e-02 | -4.50 | urinary_tract-bladder-papilloma-inverted | COSMIC cancer mutations | urinary_tract-bladder-papilloma-inverted | 4 | 1 | 16828 | 47 |
FGFR3 |
1.119e-02 | -4.49 | TPR_6 | pfam domains | PF13174 | 4 | 1 | 17795 | 50 |
FKBP5 |
1.119e-02 | -4.49 | NHS | pfam domains | PF15273 | 4 | 1 | 17795 | 50 |
NHSL1 |
1.119e-02 | -4.49 | 2-Hacid_dh | pfam domains | PF00389 | 4 | 1 | 17795 | 50 |
CTBP1 |
1.119e-02 | -4.49 | 2-Hacid_dh_C | pfam domains | PF02826 | 4 | 1 | 17795 | 50 |
CTBP1 |
1.119e-02 | -4.49 | NfI_DNAbd_pre-N | pfam domains | PF10524 | 4 | 1 | 17795 | 50 |
NFIA |
1.119e-02 | -4.49 | Apolipoprotein | pfam domains | PF01442 | 4 | 1 | 17795 | 50 |
APOA1 |
1.119e-02 | -4.49 | CTF_NFI | pfam domains | PF00859 | 4 | 1 | 17795 | 50 |
NFIA |
1.119e-02 | -4.49 | PKD_4 | pfam domains | PF18911 | 4 | 1 | 17795 | 50 |
SORCS2 |
1.120e-02 | -4.49 | cellular response to growth factor stimulus | biological process | GO:0071363 | 494 | 5 | 18204 | 50 |
NFIA,APOA1,FGFRL1,SOX5,FGFR3 |
1.120e-02 | -4.49 | tube development | biological process | GO:0035295 | 903 | 7 | 18204 | 50 |
NFIA,QKI,EGF,SLC39A12,GJA1,RORA,AMOT |
1.123e-02 | -4.49 | Reuptake of GABA | REACTOME pathways | R-HSA-888593 | 4 | 1 | 10285 | 29 |
SLC6A11 |
1.123e-02 | -4.49 | PLCG1 events in ERBB2 signaling | REACTOME pathways | R-HSA-1251932 | 4 | 1 | 10285 | 29 |
EGF |
1.125e-02 | -4.49 | bone-extraskeletal-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-extraskeletal-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 891 | 7 | 16828 | 47 |
NPAS3,PTPRZ1,LRIG1,NCKAP5,FGFR3,SLC6A11,LAMA4 |
1.126e-02 | -4.49 | urinary_tract-bladder-carcinoma-transitional_cell_carcinoma | COSMIC cancer mutations | urinary_tract-bladder-carcinoma-transitional_cell_carcinoma | 6040 | 25 | 16828 | 47 |
RFX4,LPIN2,PTPRZ1,GPC5,TNS3,SLC6A11,SLC1A3,FGFRL1,SLC4A4,GRK5,EGF,TRPS1,LRIG1,BCAR3,UNC93A,ZBTB20,FKBP5,FARP1,LAMA4,PRDM16,PREX1,ELOVL2,FGFR3,NFIA,PREX2 |
1.131e-02 | -4.48 | transitional_cell_carcinoma | COSMIC cancer mutations | transitional_cell_carcinoma | 6042 | 25 | 16828 | 47 |
BCAR3,UNC93A,FARP1,ZBTB20,FKBP5,ELOVL2,FGFR3,LAMA4,PREX1,PRDM16,NFIA,PREX2,PTPRZ1,LPIN2,RFX4,SLC6A11,GPC5,TNS3,SLC1A3,SLC4A4,FGFRL1,EGF,GRK5,TRPS1,LRIG1 |
1.132e-02 | -4.48 | cognition | biological process | GO:0050890 | 319 | 4 | 18204 | 50 |
PRKN,ADGRB3,PTN,PTPRZ1 |
1.134e-02 | -4.48 | DGKE (diacylglycerol kinase epsilon) | protein interactions | 8526 | 64 | 2 | 19454 | 49 |
DGKB,PRKN |
1.134e-02 | -4.48 | VSX1 (visual system homeobox 1) | protein interactions | 30813 | 64 | 2 | 19454 | 49 |
NFIA,TRPS1 |
1.136e-02 | -4.48 | upper_aerodigestive_tract-head_neck-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | upper_aerodigestive_tract-head_neck-carcinoma-squamous_cell_carcinoma | 9263 | 34 | 16828 | 47 |
FHOD3,NFIA,PREX2,ELOVL2,FGFR3,LAMA4,PREX1,PRDM16,UNC93A,NHSL1,FARP1,FKBP5,RORA,PTN,QKI,BCAR3,TRPS1,GPM6B,LRIG1,DGKB,SLC4A4,SOX5,SNTB1,EGF,GRK5,GPC5,TNS3,USP6NL,MSI2,SORCS2,PTPRZ1,CTBP1,AMOT,LPIN2 |
1.138e-02 | -4.48 | cell projection morphogenesis | biological process | GO:0048858 | 496 | 5 | 18204 | 50 |
FARP1,SLC39A12,PTPRZ1,PTN,PREX2 |
1.138e-02 | -4.48 | skin-scalp-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-scalp-carcinoma-squamous_cell_carcinoma | 1596 | 10 | 16828 | 47 |
TRPS1,GPC5,FARP1,PTN,RORA,FGFR3,SLC4A4,PREX1,SOX5,PTPRZ1 |
1.140e-02 | -4.47 | neuron projection development | biological process | GO:0031175 | 693 | 6 | 18204 | 50 |
FARP1,GPM6B,PTN,PREX2,SLC39A12,PTPRZ1 |
1.143e-02 | -4.47 | human chr14q13.1 | chromosome location | human chr14q13.1 | 6 | 1 | 26134 | 50 |
NPAS3 |
1.143e-02 | -4.47 | human chr1p32.2 | chromosome location | human chr1p32.2 | 6 | 1 | 26134 | 50 |
PLPP3 |
1.170e-02 | -4.45 | positive regulation of phosphate metabolic process | biological process | GO:0045937 | 697 | 6 | 18204 | 50 |
SLC4A4,ZBTB20,PLPP3,FGFR3,EGF,BCAR3 |
1.170e-02 | -4.45 | positive regulation of phosphorus metabolic process | biological process | GO:0010562 | 697 | 6 | 18204 | 50 |
SLC4A4,PLPP3,EGF,FGFR3,ZBTB20,BCAR3 |
1.171e-02 | -4.45 | organic substance transport | biological process | GO:0071702 | 1881 | 11 | 18204 | 50 |
SLC1A3,SLC39A12,SORCS2,PRKN,SLC6A11,SLC4A4,APOA1,GJA1,GPM6B,SLC1A2,QKI |
1.174e-02 | -4.44 | negative regulation of secretion | biological process | GO:0051048 | 172 | 3 | 18204 | 50 |
GJA1,PRKN,EGF |
1.178e-02 | -4.44 | transmembrane receptor protein tyrosine kinase activity | molecular function | GO:0004714 | 62 | 2 | 18094 | 48 |
FGFRL1,FGFR3 |
1.181e-02 | -4.44 | Tyr_Pase_cat | interpro domains | IPR003595 | 61 | 2 | 18521 | 50 |
PTPRZ1,TNS3 |
1.181e-02 | -4.44 | C1-like_sf | interpro domains | IPR046349 | 61 | 2 | 18521 | 50 |
DGKB,TNS3 |
1.181e-02 | -4.44 | HNF1B (HNF1 homeobox B) | protein interactions | 6928 | 188 | 3 | 19454 | 49 |
NFIA,TRPS1,SOX5 |
1.182e-02 | -4.44 | export across plasma membrane | biological process | GO:0140115 | 60 | 2 | 18204 | 50 |
SLC4A4,GJA1 |
1.192e-02 | -4.43 | chemical homeostasis | biological process | GO:0048878 | 914 | 7 | 18204 | 50 |
SLC39A12,SLC1A3,SLC4A4,AQP4,RORA,APOA1,ZBTB20 |
1.192e-02 | -4.43 | cartilage development | biological process | GO:0051216 | 173 | 3 | 18204 | 50 |
FGFR3,SOX5,NFIA |
1.203e-02 | -4.42 | MAML1 (mastermind like transcriptional coactivator 1) | protein interactions | 9794 | 66 | 2 | 19454 | 49 |
NFIA,CTBP1 |
1.203e-02 | -4.42 | DDX49 (DEAD-box helicase 49) | protein interactions | 54555 | 66 | 2 | 19454 | 49 |
PRDM16,PRKN |
1.205e-02 | -4.42 | extraskeletal | COSMIC cancer mutations | extraskeletal | 903 | 7 | 16828 | 47 |
LRIG1,SLC6A11,NCKAP5,PTPRZ1,NPAS3,FGFR3,LAMA4 |
1.205e-02 | -4.42 | Phospholipase D signaling pathway | KEGG pathways | ko04072 | 145 | 3 | 7161 | 24 |
PLPP3,EGF,DGKB |
1.205e-02 | -4.42 | Phospholipase D signaling pathway | KEGG pathways | hsa04072 | 145 | 3 | 7161 | 24 |
EGF,DGKB,PLPP3 |
1.215e-02 | -4.41 | CEP192 (centrosomal protein 192) | protein interactions | 55125 | 190 | 3 | 19454 | 49 |
PRKN,FGFR3,AMOT |
1.220e-02 | -4.41 | PH | smart domains | SM00233 | 259 | 4 | 9717 | 34 |
PREX1,FARP1,PREX2,SNTB1 |
1.220e-02 | -4.41 | bone mineralization | biological process | GO:0030282 | 61 | 2 | 18204 | 50 |
PTN,FGFR3 |
1.224e-02 | -4.40 | RBBP4 (RB binding protein 4, chromatin remodeling factor) | protein interactions | 5928 | 551 | 5 | 19454 | 49 |
CTBP1,ZBTB20,PRKN,PRDM16,TRPS1 |
1.231e-02 | -4.40 | GRB2 (growth factor receptor bound protein 2) | protein interactions | 2885 | 769 | 6 | 19454 | 49 |
MSI2,USP6NL,SLC1A2,PRKN,FGFR3,EGF |
1.233e-02 | -4.40 | SON (SON DNA and RNA binding protein) | protein interactions | 6651 | 191 | 3 | 19454 | 49 |
NFIA,PRDM16,PRKN |
1.233e-02 | -4.40 | PFKL (phosphofructokinase, liver type) | protein interactions | 5211 | 191 | 3 | 19454 | 49 |
PRKN,FGFR3,PRDM16 |
1.235e-02 | -4.39 | CXADR (CXADR Ig-like cell adhesion molecule) | protein interactions | 1525 | 357 | 4 | 19454 | 49 |
GJA1,FARP1,USP6NL,AMOT |
1.238e-02 | -4.39 | C15orf39 (chromosome 15 open reading frame 39) | protein interactions | 56905 | 67 | 2 | 19454 | 49 |
CTBP1,PRKN |
1.252e-02 | -4.38 | breast-carcinoma-ductolobular_carcinoma | COSMIC cancer mutations | breast-carcinoma-ductolobular_carcinoma | 1619 | 10 | 16828 | 47 |
QKI,PTPRZ1,FGFR3,SLC39A12,LAMA4,FARP1,DGKB,RORA,FHOD3,PREX2 |
1.252e-02 | -4.38 | ductolobular_carcinoma | COSMIC cancer mutations | ductolobular_carcinoma | 1619 | 10 | 16828 | 47 |
LAMA4,SLC39A12,FGFR3,QKI,PTPRZ1,PREX2,FHOD3,RORA,FARP1,DGKB |
1.253e-02 | -4.38 | TRANK1 (tetratricopeptide repeat and ankyrin repeat containing 1) | protein interactions | 9881 | 5 | 1 | 19454 | 49 |
PRKN |
1.253e-02 | -4.38 | SCUBE3 (signal peptide, CUB domain and EGF like domain containing 3) | protein interactions | 222663 | 5 | 1 | 19454 | 49 |
PRKN |
1.253e-02 | -4.38 | TRPM6 (transient receptor potential cation channel subfamily M member 6) | protein interactions | 140803 | 5 | 1 | 19454 | 49 |
PRKN |
1.253e-02 | -4.38 | SIM1 (SIM bHLH transcription factor 1) | protein interactions | 6492 | 5 | 1 | 19454 | 49 |
PRKN |
1.253e-02 | -4.38 | SLIT3 (slit guidance ligand 3) | protein interactions | 6586 | 5 | 1 | 19454 | 49 |
PRKN |
1.253e-02 | -4.38 | RNF212 (ring finger protein 212) | protein interactions | 285498 | 5 | 1 | 19454 | 49 |
PRKN |
1.253e-02 | -4.38 | SLC25A36 (solute carrier family 25 member 36) | protein interactions | 55186 | 5 | 1 | 19454 | 49 |
PTN |
1.253e-02 | -4.38 | GCSAM (germinal center associated signaling and motility) | protein interactions | 257144 | 5 | 1 | 19454 | 49 |
PRKN |
1.253e-02 | -4.38 | CFAP251 (cilia and flagella associated protein 251) | protein interactions | 144406 | 5 | 1 | 19454 | 49 |
PRKN |
1.253e-02 | -4.38 | ATP8B3 (ATPase phospholipid transporting 8B3) | protein interactions | 148229 | 5 | 1 | 19454 | 49 |
PRKN |
1.253e-02 | -4.38 | PDE1A (phosphodiesterase 1A) | protein interactions | 5136 | 5 | 1 | 19454 | 49 |
APOA1 |
1.253e-02 | -4.38 | CCDC152 (coiled-coil domain containing 152) | protein interactions | 100129792 | 5 | 1 | 19454 | 49 |
PRKN |
1.253e-02 | -4.38 | SPATA31A7 (SPATA31 subfamily A member 7) | protein interactions | 26165 | 5 | 1 | 19454 | 49 |
GRK5 |
1.253e-02 | -4.38 | DENND2A (DENN domain containing 2A) | protein interactions | 27147 | 5 | 1 | 19454 | 49 |
PRKN |
1.253e-02 | -4.38 | RFX4 (regulatory factor X4) | protein interactions | 5992 | 5 | 1 | 19454 | 49 |
RFX4 |
1.253e-02 | -4.38 | ANKRD20A4P (ankyrin repeat domain 20 family member A4, pseudogene) | protein interactions | 728747 | 5 | 1 | 19454 | 49 |
PRKN |
1.253e-02 | -4.38 | SPIC (Spi-C transcription factor) | protein interactions | 121599 | 5 | 1 | 19454 | 49 |
PRKN |
1.253e-02 | -4.38 | ANKRD30B (ankyrin repeat domain 30B) | protein interactions | 374860 | 5 | 1 | 19454 | 49 |
PRKN |
1.253e-02 | -4.38 | CCDC191 (coiled-coil domain containing 191) | protein interactions | 57577 | 5 | 1 | 19454 | 49 |
PRKN |
1.255e-02 | -4.38 | skin-extremity-malignant_melanoma | COSMIC cancer mutations | skin-extremity-malignant_melanoma | 1875 | 11 | 16828 | 47 |
FHOD3,SLC6A11,PREX2,APOA1,USP6NL,FKBP5,PRDM16,SORCS2,CTBP1,PTPRZ1,BCAR3 |
1.259e-02 | -4.38 | regulation of substrate adhesion-dependent cell spreading | biological process | GO:1900024 | 62 | 2 | 18204 | 50 |
APOA1,PREX1 |
1.259e-02 | -4.38 | regulation of carbohydrate catabolic process | biological process | GO:0043470 | 62 | 2 | 18204 | 50 |
SLC4A4,ZBTB20 |
1.263e-02 | -4.37 | lower_leg | COSMIC cancer mutations | lower_leg | 174 | 3 | 16828 | 47 |
FGFR3,SLC6A11,PREX2 |
1.268e-02 | -4.37 | UBE2J1 (ubiquitin conjugating enzyme E2 J1) | protein interactions | 51465 | 193 | 3 | 19454 | 49 |
PRKN,GJA1,CTBP1 |
1.268e-02 | -4.37 | regulation of phosphate metabolic process | biological process | GO:0019220 | 1154 | 8 | 18204 | 50 |
BCAR3,PLPP3,EGF,FGFR3,APOA1,SLC4A4,PRKN,ZBTB20 |
1.270e-02 | -4.37 | CTBP1 (C-terminal binding protein 1) | protein interactions | 1487 | 360 | 4 | 19454 | 49 |
PRDM16,TRPS1,PRKN,CTBP1 |
1.274e-02 | -4.36 | FOXP2 (forkhead box P2) | protein interactions | 93986 | 68 | 2 | 19454 | 49 |
SOX5,CTBP1 |
1.274e-02 | -4.36 | MOB1A (MOB kinase activator 1A) | protein interactions | 55233 | 68 | 2 | 19454 | 49 |
PRKN,AMOT |
1.274e-02 | -4.36 | MARK1 (microtubule affinity regulating kinase 1) | protein interactions | 4139 | 68 | 2 | 19454 | 49 |
SNTB1,GJA1 |
1.274e-02 | -4.36 | CTF_NFI_2 | prosite domains | PS51080 | 4 | 1 | 12186 | 39 |
NFIA |
1.274e-02 | -4.36 | D_2_HYDROXYACID_DH_3 | prosite domains | PS00671 | 4 | 1 | 12186 | 39 |
CTBP1 |
1.274e-02 | -4.36 | CTF_NFI_1 | prosite domains | PS00349 | 4 | 1 | 12186 | 39 |
NFIA |
1.274e-02 | -4.36 | regulation of phosphorus metabolic process | biological process | GO:0051174 | 1155 | 8 | 18204 | 50 |
PRKN,ZBTB20,SLC4A4,APOA1,BCAR3,PLPP3,FGFR3,EGF |
1.287e-02 | -4.35 | viral life cycle | biological process | GO:0019058 | 178 | 3 | 18204 | 50 |
CTBP1,USP6NL,NFIA |
1.299e-02 | -4.34 | oesophagus-carcinoma-adenocarcinoma | COSMIC cancer mutations | oesophagus-carcinoma-adenocarcinoma | 13112 | 43 | 16828 | 47 |
LRIG1,DGKB,TRPS1,GRK5,SNTB1,EGF,SOX5,FGFRL1,SLC4A4,SLC39A12,USP6NL,SLC1A3,GPC5,TNS3,SLC6A11,RFX4,LPIN2,AMOT,PTPRZ1,CTBP1,NPAS3,SORCS2,ASPA,PREX2,FHOD3,SLC1A2,LAMA4,PRDM16,PREX1,ELOVL2,FGFR3,FKBP5,ZBTB20,RORA,PTN,FARP1,NHSL1,UNC93A,GJA1,BCAR3,NCKAP5,QKI,AQP4 |
1.306e-02 | -4.34 | lipid homeostasis | biological process | GO:0055088 | 179 | 3 | 18204 | 50 |
APOA1,RORA,ZBTB20 |
1.308e-02 | -4.34 | skin-ear-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | skin-ear-carcinoma-squamous_cell_carcinoma | 506 | 5 | 16828 | 47 |
LAMA4,UNC93A,FGFR3,ZBTB20,NPAS3 |
1.309e-02 | -4.34 | upper_back | COSMIC cancer mutations | upper_back | 328 | 4 | 16828 | 47 |
GPC5,FGFR3,FHOD3,SLC6A11 |
1.310e-02 | -4.34 | CTH (cystathionine gamma-lyase) | protein interactions | 1491 | 69 | 2 | 19454 | 49 |
PRKN,CTBP1 |
1.310e-02 | -4.34 | FMNL2 (formin like 2) | protein interactions | 114793 | 69 | 2 | 19454 | 49 |
GRK5,PRKN |
1.317e-02 | -4.33 | carboxylic acid transmembrane transporter activity | molecular function | GO:0046943 | 186 | 3 | 18094 | 48 |
SLC1A3,SLC6A11,SLC1A2 |
1.320e-02 | -4.33 | glutathione transmembrane transporter activity | molecular function | GO:0034634 | 5 | 1 | 18094 | 48 |
GJA1 |
1.320e-02 | -4.33 | taurine transmembrane transporter activity | molecular function | GO:0005368 | 5 | 1 | 18094 | 48 |
SLC6A11 |
1.320e-02 | -4.33 | gap junction channel activity involved in cardiac conduction electrical coupling | molecular function | GO:0086075 | 5 | 1 | 18094 | 48 |
GJA1 |
1.321e-02 | -4.33 | primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | primitive_neuroectodermal_tumour-medulloblastoma | 15350 | 47 | 16828 | 47 |
GPC5,TNS3,USP6NL,SLC1A3,MSI2,LPIN2,RFX4,PTPRZ1,CTBP1,SLC39A12,GRK5,EGF,RORA,PTN,FARP1,BCAR3,NFIA,PREX2,PRDM16,SLC6A11,SORCS2,ASPA,AMOT,NPAS3,GPM6B,TRPS1,LRIG1,DGKB,FGFRL1,SOX5,SLC4A4,SNTB1,NHSL1,UNC93A,FKBP5,ZBTB20,AQP4,GJA1,NCKAP5,QKI,FHOD3,APOA1,LAMA4,PREX1,ELOVL2,FGFR3,SLC1A2 |
1.327e-02 | -4.32 | L-amino acid transmembrane transporter activity | molecular function | GO:0015179 | 66 | 2 | 18094 | 48 |
SLC1A3,SLC1A2 |
1.332e-02 | -4.32 | human chr8q13.2 | chromosome location | human chr8q13.2 | 7 | 1 | 26134 | 50 |
PREX2 |
1.336e-02 | -4.32 | organic acid transmembrane transporter activity | molecular function | GO:0005342 | 187 | 3 | 18094 | 48 |
SLC1A2,SLC6A11,SLC1A3 |
1.338e-02 | -4.31 | PDZ | smart domains | SM00228 | 143 | 3 | 9717 | 34 |
PREX2,PREX1,SNTB1 |
1.343e-02 | -4.31 | BBP-like | interpro domains | IPR045071 | 5 | 1 | 18521 | 50 |
QKI |
1.343e-02 | -4.31 | Laminin_dom_II | interpro domains | IPR010307 | 5 | 1 | 18521 | 50 |
LAMA4 |
1.343e-02 | -4.31 | Sortilin_C | interpro domains | IPR031777 | 5 | 1 | 18521 | 50 |
SORCS2 |
1.343e-02 | -4.31 | Na/HCO3_transpt | interpro domains | IPR003024 | 5 | 1 | 18521 | 50 |
SLC4A4 |
1.343e-02 | -4.31 | Syntrophin | interpro domains | IPR015482 | 5 | 1 | 18521 | 50 |
SNTB1 |
1.343e-02 | -4.31 | Sortilin_N | interpro domains | IPR031778 | 5 | 1 | 18521 | 50 |
SORCS2 |
1.343e-02 | -4.31 | VPS10 | interpro domains | IPR006581 | 5 | 1 | 18521 | 50 |
SORCS2 |
1.343e-02 | -4.31 | Laminin_aI | interpro domains | IPR009254 | 5 | 1 | 18521 | 50 |
LAMA4 |
1.346e-02 | -4.31 | ITGB3 (integrin subunit beta 3) | protein interactions | 3690 | 70 | 2 | 19454 | 49 |
PTN,PTPRZ1 |
1.346e-02 | -4.31 | TSHZ3 (teashirt zinc finger homeobox 3) | protein interactions | 57616 | 70 | 2 | 19454 | 49 |
CTBP1,SOX5 |
1.346e-02 | -4.31 | PGAM2 (phosphoglycerate mutase 2) | protein interactions | 5224 | 70 | 2 | 19454 | 49 |
SOX5,PLPP3 |
1.346e-02 | -4.31 | TMPPE (transmembrane protein with metallophosphoesterase domain) | protein interactions | 643853 | 70 | 2 | 19454 | 49 |
PRKN,SLC39A12 |
1.348e-02 | -4.31 | - | gene3d domains | 3.30.60.20 | 64 | 2 | 14470 | 40 |
TNS3,DGKB |
1.353e-02 | -4.30 | monocarboxylic acid metabolic process | biological process | GO:0032787 | 518 | 5 | 18204 | 50 |
SLC1A3,ASPA,ELOVL2,QKI,LPIN2 |
1.354e-02 | -4.30 | transporter activity | molecular function | GO:0005215 | 1211 | 8 | 18094 | 48 |
SLC1A3,GJA1,SLC6A11,SLC1A2,SLC39A12,APOA1,SLC4A4,AQP4 |
1.357e-02 | -4.30 | TPX2 (TPX2 microtubule nucleation factor) | protein interactions | 22974 | 198 | 3 | 19454 | 49 |
PREX1,FARP1,PRDM16 |
1.357e-02 | -4.30 | GSTP1 (glutathione S-transferase pi 1) | protein interactions | 2950 | 198 | 3 | 19454 | 49 |
PTN,GJA1,PRKN |
1.357e-02 | -4.30 | NDUFA7 (NADH:ubiquinone oxidoreductase subunit A7) | protein interactions | 4701 | 198 | 3 | 19454 | 49 |
QKI,PRKN,GJA1 |
1.357e-02 | -4.30 | NFIX (nuclear factor I X) | protein interactions | 4784 | 198 | 3 | 19454 | 49 |
TRPS1,NFIA,SOX5 |
1.365e-02 | -4.29 | sterol binding | molecular function | GO:0032934 | 67 | 2 | 18094 | 48 |
RORA,APOA1 |
1.366e-02 | -4.29 | retrograde trans-synaptic signaling | biological process | GO:0098917 | 5 | 1 | 18204 | 50 |
FARP1 |
1.366e-02 | -4.29 | otolith morphogenesis | biological process | GO:0032474 | 5 | 1 | 18204 | 50 |
LRIG1 |
1.366e-02 | -4.29 | regulation protein catabolic process at synapse | biological process | GO:0140250 | 5 | 1 | 18204 | 50 |
PRKN |
1.366e-02 | -4.29 | regulation of synaptic vesicle transport | biological process | GO:1902803 | 5 | 1 | 18204 | 50 |
PRKN |
1.366e-02 | -4.29 | regulation of glucokinase activity | biological process | GO:0033131 | 5 | 1 | 18204 | 50 |
PRKN |
1.366e-02 | -4.29 | regulation of endosome organization | biological process | GO:1904978 | 5 | 1 | 18204 | 50 |
PRKN |
1.366e-02 | -4.29 | head_neck | COSMIC cancer mutations | head_neck | 15361 | 47 | 16828 | 47 |
PRDM16,NFIA,PREX2,BCAR3,RORA,PTN,FARP1,GRK5,EGF,SLC39A12,LPIN2,RFX4,PTPRZ1,CTBP1,MSI2,USP6NL,SLC1A3,GPC5,TNS3,SLC1A2,LAMA4,PREX1,ELOVL2,FGFR3,APOA1,FHOD3,GJA1,NCKAP5,QKI,AQP4,FKBP5,ZBTB20,NHSL1,UNC93A,SNTB1,FGFRL1,SOX5,SLC4A4,LRIG1,DGKB,GPM6B,TRPS1,AMOT,NPAS3,SORCS2,ASPA,SLC6A11 |
1.372e-02 | -4.29 | PE/DAG-bd | interpro domains | IPR002219 | 66 | 2 | 18521 | 50 |
TNS3,DGKB |
1.375e-02 | -4.29 | - | gene3d domains | 3.30.60.270 | 5 | 1 | 14470 | 40 |
SORCS2 |
1.375e-02 | -4.29 | Apolipoprotein | gene3d domains | 1.20.120.20 | 5 | 1 | 14470 | 40 |
APOA1 |
1.375e-02 | -4.29 | - | gene3d domains | 2.10.70.80 | 5 | 1 | 14470 | 40 |
SORCS2 |
1.376e-02 | -4.29 | WDR1 (WD repeat domain 1) | protein interactions | 9948 | 199 | 3 | 19454 | 49 |
PRKN,CTBP1,MSI2 |
1.377e-02 | -4.29 | tissue regeneration | biological process | GO:0042246 | 65 | 2 | 18204 | 50 |
PTN,GJA1 |
1.383e-02 | -4.28 | UNKL (unk like zinc finger) | protein interactions | 64718 | 71 | 2 | 19454 | 49 |
QKI,CTBP1 |
1.383e-02 | -4.28 | TRAPPC8 (trafficking protein particle complex subunit 8) | protein interactions | 22878 | 71 | 2 | 19454 | 49 |
GJA1,PRKN |
1.383e-02 | -4.28 | ABCB10 (ATP binding cassette subfamily B member 10) | protein interactions | 23456 | 71 | 2 | 19454 | 49 |
SLC39A12,PRKN |
1.384e-02 | -4.28 | regulation of cytoskeleton organization | biological process | GO:0051493 | 521 | 5 | 18204 | 50 |
GPM6B,SLC39A12,PREX1,PRKN,APOA1 |
1.384e-02 | -4.28 | muscle structure development | biological process | GO:0061061 | 521 | 5 | 18204 | 50 |
RORA,FGFRL1,QKI,FHOD3,ADGRB3 |
1.386e-02 | -4.28 | regulation of lipid localization | biological process | GO:1905952 | 183 | 3 | 18204 | 50 |
PRKN,EGF,APOA1 |
1.386e-02 | -4.28 | regulation of protein localization to membrane | biological process | GO:1905475 | 183 | 3 | 18204 | 50 |
GPC5,FARP1,PRKN |
1.389e-02 | -4.28 | regulation of Wnt signaling pathway | biological process | GO:0030111 | 339 | 4 | 18204 | 50 |
GPC5,EGF,PLPP3,PRKN |
1.389e-02 | -4.28 | CDC42 (cell division cycle 42) | protein interactions | 998 | 1280 | 8 | 19454 | 49 |
ELOVL2,SLC1A3,PRKN,PREX2,FARP1,GJA1,PREX1,USP6NL |
1.389e-02 | -4.28 | skin-shoulder-other-lichenoid_keratosis | COSMIC cancer mutations | skin-shoulder-other-lichenoid_keratosis | 5 | 1 | 16828 | 47 |
FGFR3 |
1.389e-02 | -4.28 | skin-face-other-nevus_sebaceous | COSMIC cancer mutations | skin-face-other-nevus_sebaceous | 5 | 1 | 16828 | 47 |
FGFR3 |
1.389e-02 | -4.28 | skin-forearm-other-lichenoid_keratosis | COSMIC cancer mutations | skin-forearm-other-lichenoid_keratosis | 5 | 1 | 16828 | 47 |
FGFR3 |
1.389e-02 | -4.28 | skin-ear-other-nevus_sebaceous | COSMIC cancer mutations | skin-ear-other-nevus_sebaceous | 5 | 1 | 16828 | 47 |
FGFR3 |
1.389e-02 | -4.28 | skin-neck-other-nevus_sebaceous | COSMIC cancer mutations | skin-neck-other-nevus_sebaceous | 5 | 1 | 16828 | 47 |
FGFR3 |
1.389e-02 | -4.28 | skin-lower_leg-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-lower_leg-malignant_melanoma-superficial_spreading | 5 | 1 | 16828 | 47 |
PREX2 |
1.389e-02 | -4.28 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-monoclonal_gammopathy_of_undetermined_significance | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-monoclonal_gammopathy_of_undetermined_significance | 5 | 1 | 16828 | 47 |
FGFR3 |
1.389e-02 | -4.28 | skin-adnexal_tumour-syringocystadenoma_papilliferum | COSMIC cancer mutations | skin-adnexal_tumour-syringocystadenoma_papilliferum | 5 | 1 | 16828 | 47 |
FGFR3 |
1.389e-02 | -4.28 | skin-upper_arm-other-lichenoid_keratosis | COSMIC cancer mutations | skin-upper_arm-other-lichenoid_keratosis | 5 | 1 | 16828 | 47 |
FGFR3 |
1.389e-02 | -4.28 | lichenoid_keratosis | COSMIC cancer mutations | lichenoid_keratosis | 5 | 1 | 16828 | 47 |
FGFR3 |
1.389e-02 | -4.28 | skin-hand-other-lichenoid_keratosis | COSMIC cancer mutations | skin-hand-other-lichenoid_keratosis | 5 | 1 | 16828 | 47 |
FGFR3 |
1.389e-02 | -4.28 | skin-shoulder-other-nevus_sebaceous | COSMIC cancer mutations | skin-shoulder-other-nevus_sebaceous | 5 | 1 | 16828 | 47 |
FGFR3 |
1.389e-02 | -4.28 | skin-lower_leg-other-lichenoid_keratosis | COSMIC cancer mutations | skin-lower_leg-other-lichenoid_keratosis | 5 | 1 | 16828 | 47 |
FGFR3 |
1.389e-02 | -4.28 | skin-face-other-lichenoid_keratosis | COSMIC cancer mutations | skin-face-other-lichenoid_keratosis | 5 | 1 | 16828 | 47 |
FGFR3 |
1.389e-02 | -4.28 | syringocystadenoma_papilliferum | COSMIC cancer mutations | syringocystadenoma_papilliferum | 5 | 1 | 16828 | 47 |
FGFR3 |
1.389e-02 | -4.28 | skin-other-lichenoid_keratosis | COSMIC cancer mutations | skin-other-lichenoid_keratosis | 5 | 1 | 16828 | 47 |
FGFR3 |
1.389e-02 | -4.28 | skin-upper_back-other-lichenoid_keratosis | COSMIC cancer mutations | skin-upper_back-other-lichenoid_keratosis | 5 | 1 | 16828 | 47 |
FGFR3 |
1.389e-02 | -4.28 | skin-breast-other-lichenoid_keratosis | COSMIC cancer mutations | skin-breast-other-lichenoid_keratosis | 5 | 1 | 16828 | 47 |
FGFR3 |
1.389e-02 | -4.28 | monoclonal_gammopathy_of_undetermined_significance | COSMIC cancer mutations | monoclonal_gammopathy_of_undetermined_significance | 5 | 1 | 16828 | 47 |
FGFR3 |
1.389e-02 | -4.28 | skin-chest-other-lichenoid_keratosis | COSMIC cancer mutations | skin-chest-other-lichenoid_keratosis | 5 | 1 | 16828 | 47 |
FGFR3 |
1.389e-02 | -4.28 | skin-arm-other-seborrhoeic_keratosis | COSMIC cancer mutations | skin-arm-other-seborrhoeic_keratosis | 5 | 1 | 16828 | 47 |
FGFR3 |
1.389e-02 | -4.28 | skin-forearm-other-seborrhoeic_keratosis | COSMIC cancer mutations | skin-forearm-other-seborrhoeic_keratosis | 5 | 1 | 16828 | 47 |
FGFR3 |
1.389e-02 | -4.28 | skin-breast-other-nevus_sebaceous | COSMIC cancer mutations | skin-breast-other-nevus_sebaceous | 5 | 1 | 16828 | 47 |
FGFR3 |
1.389e-02 | -4.28 | skin-scalp-other-nevus_sebaceous | COSMIC cancer mutations | skin-scalp-other-nevus_sebaceous | 5 | 1 | 16828 | 47 |
FGFR3 |
1.389e-02 | -4.28 | skin-hip-other-seborrhoeic_keratosis | COSMIC cancer mutations | skin-hip-other-seborrhoeic_keratosis | 5 | 1 | 16828 | 47 |
FGFR3 |
1.389e-02 | -4.28 | skin-neck-other-lichenoid_keratosis | COSMIC cancer mutations | skin-neck-other-lichenoid_keratosis | 5 | 1 | 16828 | 47 |
FGFR3 |
1.389e-02 | -4.28 | skin-flank-other-lichenoid_keratosis | COSMIC cancer mutations | skin-flank-other-lichenoid_keratosis | 5 | 1 | 16828 | 47 |
FGFR3 |
1.389e-02 | -4.28 | skin-upper_leg-other-lichenoid_keratosis | COSMIC cancer mutations | skin-upper_leg-other-lichenoid_keratosis | 5 | 1 | 16828 | 47 |
FGFR3 |
1.389e-02 | -4.28 | skin-lower_back-other-nevus_sebaceous | COSMIC cancer mutations | skin-lower_back-other-nevus_sebaceous | 5 | 1 | 16828 | 47 |
FGFR3 |
1.389e-02 | -4.28 | skin-lower_back-other-lichenoid_keratosis | COSMIC cancer mutations | skin-lower_back-other-lichenoid_keratosis | 5 | 1 | 16828 | 47 |
FGFR3 |
1.392e-02 | -4.27 | extracellular matrix | cellular component | GO:0031012 | 559 | 5 | 19108 | 49 |
GPC5,APOA1,LRIG1,PTPRZ1,LAMA4 |
1.397e-02 | -4.27 | Laminin_II | pfam domains | PF06009 | 5 | 1 | 17795 | 50 |
LAMA4 |
1.397e-02 | -4.27 | Sortilin-Vps10 | pfam domains | PF15902 | 5 | 1 | 17795 | 50 |
SORCS2 |
1.397e-02 | -4.27 | Laminin_I | pfam domains | PF06008 | 5 | 1 | 17795 | 50 |
LAMA4 |
1.397e-02 | -4.27 | Sortilin_C | pfam domains | PF15901 | 5 | 1 | 17795 | 50 |
SORCS2 |
1.402e-02 | -4.27 | external encapsulating structure | cellular component | GO:0030312 | 560 | 5 | 19108 | 49 |
GPC5,LRIG1,APOA1,PTPRZ1,LAMA4 |
1.402e-02 | -4.27 | MET interacts with TNS proteins | REACTOME pathways | R-HSA-8875513 | 5 | 1 | 10285 | 29 |
TNS3 |
1.402e-02 | -4.27 | Scavenging by Class B Receptors | REACTOME pathways | R-HSA-3000471 | 5 | 1 | 10285 | 29 |
APOA1 |
1.403e-02 | -4.27 | monoatomic ion transmembrane transporter activity | molecular function | GO:0015075 | 752 | 6 | 18094 | 48 |
SLC1A2,SLC39A12,GJA1,SLC6A11,SLC4A4,SLC1A3 |
1.403e-02 | -4.27 | central_nervous_system-brainstem-primitive_neuroectodermal_tumour-medulloblastoma-WNT_subtype | COSMIC cancer mutations | central_nervous_system-brainstem-primitive_neuroectodermal_tumour-medulloblastoma-WNT_subtype | 181 | 3 | 16828 | 47 |
EGF,NPAS3,NCKAP5 |
1.408e-02 | -4.26 | regulation of hydrolase activity | biological process | GO:0051336 | 726 | 6 | 18204 | 50 |
FGFR3,BCAR3,APOA1,USP6NL,PREX1,PREX2 |
1.418e-02 | -4.26 | L-alpha-amino acid transmembrane transport | biological process | GO:1902475 | 66 | 2 | 18204 | 50 |
SLC1A2,SLC1A3 |
1.418e-02 | -4.26 | regulation of morphogenesis of an epithelium | biological process | GO:1905330 | 66 | 2 | 18204 | 50 |
GJA1,EGF |
1.418e-02 | -4.26 | ERBB signaling pathway | biological process | GO:0038127 | 66 | 2 | 18204 | 50 |
EGF,BCAR3 |
1.420e-02 | -4.25 | GJA1 (gap junction protein alpha 1) | protein interactions | 2697 | 572 | 5 | 19454 | 49 |
USP6NL,SLC39A12,APOA1,GJA1,FARP1 |
1.423e-02 | -4.25 | G protein-coupled receptor signaling pathway | biological process | GO:0007186 | 1178 | 8 | 18204 | 50 |
BCAR3,GRK5,ADGRB3,PREX2,SORCS2,PREX1,APOA1,DGKB |
1.424e-02 | -4.25 | WNT_subtype | COSMIC cancer mutations | WNT_subtype | 182 | 3 | 16828 | 47 |
EGF,NPAS3,NCKAP5 |
1.424e-02 | -4.25 | pancreas-carcinoma-adenocarcinoma | COSMIC cancer mutations | pancreas-carcinoma-adenocarcinoma | 517 | 5 | 16828 | 47 |
SLC39A12,LAMA4,GPC5,PREX2,PRDM16 |
1.427e-02 | -4.25 | response to growth factor | biological process | GO:0070848 | 525 | 5 | 18204 | 50 |
SOX5,FGFR3,FGFRL1,APOA1,NFIA |
1.430e-02 | -4.25 | regulation of actin cytoskeleton organization | biological process | GO:0032956 | 342 | 4 | 18204 | 50 |
PRKN,PREX1,APOA1,GPM6B |
1.431e-02 | -4.25 | Constitutive Signaling by Aberrant PI3K in Cancer | REACTOME pathways | R-HSA-2219530 | 65 | 2 | 10285 | 29 |
EGF,FGFR3 |
1.432e-02 | -4.25 | FEV (FEV transcription factor, ETS family member) | protein interactions | 54738 | 202 | 3 | 19454 | 49 |
NFIA,TRPS1,SOX5 |
1.433e-02 | -4.25 | oesophagus-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | oesophagus-carcinoma-squamous_cell_carcinoma | 6486 | 26 | 16828 | 47 |
AQP4,NCKAP5,UNC93A,FARP1,ZBTB20,FKBP5,FGFR3,LAMA4,PRDM16,PREX2,APOA1,SORCS2,PTPRZ1,NPAS3,AMOT,LPIN2,GPC5,TNS3,SLC4A4,SLC39A12,FGFRL1,SOX5,SNTB1,EGF,TRPS1,DGKB |
1.445e-02 | -4.24 | Signal Transduction | REACTOME pathways | R-HSA-162582 | 2547 | 13 | 10285 | 29 |
CTBP1,GPC5,GRK5,FGFR3,FGFRL1,EGF,LRIG1,PREX1,LAMA4,AMOT,TNS3,DGKB,APOA1 |
1.448e-02 | -4.23 | kidney | COSMIC cancer mutations | kidney | 15380 | 47 | 16828 | 47 |
SLC1A2,PREX1,LAMA4,FGFR3,ELOVL2,APOA1,FHOD3,GJA1,QKI,NCKAP5,AQP4,ZBTB20,FKBP5,NHSL1,UNC93A,SNTB1,SOX5,FGFRL1,SLC4A4,DGKB,LRIG1,GPM6B,TRPS1,AMOT,NPAS3,SORCS2,ASPA,SLC6A11,PRDM16,PREX2,NFIA,BCAR3,PTN,RORA,FARP1,GRK5,EGF,SLC39A12,RFX4,LPIN2,CTBP1,PTPRZ1,MSI2,SLC1A3,USP6NL,TNS3,GPC5 |
1.451e-02 | -4.23 | RBMS1 (RNA binding motif single stranded interacting protein 1) | protein interactions | 5937 | 203 | 3 | 19454 | 49 |
QKI,MSI2,GRK5 |
1.455e-02 | -4.23 | Fosphenytoin (Antiarrhythmic) Metabolism Pathway | SMPDB pathways | SMP0000618 | 4 | 1 | 1369 | 5 |
SNTB1 |
1.458e-02 | -4.23 | KIAA0232 (KIAA0232) | protein interactions | 9778 | 73 | 2 | 19454 | 49 |
FGFRL1,PRKN |
1.458e-02 | -4.23 | KIF16B (kinesin family member 16B) | protein interactions | 55614 | 73 | 2 | 19454 | 49 |
AMOT,GJA1 |
1.458e-02 | -4.23 | AGAP3 (ArfGAP with GTPase domain, ankyrin repeat and PH domain 3) | protein interactions | 116988 | 73 | 2 | 19454 | 49 |
PRKN,NCKAP5 |
1.468e-02 | -4.22 | phosphate-containing compound metabolic process | biological process | GO:0006796 | 1681 | 10 | 18204 | 50 |
PLPP3,FGFR3,GRK5,PTPRZ1,CTBP1,DGKB,APOA1,ELOVL2,RORA,TNS3 |
1.469e-02 | -4.22 | inclusion body | cellular component | GO:0016234 | 72 | 2 | 19108 | 49 |
PRKN,PRDM16 |
1.470e-02 | -4.22 | NFIC (nuclear factor I C) | protein interactions | 4782 | 204 | 3 | 19454 | 49 |
TRPS1,NFIA,SOX5 |
1.470e-02 | -4.22 | CASK (calcium/calmodulin dependent serine protein kinase) | protein interactions | 8573 | 204 | 3 | 19454 | 49 |
GJA1,SNTB1,PRKN |
1.472e-02 | -4.22 | chemotaxis | biological process | GO:0006935 | 345 | 4 | 18204 | 50 |
PTN,PREX1,AMOT,APOA1 |
1.474e-02 | -4.22 | ZF_DAG_PE_1 | prosite domains | PS00479 | 58 | 2 | 12186 | 39 |
TNS3,DGKB |
1.489e-02 | -4.21 | CTDP1 (CTD phosphatase subunit 1) | protein interactions | 9150 | 205 | 3 | 19454 | 49 |
GRK5,PRKN,AMOT |
1.495e-02 | -4.20 | PDGFRA (platelet derived growth factor receptor alpha) | protein interactions | 5156 | 378 | 4 | 19454 | 49 |
LRIG1,FARP1,PRKN,FGFR3 |
1.496e-02 | -4.20 | ERCC6L (ERCC excision repair 6 like, spindle assembly checkpoint helicase) | protein interactions | 54821 | 74 | 2 | 19454 | 49 |
AMOT,PRKN |
1.496e-02 | -4.20 | DNAJC21 (DnaJ heat shock protein family (Hsp40) member C21) | protein interactions | 134218 | 74 | 2 | 19454 | 49 |
FKBP5,PRKN |
1.496e-02 | -4.20 | MORC3 (MORC family CW-type zinc finger 3) | protein interactions | 23515 | 74 | 2 | 19454 | 49 |
SNTB1,PRKN |
1.500e-02 | -4.20 | RAB5C (RAB5C, member RAS oncogene family) | protein interactions | 5878 | 580 | 5 | 19454 | 49 |
ELOVL2,GJA1,PRKN,CTBP1,PLPP3 |
1.501e-02 | -4.20 | negative regulation of hormone secretion | biological process | GO:0046888 | 68 | 2 | 18204 | 50 |
GJA1,PRKN |
1.501e-02 | -4.20 | regulation of tumor necrosis factor-mediated signaling pathway | biological process | GO:0010803 | 68 | 2 | 18204 | 50 |
APOA1,PRKN |
1.501e-02 | -4.20 | taxis | biological process | GO:0042330 | 347 | 4 | 18204 | 50 |
PTN,PREX1,APOA1,AMOT |
1.502e-02 | -4.20 | FGF23 (fibroblast growth factor 23) | protein interactions | 8074 | 6 | 1 | 19454 | 49 |
FGFR3 |
1.502e-02 | -4.20 | CFHR1 (complement factor H related 1) | protein interactions | 3078 | 6 | 1 | 19454 | 49 |
APOA1 |
1.502e-02 | -4.20 | SOX11 (SRY-box transcription factor 11) | protein interactions | 6664 | 6 | 1 | 19454 | 49 |
SOX5 |
1.502e-02 | -4.20 | CCDC181 (coiled-coil domain containing 181) | protein interactions | 57821 | 6 | 1 | 19454 | 49 |
PRKN |
1.502e-02 | -4.20 | DAZ4 (deleted in azoospermia 4) | protein interactions | 57135 | 6 | 1 | 19454 | 49 |
QKI |
1.502e-02 | -4.20 | CA13 (carbonic anhydrase 13) | protein interactions | 377677 | 6 | 1 | 19454 | 49 |
PRKN |
1.502e-02 | -4.20 | TXNDC8 (thioredoxin domain containing 8) | protein interactions | 255220 | 6 | 1 | 19454 | 49 |
PRKN |
1.502e-02 | -4.20 | ABCA10 (ATP binding cassette subfamily A member 10) | protein interactions | 10349 | 6 | 1 | 19454 | 49 |
PRKN |
1.502e-02 | -4.20 | ARHGEF37 (Rho guanine nucleotide exchange factor 37) | protein interactions | 389337 | 6 | 1 | 19454 | 49 |
PRKN |
1.502e-02 | -4.20 | SIAH3 (siah E3 ubiquitin protein ligase family member 3) | protein interactions | 283514 | 6 | 1 | 19454 | 49 |
PRKN |
1.502e-02 | -4.20 | PBP2 (Pbp2p) | protein interactions | 852533 | 6 | 1 | 19454 | 49 |
QKI |
1.502e-02 | -4.20 | PKDREJ (polycystin family receptor for egg jelly) | protein interactions | 10343 | 6 | 1 | 19454 | 49 |
PRKN |
1.502e-02 | -4.20 | Map1b (microtubule-associated protein 1B) | protein interactions | 17755 | 6 | 1 | 19454 | 49 |
PRKN |
1.502e-02 | -4.20 | GARIN1B (golgi associated RAB2 interactor 1B) | protein interactions | 84691 | 6 | 1 | 19454 | 49 |
PRKN |
1.502e-02 | -4.20 | N6AMT1 (N-6 adenine-specific DNA methyltransferase 1) | protein interactions | 29104 | 6 | 1 | 19454 | 49 |
PRKN |
1.502e-02 | -4.20 | SAA4 (serum amyloid A4, constitutive) | protein interactions | 6291 | 6 | 1 | 19454 | 49 |
GJA1 |
1.502e-02 | -4.20 | LCAT (lecithin-cholesterol acyltransferase) | protein interactions | 3931 | 6 | 1 | 19454 | 49 |
APOA1 |
1.502e-02 | -4.20 | FGF18 (fibroblast growth factor 18) | protein interactions | 8817 | 6 | 1 | 19454 | 49 |
FGFR3 |
1.502e-02 | -4.20 | SOX1 (SRY-box transcription factor 1) | protein interactions | 6656 | 6 | 1 | 19454 | 49 |
SOX5 |
1.502e-02 | -4.20 | COL15A1 (collagen type XV alpha 1 chain) | protein interactions | 1306 | 6 | 1 | 19454 | 49 |
PRKN |
1.502e-02 | -4.20 | NEK5 (NIMA related kinase 5) | protein interactions | 341676 | 6 | 1 | 19454 | 49 |
PRKN |
1.502e-02 | -4.20 | FGF6 (fibroblast growth factor 6) | protein interactions | 2251 | 6 | 1 | 19454 | 49 |
FGFR3 |
1.502e-02 | -4.20 | Csnk1d (casein kinase 1, delta) | protein interactions | 64462 | 6 | 1 | 19454 | 49 |
PRKN |
1.502e-02 | -4.20 | Map3k12 (mitogen-activated protein kinase kinase kinase 12) | protein interactions | 26404 | 6 | 1 | 19454 | 49 |
USP6NL |
1.508e-02 | -4.19 | PPFIA1 (PTPRF interacting protein alpha 1) | protein interactions | 8500 | 206 | 3 | 19454 | 49 |
PRKN,GJA1,AMOT |
1.521e-02 | -4.19 | human chr7p21.2 | chromosome location | human chr7p21.2 | 8 | 1 | 26134 | 50 |
DGKB |
1.524e-02 | -4.18 | upper_aerodigestive_tract | COSMIC cancer mutations | upper_aerodigestive_tract | 13181 | 43 | 16828 | 47 |
BCAR3,NCKAP5,QKI,RORA,ZBTB20,FKBP5,PTN,FARP1,NHSL1,UNC93A,SLC1A2,LAMA4,PRDM16,PREX1,ELOVL2,FGFR3,APOA1,NFIA,PREX2,FHOD3,RFX4,LPIN2,AMOT,PTPRZ1,CTBP1,NPAS3,SORCS2,MSI2,USP6NL,SLC1A3,GPC5,TNS3,GRK5,SNTB1,EGF,FGFRL1,SOX5,SLC4A4,SLC39A12,LRIG1,DGKB,GPM6B,TRPS1 |
1.534e-02 | -4.18 | BCAS3 (BCAS3 microtubule associated cell migration factor) | protein interactions | 54828 | 75 | 2 | 19454 | 49 |
CTBP1,PRKN |
1.534e-02 | -4.18 | MICU1 (mitochondrial calcium uptake 1) | protein interactions | 10367 | 75 | 2 | 19454 | 49 |
PRKN,SLC39A12 |
1.534e-02 | -4.18 | CLRN2 (clarin 2) | protein interactions | 645104 | 75 | 2 | 19454 | 49 |
LRIG1,GJA1 |
1.535e-02 | -4.18 | GRWD1 (glutamate rich WD repeat containing 1) | protein interactions | 83743 | 381 | 4 | 19454 | 49 |
FGFR3,GRK5,PRKN,LPIN2 |
1.535e-02 | -4.18 | phosphoric ester hydrolase activity | molecular function | GO:0042578 | 362 | 4 | 18094 | 48 |
PTPRZ1,PLPP3,LPIN2,TNS3 |
1.547e-02 | -4.17 | cell-cell contact zone | cellular component | GO:0044291 | 74 | 2 | 19108 | 49 |
GJA1,FGFRL1 |
1.547e-02 | -4.17 | PI4KA (phosphatidylinositol 4-kinase alpha) | protein interactions | 5297 | 208 | 3 | 19454 | 49 |
GJA1,FGFR3,FKBP5 |
1.559e-02 | -4.16 | PH | pfam domains | PF00169 | 187 | 3 | 17795 | 50 |
PREX2,FARP1,SNTB1 |
1.573e-02 | -4.15 | PGM3 (phosphoglucomutase 3) | protein interactions | 5238 | 76 | 2 | 19454 | 49 |
PRKN,TNS3 |
1.573e-02 | -4.15 | KIAA1549 (KIAA1549) | protein interactions | 57670 | 76 | 2 | 19454 | 49 |
GJA1,AMOT |
1.573e-02 | -4.15 | MIR200A (microRNA 200a) | protein interactions | 406983 | 76 | 2 | 19454 | 49 |
QKI,MSI2 |
1.576e-02 | -4.15 | Spinal Cord Injury | WikiPathways | WP2431 | 119 | 3 | 5310 | 24 |
PTPRZ1,GJA1,AQP4 |
1.581e-02 | -4.15 | sodium:bicarbonate symporter activity | molecular function | GO:0008510 | 6 | 1 | 18094 | 48 |
SLC4A4 |
1.581e-02 | -4.15 | histone H3K9 monomethyltransferase activity | molecular function | GO:0140948 | 6 | 1 | 18094 | 48 |
PRDM16 |
1.581e-02 | -4.15 | phosphatidylcholine-sterol O-acyltransferase activator activity | molecular function | GO:0060228 | 6 | 1 | 18094 | 48 |
APOA1 |
1.581e-02 | -4.15 | gamma-aminobutyric acid:sodium:chloride symporter activity | molecular function | GO:0005332 | 6 | 1 | 18094 | 48 |
SLC6A11 |
1.581e-02 | -4.15 | gap junction hemi-channel activity | molecular function | GO:0055077 | 6 | 1 | 18094 | 48 |
GJA1 |
1.583e-02 | -4.15 | MARCKS (myristoylated alanine rich protein kinase C substrate) | protein interactions | 4082 | 588 | 5 | 19454 | 49 |
USP6NL,PRKN,SLC1A3,ELOVL2,FARP1 |
1.587e-02 | -4.14 | TLE1 (TLE family member 1, transcriptional corepressor) | protein interactions | 7088 | 210 | 3 | 19454 | 49 |
NFIA,PRKN,SOX5 |
1.587e-02 | -4.14 | ZNF326 (zinc finger protein 326) | protein interactions | 284695 | 210 | 3 | 19454 | 49 |
NFIA,FGFR3,PRKN |
1.607e-02 | -4.13 | CDK6 (cyclin dependent kinase 6) | protein interactions | 1021 | 211 | 3 | 19454 | 49 |
FKBP5,SOX5,FGFR3 |
1.609e-02 | -4.13 | Glypican | interpro domains | IPR001863 | 6 | 1 | 18521 | 50 |
GPC5 |
1.609e-02 | -4.13 | Glypican_CS | interpro domains | IPR019803 | 6 | 1 | 18521 | 50 |
GPC5 |
1.609e-02 | -4.13 | ELO_CS | interpro domains | IPR030457 | 6 | 1 | 18521 | 50 |
ELOVL2 |
1.609e-02 | -4.13 | LNS2/PITP | interpro domains | IPR031315 | 6 | 1 | 18521 | 50 |
LPIN2 |
1.613e-02 | -4.13 | TNS3 (tensin 3) | protein interactions | 64759 | 77 | 2 | 19454 | 49 |
APOA1,SNTB1 |
1.613e-02 | -4.13 | ADD2 (adducin 2) | protein interactions | 119 | 77 | 2 | 19454 | 49 |
PRKN,PTPRZ1 |
1.613e-02 | -4.13 | PTPN5 (protein tyrosine phosphatase non-receptor type 5) | protein interactions | 84867 | 77 | 2 | 19454 | 49 |
PRKN,APOA1 |
1.613e-02 | -4.13 | SDC1 (syndecan 1) | protein interactions | 6382 | 77 | 2 | 19454 | 49 |
PTN,FARP1 |
1.622e-02 | -4.12 | phosphorus metabolic process | biological process | GO:0006793 | 1707 | 10 | 18204 | 50 |
PLPP3,FGFR3,GRK5,PTPRZ1,RORA,ELOVL2,APOA1,DGKB,CTBP1,TNS3 |
1.630e-02 | -4.12 | SMC1A (structural maintenance of chromosomes 1A) | protein interactions | 8243 | 388 | 4 | 19454 | 49 |
FGFR3,PRKN,RORA,AMOT |
1.637e-02 | -4.11 | regulation of synapse pruning | biological process | GO:1905806 | 6 | 1 | 18204 | 50 |
ADGRB3 |
1.637e-02 | -4.11 | regulation of spontaneous synaptic transmission | biological process | GO:0150003 | 6 | 1 | 18204 | 50 |
PRKN |
1.637e-02 | -4.11 | negative regulation of neurotransmitter secretion | biological process | GO:0046929 | 6 | 1 | 18204 | 50 |
PRKN |
1.637e-02 | -4.11 | asymmetric neuroblast division | biological process | GO:0055059 | 6 | 1 | 18204 | 50 |
SOX5 |
1.637e-02 | -4.11 | intracellular water homeostasis | biological process | GO:0009992 | 6 | 1 | 18204 | 50 |
AQP4 |
1.637e-02 | -4.11 | cell-cell adhesion mediated by integrin | biological process | GO:0033631 | 6 | 1 | 18204 | 50 |
PLPP3 |
1.637e-02 | -4.11 | positive regulation of neurotransmitter uptake | biological process | GO:0051582 | 6 | 1 | 18204 | 50 |
PRKN |
1.637e-02 | -4.11 | dopamine uptake involved in synaptic transmission | biological process | GO:0051583 | 6 | 1 | 18204 | 50 |
PRKN |
1.637e-02 | -4.11 | regulation of hexokinase activity | biological process | GO:1903299 | 6 | 1 | 18204 | 50 |
PRKN |
1.637e-02 | -4.11 | gamma-aminobutyric acid biosynthetic process | biological process | GO:0009449 | 6 | 1 | 18204 | 50 |
SLC1A3 |
1.637e-02 | -4.11 | cell surface receptor protein tyrosine phosphatase signaling pathway | biological process | GO:0007185 | 6 | 1 | 18204 | 50 |
PTN |
1.637e-02 | -4.11 | positive regulation of skeletal muscle acetylcholine-gated channel clustering | biological process | GO:1904395 | 6 | 1 | 18204 | 50 |
FARP1 |
1.637e-02 | -4.11 | aggresome assembly | biological process | GO:0070842 | 6 | 1 | 18204 | 50 |
PRKN |
1.637e-02 | -4.11 | neuroblast migration | biological process | GO:0097402 | 6 | 1 | 18204 | 50 |
GJA1 |
1.637e-02 | -4.11 | amino acid neurotransmitter reuptake | biological process | GO:0051933 | 6 | 1 | 18204 | 50 |
SLC6A11 |
1.637e-02 | -4.11 | cholesterol import | biological process | GO:0070508 | 6 | 1 | 18204 | 50 |
APOA1 |
1.637e-02 | -4.11 | regulation of very-low-density lipoprotein particle remodeling | biological process | GO:0010901 | 6 | 1 | 18204 | 50 |
APOA1 |
1.637e-02 | -4.11 | positive regulation of cerebellar granule cell precursor proliferation | biological process | GO:0021940 | 6 | 1 | 18204 | 50 |
EGF |
1.637e-02 | -4.11 | catecholamine uptake involved in synaptic transmission | biological process | GO:0051934 | 6 | 1 | 18204 | 50 |
PRKN |
1.645e-02 | -4.11 | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | COSMIC cancer mutations | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-large_cell | 14773 | 46 | 16828 | 47 |
PREX1,LAMA4,FGFR3,ELOVL2,SLC1A2,FHOD3,APOA1,AQP4,GJA1,QKI,NHSL1,UNC93A,ZBTB20,FKBP5,SOX5,FGFRL1,SLC4A4,SNTB1,GPM6B,TRPS1,DGKB,LRIG1,SORCS2,ASPA,AMOT,NPAS3,SLC6A11,PRDM16,PREX2,NFIA,BCAR3,PTN,RORA,FARP1,SLC39A12,GRK5,EGF,MSI2,RFX4,LPIN2,CTBP1,PTPRZ1,TNS3,GPC5,SLC1A3,USP6NL |
1.645e-02 | -4.11 | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-desmoplastic | COSMIC cancer mutations | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-desmoplastic | 14773 | 46 | 16828 | 47 |
PREX1,LAMA4,FGFR3,ELOVL2,SLC1A2,FHOD3,APOA1,AQP4,GJA1,QKI,NHSL1,UNC93A,FKBP5,ZBTB20,SOX5,FGFRL1,SLC4A4,SNTB1,GPM6B,TRPS1,DGKB,LRIG1,SORCS2,ASPA,AMOT,NPAS3,SLC6A11,PRDM16,PREX2,NFIA,BCAR3,PTN,RORA,FARP1,SLC39A12,GRK5,EGF,MSI2,RFX4,LPIN2,CTBP1,PTPRZ1,TNS3,GPC5,SLC1A3,USP6NL |
1.645e-02 | -4.11 | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma | COSMIC cancer mutations | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma | 14773 | 46 | 16828 | 47 |
BCAR3,FARP1,PTN,RORA,PRDM16,PREX2,NFIA,CTBP1,PTPRZ1,LPIN2,RFX4,MSI2,SLC1A3,USP6NL,TNS3,GPC5,EGF,GRK5,SLC39A12,QKI,GJA1,AQP4,FKBP5,ZBTB20,UNC93A,NHSL1,SLC1A2,FGFR3,ELOVL2,PREX1,LAMA4,APOA1,FHOD3,NPAS3,AMOT,ASPA,SORCS2,SLC6A11,SNTB1,SLC4A4,FGFRL1,SOX5,DGKB,LRIG1,TRPS1,GPM6B |
1.645e-02 | -4.11 | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-classic | COSMIC cancer mutations | central_nervous_system-medulla-primitive_neuroectodermal_tumour-medulloblastoma-classic | 14773 | 46 | 16828 | 47 |
GPM6B,TRPS1,DGKB,LRIG1,FGFRL1,SOX5,SLC4A4,SNTB1,SLC6A11,SORCS2,ASPA,AMOT,NPAS3,FHOD3,APOA1,PREX1,LAMA4,FGFR3,ELOVL2,SLC1A2,NHSL1,UNC93A,ZBTB20,FKBP5,AQP4,GJA1,QKI,SLC39A12,GRK5,EGF,TNS3,GPC5,SLC1A3,USP6NL,MSI2,RFX4,LPIN2,CTBP1,PTPRZ1,PREX2,NFIA,PRDM16,PTN,RORA,FARP1,BCAR3 |
1.648e-02 | -4.11 | SEC24A (SEC24 homolog A, COPII coat complex component) | protein interactions | 10802 | 213 | 3 | 19454 | 49 |
GJA1,FGFR3,PRKN |
1.648e-02 | -4.11 | RPS6KA3 (ribosomal protein S6 kinase A3) | protein interactions | 6197 | 213 | 3 | 19454 | 49 |
PRKN,FGFR3,CTBP1 |
1.648e-02 | -4.11 | COX5A (cytochrome c oxidase subunit 5A) | protein interactions | 9377 | 213 | 3 | 19454 | 49 |
FKBP5,PRKN,PRDM16 |
1.649e-02 | -4.11 | homeostatic process | biological process | GO:0042592 | 1456 | 9 | 18204 | 50 |
PRKN,ZBTB20,AQP4,RORA,SLC4A4,APOA1,GJA1,SLC1A3,SLC39A12 |
1.649e-02 | -4.11 | classic | COSMIC cancer mutations | classic | 14774 | 46 | 16828 | 47 |
APOA1,FHOD3,SLC1A2,ELOVL2,FGFR3,LAMA4,PREX1,ZBTB20,FKBP5,UNC93A,NHSL1,QKI,GJA1,AQP4,LRIG1,DGKB,TRPS1,GPM6B,SNTB1,SLC4A4,SOX5,FGFRL1,SLC6A11,NPAS3,AMOT,ASPA,SORCS2,NFIA,PREX2,PRDM16,FARP1,RORA,PTN,BCAR3,EGF,GRK5,SLC39A12,USP6NL,SLC1A3,GPC5,TNS3,PTPRZ1,CTBP1,LPIN2,RFX4,MSI2 |
1.652e-02 | -4.10 | ANKRD40 (ankyrin repeat domain 40) | protein interactions | 91369 | 78 | 2 | 19454 | 49 |
SOX5,MSI2 |
1.652e-02 | -4.10 | SGK1 (serum/glucocorticoid regulated kinase 1) | protein interactions | 6446 | 78 | 2 | 19454 | 49 |
SLC1A3,FKBP5 |
1.652e-02 | -4.10 | ALDH9A1 (aldehyde dehydrogenase 9 family member A1) | protein interactions | 223 | 78 | 2 | 19454 | 49 |
FKBP5,PRKN |
1.652e-02 | -4.10 | MIR34C (microRNA 34c) | protein interactions | 407042 | 78 | 2 | 19454 | 49 |
MSI2,QKI |
1.660e-02 | -4.10 | lower_third | COSMIC cancer mutations | lower_third | 7961 | 30 | 16828 | 47 |
FKBP5,ZBTB20,RORA,FARP1,UNC93A,GJA1,NCKAP5,QKI,AQP4,APOA1,PREX2,FHOD3,PRDM16,PREX1,GPC5,TNS3,SLC6A11,LPIN2,PTPRZ1,NPAS3,SORCS2,ASPA,LRIG1,DGKB,GPM6B,TRPS1,SNTB1,SOX5,SLC39A12,SLC4A4 |
1.664e-02 | -4.10 | skin-face-other-seborrhoeic_keratosis | COSMIC cancer mutations | skin-face-other-seborrhoeic_keratosis | 6 | 1 | 16828 | 47 |
FGFR3 |
1.664e-02 | -4.10 | skin-back-other-seborrhoeic_keratosis | COSMIC cancer mutations | skin-back-other-seborrhoeic_keratosis | 6 | 1 | 16828 | 47 |
FGFR3 |
1.664e-02 | -4.10 | skin-abdomen-other-seborrhoeic_keratosis | COSMIC cancer mutations | skin-abdomen-other-seborrhoeic_keratosis | 6 | 1 | 16828 | 47 |
FGFR3 |
1.664e-02 | -4.10 | skin-in_situ_epithelial_neoplasm-Bowen_disease | COSMIC cancer mutations | skin-in_situ_epithelial_neoplasm-Bowen_disease | 6 | 1 | 16828 | 47 |
FGFR3 |
1.664e-02 | -4.10 | skin-arm-epidermal_nevus | COSMIC cancer mutations | skin-arm-epidermal_nevus | 6 | 1 | 16828 | 47 |
FGFR3 |
1.664e-02 | -4.10 | autonomic_ganglia-paraganglioma-benign | COSMIC cancer mutations | autonomic_ganglia-paraganglioma-benign | 6 | 1 | 16828 | 47 |
NHSL1 |
1.664e-02 | -4.10 | collecting_duct_carcinoma | COSMIC cancer mutations | collecting_duct_carcinoma | 6 | 1 | 16828 | 47 |
FGFR3 |
1.664e-02 | -4.10 | skin-benign_melanocytic_nevus-lentiginous_nevus | COSMIC cancer mutations | skin-benign_melanocytic_nevus-lentiginous_nevus | 6 | 1 | 16828 | 47 |
FGFR3 |
1.664e-02 | -4.10 | skin-forearm-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-forearm-malignant_melanoma-superficial_spreading | 6 | 1 | 16828 | 47 |
PREX2 |
1.664e-02 | -4.10 | skin-epidermal_nevus | COSMIC cancer mutations | skin-epidermal_nevus | 6 | 1 | 16828 | 47 |
FGFR3 |
1.664e-02 | -4.10 | skin-upper_leg-other-seborrhoeic_keratosis | COSMIC cancer mutations | skin-upper_leg-other-seborrhoeic_keratosis | 6 | 1 | 16828 | 47 |
FGFR3 |
1.664e-02 | -4.10 | skin-trunk-epidermal_nevus | COSMIC cancer mutations | skin-trunk-epidermal_nevus | 6 | 1 | 16828 | 47 |
FGFR3 |
1.664e-02 | -4.10 | skin-flank-other-seborrhoeic_keratosis | COSMIC cancer mutations | skin-flank-other-seborrhoeic_keratosis | 6 | 1 | 16828 | 47 |
FGFR3 |
1.664e-02 | -4.10 | skin-in_situ_epithelial_neoplasm-actinic_keratosis | COSMIC cancer mutations | skin-in_situ_epithelial_neoplasm-actinic_keratosis | 6 | 1 | 16828 | 47 |
FGFR3 |
1.664e-02 | -4.10 | skin-head_neck-epidermal_nevus | COSMIC cancer mutations | skin-head_neck-epidermal_nevus | 6 | 1 | 16828 | 47 |
FGFR3 |
1.664e-02 | -4.10 | skin-lower_back-other-seborrhoeic_keratosis | COSMIC cancer mutations | skin-lower_back-other-seborrhoeic_keratosis | 6 | 1 | 16828 | 47 |
FGFR3 |
1.664e-02 | -4.10 | skin-adnexal_tumour-trichoblastoma | COSMIC cancer mutations | skin-adnexal_tumour-trichoblastoma | 6 | 1 | 16828 | 47 |
FGFR3 |
1.664e-02 | -4.10 | skin-head_neck-malignant_melanoma | COSMIC cancer mutations | skin-head_neck-malignant_melanoma | 6 | 1 | 16828 | 47 |
PREX2 |
1.664e-02 | -4.10 | skin-lower_leg-epidermal_nevus | COSMIC cancer mutations | skin-lower_leg-epidermal_nevus | 6 | 1 | 16828 | 47 |
FGFR3 |
1.664e-02 | -4.10 | kidney-carcinoma-collecting_duct_carcinoma | COSMIC cancer mutations | kidney-carcinoma-collecting_duct_carcinoma | 6 | 1 | 16828 | 47 |
FGFR3 |
1.664e-02 | -4.10 | lentiginous_nevus | COSMIC cancer mutations | lentiginous_nevus | 6 | 1 | 16828 | 47 |
FGFR3 |
1.667e-02 | -4.09 | medulla | COSMIC cancer mutations | medulla | 14778 | 46 | 16828 | 47 |
BCAR3,RORA,PTN,FARP1,PRDM16,NFIA,PREX2,MSI2,RFX4,LPIN2,PTPRZ1,CTBP1,GPC5,TNS3,USP6NL,SLC1A3,SLC39A12,GRK5,EGF,AQP4,GJA1,QKI,NHSL1,UNC93A,ZBTB20,FKBP5,LAMA4,PREX1,ELOVL2,FGFR3,SLC1A2,FHOD3,APOA1,SORCS2,ASPA,AMOT,NPAS3,SLC6A11,SOX5,FGFRL1,SLC4A4,SNTB1,GPM6B,TRPS1,LRIG1,DGKB |
1.668e-02 | -4.09 | transcription repressor complex | cellular component | GO:0017053 | 77 | 2 | 19108 | 49 |
CTBP1,PRDM16 |
1.668e-02 | -4.09 | DLG1 (discs large MAGUK scaffold protein 1) | protein interactions | 1739 | 214 | 3 | 19454 | 49 |
AMOT,GJA1,PRKN |
1.668e-02 | -4.09 | COPG1 (COPI coat complex subunit gamma 1) | protein interactions | 22820 | 214 | 3 | 19454 | 49 |
GJA1,PRKN,FGFRL1 |
1.669e-02 | -4.09 | AKT1 (AKT serine/threonine kinase 1) | protein interactions | 207 | 596 | 5 | 19454 | 49 |
GJA1,PREX1,PRKN,CTBP1,FKBP5 |
1.671e-02 | -4.09 | desmoplastic | COSMIC cancer mutations | desmoplastic | 14779 | 46 | 16828 | 47 |
SLC39A12,GRK5,EGF,MSI2,RFX4,LPIN2,CTBP1,PTPRZ1,TNS3,GPC5,SLC1A3,USP6NL,PRDM16,PREX2,NFIA,BCAR3,PTN,RORA,FARP1,FGFRL1,SOX5,SLC4A4,SNTB1,GPM6B,TRPS1,DGKB,LRIG1,SORCS2,ASPA,AMOT,NPAS3,SLC6A11,PREX1,LAMA4,FGFR3,ELOVL2,SLC1A2,FHOD3,APOA1,AQP4,GJA1,QKI,NHSL1,UNC93A,FKBP5,ZBTB20 |
1.672e-02 | -4.09 | regulation of ATP metabolic process | biological process | GO:1903578 | 72 | 2 | 18204 | 50 |
ZBTB20,SLC4A4 |
1.674e-02 | -4.09 | Glypican | pfam domains | PF01153 | 6 | 1 | 17795 | 50 |
GPC5 |
1.679e-02 | -4.09 | femur | COSMIC cancer mutations | femur | 1197 | 8 | 16828 | 47 |
GPC5,LRIG1,PREX1,SLC4A4,ELOVL2,PTPRZ1,NCKAP5,SNTB1 |
1.693e-02 | -4.08 | CDKN2D (cyclin dependent kinase inhibitor 2D) | protein interactions | 1032 | 79 | 2 | 19454 | 49 |
QKI,CTBP1 |
1.693e-02 | -4.08 | ACTL6B (actin like 6B) | protein interactions | 51412 | 79 | 2 | 19454 | 49 |
PRKN,CTBP1 |
1.693e-02 | -4.08 | GPR21 (G protein-coupled receptor 21) | protein interactions | 2844 | 79 | 2 | 19454 | 49 |
GJA1,ELOVL2 |
1.693e-02 | -4.08 | PALS2 (protein associated with LIN7 2, MAGUK p55 family member) | protein interactions | 51678 | 79 | 2 | 19454 | 49 |
TRPS1,PRKN |
1.693e-02 | -4.08 | PRDM1 (PR/SET domain 1) | protein interactions | 639 | 79 | 2 | 19454 | 49 |
NFIA,TRPS1 |
1.693e-02 | -4.08 | CANT1 (calcium activated nucleotidase 1) | protein interactions | 124583 | 79 | 2 | 19454 | 49 |
LRIG1,GJA1 |
1.693e-02 | -4.08 | SLC39A12 (solute carrier family 39 member 12) | protein interactions | 221074 | 79 | 2 | 19454 | 49 |
GJA1,QKI |
1.693e-02 | -4.08 | DNAJB8 (DnaJ heat shock protein family (Hsp40) member B8) | protein interactions | 165721 | 79 | 2 | 19454 | 49 |
ZBTB20,FKBP5 |
1.709e-02 | -4.07 | human chr2q21.2 | chromosome location | human chr2q21.2 | 9 | 1 | 26134 | 50 |
NCKAP5 |
1.709e-02 | -4.07 | GABA-ergic synapse | cellular component | GO:0098982 | 78 | 2 | 19108 | 49 |
SLC6A11,CTBP1 |
1.710e-02 | -4.07 | ATP2B1 (ATPase plasma membrane Ca2+ transporting 1) | protein interactions | 490 | 216 | 3 | 19454 | 49 |
GJA1,PRKN,FGFR3 |
1.710e-02 | -4.07 | MAGED2 (MAGE family member D2) | protein interactions | 10916 | 216 | 3 | 19454 | 49 |
PRDM16,PRKN,FKBP5 |
1.711e-02 | -4.07 | NAHCO3TRSPRT | prints domains | PR01232 | 5 | 1 | 5227 | 18 |
SLC4A4 |
1.716e-02 | -4.07 | endothelial cell migration | biological process | GO:0043542 | 73 | 2 | 18204 | 50 |
AMOT,APOA1 |
1.716e-02 | -4.07 | vasculogenesis | biological process | GO:0001570 | 73 | 2 | 18204 | 50 |
AMOT,QKI |
1.716e-02 | -4.07 | regulation of cartilage development | biological process | GO:0061035 | 73 | 2 | 18204 | 50 |
TRPS1,SOX5 |
1.721e-02 | -4.06 | leg | COSMIC cancer mutations | leg | 969 | 7 | 16828 | 47 |
GRK5,EGF,PTPRZ1,FGFR3,SLC4A4,ZBTB20,SLC6A11 |
1.724e-02 | -4.06 | ZF_DAG_PE_2 | prosite domains | PS50081 | 63 | 2 | 12186 | 39 |
TNS3,DGKB |
1.731e-02 | -4.06 | SEC31A (SEC31 homolog A, COPII coat complex component) | protein interactions | 22872 | 217 | 3 | 19454 | 49 |
CTBP1,GJA1,PRKN |
1.733e-02 | -4.06 | PPP1CA (protein phosphatase 1 catalytic subunit alpha) | protein interactions | 100009298 | 80 | 2 | 19454 | 49 |
FARP1,PREX2 |
1.733e-02 | -4.06 | QPCTL (glutaminyl-peptide cyclotransferase like) | protein interactions | 54814 | 80 | 2 | 19454 | 49 |
PREX1,PRKN |
1.733e-02 | -4.06 | DUSP3 (dual specificity phosphatase 3) | protein interactions | 1845 | 80 | 2 | 19454 | 49 |
PRKN,EGF |
1.733e-02 | -4.06 | GPRIN1 (G protein regulated inducer of neurite outgrowth 1) | protein interactions | 114787 | 80 | 2 | 19454 | 49 |
FGFR3,GJA1 |
1.737e-02 | -4.05 | regulation of cellular process | biological process | GO:0050794 | 11468 | 39 | 18204 | 50 |
USP6NL,SLC4A4,CTBP1,RFX4,PTN,PREX2,FARP1,EGF,LPIN2,GPC5,SLC1A2,BCAR3,APOA1,GJA1,ZBTB20,MSI2,ASPA,SLC1A3,PTPRZ1,GPM6B,PRDM16,AMOT,DGKB,TRPS1,QKI,ADGRB3,NFIA,RORA,LAMA4,PREX1,PRKN,SOX5,SLC39A12,SORCS2,FGFRL1,NPAS3,PLPP3,FGFR3,GRK5 |
1.738e-02 | -4.05 | VPS10 | smart domains | SM00602 | 5 | 1 | 9717 | 34 |
SORCS2 |
1.748e-02 | -4.05 | cell surface receptor signaling pathway | biological process | GO:0007166 | 1992 | 11 | 18204 | 50 |
APOA1,GRK5,FGFRL1,PLPP3,FGFR3,PTN,NFIA,BCAR3,FARP1,EGF,ADGRB3 |
1.750e-02 | -4.05 | GIN1 (gypsy retrotransposon integrase 1) | protein interactions | 54826 | 7 | 1 | 19454 | 49 |
PRKN |
1.750e-02 | -4.05 | ZBTB45 (zinc finger and BTB domain containing 45) | protein interactions | 84878 | 7 | 1 | 19454 | 49 |
ZBTB20 |
1.750e-02 | -4.05 | Adrm1 (adhesion regulating molecule 1 26S proteasome ubiquitin receptor) | protein interactions | 56436 | 7 | 1 | 19454 | 49 |
PRKN |
1.750e-02 | -4.05 | TMC7 (transmembrane channel like 7) | protein interactions | 79905 | 7 | 1 | 19454 | 49 |
PRKN |
1.750e-02 | -4.05 | CETP (cholesteryl ester transfer protein) | protein interactions | 1071 | 7 | 1 | 19454 | 49 |
APOA1 |
1.750e-02 | -4.05 | ANKRD36C (ankyrin repeat domain 36C) | protein interactions | 400986 | 7 | 1 | 19454 | 49 |
PRKN |
1.750e-02 | -4.05 | CAPN9 (calpain 9) | protein interactions | 10753 | 7 | 1 | 19454 | 49 |
PRKN |
1.750e-02 | -4.05 | ZFYVE28 (zinc finger FYVE-type containing 28) | protein interactions | 57732 | 7 | 1 | 19454 | 49 |
EGF |
1.750e-02 | -4.05 | RLIG1 (RNA 5'-phosphate and 3'-OH ligase 1) | protein interactions | 91298 | 7 | 1 | 19454 | 49 |
PRKN |
1.750e-02 | -4.05 | SLC16A5 (solute carrier family 16 member 5) | protein interactions | 9121 | 7 | 1 | 19454 | 49 |
PTPRZ1 |
1.750e-02 | -4.05 | Pum2 (pumilio RNA-binding family member 2) | protein interactions | 80913 | 7 | 1 | 19454 | 49 |
QKI |
1.750e-02 | -4.05 | ABCC12 (ATP binding cassette subfamily C member 12) | protein interactions | 94160 | 7 | 1 | 19454 | 49 |
NPAS3 |
1.750e-02 | -4.05 | PRAMEF5 (PRAME family member 5) | protein interactions | 343068 | 7 | 1 | 19454 | 49 |
PRKN |
1.750e-02 | -4.05 | NSUN7 (NOP2/Sun RNA methyltransferase family member 7) | protein interactions | 79730 | 7 | 1 | 19454 | 49 |
PRKN |
1.750e-02 | -4.05 | CDH10 (cadherin 10) | protein interactions | 1008 | 7 | 1 | 19454 | 49 |
PTN |
1.750e-02 | -4.05 | FAM186B (family with sequence similarity 186 member B) | protein interactions | 84070 | 7 | 1 | 19454 | 49 |
PRKN |
1.750e-02 | -4.05 | ZNF160 (zinc finger protein 160) | protein interactions | 90338 | 7 | 1 | 19454 | 49 |
PRKN |
1.750e-02 | -4.05 | ABCB11 (ATP binding cassette subfamily B member 11) | protein interactions | 8647 | 7 | 1 | 19454 | 49 |
PRKN |
1.750e-02 | -4.05 | SPAG17 (sperm associated antigen 17) | protein interactions | 200162 | 7 | 1 | 19454 | 49 |
PRKN |
1.750e-02 | -4.05 | HNRNPUL2-BSCL2 (HNRNPUL2-BSCL2 readthrough (NMD candidate)) | protein interactions | 100534595 | 7 | 1 | 19454 | 49 |
PRKN |
1.750e-02 | -4.05 | C1QL3 (complement C1q like 3) | protein interactions | 389941 | 7 | 1 | 19454 | 49 |
ADGRB3 |
1.750e-02 | -4.05 | RTL1 (retrotransposon Gag like 1) | protein interactions | 388015 | 7 | 1 | 19454 | 49 |
PRKN |
1.750e-02 | -4.05 | SAA2 (serum amyloid A2) | protein interactions | 6289 | 7 | 1 | 19454 | 49 |
APOA1 |
1.750e-02 | -4.05 | LRRC18 (leucine rich repeat containing 18) | protein interactions | 474354 | 7 | 1 | 19454 | 49 |
PRKN |
1.752e-02 | -4.04 | GATAD2B (GATA zinc finger domain containing 2B) | protein interactions | 57459 | 218 | 3 | 19454 | 49 |
PRKN,TRPS1,PRDM16 |
1.769e-02 | -4.03 | hepatocellular_carcinoma | COSMIC cancer mutations | hepatocellular_carcinoma | 14800 | 46 | 16828 | 47 |
SLC1A2,PREX1,LAMA4,FGFR3,ELOVL2,APOA1,FHOD3,GJA1,QKI,NCKAP5,AQP4,ZBTB20,FKBP5,NHSL1,UNC93A,SNTB1,SOX5,FGFRL1,SLC4A4,DGKB,LRIG1,GPM6B,TRPS1,AMOT,NPAS3,SORCS2,ASPA,SLC6A11,PRDM16,PREX2,NFIA,BCAR3,PTN,RORA,FARP1,GRK5,EGF,SLC39A12,LPIN2,RFX4,CTBP1,PTPRZ1,SLC1A3,USP6NL,TNS3,GPC5 |
1.769e-02 | -4.03 | liver-carcinoma-hepatocellular_carcinoma | COSMIC cancer mutations | liver-carcinoma-hepatocellular_carcinoma | 14800 | 46 | 16828 | 47 |
BCAR3,RORA,PTN,FARP1,PRDM16,NFIA,PREX2,LPIN2,RFX4,PTPRZ1,CTBP1,GPC5,TNS3,USP6NL,SLC1A3,SLC39A12,GRK5,EGF,AQP4,GJA1,NCKAP5,QKI,NHSL1,UNC93A,ZBTB20,FKBP5,LAMA4,PREX1,ELOVL2,FGFR3,SLC1A2,FHOD3,APOA1,SORCS2,ASPA,AMOT,NPAS3,SLC6A11,SOX5,FGFRL1,SLC4A4,SNTB1,GPM6B,TRPS1,LRIG1,DGKB |
1.774e-02 | -4.03 | ARNT2 (aryl hydrocarbon receptor nuclear translocator 2) | protein interactions | 9915 | 81 | 2 | 19454 | 49 |
NPAS3,CTBP1 |
1.774e-02 | -4.03 | SOX17 (SRY-box transcription factor 17) | protein interactions | 64321 | 81 | 2 | 19454 | 49 |
NFIA,TRPS1 |
1.774e-02 | -4.03 | C11orf58 (chromosome 11 open reading frame 58) | protein interactions | 10944 | 81 | 2 | 19454 | 49 |
PTN,PRKN |
1.774e-02 | -4.03 | PPP2R5C (protein phosphatase 2 regulatory subunit B'gamma) | protein interactions | 5527 | 81 | 2 | 19454 | 49 |
FKBP5,PRKN |
1.774e-02 | -4.03 | FADS1 (fatty acid desaturase 1) | protein interactions | 3992 | 81 | 2 | 19454 | 49 |
SLC39A12,PRKN |
1.782e-02 | -4.03 | cerebellar climbing fiber to Purkinje cell synapse | cellular component | GO:0150053 | 7 | 1 | 19108 | 49 |
ADGRB3 |
1.794e-02 | -4.02 | MTREX (Mtr4 exosome RNA helicase) | protein interactions | 23517 | 220 | 3 | 19454 | 49 |
PRDM16,GRK5,PRKN |
1.799e-02 | -4.02 | cellular response to stimulus | biological process | GO:0051716 | 6307 | 25 | 18204 | 50 |
SLC1A3,APOA1,GJA1,ZBTB20,BCAR3,SLC1A2,FARP1,LPIN2,EGF,PREX2,PTN,AQP4,GRK5,FGFRL1,PLPP3,FGFR3,SORCS2,SLC39A12,RORA,PREX1,PRKN,NFIA,ADGRB3,DGKB,AMOT |
1.803e-02 | -4.02 | SOX2 (SRY-box transcription factor 2) | protein interactions | 6657 | 1342 | 8 | 19454 | 49 |
NFIA,TRPS1,APOA1,QKI,GJA1,CTBP1,MSI2,SOX5 |
1.806e-02 | -4.01 | regulation of DNA binding | biological process | GO:0051101 | 75 | 2 | 18204 | 50 |
EGF,PRKN |
1.807e-02 | -4.01 | locomotion | biological process | GO:0040011 | 367 | 4 | 18204 | 50 |
PREX1,AMOT,APOA1,PTN |
1.816e-02 | -4.01 | B4GALT1 (beta-1,4-galactosyltransferase 1) | protein interactions | 2683 | 82 | 2 | 19454 | 49 |
CTBP1,SLC39A12 |
1.816e-02 | -4.01 | MADD (MAP kinase activating death domain) | protein interactions | 8567 | 82 | 2 | 19454 | 49 |
GRK5,PRKN |
1.816e-02 | -4.01 | RPS6KA1 (ribosomal protein S6 kinase A1) | protein interactions | 6195 | 221 | 3 | 19454 | 49 |
PRKN,SNTB1,CTBP1 |
1.838e-02 | -4.00 | MRPL44 (mitochondrial ribosomal protein L44) | protein interactions | 65080 | 222 | 3 | 19454 | 49 |
PTN,QKI,PRKN |
1.838e-02 | -4.00 | PKP2 (plakophilin 2) | protein interactions | 5318 | 222 | 3 | 19454 | 49 |
CTBP1,PRKN,GJA1 |
1.838e-02 | -4.00 | FGFR1 (fibroblast growth factor receptor 1) | protein interactions | 2260 | 611 | 5 | 19454 | 49 |
FGFR3,SNTB1,NHSL1,FARP1,USP6NL |
1.838e-02 | -4.00 | animal organ development | biological process | GO:0048513 | 2846 | 14 | 18204 | 50 |
PTN,RFX4,BCAR3,NFIA,SLC1A2,EGF,SOX5,APOA1,RORA,GJA1,FHOD3,LRIG1,FGFR3,FGFRL1 |
1.843e-02 | -3.99 | tripeptide transmembrane transporter activity | molecular function | GO:0042937 | 7 | 1 | 18094 | 48 |
GJA1 |
1.843e-02 | -3.99 | G protein-coupled receptor kinase activity | molecular function | GO:0004703 | 7 | 1 | 18094 | 48 |
GRK5 |
1.843e-02 | -3.99 | sphingosine-1-phosphate phosphatase activity | molecular function | GO:0042392 | 7 | 1 | 18094 | 48 |
PLPP3 |
1.843e-02 | -3.99 | histone H3K9me2 methyltransferase activity | molecular function | GO:0140947 | 7 | 1 | 18094 | 48 |
PRDM16 |
1.843e-02 | -3.99 | apolipoprotein receptor binding | molecular function | GO:0034190 | 7 | 1 | 18094 | 48 |
APOA1 |
1.843e-02 | -3.99 | fatty acid elongase activity | molecular function | GO:0009922 | 7 | 1 | 18094 | 48 |
ELOVL2 |
1.847e-02 | -3.99 | FBXO2 (F-box protein 2) | protein interactions | 26232 | 403 | 4 | 19454 | 49 |
AMOT,LRIG1,LAMA4,FGFR3 |
1.852e-02 | -3.99 | actin-mediated cell contraction | biological process | GO:0070252 | 76 | 2 | 18204 | 50 |
QKI,GJA1 |
1.858e-02 | -3.99 | TUT4 (terminal uridylyl transferase 4) | protein interactions | 23318 | 83 | 2 | 19454 | 49 |
FKBP5,PRKN |
1.858e-02 | -3.99 | PAX2 (paired box 2) | protein interactions | 5076 | 83 | 2 | 19454 | 49 |
TRPS1,NFIA |
1.858e-02 | -3.99 | EPHB6 (EPH receptor B6) | protein interactions | 2051 | 83 | 2 | 19454 | 49 |
FKBP5,USP6NL |
1.858e-02 | -3.99 | DNM3 (dynamin 3) | protein interactions | 26052 | 83 | 2 | 19454 | 49 |
PRKN,FGFR3 |
1.858e-02 | -3.99 | PPP2R5A (protein phosphatase 2 regulatory subunit B'alpha) | protein interactions | 5525 | 83 | 2 | 19454 | 49 |
NHSL1,PRKN |
1.859e-02 | -3.98 | UBE2A (ubiquitin conjugating enzyme E2 A) | protein interactions | 7319 | 223 | 3 | 19454 | 49 |
PRKN,BCAR3,GJA1 |
1.875e-02 | -3.98 | Aquaporin_transptr | interpro domains | IPR034294 | 7 | 1 | 18521 | 50 |
AQP4 |
1.875e-02 | -3.98 | GPCR_kinase | interpro domains | IPR000239 | 7 | 1 | 18521 | 50 |
GRK5 |
1.875e-02 | -3.98 | ELO_fam | interpro domains | IPR002076 | 7 | 1 | 18521 | 50 |
ELOVL2 |
1.877e-02 | -3.98 | PSMD2 (proteasome 26S subunit ubiquitin receptor, non-ATPase 2) | protein interactions | 5708 | 405 | 4 | 19454 | 49 |
GRK5,PRKN,GJA1,PTN |
1.891e-02 | -3.97 | system process | biological process | GO:0003008 | 2015 | 11 | 18204 | 50 |
SLC1A2,ADGRB3,PTN,SNTB1,AQP4,SLC4A4,PTPRZ1,LRIG1,SLC1A3,PRKN,GJA1 |
1.893e-02 | -3.97 | lung-left_upper_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-left_upper_lobe-carcinoma-adenocarcinoma | 556 | 5 | 16828 | 47 |
DGKB,PREX1,SLC4A4,SLC6A11,TRPS1 |
1.897e-02 | -3.96 | human chr10p12.33 | chromosome location | human chr10p12.33 | 10 | 1 | 26134 | 50 |
SLC39A12 |
1.898e-02 | -3.96 | regulation of cholesterol transport | biological process | GO:0032374 | 77 | 2 | 18204 | 50 |
APOA1,EGF |
1.898e-02 | -3.96 | regulation of sterol transport | biological process | GO:0032371 | 77 | 2 | 18204 | 50 |
EGF,APOA1 |
1.900e-02 | -3.96 | ELP2 (elongator acetyltransferase complex subunit 2) | protein interactions | 55250 | 84 | 2 | 19454 | 49 |
FKBP5,PRKN |
1.900e-02 | -3.96 | AMOTL1 (angiomotin like 1) | protein interactions | 154810 | 84 | 2 | 19454 | 49 |
AMOT,PRKN |
1.900e-02 | -3.96 | BCL2L11 (BCL2 like 11) | protein interactions | 10018 | 84 | 2 | 19454 | 49 |
SLC39A12,PRKN |
1.904e-02 | -3.96 | FOXC1 (forkhead box C1) | protein interactions | 2296 | 225 | 3 | 19454 | 49 |
CTBP1,SOX5,NFIA |
1.905e-02 | -3.96 | Diseases of signal transduction | REACTOME pathways | R-HSA-5663202 | 369 | 4 | 10285 | 29 |
FGFR3,CTBP1,QKI,EGF |
1.905e-02 | -3.96 | ELO | prosite domains | PS01188 | 6 | 1 | 12186 | 39 |
ELOVL2 |
1.905e-02 | -3.96 | GLYPICAN | prosite domains | PS01207 | 6 | 1 | 12186 | 39 |
GPC5 |
1.906e-02 | -3.96 | central_nervous_system-brain-glioma | COSMIC cancer mutations | central_nervous_system-brain-glioma | 15470 | 47 | 16828 | 47 |
SNTB1,SLC4A4,SOX5,FGFRL1,DGKB,LRIG1,TRPS1,GPM6B,NPAS3,AMOT,ASPA,SORCS2,SLC6A11,SLC1A2,FGFR3,ELOVL2,PREX1,LAMA4,APOA1,FHOD3,QKI,NCKAP5,GJA1,AQP4,ZBTB20,FKBP5,UNC93A,NHSL1,EGF,GRK5,SLC39A12,CTBP1,PTPRZ1,LPIN2,RFX4,MSI2,SLC1A3,USP6NL,TNS3,GPC5,PRDM16,PREX2,NFIA,BCAR3,FARP1,PTN,RORA |
1.907e-02 | -3.96 | regulation of skeletal muscle acetylcholine-gated channel clustering | biological process | GO:1904393 | 7 | 1 | 18204 | 50 |
FARP1 |
1.907e-02 | -3.96 | fatty acid elongation, unsaturated fatty acid | biological process | GO:0019368 | 7 | 1 | 18204 | 50 |
ELOVL2 |
1.907e-02 | -3.96 | glutathione transmembrane transport | biological process | GO:0034775 | 7 | 1 | 18204 | 50 |
GJA1 |
1.907e-02 | -3.96 | regulation of retrograde transport, endosome to Golgi | biological process | GO:1905279 | 7 | 1 | 18204 | 50 |
PRKN |
1.907e-02 | -3.96 | inclusion body assembly | biological process | GO:0070841 | 7 | 1 | 18204 | 50 |
PRKN |
1.907e-02 | -3.96 | free ubiquitin chain polymerization | biological process | GO:0010994 | 7 | 1 | 18204 | 50 |
PRKN |
1.907e-02 | -3.96 | fatty acid elongation, monounsaturated fatty acid | biological process | GO:0034625 | 7 | 1 | 18204 | 50 |
ELOVL2 |
1.907e-02 | -3.96 | trans-synaptic signaling by trans-synaptic complex | biological process | GO:0099545 | 7 | 1 | 18204 | 50 |
FARP1 |
1.907e-02 | -3.96 | regulation of oligodendrocyte progenitor proliferation | biological process | GO:0070445 | 7 | 1 | 18204 | 50 |
PTPRZ1 |
1.907e-02 | -3.96 | regulation of 3'-UTR-mediated mRNA stabilization | biological process | GO:1905868 | 7 | 1 | 18204 | 50 |
QKI |
1.907e-02 | -3.96 | glial cell fate specification | biological process | GO:0021780 | 7 | 1 | 18204 | 50 |
NFIA |
1.907e-02 | -3.96 | high-density lipoprotein particle clearance | biological process | GO:0034384 | 7 | 1 | 18204 | 50 |
APOA1 |
1.907e-02 | -3.96 | fatty acid elongation, polyunsaturated fatty acid | biological process | GO:0034626 | 7 | 1 | 18204 | 50 |
ELOVL2 |
1.912e-02 | -3.96 | PTPc_motif | smart domains | SM00404 | 61 | 2 | 9717 | 34 |
PTPRZ1,TNS3 |
1.920e-02 | -3.95 | left_upper_lobe | COSMIC cancer mutations | left_upper_lobe | 558 | 5 | 16828 | 47 |
DGKB,PREX1,SLC4A4,SLC6A11,TRPS1 |
1.923e-02 | -3.95 | ESYT1 (extended synaptotagmin 1) | protein interactions | 23344 | 408 | 4 | 19454 | 49 |
GPM6B,PRKN,GJA1,ELOVL2 |
1.926e-02 | -3.95 | TGM2 (transglutaminase 2) | protein interactions | 7052 | 226 | 3 | 19454 | 49 |
GJA1,PREX1,PRKN |
1.930e-02 | -3.95 | WH_DNA-bd_sf | interpro domains | IPR036390 | 211 | 3 | 18521 | 50 |
PREX1,PREX2,RFX4 |
1.939e-02 | -3.94 | SEC16A (SEC16 homolog A, endoplasmic reticulum export factor) | protein interactions | 9919 | 409 | 4 | 19454 | 49 |
TRPS1,PRKN,GJA1,AMOT |
1.939e-02 | -3.94 | urinary_tract-carcinoma-transitional_cell_carcinoma | COSMIC cancer mutations | urinary_tract-carcinoma-transitional_cell_carcinoma | 7 | 1 | 16828 | 47 |
FGFR3 |
1.939e-02 | -3.94 | skin-face-adnexal_tumour-malignant_adnexal_tumour | COSMIC cancer mutations | skin-face-adnexal_tumour-malignant_adnexal_tumour | 7 | 1 | 16828 | 47 |
FGFR3 |
1.939e-02 | -3.94 | skin-chest-other-seborrhoeic_keratosis | COSMIC cancer mutations | skin-chest-other-seborrhoeic_keratosis | 7 | 1 | 16828 | 47 |
FGFR3 |
1.939e-02 | -3.94 | skin-face-malignant_melanoma-nodular | COSMIC cancer mutations | skin-face-malignant_melanoma-nodular | 7 | 1 | 16828 | 47 |
PREX2 |
1.939e-02 | -3.94 | trichilemmoma | COSMIC cancer mutations | trichilemmoma | 7 | 1 | 16828 | 47 |
FGFR3 |
1.939e-02 | -3.94 | nevus_sebaceous | COSMIC cancer mutations | nevus_sebaceous | 7 | 1 | 16828 | 47 |
FGFR3 |
1.939e-02 | -3.94 | skin-benign_melanocytic_nevus-compound | COSMIC cancer mutations | skin-benign_melanocytic_nevus-compound | 7 | 1 | 16828 | 47 |
FGFR3 |
1.939e-02 | -3.94 | skin-upper_leg-malignant_melanoma-nodular | COSMIC cancer mutations | skin-upper_leg-malignant_melanoma-nodular | 7 | 1 | 16828 | 47 |
PREX2 |
1.939e-02 | -3.94 | skin-benign_melanocytic_nevus-intradermal | COSMIC cancer mutations | skin-benign_melanocytic_nevus-intradermal | 7 | 1 | 16828 | 47 |
FGFR3 |
1.939e-02 | -3.94 | skin-other-nevus_sebaceous | COSMIC cancer mutations | skin-other-nevus_sebaceous | 7 | 1 | 16828 | 47 |
FGFR3 |
1.939e-02 | -3.94 | skin-adnexal_tumour-trichilemmoma | COSMIC cancer mutations | skin-adnexal_tumour-trichilemmoma | 7 | 1 | 16828 | 47 |
FGFR3 |
1.939e-02 | -3.94 | skin-shoulder-other-seborrhoeic_keratosis | COSMIC cancer mutations | skin-shoulder-other-seborrhoeic_keratosis | 7 | 1 | 16828 | 47 |
FGFR3 |
1.939e-02 | -3.94 | skin-neck-other-seborrhoeic_keratosis | COSMIC cancer mutations | skin-neck-other-seborrhoeic_keratosis | 7 | 1 | 16828 | 47 |
FGFR3 |
1.943e-02 | -3.94 | CCND3 (cyclin D3) | protein interactions | 896 | 85 | 2 | 19454 | 49 |
PRKN,QKI |
1.943e-02 | -3.94 | ABHD12 (abhydrolase domain containing 12, lysophospholipase) | protein interactions | 26090 | 85 | 2 | 19454 | 49 |
SLC39A12,PRKN |
1.943e-02 | -3.94 | DDX19A (DEAD-box helicase 19A) | protein interactions | 55308 | 85 | 2 | 19454 | 49 |
FGFR3,PRKN |
1.943e-02 | -3.94 | CFAP298 (cilia and flagella associated protein 298) | protein interactions | 56683 | 85 | 2 | 19454 | 49 |
FKBP5,TRPS1 |
1.944e-02 | -3.94 | inorganic cation transmembrane transporter activity | molecular function | GO:0022890 | 589 | 5 | 18094 | 48 |
SLC4A4,SLC1A3,SLC6A11,SLC1A2,SLC39A12 |
1.948e-02 | -3.94 | FOXK1 (forkhead box K1) | protein interactions | 221937 | 227 | 3 | 19454 | 49 |
SOX5,AMOT,CTBP1 |
1.948e-02 | -3.94 | ARMC8 (armadillo repeat containing 8) | protein interactions | 25852 | 227 | 3 | 19454 | 49 |
MSI2,NCKAP5,PRKN |
1.951e-02 | -3.94 | ELO | pfam domains | PF01151 | 7 | 1 | 17795 | 50 |
ELOVL2 |
1.954e-02 | -3.94 | transmembrane receptor protein kinase activity | molecular function | GO:0019199 | 81 | 2 | 18094 | 48 |
FGFRL1,FGFR3 |
1.958e-02 | -3.93 | FGFR3b ligand binding and activation | REACTOME pathways | R-HSA-190371 | 7 | 1 | 10285 | 29 |
FGFR3 |
1.971e-02 | -3.93 | CSK (C-terminal Src kinase) | protein interactions | 1445 | 854 | 6 | 19454 | 49 |
USP6NL,PTPRZ1,AMOT,TNS3,GJA1,PRKN |
1.973e-02 | -3.93 | regulation of neurogenesis | biological process | GO:0050767 | 377 | 4 | 18204 | 50 |
QKI,PTPRZ1,PTN,ASPA |
1.982e-02 | -3.92 | CDC37 (cell division cycle 37, HSP90 cochaperone) | protein interactions | 11140 | 623 | 5 | 19454 | 49 |
FARP1,PRKN,GRK5,FGFR3,FKBP5 |
1.986e-02 | -3.92 | DNPEP (aspartyl aminopeptidase) | protein interactions | 23549 | 86 | 2 | 19454 | 49 |
TNS3,PRKN |
1.986e-02 | -3.92 | EGLN1 (egl-9 family hypoxia inducible factor 1) | protein interactions | 54583 | 86 | 2 | 19454 | 49 |
FGFR3,FKBP5 |
1.986e-02 | -3.92 | LIN54 (lin-54 DREAM MuvB core complex component) | protein interactions | 132660 | 86 | 2 | 19454 | 49 |
SOX5,PRKN |
1.998e-02 | -3.91 | DENND10P1 (DENND10 pseudogene 1) | protein interactions | 55855 | 8 | 1 | 19454 | 49 |
PRKN |
1.998e-02 | -3.91 | DEFB104A (defensin beta 104A) | protein interactions | 140596 | 8 | 1 | 19454 | 49 |
GJA1 |
1.998e-02 | -3.91 | AMDHD2 (amidohydrolase domain containing 2) | protein interactions | 51005 | 8 | 1 | 19454 | 49 |
PRKN |
1.998e-02 | -3.91 | CNMD (chondromodulin) | protein interactions | 11061 | 8 | 1 | 19454 | 49 |
APOA1 |
1.998e-02 | -3.91 | ASPA (aspartoacylase) | protein interactions | 443 | 8 | 1 | 19454 | 49 |
ASPA |
1.998e-02 | -3.91 | MARCHF10 (membrane associated ring-CH-type finger 10) | protein interactions | 162333 | 8 | 1 | 19454 | 49 |
CTBP1 |
1.998e-02 | -3.91 | Prkca (protein kinase C, alpha) | protein interactions | 24680 | 8 | 1 | 19454 | 49 |
PRKN |
1.998e-02 | -3.91 | GRIK4 (glutamate ionotropic receptor kainate type subunit 4) | protein interactions | 2900 | 8 | 1 | 19454 | 49 |
PRKN |
1.998e-02 | -3.91 | CCDC30 (coiled-coil domain containing 30) | protein interactions | 728621 | 8 | 1 | 19454 | 49 |
PRKN |
1.998e-02 | -3.91 | IGKV2-30 (immunoglobulin kappa variable 2-30) | protein interactions | 28919 | 8 | 1 | 19454 | 49 |
PRKN |
1.998e-02 | -3.91 | HSD11B2 (hydroxysteroid 11-beta dehydrogenase 2) | protein interactions | 3291 | 8 | 1 | 19454 | 49 |
CTBP1 |
1.998e-02 | -3.91 | ARHGAP28 (Rho GTPase activating protein 28) | protein interactions | 79822 | 8 | 1 | 19454 | 49 |
PRKN |
1.998e-02 | -3.91 | HSD3B1 (hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1) | protein interactions | 3283 | 8 | 1 | 19454 | 49 |
PRKN |
1.998e-02 | -3.91 | GLYAT (glycine-N-acyltransferase) | protein interactions | 10249 | 8 | 1 | 19454 | 49 |
PTN |
1.998e-02 | -3.91 | DENND6B (DENN domain containing 6B) | protein interactions | 414918 | 8 | 1 | 19454 | 49 |
PRKN |
1.998e-02 | -3.91 | PDE6B (phosphodiesterase 6B) | protein interactions | 5158 | 8 | 1 | 19454 | 49 |
CTBP1 |
1.998e-02 | -3.91 | DEPP1 (DEPP autophagy regulator 1) | protein interactions | 11067 | 8 | 1 | 19454 | 49 |
QKI |
1.998e-02 | -3.91 | HHIP (hedgehog interacting protein) | protein interactions | 64399 | 8 | 1 | 19454 | 49 |
PRKN |
1.998e-02 | -3.91 | BPI (bactericidal permeability increasing protein) | protein interactions | 671 | 8 | 1 | 19454 | 49 |
PRKN |
2.000e-02 | -3.91 | oesophagus-lower_third-carcinoma-adenocarcinoma | COSMIC cancer mutations | oesophagus-lower_third-carcinoma-adenocarcinoma | 6302 | 25 | 16828 | 47 |
DGKB,TRPS1,GPM6B,SNTB1,SLC39A12,SOX5,SLC6A11,GPC5,NPAS3,PTPRZ1,LPIN2,ASPA,SORCS2,APOA1,FHOD3,PREX2,PREX1,FARP1,RORA,FKBP5,ZBTB20,QKI,NCKAP5,GJA1,AQP4 |
2.006e-02 | -3.91 | intracellular signal transduction | biological process | GO:0035556 | 1505 | 9 | 18204 | 50 |
BCAR3,FARP1,EGF,FGFR3,PREX2,AMOT,APOA1,DGKB,PREX1 |
2.029e-02 | -3.90 | ADPGK (ADP dependent glucokinase) | protein interactions | 83440 | 87 | 2 | 19454 | 49 |
PRKN,SLC39A12 |
2.029e-02 | -3.90 | CSTF2T (cleavage stimulation factor subunit 2 tau variant) | protein interactions | 23283 | 87 | 2 | 19454 | 49 |
PRKN,SORCS2 |
2.029e-02 | -3.90 | MIR141 (microRNA 141) | protein interactions | 406933 | 87 | 2 | 19454 | 49 |
QKI,MSI2 |
2.029e-02 | -3.90 | Kctd5 (potassium channel tetramerisation domain containing 5) | protein interactions | 69259 | 87 | 2 | 19454 | 49 |
TRPS1,SLC1A3 |
2.029e-02 | -3.90 | ZNF608 (zinc finger protein 608) | protein interactions | 57507 | 87 | 2 | 19454 | 49 |
NFIA,SOX5 |
2.029e-02 | -3.90 | NHLH1 (nescient helix-loop-helix 1) | protein interactions | 4807 | 87 | 2 | 19454 | 49 |
TRPS1,NFIA |
2.029e-02 | -3.90 | FANCC (FA complementation group C) | protein interactions | 2176 | 87 | 2 | 19454 | 49 |
PRKN,CTBP1 |
2.034e-02 | -3.90 | Lewy body | cellular component | GO:0097413 | 8 | 1 | 19108 | 49 |
PRKN |
2.034e-02 | -3.90 | extrinsic component of postsynaptic membrane | cellular component | GO:0098890 | 8 | 1 | 19108 | 49 |
FARP1 |
2.034e-02 | -3.90 | spherical high-density lipoprotein particle | cellular component | GO:0034366 | 8 | 1 | 19108 | 49 |
APOA1 |
2.044e-02 | -3.89 | RHOJ (ras homolog family member J) | protein interactions | 57381 | 628 | 5 | 19454 | 49 |
USP6NL,GJA1,FARP1,SLC1A3,SNTB1 |
2.049e-02 | -3.89 | EGFTGF | prints domains | PR00009 | 6 | 1 | 5227 | 18 |
EGF |
2.062e-02 | -3.88 | CTNND1 (catenin delta 1) | protein interactions | 1500 | 232 | 3 | 19454 | 49 |
GJA1,PRKN,PLPP3 |
2.062e-02 | -3.88 | PRKAA2 (protein kinase AMP-activated catalytic subunit alpha 2) | protein interactions | 5563 | 232 | 3 | 19454 | 49 |
AMOT,PRKN,SLC4A4 |
2.073e-02 | -3.88 | FGA (fibrinogen alpha chain) | protein interactions | 2243 | 88 | 2 | 19454 | 49 |
APOA1,GJA1 |
2.073e-02 | -3.88 | TMEM128 (transmembrane protein 128) | protein interactions | 85013 | 88 | 2 | 19454 | 49 |
GJA1,SLC1A3 |
2.074e-02 | -3.88 | bone-fibula-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-fibula-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 377 | 4 | 16828 | 47 |
NCKAP5,GRK5,FGFR3,SORCS2 |
2.082e-02 | -3.87 | LNS2 | smart domains | SM00775 | 6 | 1 | 9717 | 34 |
LPIN2 |
2.086e-02 | -3.87 | SEC23IP (SEC23 interacting protein) | protein interactions | 11196 | 233 | 3 | 19454 | 49 |
CTBP1,GJA1,PRKN |
2.087e-02 | -3.87 | adult locomotory behavior | biological process | GO:0008344 | 81 | 2 | 18204 | 50 |
PREX2,PRKN |
2.094e-02 | -3.87 | protein stabilization | biological process | GO:0050821 | 214 | 3 | 18204 | 50 |
APOA1,PRKN,PLPP3 |
2.095e-02 | -3.87 | regulation of actin filament-based process | biological process | GO:0032970 | 384 | 4 | 18204 | 50 |
GPM6B,APOA1,PRKN,PREX1 |
2.103e-02 | -3.86 | glutamate binding | molecular function | GO:0016595 | 8 | 1 | 18094 | 48 |
SLC1A3 |
2.103e-02 | -3.86 | gap junction channel activity involved in cell communication by electrical coupling | molecular function | GO:1903763 | 8 | 1 | 18094 | 48 |
GJA1 |
2.105e-02 | -3.86 | glutamatergic synapse | cellular component | GO:0098978 | 412 | 4 | 19108 | 49 |
SLC1A2,FARP1,CTBP1,ADGRB3 |
2.109e-02 | -3.86 | SEC24B (SEC24 homolog B, COPII coat complex component) | protein interactions | 10427 | 234 | 3 | 19454 | 49 |
FGFR3,PRKN,GJA1 |
2.109e-02 | -3.86 | HMG20A (high mobility group 20A) | protein interactions | 10363 | 234 | 3 | 19454 | 49 |
SOX5,NFIA,SNTB1 |
2.117e-02 | -3.86 | intracellular chemical homeostasis | biological process | GO:0055082 | 581 | 5 | 18204 | 50 |
ZBTB20,SLC4A4,AQP4,SLC1A3,SLC39A12 |
2.117e-02 | -3.85 | SOX10 (SRY-box transcription factor 10) | protein interactions | 6663 | 89 | 2 | 19454 | 49 |
NFIA,TRPS1 |
2.117e-02 | -3.85 | KNSTRN (kinetochore localized astrin (SPAG5) binding protein) | protein interactions | 90417 | 89 | 2 | 19454 | 49 |
NCKAP5,PRKN |
2.119e-02 | -3.85 | Alpha-synuclein signaling | Pathway Interaction DB | alphasynuclein_pathway | 32 | 2 | 2226 | 16 |
PRKN,GRK5 |
2.120e-02 | -3.85 | dephosphorylation | biological process | GO:0016311 | 215 | 3 | 18204 | 50 |
PTPRZ1,TNS3,PLPP3 |
2.127e-02 | -3.85 | positive regulation of metabolic process | biological process | GO:0009893 | 3796 | 17 | 18204 | 50 |
NPAS3,PLPP3,FGFR3,PRDM16,RORA,APOA1,GJA1,PRKN,ZBTB20,QKI,EGF,LPIN2,BCAR3,NFIA,SLC4A4,CTBP1,RFX4 |
2.133e-02 | -3.85 | MARK3 (microtubule affinity regulating kinase 3) | protein interactions | 4140 | 235 | 3 | 19454 | 49 |
GJA1,SNTB1,PRKN |
2.135e-02 | -3.85 | lens development in camera-type eye | biological process | GO:0002088 | 82 | 2 | 18204 | 50 |
GJA1,BCAR3 |
2.140e-02 | -3.84 | PTB | interpro domains | IPR013625 | 8 | 1 | 18521 | 50 |
TNS3 |
2.140e-02 | -3.84 | RFX-like | interpro domains | IPR039779 | 8 | 1 | 18521 | 50 |
RFX4 |
2.140e-02 | -3.84 | Tensin_C2-dom | interpro domains | IPR014020 | 8 | 1 | 18521 | 50 |
TNS3 |
2.140e-02 | -3.84 | PKD/Chitinase_dom | interpro domains | IPR022409 | 8 | 1 | 18521 | 50 |
SORCS2 |
2.140e-02 | -3.84 | Tensin_phosphatase | interpro domains | IPR029023 | 8 | 1 | 18521 | 50 |
TNS3 |
2.140e-02 | -3.84 | DAD_dom | interpro domains | IPR014767 | 8 | 1 | 18521 | 50 |
FHOD3 |
2.151e-02 | -3.84 | forearm | COSMIC cancer mutations | forearm | 81 | 2 | 16828 | 47 |
PREX2,FGFR3 |
2.154e-02 | -3.84 | C1 | smart domains | SM00109 | 65 | 2 | 9717 | 34 |
DGKB,TNS3 |
2.155e-02 | -3.84 | central_nervous_system-brain-atypical_teratoid-rhabdoid_tumour | COSMIC cancer mutations | central_nervous_system-brain-atypical_teratoid-rhabdoid_tumour | 213 | 3 | 16828 | 47 |
FGFR3,PREX1,NCKAP5 |
2.155e-02 | -3.84 | atypical_teratoid-rhabdoid_tumour | COSMIC cancer mutations | atypical_teratoid-rhabdoid_tumour | 213 | 3 | 16828 | 47 |
PREX1,FGFR3,NCKAP5 |
2.162e-02 | -3.83 | BRAP (BRCA1 associated protein) | protein interactions | 8315 | 90 | 2 | 19454 | 49 |
APOA1,PRKN |
2.162e-02 | -3.83 | PRTN3 (proteinase 3) | protein interactions | 5657 | 90 | 2 | 19454 | 49 |
CTBP1,FGFR3 |
2.167e-02 | -3.83 | regulation of supramolecular fiber organization | biological process | GO:1902903 | 388 | 4 | 18204 | 50 |
APOA1,PRKN,PREX1,SLC39A12 |
2.172e-02 | -3.83 | positive regulation of cellular catabolic process | biological process | GO:0031331 | 217 | 3 | 18204 | 50 |
ZBTB20,PRKN,SLC4A4 |
2.172e-02 | -3.83 | regulation of cell junction assembly | biological process | GO:1901888 | 217 | 3 | 18204 | 50 |
ADGRB3,FARP1,GPM6B |
2.177e-02 | -3.83 | regulation of epithelial tube formation | biological process | GO:1905276 | 8 | 1 | 18204 | 50 |
EGF |
2.177e-02 | -3.83 | motor learning | biological process | GO:0061743 | 8 | 1 | 18204 | 50 |
ADGRB3 |
2.177e-02 | -3.83 | regulation of ventricular cardiac muscle cell membrane depolarization | biological process | GO:0060373 | 8 | 1 | 18204 | 50 |
GJA1 |
2.177e-02 | -3.83 | taurine transmembrane transport | biological process | GO:0015734 | 8 | 1 | 18204 | 50 |
SLC6A11 |
2.177e-02 | -3.83 | aspartate metabolic process | biological process | GO:0006531 | 8 | 1 | 18204 | 50 |
ASPA |
2.177e-02 | -3.83 | positive regulation of mitophagy in response to mitochondrial depolarization | biological process | GO:0098779 | 8 | 1 | 18204 | 50 |
PRKN |
2.177e-02 | -3.83 | ERBB2-EGFR signaling pathway | biological process | GO:0038134 | 8 | 1 | 18204 | 50 |
EGF |
2.177e-02 | -3.83 | negative regulation of mitochondrial fusion | biological process | GO:0010637 | 8 | 1 | 18204 | 50 |
PRKN |
2.177e-02 | -3.83 | leukocyte chemotaxis involved in inflammatory response | biological process | GO:0002232 | 8 | 1 | 18204 | 50 |
PTN |
2.177e-02 | -3.83 | alkanesulfonate transmembrane transport | biological process | GO:0042918 | 8 | 1 | 18204 | 50 |
SLC6A11 |
2.177e-02 | -3.83 | negative regulation of gonadotropin secretion | biological process | GO:0032277 | 8 | 1 | 18204 | 50 |
GJA1 |
2.177e-02 | -3.83 | gamma-aminobutyric acid metabolic process | biological process | GO:0009448 | 8 | 1 | 18204 | 50 |
SLC1A3 |
2.177e-02 | -3.83 | plasma membrane to endosome transport | biological process | GO:0048227 | 8 | 1 | 18204 | 50 |
USP6NL |
2.177e-02 | -3.83 | fatty acid elongation, saturated fatty acid | biological process | GO:0019367 | 8 | 1 | 18204 | 50 |
ELOVL2 |
2.177e-02 | -3.83 | negative regulation of trophoblast cell migration | biological process | GO:1901164 | 8 | 1 | 18204 | 50 |
GJA1 |
2.177e-02 | -3.83 | regulation of Cdc42 protein signal transduction | biological process | GO:0032489 | 8 | 1 | 18204 | 50 |
APOA1 |
2.177e-02 | -3.83 | positive regulation of epithelial tube formation | biological process | GO:1905278 | 8 | 1 | 18204 | 50 |
EGF |
2.177e-02 | -3.83 | gap junction assembly | biological process | GO:0016264 | 8 | 1 | 18204 | 50 |
GJA1 |
2.177e-02 | -3.83 | regulation of hyaluronan biosynthetic process | biological process | GO:1900125 | 8 | 1 | 18204 | 50 |
EGF |
2.177e-02 | -3.83 | positive regulation of CoA-transferase activity | biological process | GO:1905920 | 8 | 1 | 18204 | 50 |
APOA1 |
2.177e-02 | -3.83 | tachykinin receptor signaling pathway | biological process | GO:0007217 | 8 | 1 | 18204 | 50 |
GRK5 |
2.180e-02 | -3.83 | CREB1 (cAMP responsive element binding protein 1) | protein interactions | 1385 | 237 | 3 | 19454 | 49 |
NFIA,BCAR3,PRKN |
2.186e-02 | -3.82 | PDZ domain binding | molecular function | GO:0030165 | 86 | 2 | 18094 | 48 |
SNTB1,PRKN |
2.191e-02 | -3.82 | - | gene3d domains | 2.20.25.20 | 8 | 1 | 14470 | 40 |
PRKN |
2.191e-02 | -3.82 | - | gene3d domains | 2.60.40.1110 | 8 | 1 | 14470 | 40 |
TNS3 |
2.204e-02 | -3.81 | CDC16 (cell division cycle 16) | protein interactions | 8881 | 238 | 3 | 19454 | 49 |
FHOD3,TRPS1,PRKN |
2.207e-02 | -3.81 | TRMT6 (tRNA methyltransferase 6 non-catalytic subunit) | protein interactions | 51605 | 91 | 2 | 19454 | 49 |
PRKN,FKBP5 |
2.207e-02 | -3.81 | MICU2 (mitochondrial calcium uptake 2) | protein interactions | 221154 | 91 | 2 | 19454 | 49 |
PRKN,SLC39A12 |
2.207e-02 | -3.81 | TRAPPC12 (trafficking protein particle complex subunit 12) | protein interactions | 51112 | 91 | 2 | 19454 | 49 |
PRKN,CTBP1 |
2.207e-02 | -3.81 | TRIO (trio Rho guanine nucleotide exchange factor) | protein interactions | 7204 | 91 | 2 | 19454 | 49 |
PRDM16,GJA1 |
2.207e-02 | -3.81 | FOXI1 (forkhead box I1) | protein interactions | 2299 | 91 | 2 | 19454 | 49 |
TRPS1,NFIA |
2.207e-02 | -3.81 | NEIL3 (nei like DNA glycosylase 3) | protein interactions | 55247 | 91 | 2 | 19454 | 49 |
FKBP5,QKI |
2.213e-02 | -3.81 | junctional | COSMIC cancer mutations | junctional | 8 | 1 | 16828 | 47 |
FGFR3 |
2.213e-02 | -3.81 | trichoblastoma | COSMIC cancer mutations | trichoblastoma | 8 | 1 | 16828 | 47 |
FGFR3 |
2.213e-02 | -3.81 | skin-chest-malignant_melanoma-nodular | COSMIC cancer mutations | skin-chest-malignant_melanoma-nodular | 8 | 1 | 16828 | 47 |
PREX2 |
2.213e-02 | -3.81 | cervical_intraepithelial_neoplasia_Grade_I | COSMIC cancer mutations | cervical_intraepithelial_neoplasia_Grade_I | 8 | 1 | 16828 | 47 |
FGFR3 |
2.213e-02 | -3.81 | actinic_keratosis | COSMIC cancer mutations | actinic_keratosis | 8 | 1 | 16828 | 47 |
FGFR3 |
2.213e-02 | -3.81 | urinary_tract-ureter-carcinoma-transitional_cell_carcinoma | COSMIC cancer mutations | urinary_tract-ureter-carcinoma-transitional_cell_carcinoma | 8 | 1 | 16828 | 47 |
FGFR3 |
2.213e-02 | -3.81 | cervix-in_situ_neoplasm-cervical_intraepithelial_neoplasia_Grade_I | COSMIC cancer mutations | cervix-in_situ_neoplasm-cervical_intraepithelial_neoplasia_Grade_I | 8 | 1 | 16828 | 47 |
FGFR3 |
2.213e-02 | -3.81 | central_nervous_system-chiasm-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-chiasm-glioma-astrocytoma_Grade_I | 8 | 1 | 16828 | 47 |
QKI |
2.216e-02 | -3.81 | monoatomic ion transmembrane transport | biological process | GO:0034220 | 804 | 6 | 18204 | 50 |
SLC6A11,SLC4A4,GJA1,SLC1A2,SLC1A3,SLC39A12 |
2.216e-02 | -3.81 | embryonic morphogenesis | biological process | GO:0048598 | 588 | 5 | 18204 | 50 |
SLC39A12,LRIG1,PLPP3,GJA1,AMOT |
2.218e-02 | -3.81 | Triglyceride Biosynthesis | REACTOME pathways | R-HSA-75109 | 82 | 2 | 10285 | 29 |
ELOVL2,LPIN2 |
2.226e-02 | -3.80 | PTEN_C2 | pfam domains | PF10409 | 8 | 1 | 17795 | 50 |
TNS3 |
2.226e-02 | -3.80 | PTB | pfam domains | PF08416 | 8 | 1 | 17795 | 50 |
TNS3 |
2.233e-02 | -3.80 | L-amino acid transport | biological process | GO:0015807 | 84 | 2 | 18204 | 50 |
SLC1A2,SLC1A3 |
2.233e-02 | -3.80 | regulation of stem cell differentiation | biological process | GO:2000736 | 84 | 2 | 18204 | 50 |
PTN,SOX5 |
2.234e-02 | -3.80 | Release of Hh-Np from the secreting cell | REACTOME pathways | R-HSA-5362798 | 8 | 1 | 10285 | 29 |
GPC5 |
2.239e-02 | -3.80 | spindle | COSMIC cancer mutations | spindle | 386 | 4 | 16828 | 47 |
GRK5,FGFRL1,PREX2,FGFR3 |
2.245e-02 | -3.80 | GUSBP1 (GUSB pseudogene 1) | protein interactions | 728411 | 9 | 1 | 19454 | 49 |
FGFR3 |
2.245e-02 | -3.80 | KLB (klotho beta) | protein interactions | 152831 | 9 | 1 | 19454 | 49 |
FGFR3 |
2.245e-02 | -3.80 | PABPC1L2A (poly(A) binding protein cytoplasmic 1 like 2A) | protein interactions | 340529 | 9 | 1 | 19454 | 49 |
PRKN |
2.245e-02 | -3.80 | Ywhag (tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide) | protein interactions | 22628 | 9 | 1 | 19454 | 49 |
QKI |
2.245e-02 | -3.80 | SOBP (sine oculis binding protein homolog) | protein interactions | 55084 | 9 | 1 | 19454 | 49 |
CTBP1 |
2.245e-02 | -3.80 | ABI3BP (ABI family member 3 binding protein) | protein interactions | 25890 | 9 | 1 | 19454 | 49 |
GRK5 |
2.245e-02 | -3.80 | MMP28 (matrix metallopeptidase 28) | protein interactions | 79148 | 9 | 1 | 19454 | 49 |
PRKN |
2.245e-02 | -3.80 | AMY2B (amylase alpha 2B) | protein interactions | 280 | 9 | 1 | 19454 | 49 |
PRKN |
2.245e-02 | -3.80 | CASS4 (Cas scaffold protein family member 4) | protein interactions | 57091 | 9 | 1 | 19454 | 49 |
PRKN |
2.245e-02 | -3.80 | Prmt5 (protein arginine N-methyltransferase 5) | protein interactions | 27374 | 9 | 1 | 19454 | 49 |
FARP1 |
2.245e-02 | -3.80 | KCNV2 (potassium voltage-gated channel modifier subfamily V member 2) | protein interactions | 169522 | 9 | 1 | 19454 | 49 |
PRKN |
2.245e-02 | -3.80 | DNAH11 (dynein axonemal heavy chain 11) | protein interactions | 8701 | 9 | 1 | 19454 | 49 |
PRKN |
2.245e-02 | -3.80 | SLC16A6 (solute carrier family 16 member 6) | protein interactions | 9120 | 9 | 1 | 19454 | 49 |
PRKN |
2.245e-02 | -3.80 | Kif18a (kinesin family member 18A) | protein interactions | 228421 | 9 | 1 | 19454 | 49 |
CTBP1 |
2.245e-02 | -3.80 | MYOM3 (myomesin 3) | protein interactions | 127294 | 9 | 1 | 19454 | 49 |
AMOT |
2.245e-02 | -3.80 | ABCA6 (ATP binding cassette subfamily A member 6) | protein interactions | 23460 | 9 | 1 | 19454 | 49 |
APOA1 |
2.250e-02 | -3.79 | regulation of peptidyl-tyrosine phosphorylation | biological process | GO:0050730 | 220 | 3 | 18204 | 50 |
EGF,FGFR3,PLPP3 |
2.253e-02 | -3.79 | ACBD3 (acyl-CoA binding domain containing 3) | protein interactions | 64746 | 240 | 3 | 19454 | 49 |
PRKN,FGFR3,GJA1 |
2.253e-02 | -3.79 | LIMS1 (LIM zinc finger domain containing 1) | protein interactions | 3987 | 92 | 2 | 19454 | 49 |
FKBP5,PRKN |
2.253e-02 | -3.79 | LEMD2 (LEM domain nuclear envelope protein 2) | protein interactions | 221496 | 92 | 2 | 19454 | 49 |
SLC39A12,PRKN |
2.253e-02 | -3.79 | FNTA (farnesyltransferase, CAAX box, subunit alpha) | protein interactions | 2339 | 92 | 2 | 19454 | 49 |
PRKN,FGFR3 |
2.253e-02 | -3.79 | ZHX1 (zinc fingers and homeoboxes 1) | protein interactions | 11244 | 92 | 2 | 19454 | 49 |
LAMA4,SOX5 |
2.253e-02 | -3.79 | ADGRG5 (adhesion G protein-coupled receptor G5) | protein interactions | 221188 | 92 | 2 | 19454 | 49 |
GJA1,GPM6B |
2.253e-02 | -3.79 | DPF1 (double PHD fingers 1) | protein interactions | 8193 | 92 | 2 | 19454 | 49 |
PRKN,NFIA |
2.253e-02 | -3.79 | SOX9 (SRY-box transcription factor 9) | protein interactions | 6662 | 92 | 2 | 19454 | 49 |
TRPS1,NFIA |
2.258e-02 | -3.79 | fibula | COSMIC cancer mutations | fibula | 387 | 4 | 16828 | 47 |
SORCS2,FGFR3,GRK5,NCKAP5 |
2.260e-02 | -3.79 | Tyr_Pase_dom | interpro domains | IPR000387 | 86 | 2 | 18521 | 50 |
PTPRZ1,TNS3 |
2.261e-02 | -3.79 | Transmission across Chemical Synapses | REACTOME pathways | R-HSA-112315 | 217 | 3 | 10285 | 29 |
SLC6A11,SLC1A2,SLC1A3 |
2.261e-02 | -3.79 | nodular | COSMIC cancer mutations | nodular | 1515 | 9 | 16828 | 47 |
PREX2,SLC6A11,FKBP5,SLC4A4,FGFR3,GRK5,PTPRZ1,NPAS3,EGF |
2.274e-02 | -3.78 | lipid biosynthetic process | biological process | GO:0008610 | 592 | 5 | 18204 | 50 |
LPIN2,QKI,DGKB,APOA1,ELOVL2 |
2.277e-02 | -3.78 | regulation of cell-substrate adhesion | biological process | GO:0010810 | 221 | 3 | 18204 | 50 |
GPM6B,PREX1,APOA1 |
2.283e-02 | -3.78 | chondrocyte differentiation | biological process | GO:0002062 | 85 | 2 | 18204 | 50 |
SOX5,FGFR3 |
2.285e-02 | -3.78 | astrocyte end-foot | cellular component | GO:0097450 | 9 | 1 | 19108 | 49 |
AQP4 |
2.285e-02 | -3.78 | fascia adherens | cellular component | GO:0005916 | 9 | 1 | 19108 | 49 |
GJA1 |
2.299e-02 | -3.77 | MPDZ (multiple PDZ domain crumbs cell polarity complex component) | protein interactions | 8777 | 93 | 2 | 19454 | 49 |
AMOT,FGFR3 |
2.299e-02 | -3.77 | MIR19B2 (microRNA 19b-2) | protein interactions | 406981 | 93 | 2 | 19454 | 49 |
QKI,MSI2 |
2.299e-02 | -3.77 | FKBP15 (FKBP prolyl isomerase family member 15) | protein interactions | 23307 | 93 | 2 | 19454 | 49 |
PRKN,AMOT |
2.299e-02 | -3.77 | PTPRG (protein tyrosine phosphatase receptor type G) | protein interactions | 5793 | 93 | 2 | 19454 | 49 |
FARP1,GJA1 |
2.299e-02 | -3.77 | TEX11 (testis expressed 11) | protein interactions | 56159 | 93 | 2 | 19454 | 49 |
QKI,SOX5 |
2.299e-02 | -3.77 | UTP25 (UTP25 small subunit processome component) | protein interactions | 27042 | 93 | 2 | 19454 | 49 |
PRKN,PREX1 |
2.299e-02 | -3.77 | RBM23 (RNA binding motif protein 23) | protein interactions | 55147 | 93 | 2 | 19454 | 49 |
QKI,PTN |
2.299e-02 | -3.77 | ODR4 (odr-4 GPCR localization factor homolog) | protein interactions | 54953 | 93 | 2 | 19454 | 49 |
LRIG1,PRKN |
2.302e-02 | -3.77 | peritoneum-appendix-other-pseudomyxoma_peritonei | COSMIC cancer mutations | peritoneum-appendix-other-pseudomyxoma_peritonei | 585 | 5 | 16828 | 47 |
NCKAP5,FARP1,TRPS1,FGFR3,TNS3 |
2.302e-02 | -3.77 | pseudomyxoma_peritonei | COSMIC cancer mutations | pseudomyxoma_peritonei | 585 | 5 | 16828 | 47 |
NCKAP5,FARP1,TRPS1,FGFR3,TNS3 |
2.304e-02 | -3.77 | MAPK cascade | biological process | GO:0000165 | 222 | 3 | 18204 | 50 |
EGF,FGFR3,APOA1 |
2.317e-02 | -3.76 | appendix | COSMIC cancer mutations | appendix | 586 | 5 | 16828 | 47 |
TRPS1,FGFR3,TNS3,NCKAP5,FARP1 |
2.324e-02 | -3.76 | Bile secretion | KEGG pathways | ko04976 | 71 | 2 | 7161 | 24 |
SLC4A4,AQP4 |
2.324e-02 | -3.76 | Bile secretion | KEGG pathways | hsa04976 | 71 | 2 | 7161 | 24 |
SLC4A4,AQP4 |
2.331e-02 | -3.76 | glycerolipid biosynthetic process | biological process | GO:0045017 | 223 | 3 | 18204 | 50 |
LPIN2,APOA1,DGKB |
2.332e-02 | -3.76 | uveal_tract | COSMIC cancer mutations | uveal_tract | 587 | 5 | 16828 | 47 |
GRK5,FGFRL1,PREX1,PREX2,FGFR3 |
2.332e-02 | -3.76 | peritoneum | COSMIC cancer mutations | peritoneum | 587 | 5 | 16828 | 47 |
FARP1,NCKAP5,FGFR3,TRPS1,TNS3 |
2.345e-02 | -3.75 | GRIN1 (glutamate ionotropic receptor NMDA type subunit 1) | protein interactions | 2902 | 94 | 2 | 19454 | 49 |
FGFR3,PRKN |
2.345e-02 | -3.75 | NANS (N-acetylneuraminate synthase) | protein interactions | 54187 | 94 | 2 | 19454 | 49 |
PRKN,FKBP5 |
2.345e-02 | -3.75 | TRAPPC11 (trafficking protein particle complex subunit 11) | protein interactions | 60684 | 94 | 2 | 19454 | 49 |
CTBP1,PRKN |
2.345e-02 | -3.75 | QSER1 (glutamine and serine rich 1) | protein interactions | 79832 | 94 | 2 | 19454 | 49 |
SOX5,NFIA |
2.345e-02 | -3.75 | FOXP4 (forkhead box P4) | protein interactions | 116113 | 94 | 2 | 19454 | 49 |
NFIA,SOX5 |
2.345e-02 | -3.75 | Wnt Signaling Pathway Netpath | WikiPathways | WP363 | 53 | 2 | 5310 | 24 |
CTBP1,GJA1 |
2.363e-02 | -3.75 | gamma-aminobutyric acid transmembrane transporter activity | molecular function | GO:0015185 | 9 | 1 | 18094 | 48 |
SLC6A11 |
2.363e-02 | -3.75 | chondroitin sulfate binding | molecular function | GO:0035374 | 9 | 1 | 18094 | 48 |
PTN |
2.376e-02 | -3.74 | SCRIB (scribble planar cell polarity protein) | protein interactions | 23513 | 245 | 3 | 19454 | 49 |
LRIG1,GJA1,PRKN |
2.377e-02 | -3.74 | Internalization of ErbB1 | Pathway Interaction DB | erbb1_internalization_pathway | 34 | 2 | 2226 | 16 |
LRIG1,EGF |
2.381e-02 | -3.74 | collagen-containing extracellular matrix | cellular component | GO:0062023 | 428 | 4 | 19108 | 49 |
GPC5,LAMA4,PTPRZ1,APOA1 |
2.384e-02 | -3.74 | cellular response to fibroblast growth factor stimulus | biological process | GO:0044344 | 87 | 2 | 18204 | 50 |
FGFRL1,FGFR3 |
2.386e-02 | -3.74 | STX7 (syntaxin 7) | protein interactions | 8417 | 654 | 5 | 19454 | 49 |
ELOVL2,GJA1,FARP1,PLPP3,USP6NL |
2.387e-02 | -3.74 | GPCRKINASE | prints domains | PR00717 | 7 | 1 | 5227 | 18 |
GRK5 |
2.391e-02 | -3.73 | SCN4A (sodium voltage-gated channel alpha subunit 4) | protein interactions | 6329 | 95 | 2 | 19454 | 49 |
SNTB1,GJA1 |
2.391e-02 | -3.73 | PNPLA6 (patatin like phospholipase domain containing 6) | protein interactions | 10908 | 95 | 2 | 19454 | 49 |
GRK5,PRKN |
2.391e-02 | -3.73 | LIMK1 (LIM domain kinase 1) | protein interactions | 3984 | 95 | 2 | 19454 | 49 |
PRKN,CTBP1 |
2.391e-02 | -3.73 | KIF21A (kinesin family member 21A) | protein interactions | 55605 | 95 | 2 | 19454 | 49 |
PRKN,MSI2 |
2.391e-02 | -3.73 | ZACN (zinc activated ion channel) | protein interactions | 353174 | 95 | 2 | 19454 | 49 |
QKI,GJA1 |
2.391e-02 | -3.73 | MPP7 (MAGUK p55 scaffold protein 7) | protein interactions | 143098 | 95 | 2 | 19454 | 49 |
AMOT,GJA1 |
2.403e-02 | -3.73 | SPTAN1 (spectrin alpha, non-erythrocytic 1) | protein interactions | 6709 | 437 | 4 | 19454 | 49 |
FKBP5,PRKN,GRK5,GJA1 |
2.404e-02 | -3.73 | DNA-bd_RFX | interpro domains | IPR003150 | 9 | 1 | 18521 | 50 |
RFX4 |
2.404e-02 | -3.73 | Band3_cytoplasmic_dom | interpro domains | IPR013769 | 9 | 1 | 18521 | 50 |
SLC4A4 |
2.429e-02 | -3.72 | stomach | COSMIC cancer mutations | stomach | 15550 | 47 | 16828 | 47 |
SLC39A12,GRK5,EGF,MSI2,RFX4,LPIN2,CTBP1,PTPRZ1,TNS3,GPC5,SLC1A3,USP6NL,PRDM16,PREX2,NFIA,BCAR3,PTN,RORA,FARP1,SOX5,FGFRL1,SLC4A4,SNTB1,GPM6B,TRPS1,DGKB,LRIG1,SORCS2,ASPA,AMOT,NPAS3,SLC6A11,PREX1,LAMA4,FGFR3,ELOVL2,SLC1A2,FHOD3,APOA1,AQP4,GJA1,QKI,NCKAP5,NHSL1,UNC93A,FKBP5,ZBTB20 |
2.438e-02 | -3.71 | SPIN1 (spindlin 1) | protein interactions | 10927 | 96 | 2 | 19454 | 49 |
PTN,GRK5 |
2.440e-02 | -3.71 | cell-cell signaling | biological process | GO:0007267 | 822 | 6 | 18204 | 50 |
FGFR3,FARP1,SLC1A2,PRKN,GJA1,SLC1A3 |
2.440e-02 | -3.71 | soft_tissue-striated_muscle-rhabdomyosarcoma | COSMIC cancer mutations | soft_tissue-striated_muscle-rhabdomyosarcoma | 594 | 5 | 16828 | 47 |
TRPS1,PREX2,PRDM16,DGKB,GJA1 |
2.446e-02 | -3.71 | zinc ion import across plasma membrane | biological process | GO:0071578 | 9 | 1 | 18204 | 50 |
SLC39A12 |
2.446e-02 | -3.71 | tripeptide transmembrane transport | biological process | GO:0035443 | 9 | 1 | 18204 | 50 |
GJA1 |
2.446e-02 | -3.71 | regulation of intestinal cholesterol absorption | biological process | GO:0030300 | 9 | 1 | 18204 | 50 |
APOA1 |
2.446e-02 | -3.71 | regulation of protein localization to early endosome | biological process | GO:1902965 | 9 | 1 | 18204 | 50 |
EGF |
2.446e-02 | -3.71 | diaphragm development | biological process | GO:0060539 | 9 | 1 | 18204 | 50 |
FGFRL1 |
2.446e-02 | -3.71 | regulation of cerebellar granule cell precursor proliferation | biological process | GO:0021936 | 9 | 1 | 18204 | 50 |
EGF |
2.446e-02 | -3.71 | glutathione transport | biological process | GO:0034635 | 9 | 1 | 18204 | 50 |
GJA1 |
2.446e-02 | -3.71 | positive regulation of protein localization to early endosome | biological process | GO:1902966 | 9 | 1 | 18204 | 50 |
EGF |
2.452e-02 | -3.71 | NCOR2 (nuclear receptor corepressor 2) | protein interactions | 9612 | 248 | 3 | 19454 | 49 |
NFIA,SOX5,CTBP1 |
2.456e-02 | -3.71 | Protein tyrosine phosphatase superfamily | gene3d domains | 3.90.190.10 | 88 | 2 | 14470 | 40 |
TNS3,PTPRZ1 |
2.461e-02 | -3.70 | - | gene3d domains | 1.25.40.610 | 9 | 1 | 14470 | 40 |
ADGRB3 |
2.470e-02 | -3.70 | WH-like_DNA-bd_sf | interpro domains | IPR036388 | 232 | 3 | 18521 | 50 |
PREX1,PREX2,RFX4 |
2.477e-02 | -3.70 | PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling | REACTOME pathways | R-HSA-6811558 | 87 | 2 | 10285 | 29 |
FGFR3,EGF |
2.478e-02 | -3.70 | NUP93 (nucleoporin 93) | protein interactions | 9688 | 249 | 3 | 19454 | 49 |
PRDM16,PRKN,FGFR3 |
2.478e-02 | -3.70 | MYO1B (myosin IB) | protein interactions | 4430 | 249 | 3 | 19454 | 49 |
PRKN,FGFR3,PRDM16 |
2.478e-02 | -3.70 | EIF3E (eukaryotic translation initiation factor 3 subunit E) | protein interactions | 3646 | 249 | 3 | 19454 | 49 |
PRDM16,PRKN,MSI2 |
2.483e-02 | -3.70 | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 16 | 16828 | 47 |
SNTB1,EGF,SLC4A4,LAMA4,FGFRL1,DGKB,FHOD3,PREX2,NCKAP5,PTPRZ1,NPAS3,ASPA,MSI2,SLC1A3,GPC5,TNS3 |
2.483e-02 | -3.70 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-chronic_lymphocytic_leukaemia-small_lymphocytic_lymphoma | 3511 | 16 | 16828 | 47 |
PREX2,FHOD3,DGKB,FGFRL1,LAMA4,SLC4A4,SNTB1,EGF,GPC5,TNS3,SLC1A3,ASPA,MSI2,PTPRZ1,NCKAP5,NPAS3 |
2.486e-02 | -3.69 | PCGF5 (polycomb group ring finger 5) | protein interactions | 84333 | 97 | 2 | 19454 | 49 |
CTBP1,QKI |
2.486e-02 | -3.69 | LIN7C (lin-7 homolog C, crumbs cell polarity complex component) | protein interactions | 55327 | 97 | 2 | 19454 | 49 |
AMOT,PRKN |
2.486e-02 | -3.69 | skin-chest-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-chest-malignant_melanoma-superficial_spreading | 9 | 1 | 16828 | 47 |
PREX2 |
2.486e-02 | -3.69 | epidermal_nevus | COSMIC cancer mutations | epidermal_nevus | 9 | 1 | 16828 | 47 |
FGFR3 |
2.486e-02 | -3.69 | skin-upper_leg-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-upper_leg-malignant_melanoma-superficial_spreading | 9 | 1 | 16828 | 47 |
PREX2 |
2.486e-02 | -3.69 | compound | COSMIC cancer mutations | compound | 9 | 1 | 16828 | 47 |
FGFR3 |
2.486e-02 | -3.69 | skin-other-seborrhoeic_keratosis | COSMIC cancer mutations | skin-other-seborrhoeic_keratosis | 9 | 1 | 16828 | 47 |
FGFR3 |
2.486e-02 | -3.69 | skin-benign_melanocytic_nevus-congenital | COSMIC cancer mutations | skin-benign_melanocytic_nevus-congenital | 9 | 1 | 16828 | 47 |
FGFR3 |
2.486e-02 | -3.69 | ovary-low_malignant_potential_(borderline)_tumour-Brenner_tumour | COSMIC cancer mutations | ovary-low_malignant_potential_(borderline)_tumour-Brenner_tumour | 9 | 1 | 16828 | 47 |
FGFR3 |
2.486e-02 | -3.69 | in_situ_epithelial_neoplasm | COSMIC cancer mutations | in_situ_epithelial_neoplasm | 9 | 1 | 16828 | 47 |
FGFR3 |
2.486e-02 | -3.69 | Bowen_disease | COSMIC cancer mutations | Bowen_disease | 9 | 1 | 16828 | 47 |
FGFR3 |
2.491e-02 | -3.69 | PLA2G1B (phospholipase A2 group IB) | protein interactions | 5319 | 10 | 1 | 19454 | 49 |
PRKN |
2.491e-02 | -3.69 | CFAP46 (cilia and flagella associated protein 46) | protein interactions | 54777 | 10 | 1 | 19454 | 49 |
PRKN |
2.491e-02 | -3.69 | CFAP57 (cilia and flagella associated protein 57) | protein interactions | 149465 | 10 | 1 | 19454 | 49 |
PRKN |
2.491e-02 | -3.69 | CREBL2 (cAMP responsive element binding protein like 2) | protein interactions | 1389 | 10 | 1 | 19454 | 49 |
PRKN |
2.491e-02 | -3.69 | IGKV2-40 (immunoglobulin kappa variable 2-40) | protein interactions | 28916 | 10 | 1 | 19454 | 49 |
APOA1 |
2.491e-02 | -3.69 | CAPN5 (calpain 5) | protein interactions | 726 | 10 | 1 | 19454 | 49 |
PRKN |
2.491e-02 | -3.69 | GUCA1B (guanylate cyclase activator 1B) | protein interactions | 2979 | 10 | 1 | 19454 | 49 |
CTBP1 |
2.491e-02 | -3.69 | GPLD1 (glycosylphosphatidylinositol specific phospholipase D1) | protein interactions | 2822 | 10 | 1 | 19454 | 49 |
APOA1 |
2.491e-02 | -3.69 | CDKL4 (cyclin dependent kinase like 4) | protein interactions | 344387 | 10 | 1 | 19454 | 49 |
FKBP5 |
2.491e-02 | -3.69 | Mrpl13 (mitochondrial ribosomal protein L13) | protein interactions | 68537 | 10 | 1 | 19454 | 49 |
QKI |
2.491e-02 | -3.69 | BANK1 (B cell scaffold protein with ankyrin repeats 1) | protein interactions | 55024 | 10 | 1 | 19454 | 49 |
PRKN |
2.491e-02 | -3.69 | Hsp90aa1 (heat shock protein 90, alpha (cytosolic), class A member 1) | protein interactions | 15519 | 10 | 1 | 19454 | 49 |
QKI |
2.491e-02 | -3.69 | ZNF561 (zinc finger protein 561) | protein interactions | 93134 | 10 | 1 | 19454 | 49 |
PRKN |
2.491e-02 | -3.69 | SESN3 (sestrin 3) | protein interactions | 143686 | 10 | 1 | 19454 | 49 |
PRKN |
2.491e-02 | -3.69 | P2rx7 (purinergic receptor P2X 7) | protein interactions | 29665 | 10 | 1 | 19454 | 49 |
PTPRZ1 |
2.491e-02 | -3.69 | TENT4A (terminal nucleotidyltransferase 4A) | protein interactions | 11044 | 10 | 1 | 19454 | 49 |
PRKN |
2.491e-02 | -3.69 | MACC1 (MET transcriptional regulator MACC1) | protein interactions | 346389 | 10 | 1 | 19454 | 49 |
PRKN |
2.491e-02 | -3.69 | IL12RB2 (interleukin 12 receptor subunit beta 2) | protein interactions | 3595 | 10 | 1 | 19454 | 49 |
PRKN |
2.491e-02 | -3.69 | HAS1 (hyaluronan synthase 1) | protein interactions | 3036 | 10 | 1 | 19454 | 49 |
PRKN |
2.491e-02 | -3.69 | HMCN1 (hemicentin 1) | protein interactions | 83872 | 10 | 1 | 19454 | 49 |
PRKN |
2.491e-02 | -3.69 | RNF17 (ring finger protein 17) | protein interactions | 56163 | 10 | 1 | 19454 | 49 |
PRKN |
2.491e-02 | -3.69 | ARHGAP27 (Rho GTPase activating protein 27) | protein interactions | 201176 | 10 | 1 | 19454 | 49 |
PRKN |
2.491e-02 | -3.69 | Eps15 (epidermal growth factor receptor pathway substrate 15) | protein interactions | 13858 | 10 | 1 | 19454 | 49 |
PRKN |
2.496e-02 | -3.69 | DNA-binding transcription factor activity, RNA polymerase II-specific | molecular function | GO:0000981 | 1355 | 8 | 18094 | 48 |
RFX4,SOX5,PRDM16,TRPS1,RORA,ZBTB20,NPAS3,NFIA |
2.501e-02 | -3.69 | RFX_DNA_binding | pfam domains | PF02257 | 9 | 1 | 17795 | 50 |
RFX4 |
2.501e-02 | -3.69 | Band_3_cyto | pfam domains | PF07565 | 9 | 1 | 17795 | 50 |
SLC4A4 |
2.501e-02 | -3.69 | regulation of cell migration | biological process | GO:0030334 | 1061 | 7 | 18204 | 50 |
PLPP3,EGF,PTN,AMOT,GJA1,PREX1,LAMA4 |
2.501e-02 | -3.69 | RHOG (ras homolog family member G) | protein interactions | 391 | 902 | 6 | 19454 | 49 |
USP6NL,PREX2,PRKN,ELOVL2,FARP1,GJA1 |
2.510e-02 | -3.68 | Formation of annular gap junctions | REACTOME pathways | R-HSA-196025 | 9 | 1 | 10285 | 29 |
GJA1 |
2.515e-02 | -3.68 | monoatomic cation transmembrane transporter activity | molecular function | GO:0008324 | 630 | 5 | 18094 | 48 |
SLC1A3,SLC4A4,SLC39A12,SLC1A2,SLC6A11 |
2.525e-02 | -3.68 | large_intestine-colon | COSMIC cancer mutations | large_intestine-colon | 1291 | 8 | 16828 | 47 |
LAMA4,PREX1,SNTB1,PTPRZ1,FHOD3,DGKB,USP6NL,ZBTB20 |
2.533e-02 | -3.68 | PPASE_TENSIN | prosite domains | PS51181 | 8 | 1 | 12186 | 39 |
TNS3 |
2.533e-02 | -3.68 | DAD | prosite domains | PS51231 | 8 | 1 | 12186 | 39 |
FHOD3 |
2.533e-02 | -3.68 | GATA_ZN_FINGER_1 | prosite domains | PS00344 | 8 | 1 | 12186 | 39 |
TRPS1 |
2.533e-02 | -3.68 | C2_TENSIN | prosite domains | PS51182 | 8 | 1 | 12186 | 39 |
TNS3 |
2.534e-02 | -3.68 | FRS2 (fibroblast growth factor receptor substrate 2) | protein interactions | 10818 | 98 | 2 | 19454 | 49 |
FGFR3,GJA1 |
2.534e-02 | -3.68 | WDCP (WD repeat and coiled coil containing) | protein interactions | 80304 | 98 | 2 | 19454 | 49 |
CTBP1,AMOT |
2.534e-02 | -3.68 | GCC1 (GRIP and coiled-coil domain containing 1) | protein interactions | 79571 | 98 | 2 | 19454 | 49 |
GJA1,PRKN |
2.534e-02 | -3.68 | ORC4 (origin recognition complex subunit 4) | protein interactions | 5000 | 98 | 2 | 19454 | 49 |
CTBP1,PRKN |
2.534e-02 | -3.68 | DMD (dystrophin) | protein interactions | 1756 | 98 | 2 | 19454 | 49 |
SNTB1,TNS3 |
2.534e-02 | -3.68 | MED27 (mediator complex subunit 27) | protein interactions | 9442 | 98 | 2 | 19454 | 49 |
QKI,SOX5 |
2.534e-02 | -3.68 | MAP4K5 (mitogen-activated protein kinase kinase kinase kinase 5) | protein interactions | 11183 | 98 | 2 | 19454 | 49 |
GJA1,PRKN |
2.534e-02 | -3.68 | HSPA12A (heat shock protein family A (Hsp70) member 12A) | protein interactions | 259217 | 98 | 2 | 19454 | 49 |
FGFR3,PRKN |
2.534e-02 | -3.68 | MB21D2 (Mab-21 domain containing 2) | protein interactions | 151963 | 98 | 2 | 19454 | 49 |
GJA1,PRKN |
2.534e-02 | -3.68 | regulation of intracellular signal transduction | biological process | GO:1902531 | 1832 | 10 | 18204 | 50 |
PREX2,PREX1,PRKN,AMOT,RORA,GJA1,APOA1,BCAR3,FGFR3,EGF |
2.536e-02 | -3.67 | perineuronal net | cellular component | GO:0072534 | 10 | 1 | 19108 | 49 |
PTPRZ1 |
2.539e-02 | -3.67 | regulation of purine nucleotide metabolic process | biological process | GO:1900542 | 90 | 2 | 18204 | 50 |
SLC4A4,ZBTB20 |
2.542e-02 | -3.67 | pancreas-carcinoma-ductal_carcinoma | COSMIC cancer mutations | pancreas-carcinoma-ductal_carcinoma | 15565 | 47 | 16828 | 47 |
GPM6B,TRPS1,DGKB,LRIG1,FGFRL1,SOX5,SLC4A4,SNTB1,SLC6A11,SORCS2,ASPA,AMOT,NPAS3,FHOD3,APOA1,PREX1,LAMA4,FGFR3,ELOVL2,SLC1A2,NHSL1,UNC93A,ZBTB20,FKBP5,AQP4,GJA1,QKI,NCKAP5,SLC39A12,GRK5,EGF,TNS3,GPC5,SLC1A3,USP6NL,MSI2,RFX4,LPIN2,CTBP1,PTPRZ1,PREX2,NFIA,PRDM16,PTN,RORA,FARP1,BCAR3 |
2.557e-02 | -3.67 | RAC2 (Rac family small GTPase 2) | protein interactions | 5880 | 666 | 5 | 19454 | 49 |
USP6NL,TNS3,GJA1,FARP1,SLC1A3 |
2.568e-02 | -3.66 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-acute_lymphoblastic_leukaemia | 2081 | 11 | 16828 | 47 |
FGFRL1,SOX5,SLC4A4,FGFR3,GRK5,CTBP1,PTPRZ1,PREX2,NFIA,FHOD3,TRPS1 |
2.581e-02 | -3.66 | PRRC2C (proline rich coiled-coil 2C) | protein interactions | 23215 | 253 | 3 | 19454 | 49 |
PRKN,SOX5,FKBP5 |
2.581e-02 | -3.66 | connective tissue development | biological process | GO:0061448 | 232 | 3 | 18204 | 50 |
SOX5,FGFR3,NFIA |
2.582e-02 | -3.66 | ZFHX3 (zinc finger homeobox 3) | protein interactions | 463 | 99 | 2 | 19454 | 49 |
TRPS1,SOX5 |
2.582e-02 | -3.66 | PRKACG (protein kinase cAMP-activated catalytic subunit gamma) | protein interactions | 5568 | 99 | 2 | 19454 | 49 |
PRKN,FKBP5 |
2.583e-02 | -3.66 | abdomen | COSMIC cancer mutations | abdomen | 603 | 5 | 16828 | 47 |
PREX2,PRDM16,FGFR3,SLC6A11,LRIG1 |
2.584e-02 | -3.66 | Signaling by FGFR | REACTOME pathways | R-HSA-190236 | 89 | 2 | 10285 | 29 |
FGFR3,FGFRL1 |
2.592e-02 | -3.65 | regulation of nucleotide metabolic process | biological process | GO:0006140 | 91 | 2 | 18204 | 50 |
ZBTB20,SLC4A4 |
2.600e-02 | -3.65 | Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain | gene3d domains | 1.10.10.10 | 232 | 3 | 14470 | 40 |
PREX2,PREX1,RFX4 |
2.612e-02 | -3.65 | transmembrane transporter activity | molecular function | GO:0022857 | 1110 | 7 | 18094 | 48 |
SLC1A3,SLC1A2,SLC39A12,SLC6A11,GJA1,SLC4A4,AQP4 |
2.622e-02 | -3.64 | VAPB (VAMP associated protein B and C) | protein interactions | 9217 | 449 | 4 | 19454 | 49 |
SLC1A3,FGFR3,PRKN,GJA1 |
2.622e-02 | -3.64 | FK506 binding | molecular function | GO:0005528 | 10 | 1 | 18094 | 48 |
FKBP5 |
2.630e-02 | -3.64 | SFN (stratifin) | protein interactions | 2810 | 671 | 5 | 19454 | 49 |
PRKN,NFIA,AMOT,TNS3,USP6NL |
2.630e-02 | -3.64 | CIC (capicua transcriptional repressor) | protein interactions | 23152 | 671 | 5 | 19454 | 49 |
NFIA,FARP1,TRPS1,CTBP1,SOX5 |
2.630e-02 | -3.64 | PLG (plasminogen) | protein interactions | 5340 | 100 | 2 | 19454 | 49 |
PRKN,AMOT |
2.630e-02 | -3.64 | PIK3C3 (phosphatidylinositol 3-kinase catalytic subunit type 3) | protein interactions | 5289 | 100 | 2 | 19454 | 49 |
PRKN,GJA1 |
2.630e-02 | -3.64 | DTNB (dystrobrevin beta) | protein interactions | 1838 | 100 | 2 | 19454 | 49 |
SNTB1,TNS3 |
2.630e-02 | -3.64 | UMPS (uridine monophosphate synthetase) | protein interactions | 7372 | 100 | 2 | 19454 | 49 |
TNS3,PRKN |
2.631e-02 | -3.64 | eye | COSMIC cancer mutations | eye | 606 | 5 | 16828 | 47 |
GRK5,FGFR3,FGFRL1,PREX1,PREX2 |
2.637e-02 | -3.64 | intracellular signaling cassette | biological process | GO:0141124 | 837 | 6 | 18204 | 50 |
APOA1,PREX2,FGFR3,EGF,FARP1,BCAR3 |
2.638e-02 | -3.64 | PI3K/AKT Signaling in Cancer | REACTOME pathways | R-HSA-2219528 | 90 | 2 | 10285 | 29 |
FGFR3,EGF |
2.645e-02 | -3.63 | regulation of embryonic development | biological process | GO:0045995 | 92 | 2 | 18204 | 50 |
AMOT,LAMA4 |
2.646e-02 | -3.63 | human chr6p24.2 | chromosome location | human chr6p24.2 | 14 | 1 | 26134 | 50 |
ELOVL2 |
2.666e-02 | -3.62 | Ig_sub2 | interpro domains | IPR003598 | 239 | 3 | 18521 | 50 |
FGFRL1,FGFR3,LRIG1 |
2.668e-02 | -3.62 | HCO3_transpt_euk | interpro domains | IPR003020 | 10 | 1 | 18521 | 50 |
SLC4A4 |
2.668e-02 | -3.62 | E3_UB_ligase_RBR | interpro domains | IPR031127 | 10 | 1 | 18521 | 50 |
PRKN |
2.668e-02 | -3.62 | MIP_CS | interpro domains | IPR022357 | 10 | 1 | 18521 | 50 |
AQP4 |
2.668e-02 | -3.62 | PAS_fold_3 | interpro domains | IPR013655 | 10 | 1 | 18521 | 50 |
NPAS3 |
2.668e-02 | -3.62 | PTrfase/Anion_transptr | interpro domains | IPR016152 | 10 | 1 | 18521 | 50 |
SLC4A4 |
2.668e-02 | -3.62 | Diacylglycerol_kin_accessory | interpro domains | IPR000756 | 10 | 1 | 18521 | 50 |
DGKB |
2.668e-02 | -3.62 | HCO3_transpt-like_TM_dom | interpro domains | IPR011531 | 10 | 1 | 18521 | 50 |
SLC4A4 |
2.668e-02 | -3.62 | DGK | interpro domains | IPR037607 | 10 | 1 | 18521 | 50 |
DGKB |
2.668e-02 | -3.62 | PA_PP_rel | interpro domains | IPR043216 | 10 | 1 | 18521 | 50 |
PLPP3 |
2.679e-02 | -3.62 | AMPD2 (adenosine monophosphate deaminase 2) | protein interactions | 271 | 101 | 2 | 19454 | 49 |
CTBP1,PRKN |
2.679e-02 | -3.62 | STAMBP (STAM binding protein) | protein interactions | 10617 | 101 | 2 | 19454 | 49 |
PRKN,GJA1 |
2.679e-02 | -3.62 | CLEC4A (C-type lectin domain family 4 member A) | protein interactions | 50856 | 101 | 2 | 19454 | 49 |
FGFRL1,FGFR3 |
2.679e-02 | -3.62 | MYO9B (myosin IXB) | protein interactions | 4650 | 101 | 2 | 19454 | 49 |
PRKN,GRK5 |
2.679e-02 | -3.62 | ILKAP (ILK associated serine/threonine phosphatase) | protein interactions | 80895 | 101 | 2 | 19454 | 49 |
PRKN,FGFR3 |
2.697e-02 | -3.61 | FLOT1 (flotillin 1) | protein interactions | 10211 | 453 | 4 | 19454 | 49 |
FARP1,PRKN,USP6NL,SOX5 |
2.697e-02 | -3.61 | regulation of endothelial cell migration | biological process | GO:0010594 | 236 | 3 | 18204 | 50 |
PLPP3,EGF,PTN |
2.701e-02 | -3.61 | embryonal | COSMIC cancer mutations | embryonal | 2659 | 13 | 16828 | 47 |
PREX2,NFIA,RORA,DGKB,PRDM16,SORCS2,FGFRL1,FGFR3,AQP4,ELOVL2,GRK5,NPAS3,PTPRZ1 |
2.701e-02 | -3.61 | soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal | COSMIC cancer mutations | soft_tissue-striated_muscle-rhabdomyosarcoma-embryonal | 2659 | 13 | 16828 | 47 |
SORCS2,AQP4,NPAS3,PTPRZ1,RORA,PRDM16,FGFRL1,FGFR3,ELOVL2,GRK5,PREX2,NFIA,DGKB |
2.714e-02 | -3.61 | cellular response to manganese ion | biological process | GO:0071287 | 10 | 1 | 18204 | 50 |
PRKN |
2.714e-02 | -3.61 | regulation of CoA-transferase activity | biological process | GO:1905918 | 10 | 1 | 18204 | 50 |
APOA1 |
2.714e-02 | -3.61 | regulation of mesenchymal stem cell differentiation | biological process | GO:2000739 | 10 | 1 | 18204 | 50 |
SOX5 |
2.714e-02 | -3.61 | regulation of intestinal lipid absorption | biological process | GO:1904729 | 10 | 1 | 18204 | 50 |
APOA1 |
2.714e-02 | -3.61 | positive regulation of receptor clustering | biological process | GO:1903911 | 10 | 1 | 18204 | 50 |
FARP1 |
2.714e-02 | -3.61 | protein oxidation | biological process | GO:0018158 | 10 | 1 | 18204 | 50 |
APOA1 |
2.714e-02 | -3.61 | alpha-linolenic acid metabolic process | biological process | GO:0036109 | 10 | 1 | 18204 | 50 |
ELOVL2 |
2.714e-02 | -3.61 | high-density lipoprotein particle assembly | biological process | GO:0034380 | 10 | 1 | 18204 | 50 |
APOA1 |
2.714e-02 | -3.61 | regulation of atrial cardiac muscle cell membrane depolarization | biological process | GO:0060371 | 10 | 1 | 18204 | 50 |
GJA1 |
2.714e-02 | -3.61 | regulation of mesodermal cell differentiation | biological process | GO:1905770 | 10 | 1 | 18204 | 50 |
GJA1 |
2.714e-02 | -3.61 | positive regulation of hepatocyte proliferation | biological process | GO:2000347 | 10 | 1 | 18204 | 50 |
PTN |
2.714e-02 | -3.61 | protein K29-linked ubiquitination | biological process | GO:0035519 | 10 | 1 | 18204 | 50 |
PRKN |
2.714e-02 | -3.61 | otolith development | biological process | GO:0048840 | 10 | 1 | 18204 | 50 |
LRIG1 |
2.715e-02 | -3.61 | MTNAP1 (mitochondrial nucleoid associated protein 1) | protein interactions | 55028 | 258 | 3 | 19454 | 49 |
SLC39A12,PRKN,FARP1 |
2.724e-02 | -3.60 | GATAZNFINGER | prints domains | PR00619 | 8 | 1 | 5227 | 18 |
TRPS1 |
2.727e-02 | -3.60 | anatomical structure maturation | biological process | GO:0071695 | 237 | 3 | 18204 | 50 |
GJA1,FGFR3,ADGRB3 |
2.728e-02 | -3.60 | TNFRSF10C (TNF receptor superfamily member 10c) | protein interactions | 8794 | 102 | 2 | 19454 | 49 |
APOA1,PLPP3 |
2.728e-02 | -3.60 | FNTB (farnesyltransferase, CAAX box, subunit beta) | protein interactions | 2342 | 102 | 2 | 19454 | 49 |
PRKN,LPIN2 |
2.728e-02 | -3.60 | UFSP2 (UFM1 specific peptidase 2) | protein interactions | 55325 | 102 | 2 | 19454 | 49 |
LRIG1,PRKN |
2.728e-02 | -3.60 | MAT2B (methionine adenosyltransferase 2 non-catalytic beta subunit) | protein interactions | 27430 | 102 | 2 | 19454 | 49 |
PRKN,TNS3 |
2.728e-02 | -3.60 | MIR7-1 (microRNA 7-1) | protein interactions | 407043 | 102 | 2 | 19454 | 49 |
QKI,MSI2 |
2.728e-02 | -3.60 | PIK3R4 (phosphoinositide-3-kinase regulatory subunit 4) | protein interactions | 30849 | 102 | 2 | 19454 | 49 |
GJA1,PRKN |
2.731e-02 | -3.60 | Helical hairpin bin | gene3d domains | 1.10.287.570 | 10 | 1 | 14470 | 40 |
SLC4A4 |
2.737e-02 | -3.60 | SLC9A2 (solute carrier family 9 member A2) | protein interactions | 6549 | 11 | 1 | 19454 | 49 |
PRKN |
2.737e-02 | -3.60 | CCDC17 (coiled-coil domain containing 17) | protein interactions | 149483 | 11 | 1 | 19454 | 49 |
FGFR3 |
2.737e-02 | -3.60 | DDT (D-dopachrome tautomerase) | protein interactions | 1652 | 11 | 1 | 19454 | 49 |
PRKN |
2.737e-02 | -3.60 | ABCA13 (ATP binding cassette subfamily A member 13) | protein interactions | 154664 | 11 | 1 | 19454 | 49 |
APOA1 |
2.737e-02 | -3.60 | GAL3ST1 (galactose-3-O-sulfotransferase 1) | protein interactions | 9514 | 11 | 1 | 19454 | 49 |
LRIG1 |
2.737e-02 | -3.60 | CACNA1D (calcium voltage-gated channel subunit alpha1 D) | protein interactions | 776 | 11 | 1 | 19454 | 49 |
PRKN |
2.737e-02 | -3.60 | C22orf42 (chromosome 22 open reading frame 42) | protein interactions | 150297 | 11 | 1 | 19454 | 49 |
PRKN |
2.737e-02 | -3.60 | ZNF84 (zinc finger protein 84) | protein interactions | 7637 | 11 | 1 | 19454 | 49 |
PRKN |
2.737e-02 | -3.60 | Gtf2e2 (general transcription factor II E, polypeptide 2 (beta subunit)) | protein interactions | 68153 | 11 | 1 | 19454 | 49 |
NHSL1 |
2.737e-02 | -3.60 | LCORL (ligand dependent nuclear receptor corepressor like) | protein interactions | 254251 | 11 | 1 | 19454 | 49 |
CTBP1 |
2.737e-02 | -3.60 | EVA1A (eva-1 homolog A, regulator of programmed cell death) | protein interactions | 84141 | 11 | 1 | 19454 | 49 |
PTN |
2.737e-02 | -3.60 | TBCEL (tubulin folding cofactor E like) | protein interactions | 219899 | 11 | 1 | 19454 | 49 |
PRKN |
2.737e-02 | -3.60 | DNAH12 (dynein axonemal heavy chain 12) | protein interactions | 201625 | 11 | 1 | 19454 | 49 |
PRKN |
2.737e-02 | -3.60 | DNAH9 (dynein axonemal heavy chain 9) | protein interactions | 1770 | 11 | 1 | 19454 | 49 |
PRKN |
2.737e-02 | -3.60 | CYP1A2 (cytochrome P450 family 1 subfamily A member 2) | protein interactions | 1544 | 11 | 1 | 19454 | 49 |
PRKN |
2.737e-02 | -3.60 | DNAH8 (dynein axonemal heavy chain 8) | protein interactions | 1769 | 11 | 1 | 19454 | 49 |
PRKN |
2.737e-02 | -3.60 | HYDIN (HYDIN axonemal central pair apparatus protein) | protein interactions | 54768 | 11 | 1 | 19454 | 49 |
PRKN |
2.737e-02 | -3.60 | IL7 (interleukin 7) | protein interactions | 3574 | 11 | 1 | 19454 | 49 |
QKI |
2.737e-02 | -3.60 | DAZ1 (deleted in azoospermia 1) | protein interactions | 1617 | 11 | 1 | 19454 | 49 |
QKI |
2.737e-02 | -3.60 | ENOSF1 (enolase superfamily member 1) | protein interactions | 55556 | 11 | 1 | 19454 | 49 |
PRKN |
2.742e-02 | -3.60 | MARK2 (microtubule affinity regulating kinase 2) | protein interactions | 2011 | 259 | 3 | 19454 | 49 |
SNTB1,PRKN,GJA1 |
2.742e-02 | -3.60 | positive regulation of catabolic process | biological process | GO:0009896 | 622 | 5 | 18204 | 50 |
SLC4A4,QKI,EGF,PRKN,ZBTB20 |
2.759e-02 | -3.59 | chiasm | COSMIC cancer mutations | chiasm | 10 | 1 | 16828 | 47 |
QKI |
2.759e-02 | -3.59 | lung-carcinoma-pleomorphic_carcinoma | COSMIC cancer mutations | lung-carcinoma-pleomorphic_carcinoma | 10 | 1 | 16828 | 47 |
FGFR3 |
2.759e-02 | -3.59 | skin-back-malignant_melanoma-nodular | COSMIC cancer mutations | skin-back-malignant_melanoma-nodular | 10 | 1 | 16828 | 47 |
PREX2 |
2.759e-02 | -3.59 | intradermal | COSMIC cancer mutations | intradermal | 10 | 1 | 16828 | 47 |
FGFR3 |
2.759e-02 | -3.59 | cervix-in_situ_neoplasm-cervical_intraepithelial_neoplasia_Grade_III | COSMIC cancer mutations | cervix-in_situ_neoplasm-cervical_intraepithelial_neoplasia_Grade_III | 10 | 1 | 16828 | 47 |
FGFR3 |
2.759e-02 | -3.59 | cervical_intraepithelial_neoplasia_Grade_III | COSMIC cancer mutations | cervical_intraepithelial_neoplasia_Grade_III | 10 | 1 | 16828 | 47 |
FGFR3 |
2.759e-02 | -3.59 | renal_cell_carcinoma_unclassified | COSMIC cancer mutations | renal_cell_carcinoma_unclassified | 10 | 1 | 16828 | 47 |
FGFR3 |
2.759e-02 | -3.59 | kidney-carcinoma-renal_cell_carcinoma_unclassified | COSMIC cancer mutations | kidney-carcinoma-renal_cell_carcinoma_unclassified | 10 | 1 | 16828 | 47 |
FGFR3 |
2.762e-02 | -3.59 | trunk | COSMIC cancer mutations | trunk | 3554 | 16 | 16828 | 47 |
PRDM16,SOX5,FGFR3,EGF,SNTB1,PREX2,TRPS1,DGKB,AMOT,NPAS3,PTPRZ1,NCKAP5,UNC93A,SLC6A11,SLC1A3,FKBP5 |
2.766e-02 | -3.59 | PKD | smart domains | SM00089 | 8 | 1 | 9717 | 34 |
SORCS2 |
2.766e-02 | -3.59 | PTEN_C2 | smart domains | SM01326 | 8 | 1 | 9717 | 34 |
TNS3 |
2.769e-02 | -3.59 | postsynaptic density membrane | cellular component | GO:0098839 | 101 | 2 | 19108 | 49 |
ADGRB3,SORCS2 |
2.775e-02 | -3.58 | HCO3_cotransp | pfam domains | PF00955 | 10 | 1 | 17795 | 50 |
SLC4A4 |
2.775e-02 | -3.58 | PAS_3 | pfam domains | PF08447 | 10 | 1 | 17795 | 50 |
NPAS3 |
2.775e-02 | -3.58 | DAGK_acc | pfam domains | PF00609 | 10 | 1 | 17795 | 50 |
DGKB |
2.778e-02 | -3.58 | NPRL3 (NPR3 like, GATOR1 complex subunit) | protein interactions | 8131 | 103 | 2 | 19454 | 49 |
PRKN,CTBP1 |
2.778e-02 | -3.58 | NEK9 (NIMA related kinase 9) | protein interactions | 91754 | 103 | 2 | 19454 | 49 |
PRKN,AMOT |
2.778e-02 | -3.58 | BACH1 (BTB domain and CNC homolog 1) | protein interactions | 571 | 103 | 2 | 19454 | 49 |
FGFRL1,PRKN |
2.778e-02 | -3.58 | TXNRD1 (thioredoxin reductase 1) | protein interactions | 7296 | 103 | 2 | 19454 | 49 |
PRKN,FKBP5 |
2.778e-02 | -3.58 | PLEKHA1 (pleckstrin homology domain containing A1) | protein interactions | 59338 | 103 | 2 | 19454 | 49 |
GJA1,PRKN |
2.781e-02 | -3.58 | oesophagus | COSMIC cancer mutations | oesophagus | 14970 | 46 | 16828 | 47 |
APOA1,FHOD3,SLC1A2,PREX1,LAMA4,FGFR3,ELOVL2,FKBP5,ZBTB20,NHSL1,UNC93A,GJA1,QKI,NCKAP5,AQP4,DGKB,LRIG1,GPM6B,TRPS1,SNTB1,SOX5,FGFRL1,SLC4A4,SLC6A11,AMOT,NPAS3,SORCS2,ASPA,PREX2,NFIA,PRDM16,PTN,RORA,FARP1,BCAR3,GRK5,EGF,SLC39A12,SLC1A3,USP6NL,TNS3,GPC5,RFX4,LPIN2,CTBP1,PTPRZ1 |
2.785e-02 | -3.58 | Gap junction degradation | REACTOME pathways | R-HSA-190873 | 10 | 1 | 10285 | 29 |
GJA1 |
2.785e-02 | -3.58 | Signaling by FGFR3 fusions in cancer | REACTOME pathways | R-HSA-8853334 | 10 | 1 | 10285 | 29 |
FGFR3 |
2.785e-02 | -3.58 | Linoleic acid (LA) metabolism | REACTOME pathways | R-HSA-2046105 | 10 | 1 | 10285 | 29 |
ELOVL2 |
2.785e-02 | -3.58 | Bicarbonate transporters | REACTOME pathways | R-HSA-425381 | 10 | 1 | 10285 | 29 |
SLC4A4 |
2.786e-02 | -3.58 | perisynaptic extracellular matrix | cellular component | GO:0098966 | 11 | 1 | 19108 | 49 |
PTPRZ1 |
2.793e-02 | -3.58 | PPP2CA (protein phosphatase 2 catalytic subunit alpha) | protein interactions | 5515 | 458 | 4 | 19454 | 49 |
NHSL1,PRDM16,PRKN,PTN |
2.802e-02 | -3.58 | RNA polymerase II transcription regulatory region sequence-specific DNA binding | molecular function | GO:0000977 | 1385 | 8 | 18094 | 48 |
RFX4,TRPS1,RORA,PRDM16,SOX5,NFIA,ZBTB20,NPAS3 |
2.807e-02 | -3.57 | response to fibroblast growth factor | biological process | GO:0071774 | 95 | 2 | 18204 | 50 |
FGFR3,FGFRL1 |
2.814e-02 | -3.57 | basolateral plasma membrane | cellular component | GO:0016323 | 257 | 3 | 19108 | 49 |
AQP4,PLPP3,SLC4A4 |
2.824e-02 | -3.57 | MTA1 (metastasis associated 1) | protein interactions | 9112 | 262 | 3 | 19454 | 49 |
PRKN,PRDM16,TRPS1 |
2.828e-02 | -3.57 | ARHGAP18 (Rho GTPase activating protein 18) | protein interactions | 93663 | 104 | 2 | 19454 | 49 |
PRKN,PREX2 |
2.828e-02 | -3.57 | MYCBP (MYC binding protein) | protein interactions | 26292 | 104 | 2 | 19454 | 49 |
PREX1,PTN |
2.832e-02 | -3.56 | human chr8q24.12 | chromosome location | human chr8q24.12 | 15 | 1 | 26134 | 50 |
SNTB1 |
2.835e-02 | -3.56 | EGFR tyrosine kinase inhibitor resistance | KEGG pathways | hsa01521 | 79 | 2 | 7161 | 24 |
EGF,FGFR3 |
2.835e-02 | -3.56 | EGFR tyrosine kinase inhibitor resistance | KEGG pathways | ko01521 | 79 | 2 | 7161 | 24 |
EGF,FGFR3 |
2.845e-02 | -3.56 | RFX_DBD | prosite domains | PS51526 | 9 | 1 | 12186 | 39 |
RFX4 |
2.845e-02 | -3.56 | protein domain specific binding | molecular function | GO:0019904 | 651 | 5 | 18094 | 48 |
SNTB1,CTBP1,PRKN,TRPS1,QKI |
2.851e-02 | -3.56 | ARF4 (ADP ribosylation factor 4) | protein interactions | 378 | 263 | 3 | 19454 | 49 |
FGFR3,PRKN,GRK5 |
2.851e-02 | -3.56 | CACYBP (calcyclin binding protein) | protein interactions | 27101 | 263 | 3 | 19454 | 49 |
FKBP5,PRKN,FGFR3 |
2.859e-02 | -3.55 | Negative regulation of the PI3K/AKT network | REACTOME pathways | R-HSA-199418 | 94 | 2 | 10285 | 29 |
EGF,FGFR3 |
2.868e-02 | -3.55 | molecular function activator activity | molecular function | GO:0140677 | 1132 | 7 | 18094 | 48 |
EGF,PREX1,APOA1,ADGRB3,PTN,PREX2,USP6NL |
2.878e-02 | -3.55 | PTPA (protein phosphatase 2 phosphatase activator) | protein interactions | 5524 | 105 | 2 | 19454 | 49 |
PRKN,AMOT |
2.878e-02 | -3.55 | IRF2BP2 (interferon regulatory factor 2 binding protein 2) | protein interactions | 359948 | 105 | 2 | 19454 | 49 |
PRKN,NFIA |
2.878e-02 | -3.55 | CEP72 (centrosomal protein 72) | protein interactions | 55722 | 105 | 2 | 19454 | 49 |
AMOT,PRKN |
2.879e-02 | -3.55 | TECR (trans-2,3-enoyl-CoA reductase) | protein interactions | 9524 | 264 | 3 | 19454 | 49 |
PRDM16,FGFR3,PRKN |
2.880e-02 | -3.55 | oligopeptide transmembrane transporter activity | molecular function | GO:0035673 | 11 | 1 | 18094 | 48 |
GJA1 |
2.880e-02 | -3.55 | ATP-dependent diacylglycerol kinase activity | molecular function | GO:0004143 | 11 | 1 | 18094 | 48 |
DGKB |
2.880e-02 | -3.55 | structural constituent of myelin sheath | molecular function | GO:0019911 | 11 | 1 | 18094 | 48 |
GPM6B |
2.880e-02 | -3.55 | sulfur amino acid transmembrane transporter activity | molecular function | GO:0000099 | 11 | 1 | 18094 | 48 |
SLC1A2 |
2.892e-02 | -3.54 | Bile Acid Indirect Signalling Pathway | SMPDB pathways | SMP0086851 | 8 | 1 | 1369 | 5 |
FGFR3 |
2.907e-02 | -3.54 | viral process | biological process | GO:0016032 | 243 | 3 | 18204 | 50 |
NFIA,CTBP1,USP6NL |
2.917e-02 | -3.53 | acylglycerol metabolic process | biological process | GO:0006639 | 97 | 2 | 18204 | 50 |
DGKB,LPIN2 |
2.917e-02 | -3.53 | nerve development | biological process | GO:0021675 | 97 | 2 | 18204 | 50 |
LRIG1,SLC1A3 |
2.929e-02 | -3.53 | HSP90AB2P (heat shock protein 90 alpha family class B member 2, pseudogene) | protein interactions | 391634 | 106 | 2 | 19454 | 49 |
PRKN,FKBP5 |
2.929e-02 | -3.53 | CWC22 (CWC22 spliceosome associated protein homolog) | protein interactions | 57703 | 106 | 2 | 19454 | 49 |
PRKN,GRK5 |
2.929e-02 | -3.53 | FLG2 (filaggrin 2) | protein interactions | 388698 | 106 | 2 | 19454 | 49 |
FGFRL1,PRKN |
2.931e-02 | -3.53 | GBD/FH3_dom | interpro domains | IPR014768 | 11 | 1 | 18521 | 50 |
FHOD3 |
2.931e-02 | -3.53 | PKD_dom | interpro domains | IPR000601 | 11 | 1 | 18521 | 50 |
SORCS2 |
2.931e-02 | -3.53 | PKD_dom_sf | interpro domains | IPR035986 | 11 | 1 | 18521 | 50 |
SORCS2 |
2.931e-02 | -3.53 | GAIN_dom_N | interpro domains | IPR032471 | 11 | 1 | 18521 | 50 |
ADGRB3 |
2.935e-02 | -3.53 | HNRNPUL2 (heterogeneous nuclear ribonucleoprotein U like 2) | protein interactions | 221092 | 266 | 3 | 19454 | 49 |
FGFR3,PRKN,QKI |
2.940e-02 | -3.53 | breast-carcinoma-basal_(triple-negative)_carcinoma | COSMIC cancer mutations | breast-carcinoma-basal_(triple-negative)_carcinoma | 2981 | 14 | 16828 | 47 |
FHOD3,ELOVL2,SLC4A4,SLC39A12,FGFR3,LAMA4,PRDM16,EGF,UNC93A,TNS3,MSI2,NPAS3,AMOT,LPIN2 |
2.940e-02 | -3.53 | basal_(triple-negative)_carcinoma | COSMIC cancer mutations | basal_(triple-negative)_carcinoma | 2981 | 14 | 16828 | 47 |
FHOD3,SLC4A4,FGFR3,SLC39A12,ELOVL2,PRDM16,LAMA4,EGF,UNC93A,TNS3,MSI2,NPAS3,LPIN2,AMOT |
2.950e-02 | -3.52 | TYR_PHOSPHATASE_2 | prosite domains | PS50056 | 84 | 2 | 12186 | 39 |
PTPRZ1,TNS3 |
2.964e-02 | -3.52 | arm | COSMIC cancer mutations | arm | 1331 | 8 | 16828 | 47 |
FGFR3,SLC4A4,SNTB1,NPAS3,TRPS1,SLC6A11,FHOD3,ZBTB20 |
2.968e-02 | -3.52 | cell surface receptor protein tyrosine kinase signaling pathway | biological process | GO:0007169 | 428 | 4 | 18204 | 50 |
FGFRL1,FGFR3,EGF,BCAR3 |
2.972e-02 | -3.52 | neutral lipid metabolic process | biological process | GO:0006638 | 98 | 2 | 18204 | 50 |
DGKB,LPIN2 |
2.980e-02 | -3.51 | KIFAP3 (kinesin associated protein 3) | protein interactions | 22920 | 107 | 2 | 19454 | 49 |
PRKN,NCKAP5 |
2.980e-02 | -3.51 | POLR3C (RNA polymerase III subunit C) | protein interactions | 10623 | 107 | 2 | 19454 | 49 |
PRKN,PRDM16 |
2.980e-02 | -3.51 | CHMP2A (charged multivesicular body protein 2A) | protein interactions | 27243 | 107 | 2 | 19454 | 49 |
FKBP5,MSI2 |
2.981e-02 | -3.51 | intracellular mRNA localization | biological process | GO:0008298 | 11 | 1 | 18204 | 50 |
QKI |
2.981e-02 | -3.51 | dendrite arborization | biological process | GO:0140059 | 11 | 1 | 18204 | 50 |
PTN |
2.981e-02 | -3.51 | Bergmann glial cell differentiation | biological process | GO:0060020 | 11 | 1 | 18204 | 50 |
PLPP3 |
2.981e-02 | -3.51 | protein K27-linked ubiquitination | biological process | GO:0044314 | 11 | 1 | 18204 | 50 |
PRKN |
2.981e-02 | -3.51 | dopamine uptake | biological process | GO:0090494 | 11 | 1 | 18204 | 50 |
PRKN |
2.981e-02 | -3.51 | synaptic vesicle clustering | biological process | GO:0097091 | 11 | 1 | 18204 | 50 |
CTBP1 |
2.981e-02 | -3.51 | ubiquitin recycling | biological process | GO:0010992 | 11 | 1 | 18204 | 50 |
PRKN |
2.981e-02 | -3.51 | tripeptide transport | biological process | GO:0042939 | 11 | 1 | 18204 | 50 |
GJA1 |
2.981e-02 | -3.51 | glutamate secretion | biological process | GO:0014047 | 11 | 1 | 18204 | 50 |
GJA1 |
2.981e-02 | -3.51 | catecholamine uptake | biological process | GO:0090493 | 11 | 1 | 18204 | 50 |
PRKN |
2.981e-02 | -3.51 | regulation of cell-cell adhesion involved in gastrulation | biological process | GO:0070587 | 11 | 1 | 18204 | 50 |
APOA1 |
2.981e-02 | -3.51 | negative regulation of heterotypic cell-cell adhesion | biological process | GO:0034115 | 11 | 1 | 18204 | 50 |
APOA1 |
2.981e-02 | -3.51 | peptidyl-methionine modification | biological process | GO:0018206 | 11 | 1 | 18204 | 50 |
APOA1 |
2.981e-02 | -3.51 | lipid phosphorylation | biological process | GO:0046834 | 11 | 1 | 18204 | 50 |
DGKB |
2.982e-02 | -3.51 | TREM2 (triggering receptor expressed on myeloid cells 2) | protein interactions | 54209 | 12 | 1 | 19454 | 49 |
APOA1 |
2.982e-02 | -3.51 | FSIP2 (fibrous sheath interacting protein 2) | protein interactions | 401024 | 12 | 1 | 19454 | 49 |
PRKN |
2.982e-02 | -3.51 | CA4 (carbonic anhydrase 4) | protein interactions | 762 | 12 | 1 | 19454 | 49 |
SLC4A4 |
2.982e-02 | -3.51 | HEXD (hexosaminidase D) | protein interactions | 284004 | 12 | 1 | 19454 | 49 |
PRKN |
2.982e-02 | -3.51 | IL15 (interleukin 15) | protein interactions | 3600 | 12 | 1 | 19454 | 49 |
LRIG1 |
2.982e-02 | -3.51 | ROBO4 (roundabout guidance receptor 4) | protein interactions | 54538 | 12 | 1 | 19454 | 49 |
PRKN |
2.982e-02 | -3.51 | Pcbp2 (poly(rC) binding protein 2) | protein interactions | 18521 | 12 | 1 | 19454 | 49 |
FARP1 |
2.982e-02 | -3.51 | RHAG (Rh associated glycoprotein) | protein interactions | 6005 | 12 | 1 | 19454 | 49 |
UNC93A |
2.982e-02 | -3.51 | FBXO9 (F-box protein 9) | protein interactions | 26268 | 12 | 1 | 19454 | 49 |
PRKN |
2.982e-02 | -3.51 | CALN1 (calneuron 1) | protein interactions | 83698 | 12 | 1 | 19454 | 49 |
PRKN |
2.982e-02 | -3.51 | CCZ1B (CCZ1 homolog B, vacuolar protein trafficking and biogenesis associated) | protein interactions | 221960 | 12 | 1 | 19454 | 49 |
PRKN |
2.982e-02 | -3.51 | SLC48A1 (solute carrier family 48 member 1) | protein interactions | 55652 | 12 | 1 | 19454 | 49 |
UNC93A |
2.982e-02 | -3.51 | CDH11 (cadherin 11) | protein interactions | 1009 | 12 | 1 | 19454 | 49 |
AMOT |
2.982e-02 | -3.51 | PANK3 (pantothenate kinase 3) | protein interactions | 79646 | 12 | 1 | 19454 | 49 |
PRKN |
2.982e-02 | -3.51 | WDR87 (WD repeat domain 87) | protein interactions | 83889 | 12 | 1 | 19454 | 49 |
PRKN |
2.992e-02 | -3.51 | NSUN2 (NOP2/Sun RNA methyltransferase 2) | protein interactions | 54888 | 268 | 3 | 19454 | 49 |
FGFR3,PRKN,FKBP5 |
3.018e-02 | -3.50 | human chr7p12.3 | chromosome location | human chr7p12.3 | 16 | 1 | 26134 | 50 |
TNS3 |
3.020e-02 | -3.50 | AP2A1 (adaptor related protein complex 2 subunit alpha 1) | protein interactions | 160 | 269 | 3 | 19454 | 49 |
GRK5,FGFR3,PRKN |
3.020e-02 | -3.50 | AHSA1 (activator of HSP90 ATPase activity 1) | protein interactions | 10598 | 269 | 3 | 19454 | 49 |
PRKN,FGFR3,FKBP5 |
3.020e-02 | -3.50 | PNN (pinin, desmosome associated protein) | protein interactions | 5411 | 269 | 3 | 19454 | 49 |
GRK5,PRKN,CTBP1 |
3.028e-02 | -3.50 | regulation of neurotransmitter transport | biological process | GO:0051588 | 99 | 2 | 18204 | 50 |
GPM6B,PRKN |
3.031e-02 | -3.50 | skin-neck-carcinoma-basal_cell_carcinoma | COSMIC cancer mutations | skin-neck-carcinoma-basal_cell_carcinoma | 11 | 1 | 16828 | 47 |
FGFR3 |
3.031e-02 | -3.50 | kidney-other-oncocytoma | COSMIC cancer mutations | kidney-other-oncocytoma | 11 | 1 | 16828 | 47 |
FGFR3 |
3.031e-02 | -3.50 | prostate-hyperplasia | COSMIC cancer mutations | prostate-hyperplasia | 11 | 1 | 16828 | 47 |
FGFR3 |
3.031e-02 | -3.50 | skin-hand-malignant_melanoma-acral_lentiginous | COSMIC cancer mutations | skin-hand-malignant_melanoma-acral_lentiginous | 11 | 1 | 16828 | 47 |
PREX2 |
3.031e-02 | -3.50 | oncocytoma | COSMIC cancer mutations | oncocytoma | 11 | 1 | 16828 | 47 |
FGFR3 |
3.031e-02 | -3.50 | seborrhoeic_keratosis | COSMIC cancer mutations | seborrhoeic_keratosis | 11 | 1 | 16828 | 47 |
FGFR3 |
3.031e-02 | -3.50 | skin-scalp-carcinoma-basal_cell_carcinoma | COSMIC cancer mutations | skin-scalp-carcinoma-basal_cell_carcinoma | 11 | 1 | 16828 | 47 |
FGFR3 |
3.031e-02 | -3.50 | congenital | COSMIC cancer mutations | congenital | 11 | 1 | 16828 | 47 |
FGFR3 |
3.031e-02 | -3.50 | skin-back-malignant_melanoma-superficial_spreading | COSMIC cancer mutations | skin-back-malignant_melanoma-superficial_spreading | 11 | 1 | 16828 | 47 |
PREX2 |
3.031e-02 | -3.50 | pleomorphic_carcinoma | COSMIC cancer mutations | pleomorphic_carcinoma | 11 | 1 | 16828 | 47 |
FGFR3 |
3.031e-02 | -3.50 | FKBP1A (FKBP prolyl isomerase 1A) | protein interactions | 2280 | 108 | 2 | 19454 | 49 |
MSI2,CTBP1 |
3.031e-02 | -3.50 | PYGL (glycogen phosphorylase L) | protein interactions | 5836 | 108 | 2 | 19454 | 49 |
FKBP5,PRKN |
3.031e-02 | -3.50 | EN1 (engrailed homeobox 1) | protein interactions | 2019 | 108 | 2 | 19454 | 49 |
TRPS1,NFIA |
3.031e-02 | -3.50 | PAX8 (paired box 8) | protein interactions | 7849 | 108 | 2 | 19454 | 49 |
TRPS1,NFIA |
3.031e-02 | -3.50 | CAMKV (CaM kinase like vesicle associated) | protein interactions | 79012 | 108 | 2 | 19454 | 49 |
FARP1,FKBP5 |
3.034e-02 | -3.50 | trans-synaptic signaling | biological process | GO:0099537 | 431 | 4 | 18204 | 50 |
PRKN,FARP1,SLC1A3,SLC1A2 |
3.035e-02 | -3.49 | synapse-associated extracellular matrix | cellular component | GO:0099535 | 12 | 1 | 19108 | 49 |
PTPRZ1 |
3.044e-02 | -3.49 | Prot-tyrosine_phosphatase-like | interpro domains | IPR029021 | 101 | 2 | 18521 | 50 |
PTPRZ1,TNS3 |
3.049e-02 | -3.49 | GAIN | pfam domains | PF16489 | 11 | 1 | 17795 | 50 |
ADGRB3 |
3.049e-02 | -3.49 | LRRCT | pfam domains | PF01463 | 11 | 1 | 17795 | 50 |
LRIG1 |
3.060e-02 | -3.49 | Creatine metabolism | REACTOME pathways | R-HSA-71288 | 11 | 1 | 10285 | 29 |
SLC6A11 |
3.075e-02 | -3.48 | Regulation of RAC1 activity | Pathway Interaction DB | rac1_reg_pathway | 39 | 2 | 2226 | 16 |
PREX2,PREX1 |
3.083e-02 | -3.48 | DNMBP (dynamin binding protein) | protein interactions | 23268 | 109 | 2 | 19454 | 49 |
AMOT,PRKN |
3.083e-02 | -3.48 | SKIC2 (SKI2 subunit of superkiller complex) | protein interactions | 6499 | 109 | 2 | 19454 | 49 |
FKBP5,PRKN |
3.083e-02 | -3.48 | MIR34B (microRNA 34b) | protein interactions | 407041 | 109 | 2 | 19454 | 49 |
QKI,MSI2 |
3.083e-02 | -3.48 | NT5C2 (5'-nucleotidase, cytosolic II) | protein interactions | 22978 | 109 | 2 | 19454 | 49 |
PRKN,PREX2 |
3.083e-02 | -3.48 | PALLD (palladin, cytoskeletal associated protein) | protein interactions | 23022 | 109 | 2 | 19454 | 49 |
PRKN,FKBP5 |
3.083e-02 | -3.48 | RABGAP1 (RAB GTPase activating protein 1) | protein interactions | 23637 | 109 | 2 | 19454 | 49 |
GJA1,PRKN |
3.083e-02 | -3.48 | ROR1 (receptor tyrosine kinase like orphan receptor 1) | protein interactions | 4919 | 109 | 2 | 19454 | 49 |
USP6NL,GJA1 |
3.085e-02 | -3.48 | response to alkaloid | biological process | GO:0043279 | 100 | 2 | 18204 | 50 |
SLC1A3,SLC1A2 |
3.116e-02 | -3.47 | skin-scalp-malignant_melanoma | COSMIC cancer mutations | skin-scalp-malignant_melanoma | 634 | 5 | 16828 | 47 |
SLC6A11,PREX2,LAMA4,NFIA,PTPRZ1 |
3.135e-02 | -3.46 | RBM33 (RNA binding motif protein 33) | protein interactions | 155435 | 110 | 2 | 19454 | 49 |
SOX5,PRKN |
3.135e-02 | -3.46 | RAB21 (RAB21, member RAS oncogene family) | protein interactions | 23011 | 110 | 2 | 19454 | 49 |
FGFR3,PRKN |
3.135e-02 | -3.46 | KIT (KIT proto-oncogene, receptor tyrosine kinase) | protein interactions | 3815 | 110 | 2 | 19454 | 49 |
TNS3,BCAR3 |
3.135e-02 | -3.46 | SUGT1 (SGT1 homolog, MIS12 kinetochore complex assembly cochaperone) | protein interactions | 10910 | 273 | 3 | 19454 | 49 |
PRKN,FGFR3,FKBP5 |
3.138e-02 | -3.46 | macrolide binding | molecular function | GO:0005527 | 12 | 1 | 18094 | 48 |
FKBP5 |
3.142e-02 | -3.46 | positive regulation of cold-induced thermogenesis | biological process | GO:0120162 | 101 | 2 | 18204 | 50 |
GJA1,PRDM16 |
3.142e-02 | -3.46 | cholesterol homeostasis | biological process | GO:0042632 | 101 | 2 | 18204 | 50 |
APOA1,RORA |
3.142e-02 | -3.46 | regulation of glucose metabolic process | biological process | GO:0010906 | 101 | 2 | 18204 | 50 |
PRKN,RORA |
3.142e-02 | -3.46 | actin filament-based movement | biological process | GO:0030048 | 101 | 2 | 18204 | 50 |
QKI,GJA1 |
3.156e-02 | -3.46 | MIP | prosite domains | PS00221 | 10 | 1 | 12186 | 39 |
AQP4 |
3.165e-02 | -3.45 | NOC2L (NOC2 like nucleolar associated transcriptional repressor) | protein interactions | 26155 | 274 | 3 | 19454 | 49 |
FKBP5,FARP1,FGFR3 |
3.177e-02 | -3.45 | IGF2BP1 (insulin like growth factor 2 mRNA binding protein 1) | protein interactions | 10642 | 477 | 4 | 19454 | 49 |
PRKN,SOX5,MSI2,QKI |
3.188e-02 | -3.45 | HYPK (huntingtin interacting protein K) | protein interactions | 25764 | 111 | 2 | 19454 | 49 |
APOA1,QKI |
3.193e-02 | -3.44 | MAD_homology1_Dwarfin-type | interpro domains | IPR003619 | 12 | 1 | 18521 | 50 |
NFIA |
3.198e-02 | -3.44 | USP15 (ubiquitin specific peptidase 15) | protein interactions | 9958 | 478 | 4 | 19454 | 49 |
FKBP5,APOA1,GRK5,PRKN |
3.199e-02 | -3.44 | sterol homeostasis | biological process | GO:0055092 | 102 | 2 | 18204 | 50 |
APOA1,RORA |
3.213e-02 | -3.44 | SRPK2 (SRSF protein kinase 2) | protein interactions | 6733 | 708 | 5 | 19454 | 49 |
PRKN,FGFR3,SLC39A12,MSI2,TNS3 |
3.216e-02 | -3.44 | SH2 | pfam domains | PF00017 | 100 | 2 | 17795 | 50 |
TNS3,BCAR3 |
3.220e-02 | -3.44 | central_nervous_system-brain-glioma-oligodendroglioma_Grade_III | COSMIC cancer mutations | central_nervous_system-brain-glioma-oligodendroglioma_Grade_III | 249 | 3 | 16828 | 47 |
FGFR3,SLC39A12,PTPRZ1 |
3.226e-02 | -3.43 | CREB3L4 (cAMP responsive element binding protein 3 like 4) | protein interactions | 148327 | 13 | 1 | 19454 | 49 |
PRKN |
3.226e-02 | -3.43 | PSD2 (pleckstrin and Sec7 domain containing 2) | protein interactions | 84249 | 13 | 1 | 19454 | 49 |
FARP1 |
3.226e-02 | -3.43 | CACNB4 (calcium voltage-gated channel auxiliary subunit beta 4) | protein interactions | 785 | 13 | 1 | 19454 | 49 |
PTN |
3.226e-02 | -3.43 | PRRX1 (paired related homeobox 1) | protein interactions | 5396 | 13 | 1 | 19454 | 49 |
FKBP5 |
3.226e-02 | -3.43 | CAPN11 (calpain 11) | protein interactions | 11131 | 13 | 1 | 19454 | 49 |
PRKN |
3.226e-02 | -3.43 | TUBA3D (tubulin alpha 3d) | protein interactions | 113457 | 13 | 1 | 19454 | 49 |
PRKN |
3.226e-02 | -3.43 | RAB3C (RAB3C, member RAS oncogene family) | protein interactions | 115827 | 13 | 1 | 19454 | 49 |
PRKN |
3.226e-02 | -3.43 | DNTT (DNA nucleotidylexotransferase) | protein interactions | 1791 | 13 | 1 | 19454 | 49 |
APOA1 |
3.226e-02 | -3.43 | IL23R (interleukin 23 receptor) | protein interactions | 149233 | 13 | 1 | 19454 | 49 |
PRKN |
3.226e-02 | -3.43 | LRRC4B (leucine rich repeat containing 4B) | protein interactions | 94030 | 13 | 1 | 19454 | 49 |
PRKN |
3.226e-02 | -3.43 | NSUN6 (NOP2/Sun RNA methyltransferase 6) | protein interactions | 221078 | 13 | 1 | 19454 | 49 |
PRKN |
3.226e-02 | -3.43 | CD40LG (CD40 ligand) | protein interactions | 959 | 13 | 1 | 19454 | 49 |
APOA1 |
3.226e-02 | -3.43 | ACSS2 (acyl-CoA synthetase short chain family member 2) | protein interactions | 55902 | 13 | 1 | 19454 | 49 |
PRKN |
3.226e-02 | -3.43 | SLC4A4 (solute carrier family 4 member 4) | protein interactions | 8671 | 13 | 1 | 19454 | 49 |
PRKN |
3.226e-02 | -3.43 | CD300C (CD300c molecule) | protein interactions | 10871 | 13 | 1 | 19454 | 49 |
UNC93A |
3.226e-02 | -3.43 | TAS1R3 (taste 1 receptor member 3) | protein interactions | 83756 | 13 | 1 | 19454 | 49 |
GJA1 |
3.226e-02 | -3.43 | ANKEF1 (ankyrin repeat and EF-hand domain containing 1) | protein interactions | 63926 | 13 | 1 | 19454 | 49 |
PRKN |
3.226e-02 | -3.43 | Rbm47 (RNA binding motif protein 47) | protein interactions | 245945 | 13 | 1 | 19454 | 49 |
QKI |
3.226e-02 | -3.43 | ALDH8A1 (aldehyde dehydrogenase 8 family member A1) | protein interactions | 64577 | 13 | 1 | 19454 | 49 |
PRKN |
3.226e-02 | -3.43 | MOB3A (MOB kinase activator 3A) | protein interactions | 126308 | 13 | 1 | 19454 | 49 |
PRKN |
3.226e-02 | -3.43 | NCAN (neurocan) | protein interactions | 1463 | 13 | 1 | 19454 | 49 |
PTN |
3.226e-02 | -3.43 | CABP1 (calcium binding protein 1) | protein interactions | 9478 | 13 | 1 | 19454 | 49 |
GRK5 |
3.226e-02 | -3.43 | OTOA (otoancorin) | protein interactions | 146183 | 13 | 1 | 19454 | 49 |
PRKN |
3.226e-02 | -3.43 | NOL4L (nucleolar protein 4 like) | protein interactions | 140688 | 13 | 1 | 19454 | 49 |
CTBP1 |
3.226e-02 | -3.43 | TEX15 (testis expressed 15, meiosis and synapsis associated) | protein interactions | 56154 | 13 | 1 | 19454 | 49 |
PRKN |
3.226e-02 | -3.43 | PCDHA2 (protocadherin alpha 2) | protein interactions | 56146 | 13 | 1 | 19454 | 49 |
NFIA |
3.226e-02 | -3.43 | PCDHB5 (protocadherin beta 5) | protein interactions | 26167 | 13 | 1 | 19454 | 49 |
DGKB |
3.241e-02 | -3.43 | ITPR2 (inositol 1,4,5-trisphosphate receptor type 2) | protein interactions | 3709 | 112 | 2 | 19454 | 49 |
GJA1,PRKN |
3.241e-02 | -3.43 | DTL (denticleless E3 ubiquitin protein ligase homolog) | protein interactions | 51514 | 112 | 2 | 19454 | 49 |
PREX1,PRKN |
3.241e-02 | -3.43 | P4HA3 (prolyl 4-hydroxylase subunit alpha 3) | protein interactions | 283208 | 112 | 2 | 19454 | 49 |
TRPS1,PRKN |
3.248e-02 | -3.43 | sulfur amino acid transport | biological process | GO:0000101 | 12 | 1 | 18204 | 50 |
SLC1A2 |
3.248e-02 | -3.43 | negative regulation of neuroblast proliferation | biological process | GO:0007406 | 12 | 1 | 18204 | 50 |
PTN |
3.248e-02 | -3.43 | regulation of intestinal absorption | biological process | GO:1904478 | 12 | 1 | 18204 | 50 |
APOA1 |
3.248e-02 | -3.43 | regulation of gonadotropin secretion | biological process | GO:0032276 | 12 | 1 | 18204 | 50 |
GJA1 |
3.248e-02 | -3.43 | oligopeptide transmembrane transport | biological process | GO:0035672 | 12 | 1 | 18204 | 50 |
GJA1 |
3.248e-02 | -3.43 | negative regulation by host of viral genome replication | biological process | GO:0044828 | 12 | 1 | 18204 | 50 |
PRKN |
3.248e-02 | -3.43 | microglia differentiation | biological process | GO:0014004 | 12 | 1 | 18204 | 50 |
QKI |
3.248e-02 | -3.43 | negative regulation of protein localization to cell surface | biological process | GO:2000009 | 12 | 1 | 18204 | 50 |
GPM6B |
3.248e-02 | -3.43 | positive regulation of protein localization to endosome | biological process | GO:1905668 | 12 | 1 | 18204 | 50 |
EGF |
3.248e-02 | -3.43 | endothelin receptor signaling pathway | biological process | GO:0086100 | 12 | 1 | 18204 | 50 |
BCAR3 |
3.248e-02 | -3.43 | positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization | biological process | GO:1904925 | 12 | 1 | 18204 | 50 |
PRKN |
3.248e-02 | -3.43 | regulation of mitochondrial fusion | biological process | GO:0010635 | 12 | 1 | 18204 | 50 |
PRKN |
3.248e-02 | -3.43 | auditory behavior | biological process | GO:0031223 | 12 | 1 | 18204 | 50 |
SLC1A3 |
3.250e-02 | -3.43 | DNA-binding transcription repressor activity, RNA polymerase II-specific | molecular function | GO:0001227 | 263 | 3 | 18094 | 48 |
ZBTB20,PRDM16,TRPS1 |
3.253e-02 | -3.43 | RBFOX2 (RNA binding fox-1 homolog 2) | protein interactions | 23543 | 277 | 3 | 19454 | 49 |
PRKN,MSI2,QKI |
3.253e-02 | -3.43 | ACIN1 (apoptotic chromatin condensation inducer 1) | protein interactions | 22985 | 277 | 3 | 19454 | 49 |
PRKN,GRK5,NFIA |
3.254e-02 | -3.43 | breast-carcinoma | COSMIC cancer mutations | breast-carcinoma | 15030 | 46 | 16828 | 47 |
SLC4A4,FGFRL1,SOX5,SNTB1,TRPS1,GPM6B,DGKB,LRIG1,ASPA,SORCS2,NPAS3,AMOT,SLC6A11,FGFR3,ELOVL2,PREX1,LAMA4,SLC1A2,FHOD3,APOA1,AQP4,QKI,NCKAP5,GJA1,UNC93A,NHSL1,FKBP5,ZBTB20,SLC39A12,EGF,GRK5,CTBP1,PTPRZ1,LPIN2,RFX4,TNS3,GPC5,SLC1A3,USP6NL,PRDM16,PREX2,NFIA,BCAR3,FARP1,PTN,RORA |
3.262e-02 | -3.42 | regulation of cell motility | biological process | GO:2000145 | 1122 | 7 | 18204 | 50 |
PREX1,EGF,PLPP3,LAMA4,AMOT,GJA1,PTN |
3.264e-02 | -3.42 | Visual phototransduction | REACTOME pathways | R-HSA-2187338 | 101 | 2 | 10285 | 29 |
GPC5,APOA1 |
3.264e-02 | -3.42 | Amyloid fiber formation | REACTOME pathways | R-HSA-977225 | 101 | 2 | 10285 | 29 |
APOA1,PRKN |
3.276e-02 | -3.42 | steroid binding | molecular function | GO:0005496 | 107 | 2 | 18094 | 48 |
RORA,APOA1 |
3.283e-02 | -3.42 | TJP2 (tight junction protein 2) | protein interactions | 9414 | 278 | 3 | 19454 | 49 |
AMOT,GJA1,PRKN |
3.284e-02 | -3.42 | chylomicron | cellular component | GO:0042627 | 13 | 1 | 19108 | 49 |
APOA1 |
3.289e-02 | -3.41 | positive regulation of RNA metabolic process | biological process | GO:0051254 | 1912 | 10 | 18204 | 50 |
PRDM16,NFIA,LPIN2,EGF,QKI,NPAS3,RFX4,PRKN,CTBP1,RORA |
3.294e-02 | -3.41 | AGAP1 (ArfGAP with GTPase domain, ankyrin repeat and PH domain 1) | protein interactions | 116987 | 113 | 2 | 19454 | 49 |
PRKN,NCKAP5 |
3.294e-02 | -3.41 | SATB1 (SATB homeobox 1) | protein interactions | 6304 | 113 | 2 | 19454 | 49 |
CTBP1,SOX5 |
3.294e-02 | -3.41 | GYS1 (glycogen synthase 1) | protein interactions | 2997 | 113 | 2 | 19454 | 49 |
GRK5,PRKN |
3.294e-02 | -3.41 | LMF2 (lipase maturation factor 2) | protein interactions | 91289 | 113 | 2 | 19454 | 49 |
GJA1,PRKN |
3.298e-02 | -3.41 | LYN (LYN proto-oncogene, Src family tyrosine kinase) | protein interactions | 4067 | 713 | 5 | 19454 | 49 |
USP6NL,MSI2,FARP1,SLC1A3,PRKN |
3.302e-02 | -3.41 | skin-face-carcinoma-basal_cell_carcinoma | COSMIC cancer mutations | skin-face-carcinoma-basal_cell_carcinoma | 12 | 1 | 16828 | 47 |
FGFR3 |
3.302e-02 | -3.41 | central_nervous_system-fourth_ventricle-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-fourth_ventricle-glioma-astrocytoma_Grade_I | 12 | 1 | 16828 | 47 |
QKI |
3.302e-02 | -3.41 | skin-abdomen-malignant_melanoma-nodular | COSMIC cancer mutations | skin-abdomen-malignant_melanoma-nodular | 12 | 1 | 16828 | 47 |
PREX2 |
3.302e-02 | -3.41 | cervix-carcinoma-mixed_adenosquamous_carcinoma | COSMIC cancer mutations | cervix-carcinoma-mixed_adenosquamous_carcinoma | 12 | 1 | 16828 | 47 |
FGFR3 |
3.302e-02 | -3.41 | skin-benign_melanocytic_nevus | COSMIC cancer mutations | skin-benign_melanocytic_nevus | 12 | 1 | 16828 | 47 |
FGFR3 |
3.308e-02 | -3.41 | regulation of neuron projection development | biological process | GO:0010975 | 443 | 4 | 18204 | 50 |
PREX1,ADGRB3,PTN,SLC39A12 |
3.313e-02 | -3.41 | IRS4 (insulin receptor substrate 4) | protein interactions | 8471 | 279 | 3 | 19454 | 49 |
FKBP5,PRKN,GJA1 |
3.315e-02 | -3.41 | LAMTOR1 (late endosomal/lysosomal adaptor, MAPK and MTOR activator 1) | protein interactions | 55004 | 714 | 5 | 19454 | 49 |
FARP1,GJA1,SLC1A3,USP6NL,PLPP3 |
3.315e-02 | -3.41 | regulation of steroid metabolic process | biological process | GO:0019218 | 104 | 2 | 18204 | 50 |
RORA,APOA1 |
3.315e-02 | -3.41 | protein polymerization | biological process | GO:0051258 | 104 | 2 | 18204 | 50 |
PREX1,PRKN |
3.315e-02 | -3.41 | epithelial cell migration | biological process | GO:0010631 | 104 | 2 | 18204 | 50 |
APOA1,AMOT |
3.315e-02 | -3.41 | positive regulation of ubiquitin-dependent protein catabolic process | biological process | GO:2000060 | 104 | 2 | 18204 | 50 |
PRKN,EGF |
3.321e-02 | -3.40 | MH1 | pfam domains | PF03165 | 12 | 1 | 17795 | 50 |
NFIA |
3.333e-02 | -3.40 | Signaling by activated point mutants of FGFR3 | REACTOME pathways | R-HSA-1839130 | 12 | 1 | 10285 | 29 |
FGFR3 |
3.333e-02 | -3.40 | Repression of WNT target genes | REACTOME pathways | R-HSA-4641265 | 12 | 1 | 10285 | 29 |
CTBP1 |
3.333e-02 | -3.40 | Defective EXT1 causes exostoses 1, TRPS2 and CHDS | REACTOME pathways | R-HSA-3656253 | 12 | 1 | 10285 | 29 |
GPC5 |
3.333e-02 | -3.40 | Josephin domain DUBs | REACTOME pathways | R-HSA-5689877 | 12 | 1 | 10285 | 29 |
PRKN |
3.333e-02 | -3.40 | FGFR3 mutant receptor activation | REACTOME pathways | R-HSA-2033514 | 12 | 1 | 10285 | 29 |
FGFR3 |
3.333e-02 | -3.40 | Defective EXT2 causes exostoses 2 | REACTOME pathways | R-HSA-3656237 | 12 | 1 | 10285 | 29 |
GPC5 |
3.347e-02 | -3.40 | LAMP3 (lysosomal associated membrane protein 3) | protein interactions | 27074 | 485 | 4 | 19454 | 49 |
GJA1,ELOVL2,SLC1A3,PLPP3 |
3.347e-02 | -3.40 | ATP5MF (ATP synthase membrane subunit f) | protein interactions | 9551 | 114 | 2 | 19454 | 49 |
PRDM16,PRKN |
3.347e-02 | -3.40 | LSM3 (LSM3 homolog, U6 small nuclear RNA and mRNA degradation associated) | protein interactions | 27258 | 114 | 2 | 19454 | 49 |
FARP1,QKI |
3.347e-02 | -3.40 | ADSS2 (adenylosuccinate synthase 2) | protein interactions | 159 | 114 | 2 | 19454 | 49 |
PRKN,CTBP1 |
3.369e-02 | -3.39 | PRKACA (protein kinase cAMP-activated catalytic subunit alpha) | protein interactions | 5566 | 486 | 4 | 19454 | 49 |
FKBP5,SLC4A4,PRKN,SNTB1 |
3.373e-02 | -3.39 | positive regulation of protein localization to membrane | biological process | GO:1905477 | 105 | 2 | 18204 | 50 |
PRKN,FARP1 |
3.373e-02 | -3.39 | biomineral tissue development | biological process | GO:0031214 | 105 | 2 | 18204 | 50 |
PTN,FGFR3 |
3.378e-02 | -3.39 | pleura-pulmonary_blastoma | COSMIC cancer mutations | pleura-pulmonary_blastoma | 648 | 5 | 16828 | 47 |
TRPS1,FHOD3,FGFRL1,LAMA4,NCKAP5 |
3.378e-02 | -3.39 | pulmonary_blastoma | COSMIC cancer mutations | pulmonary_blastoma | 648 | 5 | 16828 | 47 |
LAMA4,FGFRL1,FHOD3,TRPS1,NCKAP5 |
3.389e-02 | -3.38 | human chr7q31.32 | chromosome location | human chr7q31.32 | 18 | 1 | 26134 | 50 |
PTPRZ1 |
3.394e-02 | -3.38 | HCO3TRNSPORT | prints domains | PR01231 | 10 | 1 | 5227 | 18 |
SLC4A4 |
3.395e-02 | -3.38 | high-density lipoprotein particle binding | molecular function | GO:0008035 | 13 | 1 | 18094 | 48 |
APOA1 |
3.395e-02 | -3.38 | histone H3K9 methyltransferase activity | molecular function | GO:0046974 | 13 | 1 | 18094 | 48 |
PRDM16 |
3.401e-02 | -3.38 | CAV1 (caveolin 1) | protein interactions | 857 | 719 | 5 | 19454 | 49 |
USP6NL,PLPP3,GRK5,SLC1A3,GJA1 |
3.401e-02 | -3.38 | LZTS1 (leucine zipper tumor suppressor 1) | protein interactions | 11178 | 115 | 2 | 19454 | 49 |
PRKN,AMOT |
3.401e-02 | -3.38 | TBXT (T-box transcription factor T) | protein interactions | 6862 | 115 | 2 | 19454 | 49 |
TRPS1,NFIA |
3.401e-02 | -3.38 | DTNA (dystrobrevin alpha) | protein interactions | 1837 | 115 | 2 | 19454 | 49 |
SNTB1,GJA1 |
3.419e-02 | -3.38 | KIF14 (kinesin family member 14) | protein interactions | 9928 | 1803 | 9 | 19454 | 49 |
FARP1,BCAR3,SOX5,USP6NL,MSI2,AMOT,SORCS2,PRKN,SLC1A3 |
3.425e-02 | -3.37 | Endochondral Ossification | WikiPathways | WP474 | 65 | 2 | 5310 | 24 |
SOX5,FGFR3 |
3.425e-02 | -3.37 | signal transduction | biological process | GO:0007165 | 4637 | 19 | 18204 | 50 |
PTN,PREX2,DGKB,AMOT,NFIA,BCAR3,FARP1,EGF,ADGRB3,SLC39A12,SORCS2,RORA,GJA1,APOA1,PREX1,GRK5,FGFRL1,PLPP3,FGFR3 |
3.432e-02 | -3.37 | regulation of actin filament bundle assembly | biological process | GO:0032231 | 106 | 2 | 18204 | 50 |
PRKN,APOA1 |
3.434e-02 | -3.37 | SNX27 (sorting nexin 27) | protein interactions | 81609 | 489 | 4 | 19454 | 49 |
USP6NL,APOA1,SLC1A3,PRKN |
3.438e-02 | -3.37 | Gastrin-CREB signalling pathway via PKC and MAPK | REACTOME pathways | R-HSA-881907 | 443 | 4 | 10285 | 29 |
FGFR3,GRK5,EGF,DGKB |
3.440e-02 | -3.37 | DNA-binding transcription factor activity | molecular function | GO:0003700 | 1441 | 8 | 18094 | 48 |
SOX5,TRPS1,RORA,PRDM16,NPAS3,ZBTB20,NFIA,RFX4 |
3.446e-02 | -3.37 | DAGKa | smart domains | SM00045 | 10 | 1 | 9717 | 34 |
DGKB |
3.454e-02 | -3.37 | FA | interpro domains | IPR014847 | 13 | 1 | 18521 | 50 |
FARP1 |
3.455e-02 | -3.37 | EHD4 (EH domain containing 4) | protein interactions | 30844 | 116 | 2 | 19454 | 49 |
CTBP1,PRKN |
3.459e-02 | -3.36 | Gap junction | KEGG pathways | ko04540 | 88 | 2 | 7161 | 24 |
EGF,GJA1 |
3.459e-02 | -3.36 | Gap junction | KEGG pathways | hsa04540 | 88 | 2 | 7161 | 24 |
EGF,GJA1 |
3.466e-02 | -3.36 | PKD | prosite domains | PS50093 | 11 | 1 | 12186 | 39 |
SORCS2 |
3.466e-02 | -3.36 | GATA_ZN_FINGER_2 | prosite domains | PS50114 | 11 | 1 | 12186 | 39 |
TRPS1 |
3.466e-02 | -3.36 | GBD_FH3 | prosite domains | PS51232 | 11 | 1 | 12186 | 39 |
FHOD3 |
3.470e-02 | -3.36 | ACSM3 (acyl-CoA synthetase medium chain family member 3) | protein interactions | 6296 | 14 | 1 | 19454 | 49 |
PRKN |
3.470e-02 | -3.36 | DNAJC27 (DnaJ heat shock protein family (Hsp40) member C27) | protein interactions | 51277 | 14 | 1 | 19454 | 49 |
FKBP5 |
3.470e-02 | -3.36 | CYP2W1 (cytochrome P450 family 2 subfamily W member 1) | protein interactions | 54905 | 14 | 1 | 19454 | 49 |
PRKN |
3.470e-02 | -3.36 | HOXC6 (homeobox C6) | protein interactions | 3223 | 14 | 1 | 19454 | 49 |
BCAR3 |
3.470e-02 | -3.36 | TTLL7 (tubulin tyrosine ligase like 7) | protein interactions | 79739 | 14 | 1 | 19454 | 49 |
PRKN |
3.470e-02 | -3.36 | PGS1 (phosphatidylglycerophosphate synthase 1) | protein interactions | 9489 | 14 | 1 | 19454 | 49 |
PRKN |
3.470e-02 | -3.36 | ZNF628 (zinc finger protein 628) | protein interactions | 89887 | 14 | 1 | 19454 | 49 |
PRKN |
3.470e-02 | -3.36 | MEIOC (meiosis specific with coiled-coil domain) | protein interactions | 284071 | 14 | 1 | 19454 | 49 |
PRKN |
3.470e-02 | -3.36 | MAOA (monoamine oxidase A) | protein interactions | 4128 | 14 | 1 | 19454 | 49 |
PRKN |
3.470e-02 | -3.36 | FGF7 (fibroblast growth factor 7) | protein interactions | 2252 | 14 | 1 | 19454 | 49 |
FGFR3 |
3.470e-02 | -3.36 | CFAP58 (cilia and flagella associated protein 58) | protein interactions | 159686 | 14 | 1 | 19454 | 49 |
PRKN |
3.470e-02 | -3.36 | GRID2 (glutamate ionotropic receptor delta type subunit 2) | protein interactions | 2895 | 14 | 1 | 19454 | 49 |
PRKN |
3.470e-02 | -3.36 | ZNF625 (zinc finger protein 625) | protein interactions | 90589 | 14 | 1 | 19454 | 49 |
PRKN |
3.470e-02 | -3.36 | RGS13 (regulator of G protein signaling 13) | protein interactions | 6003 | 14 | 1 | 19454 | 49 |
PRKN |
3.470e-02 | -3.36 | ROBO3 (roundabout guidance receptor 3) | protein interactions | 64221 | 14 | 1 | 19454 | 49 |
APOA1 |
3.470e-02 | -3.36 | Plekhg5 (pleckstrin homology domain containing, family G (with RhoGef domain) member 5) | protein interactions | 269608 | 14 | 1 | 19454 | 49 |
AMOT |
3.470e-02 | -3.36 | DACT2 (dishevelled binding antagonist of beta catenin 2) | protein interactions | 168002 | 14 | 1 | 19454 | 49 |
ZBTB20 |
3.470e-02 | -3.36 | PLPP1 (phospholipid phosphatase 1) | protein interactions | 8611 | 14 | 1 | 19454 | 49 |
PLPP3 |
3.470e-02 | -3.36 | SCRN3 (secernin 3) | protein interactions | 79634 | 14 | 1 | 19454 | 49 |
PRKN |
3.470e-02 | -3.36 | SLC1A2 (solute carrier family 1 member 2) | protein interactions | 6506 | 14 | 1 | 19454 | 49 |
SLC1A2 |
3.470e-02 | -3.36 | CHGA (chromogranin A) | protein interactions | 1113 | 14 | 1 | 19454 | 49 |
PRKN |
3.470e-02 | -3.36 | SPTBN5 (spectrin beta, non-erythrocytic 5) | protein interactions | 51332 | 14 | 1 | 19454 | 49 |
PRKN |
3.470e-02 | -3.36 | ADAP2 (ArfGAP with dual PH domains 2) | protein interactions | 55803 | 14 | 1 | 19454 | 49 |
PRKN |
3.470e-02 | -3.36 | UAP1L1 (UDP-N-acetylglucosamine pyrophosphorylase 1 like 1) | protein interactions | 91373 | 14 | 1 | 19454 | 49 |
PRKN |
3.470e-02 | -3.36 | Cstf2t (cleavage stimulation factor, 3' pre-RNA subunit 2, tau) | protein interactions | 83410 | 14 | 1 | 19454 | 49 |
CTBP1 |
3.470e-02 | -3.36 | NSUN5P2 (NSUN5 pseudogene 2) | protein interactions | 260294 | 14 | 1 | 19454 | 49 |
PRKN |
3.473e-02 | -3.36 | upper_leg | COSMIC cancer mutations | upper_leg | 880 | 6 | 16828 | 47 |
AMOT,LRIG1,PREX2,NFIA,FGFR3,SLC6A11 |
3.485e-02 | -3.36 | regulation of anatomical structure morphogenesis | biological process | GO:0022603 | 894 | 6 | 18204 | 50 |
EGF,ADGRB3,SLC39A12,AMOT,GJA1,PRKN |
3.492e-02 | -3.35 | epithelium migration | biological process | GO:0090132 | 107 | 2 | 18204 | 50 |
AMOT,APOA1 |
3.496e-02 | -3.35 | SART3 (spliceosome associated factor 3, U4/U6 recycling protein) | protein interactions | 9733 | 285 | 3 | 19454 | 49 |
PRKN,AMOT,CTBP1 |
3.496e-02 | -3.35 | MAVS (mitochondrial antiviral signaling protein) | protein interactions | 57506 | 285 | 3 | 19454 | 49 |
FGFR3,PRKN,SLC39A12 |
3.500e-02 | -3.35 | SH2 | interpro domains | IPR000980 | 109 | 2 | 18521 | 50 |
BCAR3,TNS3 |
3.505e-02 | -3.35 | transcription coactivator activity | molecular function | GO:0003713 | 271 | 3 | 18094 | 48 |
PRDM16,CTBP1,LPIN2 |
3.508e-02 | -3.35 | regulation of catalytic activity | biological process | GO:0050790 | 1395 | 8 | 18204 | 50 |
PREX2,APOA1,USP6NL,PRKN,PREX1,BCAR3,EGF,FGFR3 |
3.510e-02 | -3.35 | HSP90AB4P (heat shock protein 90 alpha family class B member 4, pseudogene) | protein interactions | 664618 | 117 | 2 | 19454 | 49 |
PRKN,FKBP5 |
3.514e-02 | -3.35 | glial cell fate commitment | biological process | GO:0021781 | 13 | 1 | 18204 | 50 |
NFIA |
3.514e-02 | -3.35 | regulation of protein localization to endosome | biological process | GO:1905666 | 13 | 1 | 18204 | 50 |
EGF |
3.514e-02 | -3.35 | regulation of autophagy of mitochondrion in response to mitochondrial depolarization | biological process | GO:1904923 | 13 | 1 | 18204 | 50 |
PRKN |
3.514e-02 | -3.35 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway | biological process | GO:1903377 | 13 | 1 | 18204 | 50 |
PRKN |
3.514e-02 | -3.35 | positive regulation of mitophagy | biological process | GO:1901526 | 13 | 1 | 18204 | 50 |
PRKN |
3.514e-02 | -3.35 | heterochromatin organization | biological process | GO:0070828 | 13 | 1 | 18204 | 50 |
PRDM16 |
3.514e-02 | -3.35 | positive regulation of neuron projection regeneration | biological process | GO:0070572 | 13 | 1 | 18204 | 50 |
PTN |
3.514e-02 | -3.35 | positive regulation of axon regeneration | biological process | GO:0048680 | 13 | 1 | 18204 | 50 |
PTN |
3.514e-02 | -3.35 | cerebellar Purkinje cell differentiation | biological process | GO:0021702 | 13 | 1 | 18204 | 50 |
RORA |
3.514e-02 | -3.35 | phospholipid efflux | biological process | GO:0033700 | 13 | 1 | 18204 | 50 |
APOA1 |
3.514e-02 | -3.35 | very long-chain fatty acid biosynthetic process | biological process | GO:0042761 | 13 | 1 | 18204 | 50 |
ELOVL2 |
3.514e-02 | -3.35 | T-helper 17 cell differentiation | biological process | GO:0072539 | 13 | 1 | 18204 | 50 |
RORA |
3.527e-02 | -3.34 | FNDC3A (fibronectin type III domain containing 3A) | protein interactions | 22862 | 286 | 3 | 19454 | 49 |
GJA1,SORCS2,AMOT |
3.527e-02 | -3.34 | EGF/EGFR Signaling Pathway | WikiPathways | WP437 | 162 | 3 | 5310 | 24 |
EGF,USP6NL,GJA1 |
3.532e-02 | -3.34 | dopaminergic synapse | cellular component | GO:0098691 | 14 | 1 | 19108 | 49 |
PRKN |
3.532e-02 | -3.34 | extrinsic component of synaptic membrane | cellular component | GO:0099243 | 14 | 1 | 19108 | 49 |
FARP1 |
3.533e-02 | -3.34 | regulation of plasma membrane bounded cell projection organization | biological process | GO:0120035 | 666 | 5 | 18204 | 50 |
PTN,SLC39A12,ADGRB3,PREX1,USP6NL |
3.538e-02 | -3.34 | DNA-binding transcription repressor activity | molecular function | GO:0001217 | 272 | 3 | 18094 | 48 |
ZBTB20,TRPS1,PRDM16 |
3.545e-02 | -3.34 | NEDD4 (NEDD4 E3 ubiquitin protein ligase) | protein interactions | 4734 | 494 | 4 | 19454 | 49 |
AMOT,GJA1,PRKN,FGFR3 |
3.551e-02 | -3.34 | tissue remodeling | biological process | GO:0048771 | 108 | 2 | 18204 | 50 |
PTN,GJA1 |
3.561e-02 | -3.34 | FTO Obesity Variant Mechanism | WikiPathways | WP3407 | 8 | 1 | 5310 | 24 |
PRDM16 |
3.565e-02 | -3.33 | SIPA1L2 (signal induced proliferation associated 1 like 2) | protein interactions | 57568 | 118 | 2 | 19454 | 49 |
AMOT,GJA1 |
3.565e-02 | -3.33 | DNAAF10 (dynein axonemal assembly factor 10) | protein interactions | 116143 | 118 | 2 | 19454 | 49 |
FKBP5,FGFR3 |
3.572e-02 | -3.33 | skin-shoulder-malignant_melanoma-nodular | COSMIC cancer mutations | skin-shoulder-malignant_melanoma-nodular | 13 | 1 | 16828 | 47 |
PREX2 |
3.572e-02 | -3.33 | cervix-carcinoma-adenocarcinoma | COSMIC cancer mutations | cervix-carcinoma-adenocarcinoma | 13 | 1 | 16828 | 47 |
FGFR3 |
3.572e-02 | -3.33 | central_nervous_system-hypothalamus-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-hypothalamus-glioma-astrocytoma_Grade_I | 13 | 1 | 16828 | 47 |
QKI |
3.572e-02 | -3.33 | Brenner_tumour | COSMIC cancer mutations | Brenner_tumour | 13 | 1 | 16828 | 47 |
FGFR3 |
3.572e-02 | -3.33 | endometrium-ovary-endometriosis | COSMIC cancer mutations | endometrium-ovary-endometriosis | 13 | 1 | 16828 | 47 |
FGFR3 |
3.572e-02 | -3.33 | skin-back-carcinoma-basal_cell_carcinoma | COSMIC cancer mutations | skin-back-carcinoma-basal_cell_carcinoma | 13 | 1 | 16828 | 47 |
FGFR3 |
3.572e-02 | -3.33 | skin-scalp-malignant_melanoma-nodular | COSMIC cancer mutations | skin-scalp-malignant_melanoma-nodular | 13 | 1 | 16828 | 47 |
PREX2 |
3.574e-02 | -3.33 | human chr6q24.1 | chromosome location | human chr6q24.1 | 19 | 1 | 26134 | 50 |
NHSL1 |
3.589e-02 | -3.33 | VASP (vasodilator stimulated phosphoprotein) | protein interactions | 7408 | 288 | 3 | 19454 | 49 |
AMOT,PRKN,NHSL1 |
3.593e-02 | -3.33 | FA | pfam domains | PF08736 | 13 | 1 | 17795 | 50 |
FARP1 |
3.593e-02 | -3.33 | Ldl_recept_b | pfam domains | PF00058 | 13 | 1 | 17795 | 50 |
EGF |
3.593e-02 | -3.33 | positive regulation of DNA-templated transcription | biological process | GO:0045893 | 1667 | 9 | 18204 | 50 |
PRDM16,NFIA,NPAS3,EGF,LPIN2,RFX4,RORA,PRKN,CTBP1 |
3.606e-02 | -3.32 | Phospholipase C-mediated cascade; FGFR3 | REACTOME pathways | R-HSA-5654227 | 13 | 1 | 10285 | 29 |
FGFR3 |
3.606e-02 | -3.32 | ERBB2 Activates PTK6 Signaling | REACTOME pathways | R-HSA-8847993 | 13 | 1 | 10285 | 29 |
EGF |
3.606e-02 | -3.32 | FGFR3c ligand binding and activation | REACTOME pathways | R-HSA-190372 | 13 | 1 | 10285 | 29 |
FGFR3 |
3.606e-02 | -3.32 | FGFRL1 modulation of FGFR1 signaling | REACTOME pathways | R-HSA-5658623 | 13 | 1 | 10285 | 29 |
FGFRL1 |
3.606e-02 | -3.32 | Passive transport by Aquaporins | REACTOME pathways | R-HSA-432047 | 13 | 1 | 10285 | 29 |
AQP4 |
3.606e-02 | -3.32 | Scavenging of heme from plasma | REACTOME pathways | R-HSA-2168880 | 13 | 1 | 10285 | 29 |
APOA1 |
3.606e-02 | -3.32 | FGFR3 ligand binding and activation | REACTOME pathways | R-HSA-190239 | 13 | 1 | 10285 | 29 |
FGFR3 |
3.612e-02 | -3.32 | long-chain fatty acid metabolic process | biological process | GO:0001676 | 109 | 2 | 18204 | 50 |
QKI,ELOVL2 |
3.620e-02 | -3.32 | regulation of canonical Wnt signaling pathway | biological process | GO:0060828 | 265 | 3 | 18204 | 50 |
EGF,PRKN,GPC5 |
3.620e-02 | -3.32 | OXCT1 (3-oxoacid CoA-transferase 1) | protein interactions | 5019 | 119 | 2 | 19454 | 49 |
ADGRB3,PRKN |
3.629e-02 | -3.32 | positive regulation of RNA biosynthetic process | biological process | GO:1902680 | 1670 | 9 | 18204 | 50 |
NFIA,PRDM16,EGF,LPIN2,NPAS3,RFX4,PRKN,CTBP1,RORA |
3.656e-02 | -3.31 | acute_lymphoblastic_leukaemia | COSMIC cancer mutations | acute_lymphoblastic_leukaemia | 2197 | 11 | 16828 | 47 |
CTBP1,PTPRZ1,GRK5,SLC4A4,FGFR3,FGFRL1,SOX5,FHOD3,TRPS1,PREX2,NFIA |
3.658e-02 | -3.31 | bone-scapula-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | COSMIC cancer mutations | bone-scapula-Ewings_sarcoma-peripheral_primitive_neuroectodermal_tumour | 108 | 2 | 16828 | 47 |
FGFR3,SNTB1 |
3.668e-02 | -3.31 | PTEN (phosphatase and tensin homolog) | protein interactions | 5728 | 734 | 5 | 19454 | 49 |
CTBP1,FKBP5,AMOT,PLPP3,PRKN |
3.670e-02 | -3.30 | positive regulation of cell development | biological process | GO:0010720 | 458 | 4 | 18204 | 50 |
QKI,PTPRZ1,PTN,ASPA |
3.672e-02 | -3.30 | positive regulation of binding | biological process | GO:0051099 | 110 | 2 | 18204 | 50 |
EGF,PRKN |
3.672e-02 | -3.30 | positive regulation of canonical Wnt signaling pathway | biological process | GO:0090263 | 110 | 2 | 18204 | 50 |
GPC5,EGF |
3.675e-02 | -3.30 | urinary_tract-bladder-carcinoma | COSMIC cancer mutations | urinary_tract-bladder-carcinoma | 14050 | 44 | 16828 | 47 |
DGKB,LRIG1,GPM6B,TRPS1,GRK5,EGF,SNTB1,SOX5,FGFRL1,SLC39A12,SLC4A4,SLC1A3,USP6NL,TNS3,GPC5,SLC6A11,LPIN2,RFX4,AMOT,CTBP1,NPAS3,PTPRZ1,SORCS2,MSI2,ASPA,PREX2,NFIA,FHOD3,SLC1A2,PREX1,PRDM16,LAMA4,FGFR3,ELOVL2,PTN,ZBTB20,RORA,FKBP5,FARP1,UNC93A,BCAR3,GJA1,QKI,NCKAP5 |
3.676e-02 | -3.30 | LPCAT1 (lysophosphatidylcholine acyltransferase 1) | protein interactions | 79888 | 120 | 2 | 19454 | 49 |
PRKN,FGFR3 |
3.676e-02 | -3.30 | ACSL4 (acyl-CoA synthetase long chain family member 4) | protein interactions | 2182 | 120 | 2 | 19454 | 49 |
PRKN,SLC39A12 |
3.676e-02 | -3.30 | TOMM70 (translocase of outer mitochondrial membrane 70) | protein interactions | 9868 | 120 | 2 | 19454 | 49 |
FKBP5,PRKN |
3.676e-02 | -3.30 | UBE2S (ubiquitin conjugating enzyme E2 S) | protein interactions | 27338 | 120 | 2 | 19454 | 49 |
USP6NL,PRKN |
3.676e-02 | -3.30 | FHL1 (four and a half LIM domains 1) | protein interactions | 2273 | 120 | 2 | 19454 | 49 |
LAMA4,PRKN |
3.676e-02 | -3.30 | LIMD1 (LIM domain containing 1) | protein interactions | 8994 | 120 | 2 | 19454 | 49 |
PRKN,AMOT |
3.677e-02 | -3.30 | transcription coregulator binding | molecular function | GO:0001221 | 114 | 2 | 18094 | 48 |
CTBP1,RORA |
3.683e-02 | -3.30 | GOPC (golgi associated PDZ and coiled-coil motif containing) | protein interactions | 57120 | 291 | 3 | 19454 | 49 |
GJA1,FGFR3,PRKN |
3.684e-02 | -3.30 | positive regulation of cell differentiation | biological process | GO:0045597 | 906 | 6 | 18204 | 50 |
PTPRZ1,QKI,ASPA,PTN,SOX5,GJA1 |
3.685e-02 | -3.30 | thyroid | COSMIC cancer mutations | thyroid | 9867 | 34 | 16828 | 47 |
SLC6A11,TNS3,GPC5,CTBP1,PTPRZ1,AMOT,ASPA,SORCS2,LRIG1,TRPS1,GPM6B,SNTB1,GRK5,SLC4A4,SOX5,FGFRL1,FARP1,PTN,FKBP5,RORA,UNC93A,NHSL1,NCKAP5,BCAR3,AQP4,FHOD3,PREX2,NFIA,SLC1A2,FGFR3,ELOVL2,PRDM16,PREX1,LAMA4 |
3.688e-02 | -3.30 | plasma membrane bounded cell projection organization | biological process | GO:0120036 | 1152 | 7 | 18204 | 50 |
GPM6B,PTPRZ1,FARP1,RFX4,PREX2,PTN,SLC39A12 |
3.695e-02 | -3.30 | synaptic signaling | biological process | GO:0099536 | 459 | 4 | 18204 | 50 |
SLC1A3,SLC1A2,PRKN,FARP1 |
3.695e-02 | -3.30 | small molecule biosynthetic process | biological process | GO:0044283 | 459 | 4 | 18204 | 50 |
SLC1A3,QKI,ELOVL2,APOA1 |
3.714e-02 | -3.29 | FGF9 (fibroblast growth factor 9) | protein interactions | 2254 | 15 | 1 | 19454 | 49 |
FGFR3 |
3.714e-02 | -3.29 | RAB40AL (RAB40A like) | protein interactions | 282808 | 15 | 1 | 19454 | 49 |
PRKN |
3.714e-02 | -3.29 | GCK (glucokinase) | protein interactions | 2645 | 15 | 1 | 19454 | 49 |
PRKN |
3.714e-02 | -3.29 | MTRR (5-methyltetrahydrofolate-homocysteine methyltransferase reductase) | protein interactions | 4552 | 15 | 1 | 19454 | 49 |
PRKN |
3.714e-02 | -3.29 | ADRA1B (adrenoceptor alpha 1B) | protein interactions | 147 | 15 | 1 | 19454 | 49 |
PRKN |
3.714e-02 | -3.29 | Cenpf (centromere protein F) | protein interactions | 108000 | 15 | 1 | 19454 | 49 |
USP6NL |
3.714e-02 | -3.29 | SEMA3F (semaphorin 3F) | protein interactions | 6405 | 15 | 1 | 19454 | 49 |
PRKN |
3.714e-02 | -3.29 | DOP1A (DOP1 leucine zipper like protein A) | protein interactions | 23033 | 15 | 1 | 19454 | 49 |
PRKN |
3.714e-02 | -3.29 | FN3K (fructosamine 3 kinase) | protein interactions | 64122 | 15 | 1 | 19454 | 49 |
PRKN |
3.714e-02 | -3.29 | DTWD1 (DTW domain containing 1) | protein interactions | 56986 | 15 | 1 | 19454 | 49 |
APOA1 |
3.714e-02 | -3.29 | RGS9 (regulator of G protein signaling 9) | protein interactions | 8787 | 15 | 1 | 19454 | 49 |
PRKN |
3.714e-02 | -3.29 | ZNF616 (zinc finger protein 616) | protein interactions | 90317 | 15 | 1 | 19454 | 49 |
PRKN |
3.714e-02 | -3.29 | ASIC2 (acid sensing ion channel subunit 2) | protein interactions | 40 | 15 | 1 | 19454 | 49 |
PRKN |
3.714e-02 | -3.29 | ACTRT1 (actin related protein T1) | protein interactions | 139741 | 15 | 1 | 19454 | 49 |
PRKN |
3.714e-02 | -3.29 | POFUT2 (protein O-fucosyltransferase 2) | protein interactions | 23275 | 15 | 1 | 19454 | 49 |
PRKN |
3.715e-02 | -3.29 | IBR_dom | interpro domains | IPR002867 | 14 | 1 | 18521 | 50 |
PRKN |
3.715e-02 | -3.29 | Aquaporin-like | interpro domains | IPR023271 | 14 | 1 | 18521 | 50 |
AQP4 |
3.715e-02 | -3.29 | MIP | interpro domains | IPR000425 | 14 | 1 | 18521 | 50 |
AQP4 |
3.715e-02 | -3.29 | LDLR_classB_rpt | interpro domains | IPR000033 | 14 | 1 | 18521 | 50 |
EGF |
3.715e-02 | -3.29 | TRIAD_supradom | interpro domains | IPR044066 | 14 | 1 | 18521 | 50 |
PRKN |
3.715e-02 | -3.29 | ZIP | interpro domains | IPR003689 | 14 | 1 | 18521 | 50 |
SLC39A12 |
3.715e-02 | -3.29 | SENP3 (SUMO specific peptidase 3) | protein interactions | 26168 | 292 | 3 | 19454 | 49 |
ZBTB20,PRDM16,PRKN |
3.715e-02 | -3.29 | HNRNPH2 (heterogeneous nuclear ribonucleoprotein H2) | protein interactions | 3188 | 292 | 3 | 19454 | 49 |
PRKN,MSI2,QKI |
3.720e-02 | -3.29 | negative regulation of transport | biological process | GO:0051051 | 460 | 4 | 18204 | 50 |
GJA1,PRKN,EGF,GPM6B |
3.724e-02 | -3.29 | regulation of signal transduction | biological process | GO:0009966 | 3114 | 14 | 18204 | 50 |
PRDM16,GRK5,FGFR3,PLPP3,PREX1,PRKN,RORA,APOA1,GJA1,GPC5,BCAR3,EGF,PREX2,AMOT |
3.732e-02 | -3.29 | MED15 (mediator complex subunit 15) | protein interactions | 51586 | 121 | 2 | 19454 | 49 |
NFIA,QKI |
3.732e-02 | -3.29 | POLR3B (RNA polymerase III subunit B) | protein interactions | 55703 | 121 | 2 | 19454 | 49 |
FKBP5,PRKN |
3.732e-02 | -3.29 | GAS8 (growth arrest specific 8) | protein interactions | 2622 | 121 | 2 | 19454 | 49 |
PRKN,BCAR3 |
3.738e-02 | -3.29 | SH2_dom_sf | interpro domains | IPR036860 | 113 | 2 | 18521 | 50 |
TNS3,BCAR3 |
3.759e-02 | -3.28 | regulation of actin filament organization | biological process | GO:0110053 | 269 | 3 | 18204 | 50 |
PRKN,PREX1,APOA1 |
3.759e-02 | -3.28 | human chr18q12.2 | chromosome location | human chr18q12.2 | 20 | 1 | 26134 | 50 |
FHOD3 |
3.765e-02 | -3.28 | SH2 domain | gene3d domains | 3.30.505.10 | 111 | 2 | 14470 | 40 |
BCAR3,TNS3 |
3.779e-02 | -3.28 | glutathione biosynthetic process | biological process | GO:0006750 | 14 | 1 | 18204 | 50 |
SLC1A2 |
3.779e-02 | -3.28 | mechanosensory behavior | biological process | GO:0007638 | 14 | 1 | 18204 | 50 |
SLC1A3 |
3.779e-02 | -3.28 | atrial cardiac muscle cell to AV node cell signaling | biological process | GO:0086026 | 14 | 1 | 18204 | 50 |
GJA1 |
3.779e-02 | -3.28 | neuron remodeling | biological process | GO:0016322 | 14 | 1 | 18204 | 50 |
ADGRB3 |
3.779e-02 | -3.28 | fatty acid elongation | biological process | GO:0030497 | 14 | 1 | 18204 | 50 |
ELOVL2 |
3.779e-02 | -3.28 | oligopeptide transport | biological process | GO:0006857 | 14 | 1 | 18204 | 50 |
GJA1 |
3.779e-02 | -3.28 | atrial cardiac muscle cell action potential | biological process | GO:0086014 | 14 | 1 | 18204 | 50 |
GJA1 |
3.779e-02 | -3.28 | positive regulation of tumor necrosis factor-mediated signaling pathway | biological process | GO:1903265 | 14 | 1 | 18204 | 50 |
PRKN |
3.779e-02 | -3.28 | negative regulation of long-term synaptic potentiation | biological process | GO:1900272 | 14 | 1 | 18204 | 50 |
PTN |
3.779e-02 | -3.28 | negative regulation of cell adhesion molecule production | biological process | GO:0060354 | 14 | 1 | 18204 | 50 |
APOA1 |
3.779e-02 | -3.28 | adult heart development | biological process | GO:0007512 | 14 | 1 | 18204 | 50 |
GJA1 |
3.779e-02 | -3.28 | sodium ion export across plasma membrane | biological process | GO:0036376 | 14 | 1 | 18204 | 50 |
SLC4A4 |
3.779e-02 | -3.28 | positive regulation of phospholipid transport | biological process | GO:2001140 | 14 | 1 | 18204 | 50 |
APOA1 |
3.779e-02 | -3.28 | cerebrospinal fluid circulation | biological process | GO:0090660 | 14 | 1 | 18204 | 50 |
AQP4 |
3.779e-02 | -3.28 | MMS19 (MMS19 homolog, cytosolic iron-sulfur assembly component) | protein interactions | 64210 | 294 | 3 | 19454 | 49 |
PRKN,FGFR3,GRK5 |
3.779e-02 | -3.28 | IGF2R (insulin like growth factor 2 receptor) | protein interactions | 3482 | 294 | 3 | 19454 | 49 |
CTBP1,PRKN,GJA1 |
3.780e-02 | -3.28 | axolemma | cellular component | GO:0030673 | 15 | 1 | 19108 | 49 |
SLC1A2 |
3.780e-02 | -3.28 | low-density lipoprotein particle | cellular component | GO:0034362 | 15 | 1 | 19108 | 49 |
APOA1 |
3.788e-02 | -3.27 | OGA (O-GlcNAcase) | protein interactions | 10724 | 122 | 2 | 19454 | 49 |
FKBP5,PRKN |
3.788e-02 | -3.27 | MED31 (mediator complex subunit 31) | protein interactions | 51003 | 122 | 2 | 19454 | 49 |
LAMA4,QKI |
3.788e-02 | -3.27 | RTCA (RNA 3'-terminal phosphate cyclase) | protein interactions | 8634 | 122 | 2 | 19454 | 49 |
AMOT,PRKN |
3.803e-02 | -3.27 | - | gene3d domains | 1.20.120.1750 | 14 | 1 | 14470 | 40 |
PRKN |
3.803e-02 | -3.27 | - | gene3d domains | 2.60.200.40 | 14 | 1 | 14470 | 40 |
DGKB |
3.803e-02 | -3.27 | Glycerol uptake facilitator protein | gene3d domains | 1.20.1080.10 | 14 | 1 | 14470 | 40 |
AQP4 |
3.821e-02 | -3.26 | cellular lipid metabolic process | biological process | GO:0044255 | 914 | 6 | 18204 | 50 |
PLPP3,QKI,LPIN2,ELOVL2,APOA1,DGKB |
3.822e-02 | -3.26 | cellular response to organic cyclic compound | biological process | GO:0071407 | 464 | 4 | 18204 | 50 |
SLC1A2,SLC1A3,RORA,PRKN |
3.829e-02 | -3.26 | carboxylic acid biosynthetic process | biological process | GO:0046394 | 271 | 3 | 18204 | 50 |
QKI,ELOVL2,SLC1A3 |
3.838e-02 | -3.26 | response to organonitrogen compound | biological process | GO:0010243 | 915 | 6 | 18204 | 50 |
SLC1A3,GJA1,PRKN,SLC1A2,BCAR3,LPIN2 |
3.841e-02 | -3.26 | small_round_cell_tumour | COSMIC cancer mutations | small_round_cell_tumour | 14 | 1 | 16828 | 47 |
FGFR3 |
3.841e-02 | -3.26 | soft_tissue-small_round_cell_tumour | COSMIC cancer mutations | soft_tissue-small_round_cell_tumour | 14 | 1 | 16828 | 47 |
FGFR3 |
3.841e-02 | -3.26 | endometriosis | COSMIC cancer mutations | endometriosis | 14 | 1 | 16828 | 47 |
FGFR3 |
3.841e-02 | -3.26 | in_situ_neoplasm | COSMIC cancer mutations | in_situ_neoplasm | 14 | 1 | 16828 | 47 |
FGFR3 |
3.841e-02 | -3.26 | urinary_tract-renal_pelvis-carcinoma-transitional_cell_carcinoma | COSMIC cancer mutations | urinary_tract-renal_pelvis-carcinoma-transitional_cell_carcinoma | 14 | 1 | 16828 | 47 |
FGFR3 |
3.843e-02 | -3.26 | RHOU (ras homolog family member U) | protein interactions | 58480 | 507 | 4 | 19454 | 49 |
FARP1,GJA1,USP6NL,TNS3 |
3.844e-02 | -3.26 | NCAPH (non-SMC condensin I complex subunit H) | protein interactions | 23397 | 296 | 3 | 19454 | 49 |
PRDM16,FGFR3,PRKN |
3.844e-02 | -3.26 | PTK2 (protein tyrosine kinase 2) | protein interactions | 5747 | 296 | 3 | 19454 | 49 |
TNS3,FKBP5,PRKN |
3.844e-02 | -3.26 | PAX7 (paired box 7) | protein interactions | 5081 | 123 | 2 | 19454 | 49 |
TRPS1,NFIA |
3.844e-02 | -3.26 | UBASH3A (ubiquitin associated and SH3 domain containing A) | protein interactions | 53347 | 123 | 2 | 19454 | 49 |
PRKN,BCAR3 |
3.844e-02 | -3.26 | NAMPT (nicotinamide phosphoribosyltransferase) | protein interactions | 10135 | 123 | 2 | 19454 | 49 |
PRKN,FGFR3 |
3.844e-02 | -3.26 | ETF1 (eukaryotic translation termination factor 1) | protein interactions | 2107 | 123 | 2 | 19454 | 49 |
PRKN,FGFR3 |
3.844e-02 | -3.26 | ACOT1 (acyl-CoA thioesterase 1) | protein interactions | 641371 | 123 | 2 | 19454 | 49 |
PRKN,FGFR3 |
3.850e-02 | -3.26 | bile_duct | COSMIC cancer mutations | bile_duct | 15095 | 46 | 16828 | 47 |
SLC1A3,USP6NL,TNS3,GPC5,RFX4,LPIN2,CTBP1,PTPRZ1,MSI2,GRK5,EGF,SLC39A12,PTN,RORA,FARP1,BCAR3,PREX2,NFIA,PRDM16,SLC6A11,AMOT,NPAS3,SORCS2,ASPA,DGKB,LRIG1,GPM6B,TRPS1,SNTB1,FGFRL1,SOX5,SLC4A4,ZBTB20,FKBP5,NHSL1,UNC93A,GJA1,QKI,AQP4,APOA1,FHOD3,SLC1A2,PREX1,LAMA4,FGFR3,ELOVL2 |
3.850e-02 | -3.26 | biliary_tract-bile_duct-carcinoma-adenocarcinoma | COSMIC cancer mutations | biliary_tract-bile_duct-carcinoma-adenocarcinoma | 15095 | 46 | 16828 | 47 |
PREX1,LAMA4,FGFR3,ELOVL2,SLC1A2,FHOD3,APOA1,AQP4,GJA1,QKI,NHSL1,UNC93A,ZBTB20,FKBP5,FGFRL1,SOX5,SLC4A4,SNTB1,GPM6B,TRPS1,DGKB,LRIG1,SORCS2,ASPA,AMOT,NPAS3,SLC6A11,PRDM16,PREX2,NFIA,BCAR3,PTN,RORA,FARP1,SLC39A12,GRK5,EGF,MSI2,RFX4,LPIN2,CTBP1,PTPRZ1,TNS3,GPC5,SLC1A3,USP6NL |
3.856e-02 | -3.26 | tissue migration | biological process | GO:0090130 | 113 | 2 | 18204 | 50 |
AMOT,APOA1 |
3.864e-02 | -3.25 | Zip | pfam domains | PF02535 | 14 | 1 | 17795 | 50 |
SLC39A12 |
3.864e-02 | -3.25 | MIP | pfam domains | PF00230 | 14 | 1 | 17795 | 50 |
AQP4 |
3.864e-02 | -3.25 | GATA | pfam domains | PF00320 | 14 | 1 | 17795 | 50 |
TRPS1 |
3.868e-02 | -3.25 | regulation of locomotion | biological process | GO:0040012 | 1164 | 7 | 18204 | 50 |
PLPP3,EGF,PREX1,LAMA4,AMOT,GJA1,PTN |
3.873e-02 | -3.25 | regulation of protein phosphorylation | biological process | GO:0001932 | 917 | 6 | 18204 | 50 |
APOA1,PRKN,PLPP3,EGF,FGFR3,BCAR3 |
3.873e-02 | -3.25 | regulation of cell projection organization | biological process | GO:0031344 | 683 | 5 | 18204 | 50 |
SLC39A12,PTN,USP6NL,ADGRB3,PREX1 |
3.878e-02 | -3.25 | Synthesis of PE | REACTOME pathways | R-HSA-1483213 | 14 | 1 | 10285 | 29 |
LPIN2 |
3.900e-02 | -3.24 | vascular process in circulatory system | biological process | GO:0003018 | 273 | 3 | 18204 | 50 |
SLC1A2,SLC1A3,SLC4A4 |
3.901e-02 | -3.24 | HMGCR (3-hydroxy-3-methylglutaryl-CoA reductase) | protein interactions | 3156 | 124 | 2 | 19454 | 49 |
CTBP1,SORCS2 |
3.908e-02 | -3.24 | monocarboxylate:sodium symporter activity | molecular function | GO:0140161 | 15 | 1 | 18094 | 48 |
SLC6A11 |
3.908e-02 | -3.24 | efflux transmembrane transporter activity | molecular function | GO:0015562 | 15 | 1 | 18094 | 48 |
GJA1 |
3.909e-02 | -3.24 | ALDH3A2 (aldehyde dehydrogenase 3 family member A2) | protein interactions | 224 | 298 | 3 | 19454 | 49 |
GJA1,FGFR3,PRKN |
3.936e-02 | -3.24 | organic acid biosynthetic process | biological process | GO:0016053 | 274 | 3 | 18204 | 50 |
QKI,ELOVL2,SLC1A3 |
3.942e-02 | -3.23 | MRPS31 (mitochondrial ribosomal protein S31) | protein interactions | 10240 | 299 | 3 | 19454 | 49 |
AMOT,PRKN,FGFR3 |
3.942e-02 | -3.23 | MRPS34 (mitochondrial ribosomal protein S34) | protein interactions | 65993 | 299 | 3 | 19454 | 49 |
SOX5,PRKN,FGFR3 |
3.943e-02 | -3.23 | human chr10q26.11 | chromosome location | human chr10q26.11 | 21 | 1 | 26134 | 50 |
GRK5 |
3.943e-02 | -3.23 | human chr13q31.3 | chromosome location | human chr13q31.3 | 21 | 1 | 26134 | 50 |
GPC5 |
3.943e-02 | -3.23 | cell migration | biological process | GO:0016477 | 921 | 6 | 18204 | 50 |
GPC5,PTN,AMOT,APOA1,GJA1,PREX1 |
3.956e-02 | -3.23 | GDPGP1 (GDP-D-glucose phosphorylase 1) | protein interactions | 390637 | 16 | 1 | 19454 | 49 |
PRKN |
3.956e-02 | -3.23 | HHV8GK18_gp78 (ORF69) | protein interactions | 4961444 | 16 | 1 | 19454 | 49 |
CTBP1 |
3.956e-02 | -3.23 | NBL1 (NBL1, DAN family BMP antagonist) | protein interactions | 4681 | 16 | 1 | 19454 | 49 |
LRIG1 |
3.956e-02 | -3.23 | PLEKHH2 (pleckstrin homology, MyTH4 and FERM domain containing H2) | protein interactions | 130271 | 16 | 1 | 19454 | 49 |
PRKN |
3.956e-02 | -3.23 | RHO (rhodopsin) | protein interactions | 6010 | 16 | 1 | 19454 | 49 |
GRK5 |
3.956e-02 | -3.23 | DPH7 (diphthamide biosynthesis 7) | protein interactions | 92715 | 16 | 1 | 19454 | 49 |
PRKN |
3.956e-02 | -3.23 | TTC39B (tetratricopeptide repeat domain 39B) | protein interactions | 158219 | 16 | 1 | 19454 | 49 |
PRKN |
3.956e-02 | -3.23 | ZFAND1 (zinc finger AN1-type containing 1) | protein interactions | 79752 | 16 | 1 | 19454 | 49 |
PRKN |
3.956e-02 | -3.23 | MT1M (metallothionein 1M) | protein interactions | 4499 | 16 | 1 | 19454 | 49 |
PRKN |
3.956e-02 | -3.23 | CTSK (cathepsin K) | protein interactions | 1513 | 16 | 1 | 19454 | 49 |
FGFR3 |
3.956e-02 | -3.23 | MKKS (MKKS centrosomal shuttling protein) | protein interactions | 8195 | 16 | 1 | 19454 | 49 |
PTN |
3.956e-02 | -3.23 | MX2 (MX dynamin like GTPase 2) | protein interactions | 4600 | 16 | 1 | 19454 | 49 |
PRKN |
3.956e-02 | -3.23 | MAML2 (mastermind like transcriptional coactivator 2) | protein interactions | 84441 | 16 | 1 | 19454 | 49 |
CTBP1 |
3.956e-02 | -3.23 | KCNH1 (potassium voltage-gated channel subfamily H member 1) | protein interactions | 3756 | 16 | 1 | 19454 | 49 |
PRKN |
3.956e-02 | -3.23 | TXNDC2 (thioredoxin domain containing 2) | protein interactions | 84203 | 16 | 1 | 19454 | 49 |
APOA1 |
3.956e-02 | -3.23 | ARHGEF3 (Rho guanine nucleotide exchange factor 3) | protein interactions | 50650 | 16 | 1 | 19454 | 49 |
PRKN |
3.956e-02 | -3.23 | PIPOX (pipecolic acid and sarcosine oxidase) | protein interactions | 51268 | 16 | 1 | 19454 | 49 |
FKBP5 |
3.956e-02 | -3.23 | TWIST2 (twist family bHLH transcription factor 2) | protein interactions | 117581 | 16 | 1 | 19454 | 49 |
ZBTB20 |
3.956e-02 | -3.23 | F13A1 (coagulation factor XIII A chain) | protein interactions | 2162 | 16 | 1 | 19454 | 49 |
PRKN |
3.956e-02 | -3.23 | PYROXD1 (pyridine nucleotide-disulphide oxidoreductase domain 1) | protein interactions | 79912 | 16 | 1 | 19454 | 49 |
PRKN |
3.956e-02 | -3.23 | IL1RL2 (interleukin 1 receptor like 2) | protein interactions | 8808 | 16 | 1 | 19454 | 49 |
PRKN |
3.956e-02 | -3.23 | SLC35E4 (solute carrier family 35 member E4) | protein interactions | 339665 | 16 | 1 | 19454 | 49 |
UNC93A |
3.958e-02 | -3.23 | CBLN4 (cerebellin 4 precursor) | protein interactions | 140689 | 125 | 2 | 19454 | 49 |
PRKN,FGFR3 |
3.958e-02 | -3.23 | UACA (uveal autoantigen with coiled-coil domains and ankyrin repeats) | protein interactions | 55075 | 125 | 2 | 19454 | 49 |
GJA1,PRKN |
3.959e-02 | -3.23 | NAD+ Signalling and Aging | SMPDB pathways | SMP0084271 | 11 | 1 | 1369 | 5 |
RORA |
3.959e-02 | -3.23 | Aspartate Metabolism | SMPDB pathways | SMP0000067 | 11 | 1 | 1369 | 5 |
ASPA |
3.959e-02 | -3.23 | Canavan Disease | SMPDB pathways | SMP0000175 | 11 | 1 | 1369 | 5 |
ASPA |
3.959e-02 | -3.23 | Hypoacetylaspartia | SMPDB pathways | SMP0000192 | 11 | 1 | 1369 | 5 |
ASPA |
3.961e-02 | -3.23 | HGS (hepatocyte growth factor-regulated tyrosine kinase substrate) | protein interactions | 9146 | 512 | 4 | 19454 | 49 |
FGFR3,PRKN,GJA1,LRIG1 |
3.975e-02 | -3.23 | Znf_GATA | interpro domains | IPR000679 | 15 | 1 | 18521 | 50 |
TRPS1 |
3.975e-02 | -3.23 | FH2_Formin_sf | interpro domains | IPR042201 | 15 | 1 | 18521 | 50 |
FHOD3 |
3.975e-02 | -3.23 | Diacylglycerol_kinase_cat_dom | interpro domains | IPR001206 | 15 | 1 | 18521 | 50 |
DGKB |
3.975e-02 | -3.23 | PPIase_FKBP_dom | interpro domains | IPR001179 | 15 | 1 | 18521 | 50 |
FKBP5 |
3.975e-02 | -3.23 | FH2_Formin | interpro domains | IPR015425 | 15 | 1 | 18521 | 50 |
FHOD3 |
3.981e-02 | -3.22 | fatty acid biosynthetic process | biological process | GO:0006633 | 115 | 2 | 18204 | 50 |
ELOVL2,QKI |
4.008e-02 | -3.22 | transcription cis-regulatory region binding | molecular function | GO:0000976 | 1485 | 8 | 18094 | 48 |
RFX4,SOX5,RORA,PRDM16,TRPS1,ZBTB20,NPAS3,NFIA |
4.016e-02 | -3.21 | CDK18 (cyclin dependent kinase 18) | protein interactions | 5129 | 126 | 2 | 19454 | 49 |
FKBP5,TRPS1 |
4.016e-02 | -3.21 | IGKC (immunoglobulin kappa constant) | protein interactions | 3514 | 126 | 2 | 19454 | 49 |
PRKN,APOA1 |
4.016e-02 | -3.21 | IFT74 (intraflagellar transport 74) | protein interactions | 80173 | 126 | 2 | 19454 | 49 |
PRKN,AMOT |
4.027e-02 | -3.21 | asymmetric, glutamatergic, excitatory synapse | cellular component | GO:0098985 | 16 | 1 | 19108 | 49 |
ADGRB3 |
4.033e-02 | -3.21 | Pathways in cancer | KEGG pathways | hsa05200 | 395 | 4 | 7161 | 24 |
LAMA4,CTBP1,FGFR3,EGF |
4.035e-02 | -3.21 | transcription regulatory region nucleic acid binding | molecular function | GO:0001067 | 1487 | 8 | 18094 | 48 |
RFX4,RORA,TRPS1,PRDM16,SOX5,NFIA,NPAS3,ZBTB20 |
4.035e-02 | -3.21 | skin-chest-malignant_melanoma | COSMIC cancer mutations | skin-chest-malignant_melanoma | 114 | 2 | 16828 | 47 |
SLC6A11,PREX2 |
4.041e-02 | -3.21 | HP1BP3 (heterochromatin protein 1 binding protein 3) | protein interactions | 50809 | 302 | 3 | 19454 | 49 |
PRKN,PRDM16,NFIA |
4.043e-02 | -3.21 | columnar/cuboidal epithelial cell maturation | biological process | GO:0002069 | 15 | 1 | 18204 | 50 |
GJA1 |
4.043e-02 | -3.21 | regulation of phospholipid transport | biological process | GO:2001138 | 15 | 1 | 18204 | 50 |
APOA1 |
4.043e-02 | -3.21 | cell migration involved in gastrulation | biological process | GO:0042074 | 15 | 1 | 18204 | 50 |
AMOT |
4.043e-02 | -3.21 | neuroblast division | biological process | GO:0055057 | 15 | 1 | 18204 | 50 |
SOX5 |
4.043e-02 | -3.21 | protein homotrimerization | biological process | GO:0070207 | 15 | 1 | 18204 | 50 |
SLC1A2 |
4.043e-02 | -3.21 | exit from mitosis | biological process | GO:0010458 | 15 | 1 | 18204 | 50 |
NFIA |
4.043e-02 | -3.21 | synapse maturation | biological process | GO:0060074 | 15 | 1 | 18204 | 50 |
NFIA |
4.043e-02 | -3.21 | chondrocyte proliferation | biological process | GO:0035988 | 15 | 1 | 18204 | 50 |
FGFR3 |
4.043e-02 | -3.21 | cerebellar Purkinje cell layer formation | biological process | GO:0021694 | 15 | 1 | 18204 | 50 |
RORA |
4.043e-02 | -3.21 | positive regulation of cholesterol metabolic process | biological process | GO:0090205 | 15 | 1 | 18204 | 50 |
APOA1 |
4.043e-02 | -3.21 | glucocorticoid metabolic process | biological process | GO:0008211 | 15 | 1 | 18204 | 50 |
APOA1 |
4.043e-02 | -3.21 | atrial cardiac muscle cell to AV node cell communication | biological process | GO:0086066 | 15 | 1 | 18204 | 50 |
GJA1 |
4.043e-02 | -3.21 | gamma-aminobutyric acid transport | biological process | GO:0015812 | 15 | 1 | 18204 | 50 |
SLC6A11 |
4.043e-02 | -3.21 | norepinephrine metabolic process | biological process | GO:0042415 | 15 | 1 | 18204 | 50 |
PRKN |
4.069e-02 | -3.20 | Formin, FH2 domain | gene3d domains | 1.20.58.2220 | 15 | 1 | 14470 | 40 |
FHOD3 |
4.074e-02 | -3.20 | ZZEF1 (zinc finger ZZ-type and EF-hand domain containing 1) | protein interactions | 23140 | 127 | 2 | 19454 | 49 |
FGFRL1,PRKN |
4.074e-02 | -3.20 | EPB41L4A (erythrocyte membrane protein band 4.1 like 4A) | protein interactions | 64097 | 127 | 2 | 19454 | 49 |
FARP1,USP6NL |
4.084e-02 | -3.20 | LDLRB | prosite domains | PS51120 | 13 | 1 | 12186 | 39 |
EGF |
4.089e-02 | -3.20 | postsynaptic specialization membrane | cellular component | GO:0099634 | 125 | 2 | 19108 | 49 |
ADGRB3,SORCS2 |
4.107e-02 | -3.19 | regulation of synapse assembly | biological process | GO:0051963 | 117 | 2 | 18204 | 50 |
FARP1,ADGRB3 |
4.110e-02 | -3.19 | hypothalamus | COSMIC cancer mutations | hypothalamus | 15 | 1 | 16828 | 47 |
QKI |
4.110e-02 | -3.19 | ureter | COSMIC cancer mutations | ureter | 15 | 1 | 16828 | 47 |
FGFR3 |
4.117e-02 | -3.19 | signaling receptor binding | molecular function | GO:0005102 | 1493 | 8 | 18094 | 48 |
APOA1,LAMA4,PTPRZ1,PLPP3,EGF,PTN,GJA1,PRKN |
4.121e-02 | -3.19 | ZnF_GATA | smart domains | SM00401 | 12 | 1 | 9717 | 34 |
TRPS1 |
4.121e-02 | -3.19 | DWA | smart domains | SM00523 | 12 | 1 | 9717 | 34 |
NFIA |
4.127e-02 | -3.19 | human chr3q13.31 | chromosome location | human chr3q13.31 | 22 | 1 | 26134 | 50 |
ZBTB20 |
4.132e-02 | -3.19 | TEAD2 (TEA domain transcription factor 2) | protein interactions | 8463 | 128 | 2 | 19454 | 49 |
TRPS1,ZBTB20 |
4.132e-02 | -3.19 | MYB (MYB proto-oncogene, transcription factor) | protein interactions | 4602 | 128 | 2 | 19454 | 49 |
NFIA,TRPS1 |
4.132e-02 | -3.19 | SLC30A5 (solute carrier family 30 member 5) | protein interactions | 64924 | 128 | 2 | 19454 | 49 |
GJA1,CTBP1 |
4.132e-02 | -3.19 | ATF7IP (activating transcription factor 7 interacting protein) | protein interactions | 55729 | 128 | 2 | 19454 | 49 |
SOX5,LAMA4 |
4.134e-02 | -3.19 | FH2 | pfam domains | PF02181 | 15 | 1 | 17795 | 50 |
FHOD3 |
4.134e-02 | -3.19 | DAGK_cat | pfam domains | PF00781 | 15 | 1 | 17795 | 50 |
DGKB |
4.134e-02 | -3.19 | FKBP_C | pfam domains | PF00254 | 15 | 1 | 17795 | 50 |
FKBP5 |
4.138e-02 | -3.18 | NS-malignant_melanoma | COSMIC cancer mutations | NS-malignant_melanoma | 3420 | 15 | 16828 | 47 |
DGKB,LRIG1,PREX2,SNTB1,GRK5,SLC39A12,FGFR3,ELOVL2,PRDM16,TNS3,GPC5,NCKAP5,PTPRZ1,AMOT,RFX4 |
4.141e-02 | -3.18 | ATAD3A (ATPase family AAA domain containing 3A) | protein interactions | 55210 | 305 | 3 | 19454 | 49 |
PRKN,PRDM16,SOX5 |
4.150e-02 | -3.18 | ERBB2 Regulates Cell Motility | REACTOME pathways | R-HSA-6785631 | 15 | 1 | 10285 | 29 |
EGF |
4.150e-02 | -3.18 | Depolymerisation of the Nuclear Lamina | REACTOME pathways | R-HSA-4419969 | 15 | 1 | 10285 | 29 |
LPIN2 |
4.150e-02 | -3.18 | alpha-linolenic acid (ALA) metabolism | REACTOME pathways | R-HSA-2046106 | 15 | 1 | 10285 | 29 |
ELOVL2 |
4.150e-02 | -3.18 | alpha-linolenic (omega3) and linoleic (omega6) acid metabolism | REACTOME pathways | R-HSA-2046104 | 15 | 1 | 10285 | 29 |
ELOVL2 |
4.158e-02 | -3.18 | SH3 domain binding | molecular function | GO:0017124 | 122 | 2 | 18094 | 48 |
QKI,PRKN |
4.163e-02 | -3.18 | water channel activity | molecular function | GO:0015250 | 16 | 1 | 18094 | 48 |
AQP4 |
4.163e-02 | -3.18 | sodium:chloride symporter activity | molecular function | GO:0015378 | 16 | 1 | 18094 | 48 |
SLC6A11 |
4.163e-02 | -3.18 | oxysterol binding | molecular function | GO:0008142 | 16 | 1 | 18094 | 48 |
RORA |
4.190e-02 | -3.17 | ALDH2 (aldehyde dehydrogenase 2 family member) | protein interactions | 217 | 129 | 2 | 19454 | 49 |
APOA1,PRKN |
4.190e-02 | -3.17 | POLA2 (DNA polymerase alpha 2, accessory subunit) | protein interactions | 23649 | 129 | 2 | 19454 | 49 |
PRKN,FGFR3 |
4.193e-02 | -3.17 | response to stimulus | biological process | GO:0050896 | 7803 | 28 | 18204 | 50 |
PREX2,PTN,FKBP5,SLC6A11,AQP4,SLC1A2,BCAR3,EGF,LPIN2,FARP1,SLC1A3,ZBTB20,APOA1,GJA1,AMOT,DGKB,NFIA,ADGRB3,SLC39A12,SORCS2,SOX5,PRKN,PREX1,RORA,GRK5,FGFR3,PLPP3,FGFRL1 |
4.198e-02 | -3.17 | Pef1 (penta-EF hand domain containing 1) | protein interactions | 67898 | 17 | 1 | 19454 | 49 |
QKI |
4.198e-02 | -3.17 | TAGAP (T cell activation RhoGTPase activating protein) | protein interactions | 117289 | 17 | 1 | 19454 | 49 |
SNTB1 |
4.198e-02 | -3.17 | CYP20A1 (cytochrome P450 family 20 subfamily A member 1) | protein interactions | 57404 | 17 | 1 | 19454 | 49 |
PRKN |
4.198e-02 | -3.17 | TRIM34 (tripartite motif containing 34) | protein interactions | 53840 | 17 | 1 | 19454 | 49 |
PRKN |
4.198e-02 | -3.17 | TAC3 (tachykinin precursor 3) | protein interactions | 6866 | 17 | 1 | 19454 | 49 |
PTN |
4.198e-02 | -3.17 | STK32A (serine/threonine kinase 32A) | protein interactions | 202374 | 17 | 1 | 19454 | 49 |
FKBP5 |
4.198e-02 | -3.17 | IGKV2D-29 (immunoglobulin kappa variable 2D-29) | protein interactions | 28882 | 17 | 1 | 19454 | 49 |
PRKN |
4.198e-02 | -3.17 | PLCE1 (phospholipase C epsilon 1) | protein interactions | 51196 | 17 | 1 | 19454 | 49 |
FKBP5 |
4.198e-02 | -3.17 | PLA2G15 (phospholipase A2 group XV) | protein interactions | 23659 | 17 | 1 | 19454 | 49 |
PRKN |
4.198e-02 | -3.17 | MSANTD2 (Myb/SANT DNA binding domain containing 2) | protein interactions | 79684 | 17 | 1 | 19454 | 49 |
SOX5 |
4.198e-02 | -3.17 | DENND5B (DENN domain containing 5B) | protein interactions | 160518 | 17 | 1 | 19454 | 49 |
GJA1 |
4.198e-02 | -3.17 | Shcbp1 (Shc SH2-domain binding protein 1) | protein interactions | 20419 | 17 | 1 | 19454 | 49 |
GPC5 |
4.198e-02 | -3.17 | KYAT1 (kynurenine aminotransferase 1) | protein interactions | 883 | 17 | 1 | 19454 | 49 |
PRKN |
4.198e-02 | -3.17 | HPR (haptoglobin-related protein) | protein interactions | 3250 | 17 | 1 | 19454 | 49 |
APOA1 |
4.198e-02 | -3.17 | Nufip2 (nuclear FMR1 interacting protein 2) | protein interactions | 68564 | 17 | 1 | 19454 | 49 |
CTBP1 |
4.198e-02 | -3.17 | FLRT3 (fibronectin leucine rich transmembrane protein 3) | protein interactions | 23767 | 17 | 1 | 19454 | 49 |
GJA1 |
4.209e-02 | -3.17 | ACTA2 (actin alpha 2, smooth muscle) | protein interactions | 59 | 307 | 3 | 19454 | 49 |
PRKN,GJA1,PTPRZ1 |
4.210e-02 | -3.17 | cellular response to organic substance | biological process | GO:0071310 | 1716 | 9 | 18204 | 50 |
SLC1A3,PRKN,ZBTB20,RORA,AQP4,GJA1,SLC1A2,BCAR3,LPIN2 |
4.210e-02 | -3.17 | urinary_tract | COSMIC cancer mutations | urinary_tract | 14112 | 44 | 16828 | 47 |
LRIG1,DGKB,TRPS1,GPM6B,SNTB1,SLC4A4,FGFRL1,SOX5,SLC6A11,NPAS3,AMOT,ASPA,SORCS2,FHOD3,SLC1A2,ELOVL2,FGFR3,LAMA4,PREX1,FKBP5,ZBTB20,UNC93A,NCKAP5,QKI,GJA1,EGF,GRK5,SLC39A12,USP6NL,SLC1A3,GPC5,TNS3,PTPRZ1,CTBP1,LPIN2,RFX4,MSI2,NFIA,PREX2,PRDM16,FARP1,RORA,PTN,BCAR3 |
4.210e-02 | -3.17 | bladder | COSMIC cancer mutations | bladder | 14112 | 44 | 16828 | 47 |
BCAR3,GJA1,NCKAP5,QKI,RORA,FKBP5,ZBTB20,PTN,FARP1,UNC93A,SLC1A2,LAMA4,PREX1,PRDM16,ELOVL2,FGFR3,NFIA,PREX2,FHOD3,RFX4,LPIN2,AMOT,PTPRZ1,NPAS3,CTBP1,SORCS2,MSI2,ASPA,USP6NL,SLC1A3,GPC5,TNS3,SLC6A11,GRK5,SNTB1,EGF,FGFRL1,SOX5,SLC4A4,SLC39A12,LRIG1,DGKB,GPM6B,TRPS1 |
4.211e-02 | -3.17 | cell-cell junction | cellular component | GO:0005911 | 513 | 4 | 19108 | 49 |
AMOT,PLPP3,GJA1,FGFRL1 |
4.229e-02 | -3.16 | central_nervous_system-brain-glioma-oligoastrocytoma_Grade_III | COSMIC cancer mutations | central_nervous_system-brain-glioma-oligoastrocytoma_Grade_III | 117 | 2 | 16828 | 47 |
FGFR3,AMOT |
4.235e-02 | -3.16 | Ez/rad/moesin-like | interpro domains | IPR000798 | 16 | 1 | 18521 | 50 |
FARP1 |
4.244e-02 | -3.16 | lung-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-carcinoma-adenocarcinoma | 15133 | 46 | 16828 | 47 |
GPC5,TNS3,USP6NL,SLC1A3,MSI2,PTPRZ1,CTBP1,RFX4,LPIN2,SLC39A12,EGF,GRK5,FARP1,RORA,PTN,BCAR3,NFIA,PREX2,PRDM16,SLC6A11,ASPA,SORCS2,NPAS3,AMOT,TRPS1,GPM6B,LRIG1,DGKB,SLC4A4,FGFRL1,SOX5,SNTB1,UNC93A,NHSL1,FKBP5,ZBTB20,AQP4,NCKAP5,QKI,GJA1,FHOD3,ELOVL2,FGFR3,LAMA4,PREX1,SLC1A2 |
4.249e-02 | -3.16 | PASK (PAS domain containing serine/threonine kinase) | protein interactions | 23178 | 130 | 2 | 19454 | 49 |
TNS3,PRKN |
4.249e-02 | -3.16 | SNX5 (sorting nexin 5) | protein interactions | 27131 | 130 | 2 | 19454 | 49 |
GJA1,PRKN |
4.249e-02 | -3.16 | DVL1 (dishevelled segment polarity protein 1) | protein interactions | 1855 | 130 | 2 | 19454 | 49 |
CTBP1,GJA1 |
4.273e-02 | -3.15 | presynaptic active zone cytoplasmic component | cellular component | GO:0098831 | 17 | 1 | 19108 | 49 |
CTBP1 |
4.274e-02 | -3.15 | Fatty acid biosynthesis, elongation, endoplasmic reticulum | KEGG pathways | M00415 | 13 | 1 | 7161 | 24 |
ELOVL2 |
4.274e-02 | -3.15 | Fatty acid biosynthesis, elongation, endoplasmic reticulum | KEGG pathways | hsa_M00415 | 13 | 1 | 7161 | 24 |
ELOVL2 |
4.277e-02 | -3.15 | ITCH (itchy E3 ubiquitin protein ligase) | protein interactions | 83737 | 309 | 3 | 19454 | 49 |
GJA1,RORA,AMOT |
4.307e-02 | -3.14 | regulation of hepatocyte proliferation | biological process | GO:2000345 | 16 | 1 | 18204 | 50 |
PTN |
4.307e-02 | -3.14 | estrous cycle | biological process | GO:0044849 | 16 | 1 | 18204 | 50 |
PTN |
4.307e-02 | -3.14 | non-proteinogenic amino acid biosynthetic process | biological process | GO:0170043 | 16 | 1 | 18204 | 50 |
SLC1A3 |
4.307e-02 | -3.14 | protein K6-linked ubiquitination | biological process | GO:0085020 | 16 | 1 | 18204 | 50 |
PRKN |
4.307e-02 | -3.14 | positive regulation of autophagy of mitochondrion | biological process | GO:1903599 | 16 | 1 | 18204 | 50 |
PRKN |
4.307e-02 | -3.14 | positive regulation of dendrite development | biological process | GO:1900006 | 16 | 1 | 18204 | 50 |
PTN |
4.307e-02 | -3.14 | nonribosomal peptide biosynthetic process | biological process | GO:0019184 | 16 | 1 | 18204 | 50 |
SLC1A2 |
4.307e-02 | -3.14 | asymmetric cell division | biological process | GO:0008356 | 16 | 1 | 18204 | 50 |
SOX5 |
4.308e-02 | -3.14 | NCOA2 (nuclear receptor coactivator 2) | protein interactions | 10499 | 131 | 2 | 19454 | 49 |
NFIA,RORA |
4.308e-02 | -3.14 | ZNF609 (zinc finger protein 609) | protein interactions | 23060 | 131 | 2 | 19454 | 49 |
NFIA,SOX5 |
4.308e-02 | -3.14 | OLA1 (Obg like ATPase 1) | protein interactions | 29789 | 131 | 2 | 19454 | 49 |
PRKN,GRK5 |
4.308e-02 | -3.14 | MAPKAPK2 (MAPK activated protein kinase 2) | protein interactions | 9261 | 131 | 2 | 19454 | 49 |
PRKN,EGF |
4.308e-02 | -3.14 | TET2 (tet methylcytosine dioxygenase 2) | protein interactions | 54790 | 131 | 2 | 19454 | 49 |
APOA1,BCAR3 |
4.312e-02 | -3.14 | PRPF6 (pre-mRNA processing factor 6) | protein interactions | 24148 | 310 | 3 | 19454 | 49 |
QKI,CTBP1,PRKN |
4.312e-02 | -3.14 | C11orf52 (chromosome 11 open reading frame 52) | protein interactions | 91894 | 310 | 3 | 19454 | 49 |
AMOT,USP6NL,FARP1 |
4.338e-02 | -3.14 | positive regulation of macromolecule metabolic process | biological process | GO:0010604 | 3485 | 15 | 18204 | 50 |
CTBP1,RFX4,LPIN2,QKI,EGF,BCAR3,NFIA,ZBTB20,PRKN,GJA1,RORA,FGFR3,PLPP3,NPAS3,PRDM16 |
4.339e-02 | -3.14 | transcription coregulator activity | molecular function | GO:0003712 | 501 | 4 | 18094 | 48 |
CTBP1,PRKN,LPIN2,PRDM16 |
4.366e-02 | -3.13 | acinar_carcinoma | COSMIC cancer mutations | acinar_carcinoma | 1978 | 10 | 16828 | 47 |
ZBTB20,NHSL1,FHOD3,AMOT,GRK5,QKI,PTPRZ1,SORCS2,SOX5,SLC39A12 |
4.366e-02 | -3.13 | pancreas-carcinoma-acinar_carcinoma | COSMIC cancer mutations | pancreas-carcinoma-acinar_carcinoma | 1978 | 10 | 16828 | 47 |
GRK5,AMOT,PTPRZ1,QKI,SOX5,SORCS2,SLC39A12,ZBTB20,NHSL1,FHOD3 |
4.367e-02 | -3.13 | ADD3 (adducin 3) | protein interactions | 120 | 132 | 2 | 19454 | 49 |
GJA1,PRKN |
4.367e-02 | -3.13 | TRAPPC5 (trafficking protein particle complex subunit 5) | protein interactions | 126003 | 132 | 2 | 19454 | 49 |
CTBP1,PRKN |
4.367e-02 | -3.13 | INA (internexin neuronal intermediate filament protein alpha) | protein interactions | 9118 | 132 | 2 | 19454 | 49 |
CTBP1,PRKN |
4.378e-02 | -3.13 | flank | COSMIC cancer mutations | flank | 16 | 1 | 16828 | 47 |
FGFR3 |
4.378e-02 | -3.13 | urinary_tract-carcinoma | COSMIC cancer mutations | urinary_tract-carcinoma | 16 | 1 | 16828 | 47 |
FGFR3 |
4.378e-02 | -3.13 | normal | COSMIC cancer mutations | normal | 16 | 1 | 16828 | 47 |
FGFR3 |
4.378e-02 | -3.13 | renal_pelvis | COSMIC cancer mutations | renal_pelvis | 16 | 1 | 16828 | 47 |
FGFR3 |
4.381e-02 | -3.13 | RTN4 (reticulon 4) | protein interactions | 57142 | 312 | 3 | 19454 | 49 |
CTBP1,LAMA4,PRKN |
4.381e-02 | -3.13 | PRKCI (protein kinase C iota) | protein interactions | 5584 | 312 | 3 | 19454 | 49 |
AMOT,CTBP1,PRKN |
4.383e-02 | -3.13 | EMD (emerin) | protein interactions | 2010 | 771 | 5 | 19454 | 49 |
ELOVL2,GJA1,PRKN,FGFR3,EGF |
4.391e-02 | -3.13 | TRIAD | prosite domains | PS51873 | 14 | 1 | 12186 | 39 |
PRKN |
4.408e-02 | -3.12 | Platelet activation, signaling and aggregation | REACTOME pathways | R-HSA-76002 | 282 | 3 | 10285 | 29 |
APOA1,EGF,DGKB |
4.413e-02 | -3.12 | right_lower_lobe | COSMIC cancer mutations | right_lower_lobe | 5692 | 22 | 16828 | 47 |
GRK5,PREX1,PRDM16,SOX5,LAMA4,SLC4A4,SLC39A12,DGKB,LRIG1,GPM6B,FHOD3,TRPS1,CTBP1,NPAS3,NCKAP5,PTPRZ1,ASPA,PTN,SLC1A3,USP6NL,GPC5,SLC6A11 |
4.413e-02 | -3.12 | lung-right_lower_lobe-carcinoma-adenocarcinoma | COSMIC cancer mutations | lung-right_lower_lobe-carcinoma-adenocarcinoma | 5692 | 22 | 16828 | 47 |
PRDM16,PREX1,LAMA4,SOX5,SLC39A12,SLC4A4,GRK5,GPM6B,FHOD3,TRPS1,DGKB,LRIG1,ASPA,NPAS3,CTBP1,NCKAP5,PTPRZ1,GPC5,SLC6A11,PTN,SLC1A3,USP6NL |
4.415e-02 | -3.12 | regulation of canonical NF-kappaB signal transduction | biological process | GO:0043122 | 287 | 3 | 18204 | 50 |
PRKN,GJA1,RORA |
4.417e-02 | -3.12 | transmembrane receptor protein phosphatase activity | molecular function | GO:0019198 | 17 | 1 | 18094 | 48 |
PTPRZ1 |
4.417e-02 | -3.12 | transmembrane receptor protein tyrosine phosphatase activity | molecular function | GO:0005001 | 17 | 1 | 18094 | 48 |
PTPRZ1 |
4.420e-02 | -3.12 | Constitutive Signaling by EGFRvIII | REACTOME pathways | R-HSA-5637810 | 16 | 1 | 10285 | 29 |
EGF |
4.420e-02 | -3.12 | GRB2 events in ERBB2 signaling | REACTOME pathways | R-HSA-1963640 | 16 | 1 | 10285 | 29 |
EGF |
4.420e-02 | -3.12 | Signaling by EGFRvIII in Cancer | REACTOME pathways | R-HSA-5637812 | 16 | 1 | 10285 | 29 |
EGF |
4.420e-02 | -3.12 | PI3K events in ERBB2 signaling | REACTOME pathways | R-HSA-1963642 | 16 | 1 | 10285 | 29 |
EGF |
4.424e-02 | -3.12 | Ig-like_fold | interpro domains | IPR013783 | 721 | 5 | 18521 | 50 |
SORCS2,FGFRL1,FGFR3,PTPRZ1,LRIG1 |
4.427e-02 | -3.12 | hairy_cell_leukaemia | COSMIC cancer mutations | hairy_cell_leukaemia | 1440 | 8 | 16828 | 47 |
PREX2,AMOT,RFX4,NCKAP5,PTPRZ1,SORCS2,SLC39A12,FGFR3 |
4.427e-02 | -3.12 | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-hairy_cell_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-lymphoid_neoplasm-hairy_cell_leukaemia | 1440 | 8 | 16828 | 47 |
NCKAP5,PTPRZ1,AMOT,RFX4,SLC39A12,FGFR3,SORCS2,PREX2 |
4.427e-02 | -3.12 | CBS (cystathionine beta-synthase) | protein interactions | 875 | 133 | 2 | 19454 | 49 |
PREX1,PRKN |
4.427e-02 | -3.12 | LURAP1 (leucine rich adaptor protein 1) | protein interactions | 541468 | 133 | 2 | 19454 | 49 |
AMOT,SNTB1 |
4.427e-02 | -3.12 | HAUS5 (HAUS augmin like complex subunit 5) | protein interactions | 23354 | 133 | 2 | 19454 | 49 |
FKBP5,PRKN |
4.427e-02 | -3.12 | PLD2 (phospholipase D2) | protein interactions | 5338 | 133 | 2 | 19454 | 49 |
PRKN,FKBP5 |
4.433e-02 | -3.12 | Composition of Lipid Particles | WikiPathways | WP3601 | 10 | 1 | 5310 | 24 |
APOA1 |
4.433e-02 | -3.12 | stomach-carcinoma-adenocarcinoma | COSMIC cancer mutations | stomach-carcinoma-adenocarcinoma | 15150 | 46 | 16828 | 47 |
QKI,NCKAP5,GJA1,AQP4,ZBTB20,FKBP5,UNC93A,SLC1A2,FGFR3,ELOVL2,PREX1,LAMA4,APOA1,FHOD3,NPAS3,AMOT,ASPA,SORCS2,SLC6A11,SNTB1,SLC4A4,SOX5,FGFRL1,DGKB,LRIG1,TRPS1,GPM6B,BCAR3,FARP1,PTN,RORA,PRDM16,PREX2,NFIA,CTBP1,PTPRZ1,RFX4,LPIN2,MSI2,SLC1A3,USP6NL,TNS3,GPC5,EGF,GRK5,SLC39A12 |
4.440e-02 | -3.11 | IRGC (immunity related GTPase cinema) | protein interactions | 56269 | 18 | 1 | 19454 | 49 |
PRKN |
4.440e-02 | -3.11 | NME6 (NME/NM23 nucleoside diphosphate kinase 6) | protein interactions | 10201 | 18 | 1 | 19454 | 49 |
PRKN |
4.440e-02 | -3.11 | SHISA2 (shisa family member 2) | protein interactions | 387914 | 18 | 1 | 19454 | 49 |
GJA1 |
4.440e-02 | -3.11 | RYR3 (ryanodine receptor 3) | protein interactions | 6263 | 18 | 1 | 19454 | 49 |
PRKN |
4.440e-02 | -3.11 | Wwtr1 (WW domain containing transcription regulator 1) | protein interactions | 97064 | 18 | 1 | 19454 | 49 |
AMOT |
4.440e-02 | -3.11 | AKAP14 (A-kinase anchoring protein 14) | protein interactions | 158798 | 18 | 1 | 19454 | 49 |
PRKN |
4.440e-02 | -3.11 | DLX2 (distal-less homeobox 2) | protein interactions | 1746 | 18 | 1 | 19454 | 49 |
PRKN |
4.440e-02 | -3.11 | ARMC9 (armadillo repeat containing 9) | protein interactions | 80210 | 18 | 1 | 19454 | 49 |
PRKN |
4.440e-02 | -3.11 | DCAF17 (DDB1 and CUL4 associated factor 17) | protein interactions | 80067 | 18 | 1 | 19454 | 49 |
PREX1 |
4.440e-02 | -3.11 | GDAP2 (ganglioside induced differentiation associated protein 2) | protein interactions | 54834 | 18 | 1 | 19454 | 49 |
PRKN |
4.440e-02 | -3.11 | OXNAD1 (oxidoreductase NAD binding domain containing 1) | protein interactions | 92106 | 18 | 1 | 19454 | 49 |
PRKN |
4.440e-02 | -3.11 | SNX15 (sorting nexin 15) | protein interactions | 29907 | 18 | 1 | 19454 | 49 |
PRKN |
4.440e-02 | -3.11 | TKTL2 (transketolase like 2) | protein interactions | 84076 | 18 | 1 | 19454 | 49 |
PRKN |
4.440e-02 | -3.11 | TLCD1 (TLC domain containing 1) | protein interactions | 116238 | 18 | 1 | 19454 | 49 |
SLC39A12 |
4.440e-02 | -3.11 | NECTIN1 (nectin cell adhesion molecule 1) | protein interactions | 5818 | 18 | 1 | 19454 | 49 |
FGFR3 |
4.440e-02 | -3.11 | PNMA3 (PNMA family member 3) | protein interactions | 29944 | 18 | 1 | 19454 | 49 |
PRKN |
4.440e-02 | -3.11 | GRK3 (G protein-coupled receptor kinase 3) | protein interactions | 157 | 18 | 1 | 19454 | 49 |
PRKN |
4.440e-02 | -3.11 | CYP2E1 (cytochrome P450 family 2 subfamily E member 1) | protein interactions | 1571 | 18 | 1 | 19454 | 49 |
PTN |
4.440e-02 | -3.11 | RAI2 (retinoic acid induced 2) | protein interactions | 10742 | 18 | 1 | 19454 | 49 |
CTBP1 |
4.440e-02 | -3.11 | COX3 (cytochrome c oxidase subunit III) | protein interactions | 4514 | 18 | 1 | 19454 | 49 |
PRKN |
4.440e-02 | -3.11 | TOR2A (torsin family 2 member A) | protein interactions | 27433 | 18 | 1 | 19454 | 49 |
CTBP1 |
4.440e-02 | -3.11 | GRIK5 (glutamate ionotropic receptor kainate type subunit 5) | protein interactions | 2901 | 18 | 1 | 19454 | 49 |
PRKN |
4.440e-02 | -3.11 | FRMD8 (FERM domain containing 8) | protein interactions | 83786 | 18 | 1 | 19454 | 49 |
PRKN |
4.440e-02 | -3.11 | GBP6 (guanylate binding protein family member 6) | protein interactions | 163351 | 18 | 1 | 19454 | 49 |
PRKN |
4.440e-02 | -3.11 | HMBS (hydroxymethylbilane synthase) | protein interactions | 3145 | 18 | 1 | 19454 | 49 |
PRKN |
4.440e-02 | -3.11 | RANBP17 (RAN binding protein 17) | protein interactions | 64901 | 18 | 1 | 19454 | 49 |
PRKN |
4.445e-02 | -3.11 | cell projection organization | biological process | GO:0030030 | 1200 | 7 | 18204 | 50 |
FARP1,PTPRZ1,GPM6B,SLC39A12,PREX2,PTN,RFX4 |
4.449e-02 | -3.11 | tight junction | cellular component | GO:0070160 | 131 | 2 | 19108 | 49 |
AMOT,GJA1 |
4.451e-02 | -3.11 | ARIH2 (ariadne RBR E3 ubiquitin protein ligase 2) | protein interactions | 10425 | 314 | 3 | 19454 | 49 |
PRKN,CTBP1,PTN |
4.451e-02 | -3.11 | ATP5PO (ATP synthase peripheral stalk subunit OSCP) | protein interactions | 539 | 314 | 3 | 19454 | 49 |
PRKN,PRDM16,PREX1 |
4.457e-02 | -3.11 | FA | smart domains | SM01195 | 13 | 1 | 9717 | 34 |
FARP1 |
4.461e-02 | -3.11 | regulation of organelle organization | biological process | GO:0033043 | 1201 | 7 | 18204 | 50 |
SLC39A12,USP6NL,APOA1,PREX1,PRKN,GPM6B,EGF |
4.471e-02 | -3.11 | seminoma | COSMIC cancer mutations | seminoma | 700 | 5 | 16828 | 47 |
TRPS1,FGFR3,LAMA4,PREX2,GRK5 |
4.475e-02 | -3.11 | positive regulation of macromolecule biosynthetic process | biological process | GO:0010557 | 2592 | 12 | 18204 | 50 |
PRKN,ZBTB20,RORA,GJA1,NPAS3,PRDM16,CTBP1,RFX4,EGF,QKI,LPIN2,NFIA |
4.493e-02 | -3.10 | NAD/diacylglycerol_kinase_sf | interpro domains | IPR016064 | 17 | 1 | 18521 | 50 |
DGKB |
4.493e-02 | -3.10 | CA_dom_sf | interpro domains | IPR036398 | 17 | 1 | 18521 | 50 |
PTPRZ1 |
4.493e-02 | -3.10 | CA_dom | interpro domains | IPR001148 | 17 | 1 | 18521 | 50 |
PTPRZ1 |
4.493e-02 | -3.10 | ATP-NAD_kinase_N | interpro domains | IPR017438 | 17 | 1 | 18521 | 50 |
DGKB |
4.519e-02 | -3.10 | dystrophin-associated glycoprotein complex | cellular component | GO:0016010 | 18 | 1 | 19108 | 49 |
SNTB1 |
4.547e-02 | -3.09 | SOX15 (SRY-box transcription factor 15) | protein interactions | 6665 | 135 | 2 | 19454 | 49 |
TRPS1,NFIA |
4.547e-02 | -3.09 | JAK3 (Janus kinase 3) | protein interactions | 3718 | 135 | 2 | 19454 | 49 |
APOA1,FKBP5 |
4.547e-02 | -3.09 | URI1 (URI1 prefoldin like chaperone) | protein interactions | 8725 | 135 | 2 | 19454 | 49 |
FGFR3,FKBP5 |
4.547e-02 | -3.09 | EML4 (EMAP like 4) | protein interactions | 27436 | 135 | 2 | 19454 | 49 |
FKBP5,PRKN |
4.547e-02 | -3.09 | NTRK2 (neurotrophic receptor tyrosine kinase 2) | protein interactions | 4915 | 135 | 2 | 19454 | 49 |
PRKN,USP6NL |
4.547e-02 | -3.09 | BCKDK (branched chain keto acid dehydrogenase kinase) | protein interactions | 10295 | 135 | 2 | 19454 | 49 |
FKBP5,PRKN |
4.557e-02 | -3.09 | protein-macromolecule adaptor activity | molecular function | GO:0030674 | 989 | 6 | 18094 | 48 |
PRKN,FKBP5,CTBP1,LPIN2,QKI,PRDM16 |
4.560e-02 | -3.09 | positive regulation of cell-substrate adhesion | biological process | GO:0010811 | 124 | 2 | 18204 | 50 |
APOA1,PREX1 |
4.560e-02 | -3.09 | positive regulation of lipid metabolic process | biological process | GO:0045834 | 124 | 2 | 18204 | 50 |
ZBTB20,APOA1 |
4.570e-02 | -3.09 | regulation of receptor clustering | biological process | GO:1903909 | 17 | 1 | 18204 | 50 |
FARP1 |
4.570e-02 | -3.09 | postsynaptic actin cytoskeleton organization | biological process | GO:0098974 | 17 | 1 | 18204 | 50 |
FARP1 |
4.570e-02 | -3.09 | white fat cell differentiation | biological process | GO:0050872 | 17 | 1 | 18204 | 50 |
CTBP1 |
4.570e-02 | -3.09 | T-helper 17 type immune response | biological process | GO:0072538 | 17 | 1 | 18204 | 50 |
RORA |
4.570e-02 | -3.09 | protein trimerization | biological process | GO:0070206 | 17 | 1 | 18204 | 50 |
SLC1A2 |
4.570e-02 | -3.09 | synaptic transmission, dopaminergic | biological process | GO:0001963 | 17 | 1 | 18204 | 50 |
PRKN |
4.570e-02 | -3.09 | reverse cholesterol transport | biological process | GO:0043691 | 17 | 1 | 18204 | 50 |
APOA1 |
4.570e-02 | -3.09 | positive regulation of protein polyubiquitination | biological process | GO:1902916 | 17 | 1 | 18204 | 50 |
PRKN |
4.570e-02 | -3.09 | negative regulation by host of viral process | biological process | GO:0044793 | 17 | 1 | 18204 | 50 |
PRKN |
4.570e-02 | -3.09 | regulation of Golgi organization | biological process | GO:1903358 | 17 | 1 | 18204 | 50 |
USP6NL |
4.570e-02 | -3.09 | regulation of trophoblast cell migration | biological process | GO:1901163 | 17 | 1 | 18204 | 50 |
GJA1 |
4.570e-02 | -3.09 | high-density lipoprotein particle remodeling | biological process | GO:0034375 | 17 | 1 | 18204 | 50 |
APOA1 |
4.570e-02 | -3.09 | cGMP metabolic process | biological process | GO:0046068 | 17 | 1 | 18204 | 50 |
RORA |
4.570e-02 | -3.09 | phospholipid homeostasis | biological process | GO:0055091 | 17 | 1 | 18204 | 50 |
APOA1 |
4.570e-02 | -3.09 | mitochondrial fission | biological process | GO:0000266 | 17 | 1 | 18204 | 50 |
PRKN |
4.570e-02 | -3.09 | ureter development | biological process | GO:0072189 | 17 | 1 | 18204 | 50 |
NFIA |
4.570e-02 | -3.09 | cell communication by electrical coupling involved in cardiac conduction | biological process | GO:0086064 | 17 | 1 | 18204 | 50 |
GJA1 |
4.585e-02 | -3.08 | SH2 | prosite domains | PS50001 | 107 | 2 | 12186 | 39 |
BCAR3,TNS3 |
4.599e-02 | -3.08 | Alpha carbonic anhydrase | gene3d domains | 3.10.200.10 | 17 | 1 | 14470 | 40 |
PTPRZ1 |
4.608e-02 | -3.08 | SEH1L (SEH1 like nucleoporin) | protein interactions | 81929 | 136 | 2 | 19454 | 49 |
PRKN,FGFR3 |
4.608e-02 | -3.08 | TRIM13 (tripartite motif containing 13) | protein interactions | 10206 | 136 | 2 | 19454 | 49 |
GJA1,ELOVL2 |
4.608e-02 | -3.08 | PYGB (glycogen phosphorylase B) | protein interactions | 5834 | 136 | 2 | 19454 | 49 |
FKBP5,PRKN |
4.608e-02 | -3.08 | ROCK2 (Rho associated coiled-coil containing protein kinase 2) | protein interactions | 9475 | 136 | 2 | 19454 | 49 |
GJA1,PRKN |
4.608e-02 | -3.08 | NIBAN2 (niban apoptosis regulator 2) | protein interactions | 64855 | 136 | 2 | 19454 | 49 |
GJA1,PRKN |
4.613e-02 | -3.08 | PDZ | pfam domains | PF00595 | 122 | 2 | 17795 | 50 |
SNTB1,PREX2 |
4.626e-02 | -3.07 | mammary gland development | biological process | GO:0030879 | 125 | 2 | 18204 | 50 |
GJA1,EGF |
4.631e-02 | -3.07 | modulation of chemical synaptic transmission | biological process | GO:0050804 | 494 | 4 | 18204 | 50 |
SORCS2,PTN,SLC1A3,PRKN |
4.646e-02 | -3.07 | breast-carcinoma-neuroendocrine_carcinoma | COSMIC cancer mutations | breast-carcinoma-neuroendocrine_carcinoma | 17 | 1 | 16828 | 47 |
FGFR3 |
4.646e-02 | -3.07 | optic_nerve | COSMIC cancer mutations | optic_nerve | 17 | 1 | 16828 | 47 |
QKI |
4.646e-02 | -3.07 | squamous_cell_carcinoma_BRAF_inhibitor_related | COSMIC cancer mutations | squamous_cell_carcinoma_BRAF_inhibitor_related | 17 | 1 | 16828 | 47 |
FGFR3 |
4.646e-02 | -3.07 | non_chronically_sun_exposed_site | COSMIC cancer mutations | non_chronically_sun_exposed_site | 17 | 1 | 16828 | 47 |
FGFR3 |
4.646e-02 | -3.07 | skin-non_chronically_sun_exposed_site-malignant_melanoma | COSMIC cancer mutations | skin-non_chronically_sun_exposed_site-malignant_melanoma | 17 | 1 | 16828 | 47 |
FGFR3 |
4.646e-02 | -3.07 | skin-other-verrucal_keratosis_BRAF_inhibitor_related | COSMIC cancer mutations | skin-other-verrucal_keratosis_BRAF_inhibitor_related | 17 | 1 | 16828 | 47 |
FGFR3 |
4.646e-02 | -3.07 | skin-carcinoma-squamous_cell_carcinoma_BRAF_inhibitor_related | COSMIC cancer mutations | skin-carcinoma-squamous_cell_carcinoma_BRAF_inhibitor_related | 17 | 1 | 16828 | 47 |
FGFR3 |
4.646e-02 | -3.07 | central_nervous_system-optic_nerve-glioma-astrocytoma_Grade_I | COSMIC cancer mutations | central_nervous_system-optic_nerve-glioma-astrocytoma_Grade_I | 17 | 1 | 16828 | 47 |
QKI |
4.646e-02 | -3.07 | verrucal_keratosis_BRAF_inhibitor_related | COSMIC cancer mutations | verrucal_keratosis_BRAF_inhibitor_related | 17 | 1 | 16828 | 47 |
FGFR3 |
4.660e-02 | -3.07 | regulation of trans-synaptic signaling | biological process | GO:0099177 | 495 | 4 | 18204 | 50 |
SLC1A3,PTN,SORCS2,PRKN |
4.662e-02 | -3.07 | RUVBL1 (RuvB like AAA ATPase 1) | protein interactions | 8607 | 540 | 4 | 19454 | 49 |
FKBP5,RORA,GRK5,PRKN |
4.669e-02 | -3.06 | NUP85 (nucleoporin 85) | protein interactions | 79902 | 137 | 2 | 19454 | 49 |
FKBP5,PRKN |
4.669e-02 | -3.06 | CLUH (clustered mitochondria homolog) | protein interactions | 23277 | 137 | 2 | 19454 | 49 |
PRKN,FGFR3 |
4.669e-02 | -3.06 | WDR12 (WD repeat domain 12) | protein interactions | 55759 | 137 | 2 | 19454 | 49 |
PRKN,GRK5 |
4.669e-02 | -3.06 | C3 (complement C3) | protein interactions | 718 | 137 | 2 | 19454 | 49 |
PRKN,GJA1 |
4.671e-02 | -3.06 | transmembrane receptor protein tyrosine kinase activator activity | molecular function | GO:0030297 | 18 | 1 | 18094 | 48 |
EGF |
4.671e-02 | -3.06 | monoatomic anion:sodium symporter activity | molecular function | GO:0015373 | 18 | 1 | 18094 | 48 |
SLC6A11 |
4.671e-02 | -3.06 | ubiquitin-specific protease binding | molecular function | GO:1990381 | 18 | 1 | 18094 | 48 |
PRKN |
4.673e-02 | -3.06 | Carb_anhydrase | pfam domains | PF00194 | 17 | 1 | 17795 | 50 |
PTPRZ1 |
4.673e-02 | -3.06 | PRDM2_PR | pfam domains | PF21549 | 17 | 1 | 17795 | 50 |
PRDM16 |
4.681e-02 | -3.06 | RCVRN (recoverin) | protein interactions | 5957 | 19 | 1 | 19454 | 49 |
GRK5 |
4.681e-02 | -3.06 | INPP4A (inositol polyphosphate-4-phosphatase type I A) | protein interactions | 3631 | 19 | 1 | 19454 | 49 |
PRKN |
4.681e-02 | -3.06 | TNR (tenascin R) | protein interactions | 7143 | 19 | 1 | 19454 | 49 |
PTPRZ1 |
4.681e-02 | -3.06 | PDIK1L (PDLIM1 interacting kinase 1 like) | protein interactions | 149420 | 19 | 1 | 19454 | 49 |
FKBP5 |
4.681e-02 | -3.06 | FBLN7 (fibulin 7) | protein interactions | 129804 | 19 | 1 | 19454 | 49 |
APOA1 |
4.681e-02 | -3.06 | DEFB125 (defensin beta 125) | protein interactions | 245938 | 19 | 1 | 19454 | 49 |
GJA1 |
4.681e-02 | -3.06 | PCDH19 (protocadherin 19) | protein interactions | 57526 | 19 | 1 | 19454 | 49 |
GJA1 |
4.681e-02 | -3.06 | RTTN (rotatin) | protein interactions | 25914 | 19 | 1 | 19454 | 49 |
PRKN |
4.681e-02 | -3.06 | ACOT11 (acyl-CoA thioesterase 11) | protein interactions | 26027 | 19 | 1 | 19454 | 49 |
PRKN |
4.681e-02 | -3.06 | HSPBAP1 (HSPB1 associated protein 1) | protein interactions | 79663 | 19 | 1 | 19454 | 49 |
PTN |
4.681e-02 | -3.06 | INKA1 (inka box actin regulator 1) | protein interactions | 389119 | 19 | 1 | 19454 | 49 |
ZBTB20 |
4.681e-02 | -3.06 | PARVB (parvin beta) | protein interactions | 29780 | 19 | 1 | 19454 | 49 |
PRKN |
4.681e-02 | -3.06 | GNAL (G protein subunit alpha L) | protein interactions | 2774 | 19 | 1 | 19454 | 49 |
PRKN |
4.681e-02 | -3.06 | APOBEC3G (apolipoprotein B mRNA editing enzyme catalytic subunit 3G) | protein interactions | 60489 | 19 | 1 | 19454 | 49 |
PTN |
4.681e-02 | -3.06 | ZNF532 (zinc finger protein 532) | protein interactions | 55205 | 19 | 1 | 19454 | 49 |
PRKN |
4.681e-02 | -3.06 | SPZ1 (spermatogenic leucine zipper 1) | protein interactions | 84654 | 19 | 1 | 19454 | 49 |
SNTB1 |
4.681e-02 | -3.06 | HMGCLL1 (3-hydroxy-3-methylglutaryl-CoA lyase like 1) | protein interactions | 54511 | 19 | 1 | 19454 | 49 |
APOA1 |
4.681e-02 | -3.06 | CEP68 (centrosomal protein 68) | protein interactions | 23177 | 19 | 1 | 19454 | 49 |
CTBP1 |
4.681e-02 | -3.06 | DCST1 (DC-STAMP domain containing 1) | protein interactions | 149095 | 19 | 1 | 19454 | 49 |
PRKN |
4.681e-02 | -3.06 | DNAH5 (dynein axonemal heavy chain 5) | protein interactions | 1767 | 19 | 1 | 19454 | 49 |
PRKN |
4.697e-02 | -3.06 | DAGK | prosite domains | PS50146 | 15 | 1 | 12186 | 39 |
DGKB |
4.697e-02 | -3.06 | FKBP_PPIASE | prosite domains | PS50059 | 15 | 1 | 12186 | 39 |
FKBP5 |
4.697e-02 | -3.06 | FH2 | prosite domains | PS51444 | 15 | 1 | 12186 | 39 |
FHOD3 |
4.699e-02 | -3.06 | ACTA1 (actin alpha 1, skeletal muscle) | protein interactions | 58 | 321 | 3 | 19454 | 49 |
PRKN,USP6NL,AMOT |
4.711e-02 | -3.06 | thyroid-carcinoma-medullary_carcinoma | COSMIC cancer mutations | thyroid-carcinoma-medullary_carcinoma | 290 | 3 | 16828 | 47 |
SLC1A2,PTN,FGFR3 |
4.711e-02 | -3.06 | medullary_carcinoma | COSMIC cancer mutations | medullary_carcinoma | 290 | 3 | 16828 | 47 |
PTN,SLC1A2,FGFR3 |
4.720e-02 | -3.05 | Immunoglobulins | gene3d domains | 2.60.40.10 | 721 | 5 | 14470 | 40 |
LRIG1,FGFR3,FGFRL1,SORCS2,PTPRZ1 |
4.720e-02 | -3.05 | MINTRINSICP | prints domains | PR00783 | 14 | 1 | 5227 | 18 |
AQP4 |
4.725e-02 | -3.05 | regulation of endocytosis | biological process | GO:0030100 | 295 | 3 | 18204 | 50 |
APOA1,PRKN,EGF |
4.730e-02 | -3.05 | STAM2 (signal transducing adaptor molecule 2) | protein interactions | 10254 | 138 | 2 | 19454 | 49 |
PRKN,GJA1 |
4.730e-02 | -3.05 | GRK6 (G protein-coupled receptor kinase 6) | protein interactions | 2870 | 138 | 2 | 19454 | 49 |
FKBP5,GRK5 |
4.737e-02 | -3.05 | PPARA activates gene expression | REACTOME pathways | R-HSA-1989781 | 124 | 2 | 10285 | 29 |
APOA1,RORA |
4.750e-02 | -3.05 | monoatomic ion transport | biological process | GO:0006811 | 964 | 6 | 18204 | 50 |
SLC1A2,SLC6A11,SLC4A4,GJA1,SLC39A12,SLC1A3 |
4.750e-02 | -3.05 | anatomical structure formation involved in morphogenesis | biological process | GO:0048646 | 964 | 6 | 18204 | 50 |
SLC39A12,EGF,ADGRB3,FHOD3,AMOT,RORA |
4.752e-02 | -3.05 | PPIase_dom_sf | interpro domains | IPR046357 | 18 | 1 | 18521 | 50 |
FKBP5 |
4.752e-02 | -3.05 | Leu-rich_rpt_4 | interpro domains | IPR025875 | 18 | 1 | 18521 | 50 |
LRIG1 |
4.752e-02 | -3.05 | P_Acid_Pase_2/haloperoxidase | interpro domains | IPR000326 | 18 | 1 | 18521 | 50 |
PLPP3 |
4.752e-02 | -3.05 | P_Acid_Pase_2/haloperoxi_sf | interpro domains | IPR036938 | 18 | 1 | 18521 | 50 |
PLPP3 |
4.761e-02 | -3.04 | postsynaptic density | cellular component | GO:0014069 | 317 | 3 | 19108 | 49 |
PRKN,SORCS2,ADGRB3 |
4.771e-02 | -3.04 | STOM (stomatin) | protein interactions | 2040 | 323 | 3 | 19454 | 49 |
GJA1,PRKN,GPM6B |
4.771e-02 | -3.04 | ATP2A2 (ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2) | protein interactions | 488 | 323 | 3 | 19454 | 49 |
PRDM16,PRKN,SLC4A4 |
4.792e-02 | -3.04 | SPCS2 (signal peptidase complex subunit 2) | protein interactions | 9789 | 139 | 2 | 19454 | 49 |
GPC5,PRKN |
4.792e-02 | -3.04 | MON2 (MON2 homolog, regulator of endosome-to-Golgi trafficking) | protein interactions | 23041 | 139 | 2 | 19454 | 49 |
PRKN,GJA1 |
4.792e-02 | -3.04 | MFN2 (mitofusin 2) | protein interactions | 9927 | 139 | 2 | 19454 | 49 |
CTBP1,PRKN |
4.792e-02 | -3.04 | DAGKc | smart domains | SM00046 | 14 | 1 | 9717 | 34 |
DGKB |
4.792e-02 | -3.04 | LY | smart domains | SM00135 | 14 | 1 | 9717 | 34 |
EGF |
4.792e-02 | -3.04 | IBR | smart domains | SM00647 | 14 | 1 | 9717 | 34 |
PRKN |
4.806e-02 | -3.04 | PIP3 activates AKT signaling | REACTOME pathways | R-HSA-1257604 | 125 | 2 | 10285 | 29 |
FGFR3,EGF |
4.827e-02 | -3.03 | glial cell development | biological process | GO:0021782 | 128 | 2 | 18204 | 50 |
GPM6B,ASPA |
4.832e-02 | -3.03 | cardiac myofibril assembly | biological process | GO:0055003 | 18 | 1 | 18204 | 50 |
FHOD3 |
4.832e-02 | -3.03 | positive regulation of circadian rhythm | biological process | GO:0042753 | 18 | 1 | 18204 | 50 |
RORA |
4.832e-02 | -3.03 | regulation of dopamine metabolic process | biological process | GO:0042053 | 18 | 1 | 18204 | 50 |
PRKN |
4.832e-02 | -3.03 | regulation of catecholamine metabolic process | biological process | GO:0042069 | 18 | 1 | 18204 | 50 |
PRKN |
4.832e-02 | -3.03 | hippo signaling | biological process | GO:0035329 | 18 | 1 | 18204 | 50 |
AMOT |
4.832e-02 | -3.03 | neuron projection arborization | biological process | GO:0140058 | 18 | 1 | 18204 | 50 |
PTN |
4.832e-02 | -3.03 | response to manganese ion | biological process | GO:0010042 | 18 | 1 | 18204 | 50 |
PRKN |
4.844e-02 | -3.03 | CTNNA1 (catenin alpha 1) | protein interactions | 1495 | 325 | 3 | 19454 | 49 |
PRKN,NHSL1,CTBP1 |
4.848e-02 | -3.03 | BCAR1 (BCAR1 scaffold protein, Cas family member) | protein interactions | 9564 | 547 | 4 | 19454 | 49 |
PLPP3,TNS3,FGFR3,BCAR3 |
4.853e-02 | -3.03 | AP3D1 (adaptor related protein complex 3 subunit delta 1) | protein interactions | 8943 | 140 | 2 | 19454 | 49 |
PRKN,GRK5 |
4.853e-02 | -3.03 | PALM2AKAP2 (PALM2 and AKAP2 fusion) | protein interactions | 445815 | 140 | 2 | 19454 | 49 |
PRKN,GJA1 |
4.853e-02 | -3.03 | BCCIP (BRCA2 and CDKN1A interacting protein) | protein interactions | 56647 | 140 | 2 | 19454 | 49 |
PRKN,PTN |
4.853e-02 | -3.03 | STEAP3 (STEAP3 metalloreductase) | protein interactions | 55240 | 140 | 2 | 19454 | 49 |
PRKN,GJA1 |
4.853e-02 | -3.03 | SERPINA1 (serpin family A member 1) | protein interactions | 5265 | 140 | 2 | 19454 | 49 |
APOA1,PRKN |
4.853e-02 | -3.03 | SATB2 (SATB homeobox 2) | protein interactions | 23314 | 140 | 2 | 19454 | 49 |
SOX5,NFIA |
4.853e-02 | -3.03 | RAB3GAP2 (RAB3 GTPase activating non-catalytic protein subunit 2) | protein interactions | 25782 | 140 | 2 | 19454 | 49 |
PRKN,FGFR3 |
4.857e-02 | -3.02 | lung-carcinoma-squamous_cell_carcinoma | COSMIC cancer mutations | lung-carcinoma-squamous_cell_carcinoma | 14664 | 45 | 16828 | 47 |
LRIG1,DGKB,TRPS1,SNTB1,SLC4A4,SOX5,FGFRL1,SLC6A11,NPAS3,AMOT,ASPA,SORCS2,FHOD3,SLC1A2,ELOVL2,FGFR3,LAMA4,PREX1,ZBTB20,FKBP5,UNC93A,NHSL1,NCKAP5,QKI,GJA1,AQP4,EGF,GRK5,SLC39A12,USP6NL,SLC1A3,GPC5,TNS3,PTPRZ1,CTBP1,RFX4,LPIN2,MSI2,NFIA,PREX2,PRDM16,FARP1,RORA,PTN,BCAR3 |
4.863e-02 | -3.02 | Phosphatidic acid phosphatase type 2/haloperoxidase | gene3d domains | 1.20.144.10 | 18 | 1 | 14470 | 40 |
PLPP3 |
4.863e-02 | -3.02 | - | gene3d domains | 3.10.50.40 | 18 | 1 | 14470 | 40 |
FKBP5 |
4.866e-02 | -3.02 | EWSR1 (EWS RNA binding protein 1) | protein interactions | 2130 | 794 | 5 | 19454 | 49 |
CTBP1,QKI,SOX5,AMOT,PRKN |
4.880e-02 | -3.02 | PXN (paxillin) | protein interactions | 5829 | 326 | 3 | 19454 | 49 |
TNS3,PRKN,BCAR3 |
4.880e-02 | -3.02 | MRPS27 (mitochondrial ribosomal protein S27) | protein interactions | 23107 | 326 | 3 | 19454 | 49 |
GRK5,PRKN,FGFR3 |
4.880e-02 | -3.02 | DTX2 (deltex E3 ubiquitin ligase 2) | protein interactions | 113878 | 326 | 3 | 19454 | 49 |
USP6NL,CTBP1,NFIA |
4.911e-02 | -3.01 | sequence-specific double-stranded DNA binding | molecular function | GO:1990837 | 1547 | 8 | 18094 | 48 |
RFX4,SOX5,TRPS1,RORA,PRDM16,NPAS3,ZBTB20,NFIA |
4.912e-02 | -3.01 | NS-mesothelioma | COSMIC cancer mutations | NS-mesothelioma | 18 | 1 | 16828 | 47 |
FGFR3 |
4.916e-02 | -3.01 | PLK4 (polo like kinase 4) | protein interactions | 10733 | 141 | 2 | 19454 | 49 |
PRDM16,GJA1 |
4.916e-02 | -3.01 | MAPK7 (mitogen-activated protein kinase 7) | protein interactions | 5598 | 141 | 2 | 19454 | 49 |
FKBP5,GJA1 |
4.917e-02 | -3.01 | ROR2 (receptor tyrosine kinase like orphan receptor 2) | protein interactions | 4920 | 327 | 3 | 19454 | 49 |
SNTB1,GJA1,USP6NL |
4.921e-02 | -3.01 | PCMTD1 (protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1) | protein interactions | 115294 | 20 | 1 | 19454 | 49 |
PRKN |
4.921e-02 | -3.01 | DDIT4 (DNA damage inducible transcript 4) | protein interactions | 54541 | 20 | 1 | 19454 | 49 |
PRKN |
4.921e-02 | -3.01 | TOR4A (torsin family 4 member A) | protein interactions | 54863 | 20 | 1 | 19454 | 49 |
GRK5 |
4.921e-02 | -3.01 | SNCB (synuclein beta) | protein interactions | 6620 | 20 | 1 | 19454 | 49 |
GRK5 |
4.921e-02 | -3.01 | CCDC87 (coiled-coil domain containing 87) | protein interactions | 55231 | 20 | 1 | 19454 | 49 |
PRKN |
4.921e-02 | -3.01 | ADRA1D (adrenoceptor alpha 1D) | protein interactions | 146 | 20 | 1 | 19454 | 49 |
SNTB1 |
4.921e-02 | -3.01 | ADAMTS17 (ADAM metallopeptidase with thrombospondin type 1 motif 17) | protein interactions | 170691 | 20 | 1 | 19454 | 49 |
PRKN |
4.921e-02 | -3.01 | OXT (oxytocin/neurophysin I prepropeptide) | protein interactions | 5020 | 20 | 1 | 19454 | 49 |
FGFR3 |
4.921e-02 | -3.01 | SERPINA4 (serpin family A member 4) | protein interactions | 5267 | 20 | 1 | 19454 | 49 |
CTBP1 |
4.921e-02 | -3.01 | MON1B (MON1 homolog B, secretory trafficking associated) | protein interactions | 22879 | 20 | 1 | 19454 | 49 |
PRKN |
4.921e-02 | -3.01 | TTC38 (tetratricopeptide repeat domain 38) | protein interactions | 55020 | 20 | 1 | 19454 | 49 |
PRKN |
4.921e-02 | -3.01 | SDK1 (sidekick cell adhesion molecule 1) | protein interactions | 221935 | 20 | 1 | 19454 | 49 |
GJA1 |
4.921e-02 | -3.01 | LMCD1 (LIM and cysteine rich domains 1) | protein interactions | 29995 | 20 | 1 | 19454 | 49 |
PRKN |
4.921e-02 | -3.01 | Pspc1 (paraspeckle protein 1) | protein interactions | 66645 | 20 | 1 | 19454 | 49 |
CTBP1 |
4.921e-02 | -3.01 | CPA5 (carboxypeptidase A5) | protein interactions | 93979 | 20 | 1 | 19454 | 49 |
PRKN |
4.921e-02 | -3.01 | PDLIM2 (PDZ and LIM domain 2) | protein interactions | 64236 | 20 | 1 | 19454 | 49 |
BCAR3 |
4.921e-02 | -3.01 | RIPOR1 (RHO family interacting cell polarization regulator 1) | protein interactions | 79567 | 20 | 1 | 19454 | 49 |
PRKN |
4.921e-02 | -3.01 | FNDC1 (fibronectin type III domain containing 1) | protein interactions | 84624 | 20 | 1 | 19454 | 49 |
APOA1 |
4.921e-02 | -3.01 | FAM228A (family with sequence similarity 228 member A) | protein interactions | 653140 | 20 | 1 | 19454 | 49 |
PRKN |
4.921e-02 | -3.01 | FNIP2 (folliculin interacting protein 2) | protein interactions | 57600 | 20 | 1 | 19454 | 49 |
PRKN |
4.921e-02 | -3.01 | ANXA13 (annexin A13) | protein interactions | 312 | 20 | 1 | 19454 | 49 |
MSI2 |
4.921e-02 | -3.01 | GJA3 (gap junction protein alpha 3) | protein interactions | 2700 | 20 | 1 | 19454 | 49 |
GJA1 |
4.921e-02 | -3.01 | ATG9B (autophagy related 9B) | protein interactions | 285973 | 20 | 1 | 19454 | 49 |
PRKN |
4.921e-02 | -3.01 | Trappc8 (trafficking protein particle complex 8) | protein interactions | 75964 | 20 | 1 | 19454 | 49 |
FARP1 |
4.921e-02 | -3.01 | CYP3A43 (cytochrome P450 family 3 subfamily A member 43) | protein interactions | 64816 | 20 | 1 | 19454 | 49 |
PRKN |
4.921e-02 | -3.01 | CCDC158 (coiled-coil domain containing 158) | protein interactions | 339965 | 20 | 1 | 19454 | 49 |
PRKN |
4.921e-02 | -3.01 | LBP (lipopolysaccharide binding protein) | protein interactions | 3929 | 20 | 1 | 19454 | 49 |
APOA1 |
4.921e-02 | -3.01 | HDDC2 (HD domain containing 2) | protein interactions | 51020 | 20 | 1 | 19454 | 49 |
PRKN |
4.921e-02 | -3.01 | PON1 (paraoxonase 1) | protein interactions | 5444 | 20 | 1 | 19454 | 49 |
APOA1 |
4.923e-02 | -3.01 | regulation of epithelial cell migration | biological process | GO:0010632 | 300 | 3 | 18204 | 50 |
PTN,PLPP3,EGF |
4.924e-02 | -3.01 | water transmembrane transporter activity | molecular function | GO:0005372 | 19 | 1 | 18094 | 48 |
AQP4 |
4.924e-02 | -3.01 | secondary active monocarboxylate transmembrane transporter activity | molecular function | GO:0015355 | 19 | 1 | 18094 | 48 |
SLC6A11 |
4.932e-02 | -3.01 | acute_myeloid_leukaemia | COSMIC cancer mutations | acute_myeloid_leukaemia | 10418 | 35 | 16828 | 47 |
BCAR3,QKI,NCKAP5,NHSL1,UNC93A,RORA,FKBP5,FARP1,PREX1,PRDM16,LAMA4,ELOVL2,SLC1A2,PREX2,NFIA,FHOD3,SORCS2,MSI2,AMOT,RFX4,LPIN2,NPAS3,PTPRZ1,TNS3,GPC5,SLC6A11,SLC1A3,USP6NL,SOX5,SLC39A12,SLC4A4,GRK5,EGF,DGKB,LRIG1 |
4.932e-02 | -3.01 | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | COSMIC cancer mutations | haematopoietic_and_lymphoid_tissue-haematopoietic_neoplasm-acute_myeloid_leukaemia | 10418 | 35 | 16828 | 47 |
SOX5,SLC39A12,SLC4A4,GRK5,EGF,LRIG1,DGKB,SORCS2,MSI2,LPIN2,RFX4,AMOT,PTPRZ1,NPAS3,GPC5,TNS3,SLC6A11,USP6NL,SLC1A3,LAMA4,PREX1,PRDM16,ELOVL2,SLC1A2,NFIA,PREX2,FHOD3,BCAR3,NCKAP5,QKI,NHSL1,UNC93A,RORA,FKBP5,FARP1 |
4.941e-02 | -3.01 | LRR_4 | pfam domains | PF12799 | 18 | 1 | 17795 | 50 |
LRIG1 |
4.941e-02 | -3.01 | PAP2 | pfam domains | PF01569 | 18 | 1 | 17795 | 50 |
PLPP3 |
4.944e-02 | -3.01 | Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | REACTOME pathways | R-HSA-400206 | 127 | 2 | 10285 | 29 |
RORA,APOA1 |
4.954e-02 | -3.01 | CPSF7 (cleavage and polyadenylation specific factor 7) | protein interactions | 79869 | 328 | 3 | 19454 | 49 |
QKI,CTBP1,PRKN |
4.954e-02 | -3.01 | SLIRP (SRA stem-loop interacting RNA binding protein) | protein interactions | 81892 | 328 | 3 | 19454 | 49 |
PRKN,LAMA4,AMOT |
4.960e-02 | -3.00 | PI-3K cascade:FGFR3 | REACTOME pathways | R-HSA-5654710 | 18 | 1 | 10285 | 29 |
FGFR3 |
4.960e-02 | -3.00 | ABC transporters in lipid homeostasis | REACTOME pathways | R-HSA-1369062 | 18 | 1 | 10285 | 29 |
APOA1 |
4.960e-02 | -3.00 | SHC-mediated cascade:FGFR3 | REACTOME pathways | R-HSA-5654704 | 18 | 1 | 10285 | 29 |
FGFR3 |
4.968e-02 | -3.00 | thyroid-carcinoma | COSMIC cancer mutations | thyroid-carcinoma | 4126 | 17 | 16828 | 47 |
UNC93A,GPC5,FARP1,AQP4,CTBP1,PTPRZ1,BCAR3,FHOD3,TRPS1,GPM6B,NFIA,LRIG1,FGFR3,PREX1,PRDM16,SOX5,LAMA4 |
4.978e-02 | -3.00 | SREBF1 (sterol regulatory element binding transcription factor 1) | protein interactions | 6720 | 142 | 2 | 19454 | 49 |
PRKN,EGF |
4.979e-02 | -3.00 | vesicle | cellular component | GO:0031982 | 4141 | 16 | 19108 | 49 |
SLC1A2,SLC39A12,AMOT,EGF,FKBP5,FGFRL1,AQP4,SLC4A4,GJA1,APOA1,FGFR3,LAMA4,SLC1A3,PRKN,SORCS2,USP6NL |
4.999e-02 | -3.00 | regulation of biological quality | biological process | GO:0065008 | 2936 | 13 | 18204 | 50 |
FARP1,ADGRB3,QKI,SLC4A4,DGKB,AQP4,PTN,PLPP3,GJA1,APOA1,PRKN,PREX1,SORCS2 |